data_2m1m_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m1m _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.028 0 N-CA-C 110.539 -1.025 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.82 HD13 ' CZ ' ' A' ' 26' ' ' ARG . 3.8 mp -94.71 106.23 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-O 121.411 0.625 . . . . 0.0 109.941 173.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -91.55 138.18 31.77 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.473 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.574 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -115.86 140.03 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -174.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.601 ' HA ' ' CD ' ' A' ' 22' ' ' LYS . 8.1 mptt -107.04 128.35 54.29 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.46 -0.791 . . . . 0.0 108.886 -174.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.766 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -124.65 133.3 69.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.474 0.654 . . . . 0.0 112.044 -169.791 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.5 m -131.9 155.5 47.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.583 -174.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 31.0 tpp -113.6 148.28 36.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.619 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -116.06 142.26 47.04 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.98 -32.57 3.74 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.457 ' O ' ' HG3' ' A' ' 14' ' ' MET . . . -133.2 142.66 45.22 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 171.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.99 124.76 7.55 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 121.924 1.749 . . . . 0.0 112.685 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.417 ' HB2' ' HB3' ' A' ' 14' ' ' MET . 68.0 m-85 -151.5 142.55 23.12 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.953 174.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.553 ' O ' ' HD2' ' A' ' 21' ' ' ARG . 5.1 mp -130.17 104.67 7.45 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.101 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.553 ' HD2' ' O ' ' A' ' 20' ' ' LEU . 3.2 mpt_? -126.43 164.1 21.86 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.316 176.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.601 ' CD ' ' HA ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -154.95 143.86 20.85 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.505 HD13 ' HH ' ' A' ' 28' ' ' TYR . 0.2 OUTLIER -153.54 174.01 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 O-C-N 123.34 0.4 . . . . 0.0 111.599 -175.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' O ' HG23 ' A' ' 27' ' ' VAL . 6.4 t70 -115.17 146.96 40.87 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.184 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.489 ' HG ' ' CG2' ' A' ' 10' ' ' VAL . 70.5 mt -72.13 -40.27 68.22 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -175.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.82 ' CZ ' HD13 ' A' ' 8' ' ' ILE . 9.4 mpt_? -71.08 -30.9 67.14 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -173.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 24' ' ' ASP . 36.0 m -62.78 -2.86 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -170.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.505 ' HH ' HD13 ' A' ' 23' ' ' ILE . 55.2 m-85 -99.21 -27.65 13.7 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.914 0.388 . . . . 0.0 111.731 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.45 12.91 14.57 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.986 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.72 171.03 32.36 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.245 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -70.0 -29.83 67.01 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.8 p -56.71 -53.72 54.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.92 0.391 . . . . 0.0 111.17 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -73.25 -27.09 61.38 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.086 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 20.8 tp -58.26 -54.01 51.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.866 0.365 . . . . 0.0 110.144 175.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.412 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 96.0 mt -66.19 -38.52 88.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.841 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.469 ' HD3' ' O ' ' A' ' 36' ' ' LYS . 1.7 tmtp? -66.0 -33.92 76.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.352 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.678 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -63.5 -40.96 98.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.286 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.438 HD12 ' HG3' ' A' ' 62' ' ' PRO . 0.4 OUTLIER -62.56 -49.32 75.74 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.056 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 28.2 mt-10 -52.87 -33.66 50.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.111 175.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.553 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 38.4 m -73.03 -39.63 65.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.245 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.678 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 93.1 mmm -58.2 -55.65 32.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.311 -168.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -104.26 10.38 35.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.013 0.435 . . . . 0.0 111.111 -174.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.58 53.6 4.04 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.649 177.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 pp -154.78 -167.07 2.48 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 61.2 m -117.69 117.04 28.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.959 0.409 . . . . 0.0 111.638 -177.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.415 ' CD1' ' HB2' ' A' ' 60' ' ' TYR . 34.8 mm -85.76 135.44 24.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.329 175.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.9 143.56 33.69 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.497 173.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -73.38 172.9 10.38 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.122 0.487 . . . . 0.0 111.46 -174.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -76.42 79.14 3.15 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.777 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.5 m -59.29 123.21 15.99 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.05 -11.24 47.06 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -168.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.505 ' HD2' ' N ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -78.9 -49.79 12.28 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.025 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.505 ' N ' ' HD2' ' A' ' 52' ' ' ARG . 90.8 mt-10 -119.32 -29.16 5.23 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.756 -0.59 . . . . 0.0 112.076 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.498 ' O ' HD11 ' A' ' 73' ' ' LEU . . . 41.78 12.1 0.01 OUTLIER Glycine 0 C--O 1.216 -1.022 0 N-CA-C 117.067 1.587 . . . . 0.0 117.067 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.576 ' HA ' ' CD1' ' A' ' 73' ' ' LEU . 17.5 m-30 -124.26 1.1 8.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 119.493 1.647 . . . . 0.0 110.492 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.422 ' HD3' ' H ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -64.78 -52.94 54.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.787 -175.602 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.422 ' H ' ' HD3' ' A' ' 56' ' ' LYS . . . 59.1 7.87 5.54 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 116.286 -0.415 . . . . 0.0 113.84 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.5 t 65.9 -82.72 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.199 0.6 . . . . 0.0 110.179 -171.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 40.5 tt0 -117.16 -15.64 10.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.595 0.236 . . . . 0.0 110.821 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.463 ' CZ ' ' HG3' ' A' ' 93' ' ' LYS . 57.7 m-85 -136.63 126.04 25.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.764 0.316 . . . . 0.0 111.432 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.412 ' HB2' HD12 ' A' ' 73' ' ' LEU . . . -103.92 105.79 49.92 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.801 175.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.466 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 28.6 Cg_endo -64.55 120.71 8.07 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.008 1.805 . . . . 0.0 111.243 172.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 72' ' ' MET . 35.9 p -127.22 154.05 45.33 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.214 0.53 . . . . 0.0 110.24 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.637 ' OH ' ' HE1' ' A' ' 72' ' ' MET . 44.0 p90 -135.28 167.04 21.75 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.744 -175.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.525 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 33.6 tt0 -108.29 117.35 33.93 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.37 179.38 7.69 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.467 ' HD2' ' N ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -64.18 -25.88 68.27 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.467 ' N ' ' HD2' ' A' ' 67' ' ' LYS . 35.1 t70 -78.15 -18.4 55.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.22 0.533 . . . . 0.0 110.095 177.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.18 15.51 47.73 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.339 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -96.41 142.38 28.59 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.553 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 68.9 m95 -101.13 118.94 37.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.432 0.634 . . . . 0.0 110.828 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.637 ' HE1' ' OH ' ' A' ' 64' ' ' TYR . 45.1 mtm -125.4 171.75 10.19 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.414 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.576 ' CD1' ' HA ' ' A' ' 55' ' ' TYR . 7.5 tt -91.63 142.17 27.92 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.432 ' N ' HD21 ' A' ' 73' ' ' LEU . 19.7 m -58.85 143.06 13.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.103 -174.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.37 3.06 25.99 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.881 -173.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -80.23 -59.54 2.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.927 0.394 . . . . 0.0 110.712 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.429 HG13 ' HD2' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -96.55 153.25 38.88 Favored Pre-proline 0 N--CA 1.445 -0.717 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 175.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.429 ' HD2' HG13 ' A' ' 77' ' ' VAL . 7.5 Cg_exo -74.2 155.32 46.92 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.475 2.117 . . . . 0.0 110.791 176.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.696 ' O ' HG22 ' A' ' 83' ' ' VAL . 61.9 t-105 -46.38 -49.64 17.6 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.862 0.726 . . . . 0.0 112.695 -171.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -55.97 -42.18 75.9 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -171.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 78.8 mtp -83.53 -33.74 25.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.239 0.543 . . . . 0.0 110.472 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.605 ' HZ ' ' CD2' ' A' ' 64' ' ' TYR . 7.1 t80 -58.32 -50.93 71.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.95 -175.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 79' ' ' TRP . 2.1 t -60.64 -39.22 80.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.126 0.488 . . . . 0.0 111.307 -171.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.6 p -79.57 -11.7 59.87 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -175.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.5 p -108.8 -28.65 9.08 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -174.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 40.4 t -66.14 136.42 55.91 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.026 0.441 . . . . 0.0 111.051 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.485 ' HZ3' ' HB3' ' A' ' 87' ' ' LYS . 7.6 mtpm? -116.86 -40.5 3.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.739 -175.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.525 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 69.9 mtt180 -137.59 161.89 35.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.198 -175.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.766 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 6.5 tp -133.76 122.97 24.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.752 -172.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -139.7 119.67 13.52 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 121.829 -0.545 . . . . 0.0 110.508 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.427 HG22 ' HA ' ' A' ' 62' ' ' PRO . 10.3 mt -116.74 135.14 58.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.427 ' HA ' ' SD ' ' A' ' 14' ' ' MET . 25.5 ptt? -159.25 162.95 36.21 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.336 0.589 . . . . 0.0 112.357 -174.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 36.4 mttt -56.93 146.78 25.61 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.062 -1.426 . . . . 0.0 113.086 -176.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -60.3 -30.09 70.31 Favored Glycine 0 CA--C 1.507 -0.454 0 CA-C-N 114.125 -1.398 . . . . 0.0 113.726 -174.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.452 HG21 ' HB3' ' A' ' 93' ' ' LYS . 1.5 t -56.78 -26.09 56.82 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.161 0.505 . . . . 0.0 111.337 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -102.67 -34.78 8.93 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.167 0.508 . . . . 0.0 110.346 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.08 -23.4 67.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.578 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.438 ' HE3' ' O ' ' A' ' 95' ' ' THR . 16.0 pttp -62.39 -19.53 63.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.962 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -71.77 -40.61 57.94 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.39 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.352 0 O-C-N 122.599 -0.354 . . . . 0.0 110.87 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.747 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 3.2 mp -114.06 104.5 17.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.184 0.516 . . . . 0.0 109.985 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -115.07 118.56 33.72 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.231 -172.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.569 ' CG2' ' HB2' ' A' ' 89' ' ' LEU . 4.1 m -116.25 162.51 14.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.165 -177.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.52 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 18.8 ptmt -104.07 134.33 47.52 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.702 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -126.47 128.08 70.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.607 0.717 . . . . 0.0 111.322 -177.003 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.3 t -122.56 155.2 36.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.763 175.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.727 ' SD ' ' HB ' ' A' ' 91' ' ' ILE . 68.6 mmm -103.18 141.92 35.04 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.847 0.356 . . . . 0.0 111.052 -177.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -110.44 125.02 52.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.024 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.34 -32.75 6.89 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -177.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.05 142.98 42.21 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 172.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.89 122.87 6.5 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 121.554 1.503 . . . . 0.0 112.355 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.478 ' HB2' ' CG ' ' A' ' 14' ' ' MET . 75.4 m-85 -153.43 151.68 30.17 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.044 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -127.81 105.56 8.52 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.008 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.481 ' C ' ' HG2' ' A' ' 22' ' ' LYS . 31.8 mmt180 -127.97 156.1 43.22 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' A' ' 11' ' ' LYS . 4.9 mmtm -147.81 130.18 15.71 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.0 pt -140.95 173.31 9.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.66 0.743 . . . . 0.0 112.168 -174.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.639 ' OD1' ' HG2' ' A' ' 26' ' ' ARG . 7.3 t70 -113.62 126.94 55.83 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.687 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.403 ' HB3' HG12 ' A' ' 83' ' ' VAL . 6.8 mp -70.8 -39.85 72.86 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.697 -174.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.639 ' HG2' ' OD1' ' A' ' 24' ' ' ASP . 8.4 ptm180 -77.66 -23.51 49.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.83 -167.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 24' ' ' ASP . 29.8 m -65.34 -16.12 19.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -176.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -84.74 -27.88 26.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.13 0.49 . . . . 0.0 110.909 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.93 14.3 30.31 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.24 -0.891 . . . . 0.0 113.688 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.07 168.5 32.02 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -70.4 -34.24 72.31 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.1 m -59.05 -51.18 71.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.846 0.355 . . . . 0.0 111.386 -175.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -72.99 -33.71 65.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.797 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.1 tp -55.82 -55.78 28.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.156 0.503 . . . . 0.0 110.796 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.7 mt -66.8 -35.48 80.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.08 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.447 ' HD3' ' C ' ' A' ' 36' ' ' LYS . 13.1 tmtt? -63.27 -43.38 98.09 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.526 -177.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.445 ' O ' ' HB ' ' A' ' 40' ' ' THR . . . -57.71 -42.31 83.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.829 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.431 ' H ' ' HG ' ' A' ' 38' ' ' LEU . 1.3 mt -65.56 -53.3 43.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.841 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.412 ' HG2' ' H ' ' A' ' 46' ' ' ILE . 40.7 mt-10 -52.01 -28.74 18.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.694 175.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.445 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 33.6 m -76.48 -45.13 32.4 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.542 175.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.408 ' HG3' ' O ' ' A' ' 37' ' ' ALA . 30.6 mtm -58.91 -55.03 40.45 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -170.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.21 9.15 36.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.249 0.547 . . . . 0.0 111.125 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? 55.24 48.81 18.54 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.792 173.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 pp -141.53 178.86 7.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.7 m -95.73 122.13 38.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.213 0.53 . . . . 0.0 112.237 -173.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.412 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 49.1 mm -102.47 135.05 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.5 174.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.448 ' HA3' ' NZ ' ' A' ' 56' ' ' LYS . . . -89.32 164.96 32.33 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.744 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.4 176.94 8.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.277 0.561 . . . . 0.0 112.009 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -78.18 93.91 4.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.755 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.56 ' N ' ' HA2' ' A' ' 54' ' ' GLY . 2.1 t -49.78 138.98 13.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.05 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -73.87 -13.28 60.89 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.131 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.53 ' HD3' ' HG3' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -104.23 -44.5 4.95 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.064 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.53 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 24.4 mt-10 -118.26 -28.41 5.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.472 0.578 . . . . 0.0 111.555 175.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.56 ' HA2' ' N ' ' A' ' 50' ' ' SER . . . 54.06 11.15 2.1 Favored Glycine 0 C--O 1.219 -0.81 0 CA-C-N 114.699 -1.137 . . . . 0.0 115.216 -178.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.428 ' HB3' HD11 ' A' ' 100' ' ' LEU . 18.5 m-85 -125.54 4.09 7.6 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 118.473 1.136 . . . . 0.0 111.247 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.448 ' HD3' ' H ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -58.74 -37.71 76.8 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -176.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.448 ' H ' ' HD3' ' A' ' 56' ' ' LYS . . . 60.86 -4.94 0.22 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 114.252 0.461 . . . . 0.0 114.252 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.428 ' H ' ' C ' ' A' ' 56' ' ' LYS . 48.8 m 69.26 -79.33 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.189 0.596 . . . . 0.0 109.892 -172.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 33.2 tt0 -118.57 -19.52 8.73 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.107 172.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.4 ' CD1' ' HE3' ' A' ' 14' ' ' MET . 24.4 m-85 -143.43 126.13 16.03 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.066 0.46 . . . . 0.0 110.974 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.445 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . . . -103.01 104.45 40.09 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.06 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.478 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 33.9 Cg_endo -67.99 121.16 8.15 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 121.714 1.609 . . . . 0.0 111.263 172.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.421 HG23 HD22 ' A' ' 100' ' ' LEU . 82.2 p -125.54 160.05 30.52 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.519 -176.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.672 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.7 p90 -121.57 164.1 17.81 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.604 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.497 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 41.3 tt0 -103.42 115.64 30.91 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 14.1 t70 -84.03 -169.25 2.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.007 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.486 ' H ' ' CG ' ' A' ' 66' ' ' ASP . 1.4 mtmp? -66.65 -45.73 78.03 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.647 0.26 . . . . 0.0 111.474 -173.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.53 -3.76 51.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.194 0.521 . . . . 0.0 110.861 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.27 24.27 19.64 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.166 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -76.18 138.81 40.92 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.558 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 90.7 m95 -115.16 113.05 23.44 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 123.405 0.441 . . . . 0.0 109.952 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.427 ' HA ' ' CD1' ' A' ' 100' ' ' LEU . 32.5 mtm -142.36 169.45 17.56 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 176.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.535 HD22 ' O ' ' A' ' 54' ' ' GLY . 2.3 tp -62.88 152.89 35.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.282 0.563 . . . . 0.0 111.204 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.74 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 99.2 t -77.55 127.78 38.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.443 174.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.57 1.68 27.56 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -170.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -63.03 -48.3 79.32 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.482 HG23 ' CD2' ' A' ' 82' ' ' PHE . 3.2 m -113.88 156.8 43.34 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.86 133.11 33.31 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.965 2.443 . . . . 0.0 113.606 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.546 ' O ' HG22 ' A' ' 83' ' ' VAL . 73.2 t-105 -40.03 -53.31 2.4 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.444 1.097 . . . . 0.0 113.552 -173.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -52.51 -42.78 64.61 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -175.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 68.1 mtm -83.75 -27.48 28.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.111 0.482 . . . . 0.0 110.545 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.74 ' CZ ' ' HA ' ' A' ' 74' ' ' VAL . 9.2 t80 -63.16 -45.49 91.59 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.502 -174.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 79' ' ' TRP . 4.7 t -61.14 -42.34 92.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.302 -171.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.7 p -78.58 -19.45 52.74 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.094 0.473 . . . . 0.0 110.985 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.8 t -83.83 -21.73 31.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.302 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.672 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 36.2 t -90.93 133.47 35.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.161 0.505 . . . . 0.0 111.182 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 13.7 pttp -121.91 -29.52 4.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.738 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.497 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 60.2 mtt180 -139.51 167.28 22.46 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 176.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.702 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 10.8 tp -136.86 138.17 40.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.299 0.571 . . . . 0.0 111.527 -173.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -139.22 129.3 25.17 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.832 0.349 . . . . 0.0 110.146 170.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.727 ' HB ' ' SD ' ' A' ' 14' ' ' MET . 13.4 mt -111.65 138.28 40.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 175.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.1 ptt? -155.9 147.55 22.93 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -170.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 21.0 ttpt -50.83 147.88 4.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 113.591 -1.641 . . . . 0.0 112.828 -175.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.53 -27.98 70.53 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 114.698 -1.137 . . . . 0.0 113.276 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.524 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 44.3 p -68.49 -16.08 63.77 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.91 0.386 . . . . 0.0 111.08 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -101.88 -2.57 29.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.453 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.405 ' HA ' HD21 ' A' ' 100' ' ' LEU . . . -59.61 -29.97 68.36 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -172.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.524 ' HE3' ' O ' ' A' ' 95' ' ' THR . 0.0 OUTLIER -59.6 -23.66 63.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.769 0.318 . . . . 0.0 110.874 178.434 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.52 -22.01 78.93 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 116.101 -0.5 . . . . 0.0 113.195 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.428 HD11 ' HB3' ' A' ' 55' ' ' TYR . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 121.355 0.598 . . . . 0.0 110.756 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.93 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.488 ' CD1' ' HD2' ' A' ' 26' ' ' ARG . 3.9 mp -92.26 106.3 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-O 121.218 0.532 . . . . 0.0 109.983 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -90.04 134.8 34.03 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.95 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.533 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -116.25 139.74 41.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.443 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -104.55 135.07 46.66 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -124.39 127.41 73.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.691 0.758 . . . . 0.0 111.472 -172.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.8 p -115.57 155.84 26.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.69 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.443 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 27.4 tpp -110.05 145.08 37.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.624 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -111.89 140.35 46.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.597 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.74 -32.44 4.54 Favored Glycine 0 C--O 1.229 -0.157 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.443 ' O ' ' HG3' ' A' ' 14' ' ' MET . . . -133.94 143.71 48.58 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 172.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.97 122.21 6.17 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 121.391 1.394 . . . . 0.0 112.262 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -153.29 143.16 22.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.766 174.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.5 mt -127.65 106.95 9.5 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.84 0.353 . . . . 0.0 110.368 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.583 ' O ' HG12 ' A' ' 12' ' ' VAL . 10.3 mmm180 -124.07 155.49 38.25 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.459 ' HD2' ' C ' ' A' ' 21' ' ' ARG . 2.5 mptp? -143.76 144.39 31.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.796 0.332 . . . . 0.0 110.551 175.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.407 ' HB ' ' HH ' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -146.87 176.06 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.979 -178.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.48 ' O ' HG21 ' A' ' 27' ' ' VAL . 9.0 t70 -111.32 132.68 54.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.273 0.559 . . . . 0.0 110.275 -175.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.454 HD23 ' HB3' ' A' ' 86' ' ' CYS . 16.6 tp -69.27 -34.31 74.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.733 -172.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.488 ' HD2' ' CD1' ' A' ' 8' ' ' ILE . 65.8 mtp180 -79.47 -32.07 42.53 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -171.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 24' ' ' ASP . 33.6 m -68.81 -0.81 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -169.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.504 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 27.0 m-85 -85.64 -28.7 24.58 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.28 177.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.86 14.86 5.8 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.328 -0.851 . . . . 0.0 114.168 177.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.21 175.94 28.71 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.633 -176.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -69.18 -31.63 70.39 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -176.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.9 p -59.69 -56.11 25.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.733 0.301 . . . . 0.0 111.44 -175.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 28' ' ' TYR . 47.1 mt-10 -73.98 -25.83 60.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.59 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.64 -56.37 23.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.233 0.54 . . . . 0.0 110.115 174.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.4 mt -69.77 -36.63 75.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.81 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 36' ' ' LYS . 68.0 mmtt -71.62 -31.29 66.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.561 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.668 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -58.59 -42.65 88.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.881 176.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.488 HD13 ' HG3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -58.24 -52.93 63.51 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.598 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 39.0 mt-10 -52.3 -30.22 27.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.896 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.556 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 53.8 m -73.95 -44.89 53.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.135 177.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.668 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 74.5 mmm -57.07 -57.13 13.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.707 -169.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -102.17 8.6 40.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.119 0.485 . . . . 0.0 110.922 -175.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.28 47.72 16.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.633 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 3.0 pp -145.51 -179.31 6.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.705 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 m -111.61 98.21 7.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -171.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.418 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 37.5 mm -65.51 127.66 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.988 172.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.5 149.59 43.82 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.891 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -68.21 162.7 24.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.117 0.484 . . . . 0.0 111.803 -174.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.53 ' CZ ' HD12 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -65.95 89.73 0.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.891 179.007 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.416 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 30.8 t -62.89 146.88 51.85 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.707 0.765 . . . . 0.0 109.849 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -76.37 -16.32 59.75 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.603 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.556 ' HD3' ' HG3' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -82.03 -56.3 4.04 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -172.457 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.556 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 39.5 mt-10 -121.34 -29.64 4.43 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.732 0.777 . . . . 0.0 109.687 165.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.523 ' O ' HD13 ' A' ' 73' ' ' LEU . . . 46.73 8.76 0.03 OUTLIER Glycine 0 C--O 1.214 -1.115 0 CA-C-N 113.317 -1.765 . . . . 0.0 116.216 -177.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.482 ' HD1' ' O ' ' A' ' 53' ' ' GLU . 11.1 m-85 -114.78 6.49 15.55 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 118.171 0.986 . . . . 0.0 110.992 -176.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.453 ' HG2' ' H ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -63.85 -39.07 93.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.647 177.324 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 60' ' ' TYR . . . 58.31 22.19 49.97 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.78 176.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.453 ' H ' ' HG2' ' A' ' 56' ' ' LYS . 20.4 t 69.27 -86.19 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -165.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -119.75 -16.61 8.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.694 0.283 . . . . 0.0 110.971 169.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.514 ' O ' ' HA3' ' A' ' 57' ' ' GLY . 30.3 m-85 -122.27 125.79 46.78 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -174.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -100.92 105.33 37.68 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.936 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.488 ' HG3' HD13 ' A' ' 38' ' ' LEU . 61.0 Cg_endo -72.8 119.65 6.2 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.986 1.791 . . . . 0.0 111.231 175.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 72' ' ' MET . 71.2 p -128.78 165.49 20.84 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.766 -175.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.544 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 4.3 p90 -137.8 164.74 28.16 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.683 0.278 . . . . 0.0 110.349 -176.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.474 ' OE1' ' HD3' ' A' ' 88' ' ' ARG . 29.5 tt0 -100.24 113.92 26.96 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.89 177.48 8.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.715 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.0 mtmm -48.72 -44.14 37.96 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.117 0.567 . . . . 0.0 111.888 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -81.86 -15.99 52.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.114 0.483 . . . . 0.0 110.74 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.99 23.86 16.56 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.57 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -95.27 143.64 26.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.544 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 67.3 m95 -110.1 114.96 28.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.065 0.46 . . . . 0.0 111.516 -173.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.524 ' HE2' ' CE1' ' A' ' 64' ' ' TYR . 2.1 mpp? -127.37 179.3 5.54 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 174.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.53 HD12 ' CZ ' ' A' ' 49' ' ' TYR . 10.8 mt -64.0 153.22 37.93 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.54 0.686 . . . . 0.0 111.531 176.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.4 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 22.9 m -77.14 137.83 21.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.855 175.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.73 8.26 80.18 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.624 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.35 -54.03 43.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.664 0.268 . . . . 0.0 111.212 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.463 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 12.4 m -98.82 155.52 36.57 Favored Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 4.2 Cg_endo -46.95 132.82 17.8 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.487 2.791 . . . . 0.0 113.326 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.528 ' O ' HG22 ' A' ' 83' ' ' VAL . 70.0 t-105 -43.41 -51.88 6.28 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -171.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -54.63 -42.66 71.48 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.628 0.251 . . . . 0.0 111.637 -174.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 57.2 ttp -84.03 -22.73 31.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.998 0.428 . . . . 0.0 110.547 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.427 ' CD2' HG22 ' A' ' 77' ' ' VAL . 11.4 t80 -66.29 -45.93 78.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.038 -177.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 79' ' ' TRP . 3.5 t -61.37 -37.28 77.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.115 0.483 . . . . 0.0 110.944 -174.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.5 p -79.46 -12.34 59.88 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.334 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.3 m -95.17 -31.32 13.58 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.454 ' HB3' HD23 ' A' ' 25' ' ' LEU . 44.6 t -80.5 130.31 35.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.762 0.791 . . . . 0.0 111.457 -175.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.459 ' HZ3' ' HB3' ' A' ' 87' ' ' LYS . 9.2 mtpm? -118.21 -40.66 2.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.674 -176.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.474 ' HD3' ' OE1' ' A' ' 65' ' ' GLU . 51.6 mtp180 -140.14 163.54 32.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.084 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.696 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 5.6 tp -130.02 137.65 50.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.879 0.371 . . . . 0.0 110.826 -171.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -139.31 115.03 10.04 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.826 175.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.1 mt -111.25 133.92 55.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 171.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.494 ' C ' ' HD1' ' A' ' 60' ' ' TYR . 21.9 ptt? -159.19 161.46 36.15 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -169.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -56.96 141.22 46.16 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.696 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.69 -22.07 45.38 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.957 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.2 t -63.63 -20.22 65.5 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.002 0.43 . . . . 0.0 111.01 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -101.25 -39.03 7.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.08 0.467 . . . . 0.0 109.887 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.44 -25.76 67.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.004 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -65.25 -23.28 67.02 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.37 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.91 -38.1 36.9 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.911 -0.661 . . . . 0.0 113.112 -177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 C--N 1.326 -0.416 0 CA-C-O 120.748 0.308 . . . . 0.0 111.65 -174.847 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.947 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 mp -125.11 107.58 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 114.229 -0.986 . . . . 0.0 109.129 170.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -103.18 141.2 36.28 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.571 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.566 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.9 OUTLIER -131.15 152.88 38.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.235 0.54 . . . . 0.0 109.927 -179.029 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -118.72 141.46 48.6 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -125.57 126.88 71.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.61 0.719 . . . . 0.0 111.313 -174.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.6 m -117.41 155.6 29.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.366 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.692 ' SD ' ' HA ' ' A' ' 92' ' ' MET . 25.7 tpp -99.69 151.98 20.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.888 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -119.06 122.46 42.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.079 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.63 -31.94 8.15 Favored Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 14' ' ' MET . . . -134.64 149.15 70.04 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 173.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.18 121.75 5.88 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.019 1.146 . . . . 0.0 112.222 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.515 ' HB2' ' CB ' ' A' ' 14' ' ' MET . 56.6 m-85 -153.09 142.89 22.05 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.557 175.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.444 HD22 ' C ' ' A' ' 19' ' ' TYR . 3.1 mm? -129.53 106.71 8.94 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.14 0.495 . . . . 0.0 111.12 -176.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.513 ' O ' HG11 ' A' ' 12' ' ' VAL . 37.3 mmt180 -125.52 155.85 39.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.808 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.511 ' HD2' ' C ' ' A' ' 21' ' ' ARG . 2.5 mptp? -146.96 137.2 23.49 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.507 HD13 ' CD2' ' A' ' 89' ' ' LEU . 1.9 pt -140.95 174.11 8.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.576 0.703 . . . . 0.0 111.87 -176.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.527 ' O ' HG21 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -113.16 124.8 53.4 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.036 -0.983 . . . . 0.0 108.956 -177.155 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.453 ' HB2' ' CG2' ' A' ' 10' ' ' VAL . 11.8 tp -71.62 -45.58 61.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -165.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -79.98 -16.37 55.33 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -171.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.527 HG21 ' O ' ' A' ' 24' ' ' ASP . 19.1 m -75.68 -0.74 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -169.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.448 ' OH ' ' HB ' ' A' ' 23' ' ' ILE . 30.5 m-85 -96.12 -28.93 14.36 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.926 0.394 . . . . 0.0 111.341 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.16 14.21 17.68 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.859 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.31 167.31 33.61 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.876 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -69.23 -34.14 74.38 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 p -57.21 -55.22 37.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.569 0.223 . . . . 0.0 111.159 -176.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -70.3 -29.95 66.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.105 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.5 tp -59.09 -55.6 33.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.187 0.518 . . . . 0.0 109.959 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.532 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 56.4 mt -67.31 -38.13 84.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.259 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 36' ' ' LYS . 62.9 mmtt -69.66 -31.96 70.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.657 -177.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 40' ' ' THR . . . -60.54 -41.82 95.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.076 0.465 . . . . 0.0 110.387 176.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.503 ' HB2' HG13 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -63.37 -54.61 34.17 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 23.6 mt-10 -52.11 -29.8 23.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.938 176.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 24.6 m -71.71 -41.89 68.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.205 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.602 ' HE2' ' CZ ' ' A' ' 42' ' ' PHE . 71.8 mtm -66.51 -55.03 17.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -171.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.602 ' CZ ' ' HE2' ' A' ' 41' ' ' MET . 0.1 OUTLIER -100.46 10.53 41.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.159 0.504 . . . . 0.0 111.929 -173.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp 55.27 47.92 20.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.622 174.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.8 pp -143.08 -176.37 4.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.007 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 63.4 m -108.18 99.86 9.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.042 0.449 . . . . 0.0 111.713 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.503 HG13 ' HB2' ' A' ' 38' ' ' LEU . 34.2 mm -76.77 123.18 32.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 172.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.02 155.52 53.58 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.013 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -71.01 171.27 11.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.296 0.57 . . . . 0.0 111.249 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -79.3 85.66 5.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.542 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.8 m -56.66 135.64 54.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.383 173.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -72.13 -25.73 61.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.282 0.563 . . . . 0.0 110.399 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.599 ' HD2' ' N ' ' A' ' 53' ' ' GLU . 3.4 ppt_? -68.24 -52.98 27.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.367 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.599 ' N ' ' HD2' ' A' ' 52' ' ' ARG . 47.6 mt-10 -122.84 -29.23 4.01 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.634 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.583 ' O ' HD12 ' A' ' 73' ' ' LEU . . . 42.21 10.87 0.01 OUTLIER Glycine 0 C--O 1.218 -0.872 0 N-CA-C 116.303 1.281 . . . . 0.0 116.303 -174.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.415 ' HD1' ' HB3' ' A' ' 73' ' ' LEU . 9.7 m-85 -126.25 6.57 7.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 118.672 1.236 . . . . 0.0 110.269 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -67.12 -31.21 71.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.5 -175.29 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 58' ' ' SER . . . 65.56 -12.74 0.31 Allowed Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.527 -0.761 . . . . 0.0 114.727 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.438 ' H ' ' C ' ' A' ' 56' ' ' LYS . 40.0 m 71.77 -80.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -172.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -118.88 -23.75 6.84 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.656 170.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.432 ' HE1' ' SD ' ' A' ' 14' ' ' MET . 37.4 m-85 -134.79 124.51 25.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.008 0.432 . . . . 0.0 111.205 175.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.401 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . . . -105.46 105.3 51.92 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.681 177.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.479 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 43.8 Cg_endo -68.51 120.17 7.13 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.499 1.466 . . . . 0.0 110.993 174.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.3 p -124.7 168.45 13.16 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.078 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.52 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 3.6 p90 -143.77 165.32 28.0 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -176.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.442 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 40.4 tt0 -108.32 121.14 44.29 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.401 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.459 ' O ' ' HE3' ' A' ' 87' ' ' LYS . 14.9 t70 -84.15 -169.34 2.54 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.567 177.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.489 ' NZ ' ' HA ' ' A' ' 85' ' ' SER . 17.4 mmtm -62.36 -49.08 76.99 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.725 0.774 . . . . 0.0 109.82 -172.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -84.39 13.93 4.94 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.714 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.79 19.58 72.84 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.942 175.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -75.61 130.0 38.08 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.52 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 92.8 m95 -106.26 120.72 42.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.167 0.508 . . . . 0.0 110.69 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 46.5 mtm -138.5 170.27 16.32 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.583 HD12 ' O ' ' A' ' 54' ' ' GLY . 10.0 tt -79.08 141.57 37.25 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 16.2 m -66.81 130.11 31.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.649 0.738 . . . . 0.0 112.219 -174.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.87 4.56 26.08 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.807 -175.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.05 -59.43 5.43 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.612 0.244 . . . . 0.0 110.869 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.8 m -98.57 156.06 36.1 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -52.16 137.14 54.67 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.172 2.581 . . . . 0.0 112.975 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.547 ' O ' HG22 ' A' ' 83' ' ' VAL . 71.9 t-105 -43.78 -41.72 5.12 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.347 -174.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -58.74 -42.63 89.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.093 0.473 . . . . 0.0 111.063 -174.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 49.9 ttp -85.11 -27.66 26.11 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.589 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 74' ' ' VAL . 11.8 t80 -63.63 -40.71 97.57 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.162 -172.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 79' ' ' TRP . 2.8 t -60.86 -39.7 82.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.415 0.626 . . . . 0.0 110.942 -173.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.7 p -79.09 -10.85 59.94 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.314 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.489 ' HA ' ' NZ ' ' A' ' 67' ' ' LYS . 68.0 m -89.3 -31.39 17.86 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 30.3 t -90.75 123.91 34.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.176 0.512 . . . . 0.0 112.043 -175.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 66' ' ' ASP . 18.8 pttp -118.83 -22.9 7.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.594 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.442 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 84.5 mtt180 -140.23 151.16 44.94 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 174.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.62 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 3.6 tp -125.73 137.72 53.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.018 0.437 . . . . 0.0 111.114 -174.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -139.31 116.08 10.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.154 0.502 . . . . 0.0 110.948 172.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 22.1 mt -106.8 136.6 41.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 173.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.692 ' HA ' ' SD ' ' A' ' 14' ' ' MET . 19.9 ptt? -157.94 160.05 37.17 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -168.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -56.02 138.66 48.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 113.666 -1.606 . . . . 0.0 111.952 -177.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -61.99 -28.72 70.89 Favored Glycine 0 CA--C 1.505 -0.582 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.127 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.3 p -64.17 -20.31 65.91 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.195 -0.502 . . . . 0.0 111.124 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -100.53 -47.53 4.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.39 0.615 . . . . 0.0 110.103 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.96 -21.85 65.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.154 -176.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.484 ' HZ1' ' HB2' ' A' ' 98' ' ' LYS . 0.1 OUTLIER -53.6 -29.74 39.09 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -175.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.58 -39.32 93.84 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.786 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 C--N 1.328 -0.361 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -174.94 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.676 0 N-CA-C 111.75 -0.54 . . . . 0.0 111.75 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.504 ' CD1' ' HD2' ' A' ' 26' ' ' ARG . 3.3 mp -104.9 105.56 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 121.249 0.547 . . . . 0.0 109.674 177.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -102.9 130.77 50.06 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.439 -172.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.481 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 2.1 t -121.12 150.75 24.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.639 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -105.95 135.13 47.95 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.692 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -124.93 125.94 70.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.449 0.642 . . . . 0.0 110.874 -175.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 p -114.76 148.19 38.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.493 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 79.0 mmm -104.73 165.84 10.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.791 -177.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -131.75 141.7 49.58 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.99 -33.19 4.32 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.887 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.12 140.09 33.77 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-O 120.805 0.336 . . . . 0.0 110.796 173.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.3 127.77 9.29 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.925 2.416 . . . . 0.0 112.729 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -149.52 172.46 14.95 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.08 103.88 5.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.818 0.818 . . . . 0.0 110.423 170.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.456 ' O ' HG11 ' A' ' 12' ' ' VAL . 39.7 mmt180 -127.68 136.63 51.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.1 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.453 ' HD2' ' C ' ' A' ' 21' ' ' ARG . 2.6 mptp? -144.42 141.27 29.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 171.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.53 HD13 ' CD2' ' A' ' 89' ' ' LEU . 3.4 pt -140.86 174.11 8.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.028 0.442 . . . . 0.0 112.142 -175.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -110.45 126.47 54.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.103 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.479 ' CD2' ' HB3' ' A' ' 86' ' ' CYS . 10.8 tp -69.84 -43.06 72.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.833 -170.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.504 ' HD2' ' CD1' ' A' ' 8' ' ' ILE . 11.5 ptm180 -80.28 -25.82 39.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.047 0.451 . . . . 0.0 110.719 -171.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -49.71 -21.81 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 124.491 1.116 . . . . 0.0 113.767 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -86.73 -28.23 23.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.972 0.415 . . . . 0.0 111.805 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.5 13.75 46.14 Favored Glycine 0 CA--C 1.519 0.293 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.414 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 161.4 176.92 34.02 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.171 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.582 ' CE1' ' HA2' ' A' ' 75' ' ' GLY . 38.3 m-85 -69.49 -30.78 68.72 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -177.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.4 m -58.68 -54.76 43.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.671 0.272 . . . . 0.0 111.414 -174.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -73.59 -28.91 62.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.801 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.441 HD23 ' HB ' ' A' ' 74' ' ' VAL . 14.2 tp -58.31 -55.32 36.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.433 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.471 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 79.7 mt -67.12 -36.79 82.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.89 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.502 ' HA ' ' OE1' ' A' ' 39' ' ' GLU . 1.5 tmtp? -64.8 -33.89 77.06 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.499 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.703 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -67.64 -37.5 82.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.298 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.49 HD12 ' HG3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -63.52 -48.84 75.9 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.495 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.606 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 51.1 mt-10 -51.34 -33.27 28.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.574 173.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.545 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 21.1 m -74.37 -34.82 63.46 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.424 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.703 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 47.0 mmm -63.39 -57.86 8.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.131 -170.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -107.73 11.67 28.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.257 0.551 . . . . 0.0 111.101 -174.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp 61.7 50.53 4.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.72 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 2.4 pp -152.83 176.1 12.17 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.384 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.9 m -102.46 105.32 15.86 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -174.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.482 HD13 ' CB ' ' A' ' 38' ' ' LEU . 2.3 mt -89.2 120.89 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.601 169.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.46 165.86 54.55 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.558 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -66.02 172.37 3.78 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.725 0.774 . . . . 0.0 112.557 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -74.72 86.18 2.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.489 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 74.5 m -55.56 129.09 37.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.424 173.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -31.19 72.3 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.042 -171.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -50.47 28.43 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -174.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -119.68 -28.66 5.22 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.223 0.535 . . . . 0.0 111.068 -177.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.546 ' O ' HD21 ' A' ' 73' ' ' LEU . . . 45.23 12.06 0.03 OUTLIER Glycine 0 C--O 1.218 -0.896 0 N-CA-C 117.102 1.601 . . . . 0.0 117.102 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.419 ' HD1' ' O ' ' A' ' 54' ' ' GLY . 17.3 m-30 -124.74 15.04 8.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 119.617 1.709 . . . . 0.0 111.144 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.44 ' HG2' ' H ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -74.44 -38.51 62.99 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.805 -177.042 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.09 7.74 5.36 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 115.797 -0.638 . . . . 0.0 114.436 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.44 ' H ' ' HG2' ' A' ' 56' ' ' LYS . 32.4 m 63.83 -83.87 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 122.733 0.413 . . . . 0.0 110.08 -171.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 39.3 tt0 -118.58 -14.52 9.62 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.681 0.277 . . . . 0.0 110.824 172.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -139.96 125.35 19.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.828 0.347 . . . . 0.0 111.036 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -100.53 103.7 25.69 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.798 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.49 ' HG3' HD12 ' A' ' 38' ' ' LEU . 57.2 Cg_endo -74.18 121.9 7.2 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.92 1.747 . . . . 0.0 111.638 174.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.2 p -124.91 157.27 36.4 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.038 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.69 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 3.4 p90 -129.23 164.5 23.33 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.468 ' CG ' ' HA2' ' A' ' 69' ' ' GLY . 43.9 tt0 -101.14 120.15 39.79 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.81 -168.72 2.31 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.355 0.41 . . . . 0.0 111.022 -176.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -57.67 -44.09 85.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.458 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -82.86 -14.65 53.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.285 0.564 . . . . 0.0 110.403 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.468 ' HA2' ' CG ' ' A' ' 65' ' ' GLU . . . 96.27 29.3 8.5 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.89 176.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -96.41 160.5 14.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.931 0.365 . . . . 0.0 110.11 172.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.69 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 39.6 m95 -122.46 114.1 20.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.902 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.444 ' HE1' ' CE1' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -131.44 174.33 10.18 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 171.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.546 HD21 ' O ' ' A' ' 54' ' ' GLY . 1.0 OUTLIER -62.59 157.33 20.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.75 0.786 . . . . 0.0 111.091 -178.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.441 ' HB ' HD23 ' A' ' 34' ' ' LEU . 31.4 m -76.26 134.54 28.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.101 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.582 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 109.96 0.67 30.22 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -171.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -56.57 -56.1 25.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.415 -0.392 . . . . 0.0 111.158 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 m -112.74 152.32 44.67 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.33 136.83 19.3 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.424 2.749 . . . . 0.0 113.203 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.517 ' O ' HG22 ' A' ' 83' ' ' VAL . 73.2 t-105 -43.21 -48.08 6.48 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 123.954 0.784 . . . . 0.0 113.107 -171.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -53.53 -43.08 68.06 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.2 0.312 . . . . 0.0 111.635 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 58.8 mtm -84.26 -25.33 29.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.963 0.411 . . . . 0.0 110.502 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -64.29 -44.84 90.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.423 -174.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 79' ' ' TRP . 2.5 t -61.68 -41.43 90.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.092 0.472 . . . . 0.0 111.023 -173.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.5 p -79.47 -15.46 57.74 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.569 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 65.8 m -91.19 -31.66 16.09 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 41.5 t -73.68 135.59 43.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.484 0.659 . . . . 0.0 111.048 -177.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -118.24 -44.17 2.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.324 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -140.15 163.38 32.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.712 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.692 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 2.0 tp -128.14 135.5 49.85 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.921 0.391 . . . . 0.0 110.702 -172.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -139.11 123.04 17.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.801 0.334 . . . . 0.0 110.868 175.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 14' ' ' MET . 6.1 mt -120.41 137.95 52.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 15.3 ptt? -156.65 158.64 37.37 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.213 0.53 . . . . 0.0 112.368 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 7.2 tttp -53.07 149.2 6.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.189 -1.368 . . . . 0.0 112.178 -175.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.67 -28.09 70.94 Favored Glycine 0 CA--C 1.505 -0.576 0 CA-C-N 114.842 -1.072 . . . . 0.0 113.348 -171.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.1 p -68.04 -20.04 64.95 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.963 0.411 . . . . 0.0 111.003 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -97.98 -9.18 26.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.937 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.682 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -60.57 -22.94 64.22 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.904 -176.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.22 -21.86 65.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.934 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.84 -4.43 63.47 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.626 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 97' ' ' ALA . 4.5 pp . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 117.386 0.593 . . . . 0.0 110.584 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.495 ' HA2' ' NH1' ' A' ' 26' ' ' ARG . . . . . . . . 0 N--CA 1.447 -0.605 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.491 HD11 ' N ' ' A' ' 8' ' ' ILE . 3.3 mp -87.54 114.45 26.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.036 0.446 . . . . 0.0 110.44 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -98.72 132.46 44.08 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.098 174.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.606 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -118.19 138.76 47.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.496 0.665 . . . . 0.0 110.707 -178.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -104.54 133.94 48.57 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.707 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -125.7 124.85 67.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.746 0.784 . . . . 0.0 111.044 -173.053 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 p -112.13 155.3 24.13 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.119 -174.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.68 ' SD ' ' HA ' ' A' ' 92' ' ' MET . 31.8 tpp -110.78 135.31 51.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.659 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.48 137.98 40.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.435 177.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.75 -33.17 5.15 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.035 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.91 141.63 39.15 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 120.619 0.247 . . . . 0.0 111.085 173.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.92 126.71 8.14 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.707 2.272 . . . . 0.0 112.661 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -151.99 166.68 30.79 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.477 ' C ' ' HD2' ' A' ' 21' ' ' ARG . 78.2 mt -125.14 103.86 8.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.05 0.452 . . . . 0.0 110.255 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.487 ' C ' ' HD2' ' A' ' 22' ' ' LYS . 3.6 mpt_? -127.2 134.15 50.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.735 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.487 ' HD2' ' C ' ' A' ' 21' ' ' ARG . 2.4 mptp? -144.1 141.42 30.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 172.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -144.11 174.48 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.135 0.493 . . . . 0.0 112.044 -175.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.452 ' HB3' ' HE ' ' A' ' 26' ' ' ARG . 1.1 m-20 -109.71 126.76 54.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.65 -175.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.504 HD22 HG21 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -69.4 -36.62 76.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.925 0.869 . . . . 0.0 110.117 -175.196 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.495 ' NH1' ' HA2' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -79.54 -19.22 50.04 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.932 -1.031 . . . . 0.0 113.294 -168.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 24' ' ' ASP . 34.0 m -80.63 -3.96 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -170.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.483 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 25.8 m-85 -85.06 -30.12 24.35 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.22 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.7 14.15 6.93 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.788 -0.642 . . . . 0.0 114.354 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.29 165.78 24.24 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.735 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.556 ' CE1' ' HA2' ' A' ' 75' ' ' GLY . 15.2 m-85 -60.91 -36.12 78.46 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.7 p -62.54 -54.36 40.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.682 0.277 . . . . 0.0 110.961 -175.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -67.67 -27.33 66.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.076 -178.706 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.424 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 8.6 tp -62.47 -56.75 15.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.285 174.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.445 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 81.5 mt -67.63 -39.87 84.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.63 -176.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -71.2 -32.54 68.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.271 -175.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.699 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -59.9 -39.79 86.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.778 0.323 . . . . 0.0 110.7 177.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.459 HD13 ' HG3' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -68.87 -50.48 49.41 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.307 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 35.3 mt-10 -52.27 -28.86 20.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.58 173.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.563 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 17.5 m -74.06 -41.02 62.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.258 175.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.699 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 71.9 mmm -54.85 -55.98 24.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.023 -172.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -102.0 9.69 40.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 -177.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.17 44.21 19.37 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.95 174.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 pp -144.51 -171.8 3.67 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 m -113.72 121.14 43.18 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.876 0.369 . . . . 0.0 111.31 -175.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.41 ' CD1' ' HB2' ' A' ' 60' ' ' TYR . 40.8 mm -84.57 -22.77 7.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 122.335 1.064 . . . . 0.0 109.738 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.03 -164.58 31.2 Favored Glycine 0 C--N 1.31 -0.889 0 CA-C-N 114.071 -1.422 . . . . 0.0 112.574 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -92.02 162.4 14.39 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.412 ' CD1' HD21 ' A' ' 73' ' ' LEU . 60.4 t80 -80.43 75.72 7.27 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 171.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 m -49.05 128.97 17.14 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.804 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -68.06 -17.82 64.5 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.049 -173.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.526 ' HD2' ' N ' ' A' ' 53' ' ' GLU . 3.0 ppt_? -74.58 -51.95 13.14 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.526 ' N ' ' HD2' ' A' ' 52' ' ' ARG . 50.9 mt-10 -122.57 -29.95 3.98 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 119.934 -0.707 . . . . 0.0 112.728 176.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.689 ' O ' HD11 ' A' ' 73' ' ' LEU . . . 48.97 12.9 0.26 Allowed Glycine 0 C--O 1.218 -0.855 0 N-CA-C 115.288 0.875 . . . . 0.0 115.288 -175.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.422 ' HA ' ' CD1' ' A' ' 73' ' ' LEU . 11.6 m-85 -124.8 10.04 8.29 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.535 1.167 . . . . 0.0 110.608 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.488 ' HZ1' ' HB2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -61.38 -51.37 69.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.428 -179.024 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.16 3.04 4.53 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 115.079 0.792 . . . . 0.0 115.079 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.2 t 67.86 -86.99 0.03 OUTLIER 'General case' 0 C--O 1.234 0.238 0 CA-C-N 117.357 0.579 . . . . 0.0 110.037 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -117.65 -6.84 11.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.741 0.305 . . . . 0.0 110.501 175.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.428 ' HE1' ' SD ' ' A' ' 14' ' ' MET . 70.3 m-85 -143.17 124.49 14.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.611 0.243 . . . . 0.0 111.354 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.2 105.06 47.46 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.619 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 42.8 Cg_endo -68.98 120.93 7.78 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.992 1.795 . . . . 0.0 111.009 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 72' ' ' MET . 77.0 p -129.92 165.67 21.61 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.478 -175.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.746 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.4 p90 -136.51 164.66 27.66 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -178.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.475 ' CG ' ' HA2' ' A' ' 69' ' ' GLY . 33.3 tt0 -104.53 121.63 43.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.711 0.291 . . . . 0.0 110.361 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.505 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 25.5 t70 -84.51 -170.87 3.32 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.519 175.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.505 ' H ' ' CG ' ' A' ' 66' ' ' ASP . 13.3 mmtm -65.46 -34.41 78.22 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.643 0.735 . . . . 0.0 109.349 -175.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -72.26 -18.52 61.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.083 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.475 ' HA2' ' CG ' ' A' ' 65' ' ' GLU . . . 92.58 11.98 58.75 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.639 -175.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -86.95 144.11 27.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.639 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 64.0 m95 -112.11 115.67 29.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.048 0.451 . . . . 0.0 110.983 -176.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.413 ' O ' ' HA ' ' A' ' 63' ' ' THR . 49.8 mtm -121.54 161.09 22.96 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.689 HD11 ' O ' ' A' ' 54' ' ' GLY . 9.5 tt -71.05 141.42 50.89 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.487 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 17.2 m -66.87 129.57 31.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.655 0.741 . . . . 0.0 112.166 -174.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.556 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 111.3 6.93 25.21 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.513 -174.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -71.57 -56.91 4.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.513 0.197 . . . . 0.0 111.302 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.49 HG23 ' CD2' ' A' ' 82' ' ' PHE . 12.6 m -98.34 155.11 37.25 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.469 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 5.1 Cg_endo -46.94 131.89 17.14 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.668 2.912 . . . . 0.0 113.667 -176.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.471 ' O ' HG22 ' A' ' 83' ' ' VAL . 72.9 t-105 -43.16 -54.28 4.55 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.68 -172.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -51.41 -42.04 61.17 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.587 0.554 . . . . 0.0 111.542 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 57.4 ttp -83.37 -31.86 26.51 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.807 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.49 ' CD2' HG23 ' A' ' 77' ' ' VAL . 6.3 t80 -58.23 -46.66 85.5 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.68 -174.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 79' ' ' TRP . 2.8 t -60.54 -48.18 89.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.342 -170.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.8 p -78.87 -14.37 59.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.55 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.6 t -85.97 -25.18 26.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.12 -175.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.746 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 40.4 t -79.22 131.15 36.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.751 0.31 . . . . 0.0 110.922 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 13.5 ptmm? -116.03 -23.94 8.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.694 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.414 ' HD3' ' OE1' ' A' ' 65' ' ' GLU . 62.1 mtp180 -140.81 154.67 46.33 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 176.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.707 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 9.6 tp -127.51 133.37 49.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.114 -176.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.431 ' HB2' ' CZ3' ' A' ' 71' ' ' TRP . 2.6 ttm180 -139.47 117.78 12.01 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.289 -0.565 . . . . 0.0 111.096 174.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.419 HG21 ' HA ' ' A' ' 62' ' ' PRO . 4.1 mt -116.1 133.55 62.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 170.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.68 ' HA ' ' SD ' ' A' ' 14' ' ' MET . 14.6 ptt? -158.13 161.13 37.9 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.212 0.53 . . . . 0.0 112.122 -170.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -53.94 141.81 26.58 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.727 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.4 -27.29 57.96 Favored Glycine 0 CA--C 1.505 -0.582 0 CA-C-N 114.437 -1.256 . . . . 0.0 113.092 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 59.1 p -60.21 -25.96 66.01 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.469 0.652 . . . . 0.0 110.779 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -101.11 -49.41 4.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.8 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.87 -21.15 66.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.635 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -53.63 -32.41 51.25 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.55 -38.43 90.49 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.727 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.413 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -175.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.923 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.432 ' N ' HD12 ' A' ' 8' ' ' ILE . 4.1 mp -117.37 105.51 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 174.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -97.76 142.51 29.44 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.068 -170.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.58 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -118.49 145.21 24.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.085 179.463 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.5 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 48.9 mttm -102.07 128.35 48.56 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -125.2 126.5 70.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.874 0.845 . . . . 0.0 111.377 -176.486 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.6 m -117.28 151.05 37.76 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.81 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.557 ' SD ' ' HB ' ' A' ' 91' ' ' ILE . 69.2 mmm -101.31 160.48 14.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.757 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -134.41 146.5 49.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.352 -0.386 . . . . 0.0 109.988 175.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.78 -34.62 3.84 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -174.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.62 138.38 28.19 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 169.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -76.72 125.5 8.22 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.419 2.079 . . . . 0.0 112.735 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.469 ' HB2' ' CG ' ' A' ' 14' ' ' MET . 93.2 m-85 -152.17 165.5 34.61 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.709 174.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.34 105.88 5.57 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 177.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.524 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 10.8 mmm180 -125.86 155.51 41.06 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.691 -176.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 21' ' ' ARG . 5.5 mmtm -148.08 140.55 24.43 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 174.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 pt -145.66 173.49 3.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.09 0.471 . . . . 0.0 111.397 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.482 ' O ' HG21 ' A' ' 27' ' ' VAL . 9.9 t70 -115.83 140.85 48.82 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.399 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.558 HD12 ' SG ' ' A' ' 86' ' ' CYS . 15.6 mt -73.61 -47.71 38.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.166 -173.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -82.33 -11.56 58.52 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -169.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 24' ' ' ASP . 35.8 m -63.94 -17.87 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 120.867 0.365 . . . . 0.0 111.283 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -84.02 -28.1 27.9 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.085 0.469 . . . . 0.0 110.893 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.77 15.92 36.28 Favored Glycine 0 CA--C 1.519 0.302 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.384 175.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.05 175.68 31.29 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.777 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -69.5 -30.56 68.46 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -176.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.8 p -60.08 -54.93 40.17 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.553 -174.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -71.5 -28.43 63.9 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.508 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.407 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 20.8 tp -58.13 -55.66 32.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.185 0.516 . . . . 0.0 109.844 174.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.453 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 63.0 mt -67.58 -37.05 82.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.333 -177.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -70.72 -32.19 69.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.241 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.691 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -62.24 -42.46 99.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.761 176.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.453 ' CD1' ' HA ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -61.89 -50.37 72.48 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.744 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 45.5 mt-10 -51.76 -30.66 23.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.828 173.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.55 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 26.5 m -76.2 -43.03 44.24 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.65 178.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.691 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 63.9 mmm -54.79 -57.87 9.83 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -168.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.668 ' CZ ' HG21 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -107.14 10.31 30.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.223 -177.168 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.8 mptt 62.51 42.55 8.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.101 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.744 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 1.2 pp -149.45 168.82 22.39 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 175.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.0 m -93.81 104.18 16.27 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -165.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.9 mm -97.64 148.97 5.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 170.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.52 -168.88 38.35 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.302 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 45.37 83.02 0.03 OUTLIER 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.1 0.96 . . . . 0.0 113.526 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 73' ' ' LEU . 30.2 t80 -66.4 86.4 0.11 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 167.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 t -65.61 151.18 47.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.388 0.613 . . . . 0.0 110.837 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -73.3 -16.13 61.38 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.021 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.581 ' HD3' ' HG3' ' A' ' 53' ' ' GLU . 1.2 tmt_? -80.42 -54.73 5.43 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.581 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 33.1 mt-10 -121.53 -29.11 4.47 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.338 171.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 43.01 10.99 0.01 OUTLIER Glycine 0 C--O 1.218 -0.9 0 CA-C-N 114.213 -1.358 . . . . 0.0 116.325 -175.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.507 ' CE1' ' HB3' ' A' ' 72' ' ' MET . 19.4 m-85 -128.64 16.69 6.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 119.222 1.511 . . . . 0.0 111.529 178.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.449 ' H ' ' HG3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -70.57 -37.14 73.95 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.979 -172.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.415 ' N ' ' HE3' ' A' ' 56' ' ' LYS . . . 58.35 19.32 39.69 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.806 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.3 t 63.77 -82.9 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -169.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 40.0 tt0 -119.28 -20.16 8.03 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.611 173.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.436 ' CE1' ' HG3' ' A' ' 93' ' ' LYS . 37.3 m-85 -131.89 125.98 33.05 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.993 0.425 . . . . 0.0 111.395 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -105.85 105.28 52.67 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.129 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.44 ' HG3' HD13 ' A' ' 38' ' ' LEU . 28.4 Cg_endo -72.24 120.33 6.71 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 121.443 1.428 . . . . 0.0 111.166 173.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 72' ' ' MET . 61.0 p -124.64 150.85 45.6 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.228 -176.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 5.2 p90 -117.74 161.85 19.03 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.506 ' HB2' ' CZ2' ' A' ' 71' ' ' TRP . 42.0 tt0 -100.37 118.82 37.4 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 173.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.21 -178.31 6.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.965 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 mtmm -51.37 -42.9 61.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.789 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -86.38 -15.93 38.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.949 0.404 . . . . 0.0 111.018 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.02 29.37 8.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.799 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -94.56 148.25 22.45 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 172.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.538 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 65.9 m95 -115.86 114.37 24.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.958 0.409 . . . . 0.0 110.576 -178.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.507 ' HB3' ' CE1' ' A' ' 55' ' ' TYR . 17.4 mtm -135.86 177.89 7.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.484 ' HG ' ' HA ' ' A' ' 55' ' ' TYR . 6.0 mt -62.34 151.4 36.81 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.642 0.734 . . . . 0.0 110.532 177.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.9 m -78.03 135.09 26.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.47 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.4 8.03 50.54 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.4 -173.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.92 -53.26 49.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.687 0.28 . . . . 0.0 111.255 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.467 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 12.9 m -103.63 157.51 33.73 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 6.4 Cg_endo -48.74 127.04 15.72 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.333 2.689 . . . . 0.0 113.226 -178.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.572 ' O ' HG23 ' A' ' 83' ' ' VAL . 70.6 t-105 -40.85 -46.09 2.65 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 113.848 -1.524 . . . . 0.0 113.811 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.2 -42.95 82.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.713 0.292 . . . . 0.0 111.272 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.2 tmm? -83.88 -27.33 28.72 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.458 ' CD2' HG21 ' A' ' 77' ' ' VAL . 9.2 t80 -60.01 -50.98 71.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.649 -174.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 79' ' ' TRP . 3.8 t -59.75 -36.77 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.129 0.49 . . . . 0.0 111.371 -170.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.2 p -79.1 -11.33 59.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.502 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.6 t -101.5 -19.96 15.3 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.795 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.558 ' SG ' HD12 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -86.1 117.48 24.97 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.302 0.572 . . . . 0.0 110.513 179.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 9.6 ptmm? -118.06 -25.52 6.67 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.572 -174.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -139.78 158.41 44.14 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.62 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 6.6 tp -134.31 131.02 37.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.237 0.541 . . . . 0.0 110.741 -175.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -138.36 123.98 19.69 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.993 0.425 . . . . 0.0 110.654 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.668 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 10.6 mt -114.08 136.61 50.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -158.45 160.79 37.17 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.722 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 52.6 mttt -52.72 149.41 6.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.703 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -61.81 -25.93 66.37 Favored Glycine 0 CA--C 1.504 -0.612 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.731 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.9 t -75.16 -13.36 60.45 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.172 0.51 . . . . 0.0 110.715 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -101.52 -46.74 4.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.99 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.73 -23.87 63.47 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -57.15 -38.11 73.04 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.681 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.82 -37.05 93.68 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.229 -0.51 . . . . 0.0 113.458 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 C--N 1.327 -0.388 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -175.194 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.436 HD13 ' HD3' ' A' ' 26' ' ' ARG . 2.0 mp -112.25 104.17 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -92.71 129.08 38.75 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.05 -174.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.579 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -114.33 142.31 27.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.465 -175.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.614 ' HA ' ' HD2' ' A' ' 22' ' ' LYS . 47.6 mtmt -98.22 127.89 44.4 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.728 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -124.54 126.87 72.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.369 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.5 m -112.93 141.48 46.72 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.852 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.449 ' HG3' ' CD2' ' A' ' 19' ' ' TYR . 73.2 mmm -97.75 122.69 41.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.041 0.448 . . . . 0.0 110.807 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.99 130.99 51.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.389 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.32 -33.45 6.52 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.882 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.19 141.31 33.84 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.48 125.11 7.43 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.356 2.037 . . . . 0.0 113.171 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.449 ' CD2' ' HG3' ' A' ' 14' ' ' MET . 97.8 m-85 -152.65 169.48 22.61 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.486 ' C ' ' HD2' ' A' ' 21' ' ' ARG . 56.0 mt -137.75 102.05 4.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.047 0.451 . . . . 0.0 110.195 169.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.486 ' HD2' ' C ' ' A' ' 20' ' ' LEU . 3.6 mpt_? -129.56 138.67 51.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.285 174.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.614 ' HD2' ' HA ' ' A' ' 11' ' ' LYS . 35.3 mmtm -132.46 142.75 49.38 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 169.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 pt -143.33 174.01 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -172.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.436 ' OD1' HG11 ' A' ' 27' ' ' VAL . 3.8 t70 -115.37 143.97 44.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.754 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.516 HD22 ' SG ' ' A' ' 86' ' ' CYS . 40.7 mt -71.62 -44.0 65.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.287 0.565 . . . . 0.0 111.576 -175.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.518 ' HG2' HG11 ' A' ' 83' ' ' VAL . 40.6 mtm180 -80.16 -22.97 41.42 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -165.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.436 HG11 ' OD1' ' A' ' 24' ' ' ASP . 28.1 m -61.11 -12.97 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -92.47 -28.5 16.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.191 0.52 . . . . 0.0 111.079 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.7 14.77 23.63 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.26 -0.882 . . . . 0.0 113.889 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.35 174.35 34.03 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.379 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -69.36 -33.4 73.02 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.9 m -57.96 -53.75 54.7 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.297 -175.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -74.49 -27.17 60.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.286 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.7 tp -60.13 -55.28 35.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.176 0.512 . . . . 0.0 110.483 175.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.486 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 77.5 mt -66.2 -35.13 79.64 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.549 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -68.45 -33.41 74.14 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.464 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.688 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -64.94 -38.5 91.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.152 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.486 ' CD1' ' HA ' ' A' ' 35' ' ' LEU . 0.5 OUTLIER -61.82 -49.91 74.41 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.043 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.703 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 41.1 mt-10 -53.25 -29.12 31.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.922 173.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.545 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 33.7 m -76.29 -42.62 44.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.475 176.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.688 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 44.2 mmm -55.0 -57.02 13.38 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.141 -169.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.462 ' C ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -109.7 7.36 24.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.081 179.586 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 0.0 OUTLIER 61.19 40.84 14.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.963 174.26 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.703 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 2.2 pp -141.34 162.41 35.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.125 176.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.3 m -85.39 103.4 14.26 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -166.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.425 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 12.1 mm -89.22 151.09 3.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 168.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -115.91 -162.03 13.06 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 121.359 -0.448 . . . . 0.0 112.76 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -89.56 171.84 9.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.764 0.792 . . . . 0.0 112.233 -174.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.457 ' CE2' ' HB2' ' A' ' 73' ' ' LEU . 41.4 t80 -72.62 81.3 1.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.292 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 54' ' ' GLY . 14.0 m -57.79 107.82 0.5 Allowed 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.356 175.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -55.74 -26.66 46.63 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -166.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.616 ' HD2' ' N ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -58.2 -49.28 77.62 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -176.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.616 ' N ' ' HD2' ' A' ' 52' ' ' ARG . 48.6 mt-10 -119.51 -26.98 5.64 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.702 0.763 . . . . 0.0 110.252 172.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 50' ' ' SER . . . 54.28 10.04 1.76 Allowed Glycine 0 C--O 1.213 -1.164 0 CA-C-N 113.913 -1.494 . . . . 0.0 115.695 177.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.58 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 19.0 m-85 -127.7 14.96 7.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 119.25 1.525 . . . . 0.0 112.355 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.712 ' HD3' ' N ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -74.66 -45.47 44.37 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.457 171.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.712 ' N ' ' HD3' ' A' ' 56' ' ' LYS . . . 58.38 -27.79 0.02 OUTLIER Glycine 0 CA--C 1.529 0.916 0 CA-C-N 115.246 -0.888 . . . . 0.0 114.485 -172.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.605 ' H ' ' C ' ' A' ' 56' ' ' LYS . 26.8 t 150.09 -138.75 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -175.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 31.2 tt0 -83.83 -5.48 59.21 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 166.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.421 ' HB2' ' CD1' ' A' ' 46' ' ' ILE . 32.1 m-85 -133.96 130.51 37.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.233 173.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.512 ' HB3' HD23 ' A' ' 73' ' ' LEU . . . -115.51 105.59 51.83 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.28 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.466 ' O ' HD22 ' A' ' 73' ' ' LEU . 32.7 Cg_endo -69.7 120.39 7.19 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 121.952 1.768 . . . . 0.0 112.08 174.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 72' ' ' MET . 38.3 p -123.73 159.51 29.28 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.436 -176.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.555 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 5.0 p90 -135.24 166.25 23.55 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.05 -177.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.548 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 44.1 tt0 -111.58 124.8 53.04 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.565 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.465 ' OD2' ' HG2' ' A' ' 67' ' ' LYS . 23.2 t70 -88.81 -179.81 6.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.968 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.465 ' HG2' ' OD2' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -63.91 -28.58 69.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.508 0.671 . . . . 0.0 110.229 179.26 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -68.11 -18.57 64.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.412 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.57 11.57 71.17 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -95.3 149.56 21.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.149 -0.525 . . . . 0.0 110.111 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.555 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 36.0 m95 -119.82 132.79 55.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.028 -176.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.548 ' HE3' ' CE1' ' A' ' 64' ' ' TYR . 2.0 mpp? -143.11 -179.73 6.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 171.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.58 ' HG ' ' HA ' ' A' ' 55' ' ' TYR . 4.8 mt -63.06 154.14 31.77 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.893 0.854 . . . . 0.0 110.996 175.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.539 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 57.9 t -78.69 122.2 33.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.866 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.06 -1.18 28.45 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -171.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.34 -46.58 79.88 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.994 0.426 . . . . 0.0 110.313 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.404 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 16.0 m -108.62 154.94 41.35 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 173.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 10.9 Cg_endo -54.59 136.57 70.94 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.88 2.387 . . . . 0.0 113.098 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.483 ' O ' HG21 ' A' ' 83' ' ' VAL . 65.1 t-105 -40.64 -48.39 2.91 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 124.096 0.872 . . . . 0.0 112.978 -173.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -53.52 -42.22 67.18 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.782 -177.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 77.2 mtp -82.67 -23.08 34.37 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.262 0.553 . . . . 0.0 110.374 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.539 ' CZ ' ' HA ' ' A' ' 74' ' ' VAL . 7.4 t80 -70.51 -46.49 63.56 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.02 -171.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.518 HG11 ' HG2' ' A' ' 26' ' ' ARG . 3.4 t -61.32 -38.57 80.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.193 0.52 . . . . 0.0 111.478 -171.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.9 p -78.76 -12.52 60.03 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.029 -175.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.2 p -106.52 -31.43 8.52 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.516 ' SG ' HD22 ' A' ' 25' ' ' LEU . 34.0 t -71.92 116.27 12.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.268 0.556 . . . . 0.0 110.978 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -119.38 -19.43 8.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.063 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.548 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 55.9 mtt180 -139.34 156.63 46.89 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 174.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.728 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 5.7 tp -136.12 134.44 38.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.992 0.425 . . . . 0.0 111.247 -173.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.0 ttp180 -140.51 123.58 16.6 Favored 'General case' 0 C--N 1.318 -0.778 0 O-C-N 122.011 -0.431 . . . . 0.0 111.227 168.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.408 HD13 HG23 ' A' ' 91' ' ' ILE . 4.4 mt -106.43 136.03 42.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 168.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -159.0 163.34 36.52 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.15 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 34.0 mtpt -48.55 140.71 7.76 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 124.25 0.969 . . . . 0.0 112.756 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -58.86 -36.33 86.78 Favored Glycine 0 CA--C 1.505 -0.547 0 CA-C-N 113.689 -1.596 . . . . 0.0 113.713 -168.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.405 ' HA ' ' HD3' ' A' ' 98' ' ' LYS . 38.9 p -60.55 -19.86 58.59 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.072 0.463 . . . . 0.0 111.807 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -97.5 -43.56 7.2 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.723 -174.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.58 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -71.16 -29.42 65.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.483 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 95' ' ' THR . 15.1 ptmm? -69.72 -6.86 34.7 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.597 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.96 -7.18 50.9 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.413 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 97' ' ' ALA . 4.0 pp . . . . . 0 CA--C 1.514 -0.415 0 O-C-N 122.496 -0.414 . . . . 0.0 110.929 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.685 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.6 mt -70.12 111.88 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.757 0.313 . . . . 0.0 110.243 175.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -89.59 139.24 30.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.69 -176.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -118.55 148.31 21.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 176.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.54 ' HA ' ' HD2' ' A' ' 22' ' ' LYS . 56.3 mtmt -107.29 130.25 54.79 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.705 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -126.4 129.41 71.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.971 -176.359 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.4 m -109.51 146.64 34.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.639 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.543 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 23.1 tpp -97.53 125.2 42.09 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.854 175.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.5 140.65 37.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.913 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.1 -33.66 4.79 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.683 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.543 ' O ' ' HG3' ' A' ' 14' ' ' MET . . . -134.75 140.2 34.61 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 120.661 0.267 . . . . 0.0 110.556 171.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.49 125.08 7.41 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.428 2.085 . . . . 0.0 112.759 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -153.19 168.17 26.85 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 123.048 0.539 . . . . 0.0 109.944 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.42 98.69 4.15 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.664 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 1.6 ptp180 -134.33 123.0 23.45 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.391 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.664 ' HD3' ' O ' ' A' ' 21' ' ' ARG . 60.7 mmtt -120.43 157.19 29.86 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 117.973 0.351 . . . . 0.0 110.602 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -144.99 172.57 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 120.868 0.366 . . . . 0.0 111.849 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.602 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -112.96 130.66 56.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.225 0.536 . . . . 0.0 110.225 -173.029 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.5 tp -70.11 -45.5 66.79 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -169.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -79.41 -10.86 59.89 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 24' ' ' ASP . 20.8 m -84.27 -0.55 5.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.521 -0.471 . . . . 0.0 112.246 -173.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.622 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 23.3 m-85 -84.12 -31.09 25.43 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.583 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 44.75 48.21 9.11 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.745 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.89 172.99 13.81 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.135 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -70.07 -29.85 66.95 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -176.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.5 m -59.36 -53.73 54.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.749 0.309 . . . . 0.0 111.37 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.622 ' HB2' ' O ' ' A' ' 28' ' ' TYR . 49.2 mm-40 -73.67 -29.74 62.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.521 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.4 tp -55.22 -56.64 17.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.103 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.6 mt -68.94 -38.74 79.66 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.592 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -67.8 -33.09 74.14 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.276 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.659 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -61.4 -41.47 97.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.54 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.474 HD11 ' HG3' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -65.58 -46.51 79.15 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.132 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 43.6 mt-10 -51.29 -32.71 25.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.441 174.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.536 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 50.2 m -73.79 -41.83 61.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.154 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.659 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 55.9 mmm -56.71 -56.66 18.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.635 -169.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.0 9.12 38.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.083 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.9 mttt 62.04 40.93 11.61 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.618 174.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 3.0 pp -145.01 174.14 11.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.157 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.1 m -102.99 100.78 10.74 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -171.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.434 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 31.5 mm -69.82 139.48 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 168.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.36 -162.3 34.11 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.293 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.58 167.3 12.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.025 0.44 . . . . 0.0 110.839 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.713 ' CE1' HD11 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -63.89 93.03 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.362 172.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.407 ' HB2' ' HA2' ' A' ' 54' ' ' GLY . 1.5 m -61.85 134.06 56.23 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.7 -23.96 60.94 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -168.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.675 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -82.15 -51.5 7.91 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.104 -0.638 . . . . 0.0 112.412 -174.019 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.675 ' N ' ' HD3' ' A' ' 52' ' ' ARG . 60.8 mt-10 -121.3 -31.22 4.13 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 118.956 0.798 . . . . 0.0 110.712 168.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.688 ' O ' HD12 ' A' ' 73' ' ' LEU . . . 38.08 7.78 0.0 OUTLIER Glycine 0 C--O 1.221 -0.701 0 CA-C-N 113.535 -1.666 . . . . 0.0 116.269 -168.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.507 ' CE1' ' HG ' ' A' ' 73' ' ' LEU . 3.8 m-30 -96.24 3.6 52.99 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 118.507 1.154 . . . . 0.0 110.753 -171.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.643 ' C ' ' H ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -69.51 -36.17 76.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.923 168.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 60' ' ' TYR . . . 59.52 -24.11 0.03 OUTLIER Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.321 -0.854 . . . . 0.0 114.399 -174.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.643 ' H ' ' C ' ' A' ' 56' ' ' LYS . 44.4 t 146.91 -89.75 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 -176.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -118.44 -3.15 10.96 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 161.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.47 ' O ' ' HA3' ' A' ' 57' ' ' GLY . 46.9 m-85 -137.47 130.05 29.86 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.748 -175.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 55' ' ' TYR . . . -101.67 104.46 34.89 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.129 176.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.566 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 60.3 Cg_endo -73.06 121.5 7.32 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.093 1.862 . . . . 0.0 111.496 172.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.6 p -132.52 164.17 27.21 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.03 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 5.0 p90 -141.61 165.68 26.82 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.52 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 30.7 tt0 -104.98 122.81 46.62 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.734 175.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.08 179.51 7.25 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.378 0.424 . . . . 0.0 110.781 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.0 mtmm -48.61 -46.95 40.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.044 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -86.6 -10.91 52.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.978 0.418 . . . . 0.0 111.382 -174.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.11 29.5 8.45 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.644 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -93.1 148.84 21.67 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 171.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.493 ' CZ2' ' HB2' ' A' ' 65' ' ' GLU . 66.2 m95 -119.16 113.85 21.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.806 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -130.23 -179.65 5.37 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 171.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.713 HD11 ' CE1' ' A' ' 49' ' ' TYR . 76.7 mt -65.62 156.27 33.3 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.344 0.592 . . . . 0.0 111.089 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.407 ' HA ' ' HZ ' ' A' ' 82' ' ' PHE . 30.2 m -75.87 128.98 37.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.494 176.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.46 8.21 56.36 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.412 -173.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.67 -61.22 2.57 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.596 0.236 . . . . 0.0 111.454 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.415 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 16.1 m -98.87 161.85 23.53 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.402 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 85.4 Cg_exo -46.25 131.96 14.94 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.189 2.593 . . . . 0.0 113.217 177.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.542 ' O ' HG23 ' A' ' 83' ' ' VAL . 66.9 t-105 -47.59 -42.19 23.38 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.816 -173.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -59.11 -42.45 90.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.946 0.403 . . . . 0.0 111.335 -176.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 73.7 mtm -82.39 -21.89 35.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.202 0.525 . . . . 0.0 109.982 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.407 ' HZ ' ' HA ' ' A' ' 74' ' ' VAL . 6.7 t80 -65.7 -55.34 17.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.348 -175.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 79' ' ' TRP . 3.0 t -61.1 -38.14 78.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.153 -171.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.7 p -76.21 -10.2 59.22 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.733 -175.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.5 m -102.7 -19.15 14.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.313 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 74.0 m -76.18 112.8 13.02 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.249 0.547 . . . . 0.0 111.823 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -118.08 -26.59 6.34 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.022 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.52 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 71.9 mtt180 -139.73 154.86 47.55 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.705 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 8.5 tp -131.67 138.35 48.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.489 -175.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.441 ' HD3' ' SD ' ' A' ' 92' ' ' MET . 10.8 ttm180 -141.11 121.45 13.97 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.243 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.0 mt -120.2 134.26 64.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 168.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.441 ' SD ' ' HD3' ' A' ' 90' ' ' ARG . 23.5 ptt? -158.96 164.31 35.71 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 123.319 0.387 . . . . 0.0 111.863 -172.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -47.11 129.46 12.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.991 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -65.51 -31.56 80.58 Favored Glycine 0 CA--C 1.506 -0.469 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.795 -172.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.8 p -66.98 -23.27 65.92 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.165 -0.518 . . . . 0.0 111.633 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -100.03 -18.23 17.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.813 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.576 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -71.18 -22.22 62.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.47 0.652 . . . . 0.0 110.303 176.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -57.33 -26.07 60.35 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.504 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.85 -33.76 85.08 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.86 -176.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 97' ' ' ALA . 3.6 pp . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 117.624 0.712 . . . . 0.0 111.868 -175.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.455 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.451 HD12 ' HD2' ' A' ' 26' ' ' ARG . 2.7 mp -82.23 110.05 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.049 0.452 . . . . 0.0 110.151 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -111.14 116.31 30.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.564 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.544 ' CG2' ' HB2' ' A' ' 89' ' ' LEU . 2.9 m -116.37 151.95 18.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -94.86 133.02 39.04 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.131 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.677 ' HB ' ' HB3' ' A' ' 89' ' ' LEU . 1.5 p -148.39 122.45 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 O-C-N 124.037 0.836 . . . . 0.0 110.844 173.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.507 ' HB2' ' N ' ' A' ' 21' ' ' ARG . 7.5 t -160.03 112.41 2.06 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.482 163.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.818 ' HE1' ' O ' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -168.02 141.54 3.3 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 118.282 -1.367 . . . . 0.0 113.888 175.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.406 ' HB2' ' OH ' ' A' ' 60' ' ' TYR . 4.2 p-10 -140.58 76.75 1.57 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.341 0.591 . . . . 0.0 111.619 162.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.505 ' H ' ' CE ' ' A' ' 14' ' ' MET . . . 88.81 -30.71 5.28 Favored Glycine 0 C--O 1.229 -0.174 0 C-N-CA 121.371 -0.442 . . . . 0.0 112.115 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.515 ' O ' ' HG2' ' A' ' 14' ' ' MET . . . -121.21 150.29 53.53 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 177.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.73 129.75 15.99 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.439 2.093 . . . . 0.0 113.736 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 13' ' ' SER . 49.5 m-85 -134.67 172.71 12.56 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.9 mt -136.26 104.14 5.54 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.212 0.529 . . . . 0.0 112.425 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.507 ' N ' ' HB2' ' A' ' 13' ' ' SER . 0.2 OUTLIER -129.91 173.21 10.9 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 167.319 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -137.85 148.93 45.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 118.979 0.809 . . . . 0.0 111.418 175.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.477 HD13 ' CD2' ' A' ' 89' ' ' LEU . 8.8 pt -129.41 175.09 11.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.861 170.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.497 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.6 OUTLIER -109.53 124.64 51.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -176.421 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.447 HD23 HG12 ' A' ' 83' ' ' VAL . 3.2 tp -72.18 -44.85 62.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.073 -167.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.451 ' HD2' HD12 ' A' ' 8' ' ' ILE . 47.2 mtp180 -79.4 -22.63 44.05 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -172.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 24' ' ' ASP . 20.7 m -65.49 -11.23 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.834 0.349 . . . . 0.0 111.719 -172.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -84.48 -27.26 27.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.006 0.431 . . . . 0.0 110.564 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.26 14.73 20.18 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 114.95 -1.023 . . . . 0.0 113.78 173.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.36 169.82 30.47 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 -176.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -70.49 -32.66 70.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -175.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.0 m -59.27 -53.86 53.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.661 0.267 . . . . 0.0 111.226 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -73.42 -30.1 63.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.726 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.446 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 9.8 tp -59.6 -55.53 33.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.38 177.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.594 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 54.1 mt -66.37 -35.99 81.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.137 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -64.39 -33.8 76.7 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.275 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.576 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -72.43 -32.56 66.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.955 0.407 . . . . 0.0 111.036 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.594 ' CD1' ' HA ' ' A' ' 35' ' ' LEU . 2.2 mt -66.9 -51.65 52.77 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.52 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -52.39 -32.43 38.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.884 173.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.568 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 20.5 m -71.37 -34.22 70.25 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.619 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.576 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 73.2 mmm -64.59 -56.71 12.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.783 0.325 . . . . 0.0 111.852 -170.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.41 12.93 25.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.09 0.472 . . . . 0.0 112.119 -177.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.8 mmtm 62.17 53.68 2.85 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.278 170.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 pp -150.28 -172.66 4.23 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.325 -0.235 . . . . 0.0 110.774 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.0 m -100.08 128.04 46.22 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -174.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.535 HG13 ' HB2' ' A' ' 38' ' ' LEU . 41.5 mm -105.16 133.39 49.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.007 174.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.517 ' HA3' ' OG ' ' A' ' 58' ' ' SER . . . -92.09 140.18 15.03 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.228 -0.987 . . . . 0.0 111.235 171.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.17 -179.42 1.95 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.46 0.647 . . . . 0.0 111.896 -173.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -73.56 82.05 1.5 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.661 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 54' ' ' GLY . 3.2 m -64.64 115.8 5.58 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.338 173.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.11 -18.6 37.05 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -169.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.588 ' HD3' ' HG3' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -69.42 -49.27 56.76 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -177.264 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.588 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 44.1 mt-10 -120.11 -27.54 5.29 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.678 0.751 . . . . 0.0 111.238 174.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.502 ' O ' HD22 ' A' ' 73' ' ' LEU . . . 46.29 8.27 0.02 OUTLIER Glycine 0 C--O 1.219 -0.813 0 CA-C-N 113.787 -1.551 . . . . 0.0 116.8 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.474 ' HA ' HD13 ' A' ' 73' ' ' LEU . 12.9 m-85 -127.81 9.24 6.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 119.286 1.543 . . . . 0.0 111.223 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.717 ' HE3' ' N ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -74.42 -24.56 59.11 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.996 -171.636 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.717 ' N ' ' HE3' ' A' ' 56' ' ' LYS . . . 59.88 -8.07 0.06 OUTLIER Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.283 -0.871 . . . . 0.0 114.551 -175.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.517 ' OG ' ' HA3' ' A' ' 47' ' ' GLY . 16.1 m 69.13 -72.44 0.1 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -171.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 33.2 tt0 -119.9 -27.87 5.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.096 166.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.416 ' HB2' HD12 ' A' ' 46' ' ' ILE . 11.1 m-85 -134.86 124.98 25.89 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 120.906 0.384 . . . . 0.0 111.001 176.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.446 ' HB2' ' CD1' ' A' ' 73' ' ' LEU . . . -102.46 105.93 46.34 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.202 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.558 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 38.1 Cg_endo -69.69 119.69 6.6 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.936 1.757 . . . . 0.0 111.335 174.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.588 ' OG1' ' HE1' ' A' ' 92' ' ' MET . 43.4 p -126.07 162.12 26.05 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.175 0.512 . . . . 0.0 110.767 -176.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.627 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 3.5 p90 -132.84 165.18 25.19 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.307 -177.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.418 ' HB2' ' CZ2' ' A' ' 71' ' ' TRP . 30.9 tt0 -108.42 115.77 30.72 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.46 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.552 ' OD2' ' HG2' ' A' ' 67' ' ' LYS . 17.7 t70 -80.53 -176.8 5.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.819 176.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.552 ' HG2' ' OD2' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -62.83 -39.37 94.12 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -171.33 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.428 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . 20.6 t70 -83.0 -0.98 51.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.18 0.514 . . . . 0.0 110.602 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.41 24.39 28.84 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.177 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.428 ' OD2' ' HB3' ' A' ' 68' ' ' ASP . 20.1 m-20 -81.52 129.0 34.5 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.627 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 71.7 m95 -110.3 113.79 26.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.019 0.438 . . . . 0.0 110.813 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 63' ' ' THR . 25.6 mtm -134.81 176.48 8.61 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' A' ' 62' ' ' PRO . 1.2 tp -68.66 154.89 41.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.498 0.665 . . . . 0.0 111.04 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.592 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 3.7 m -77.83 124.38 36.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.136 175.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.94 3.5 28.17 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -172.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.13 -56.65 15.02 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.037 0.446 . . . . 0.0 109.93 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.443 HG22 ' CD2' ' A' ' 82' ' ' PHE . 6.3 m -100.98 154.68 37.0 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 173.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 11.0 Cg_endo -54.45 136.86 71.15 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.879 2.386 . . . . 0.0 113.075 -176.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.481 ' O ' HG22 ' A' ' 83' ' ' VAL . 69.9 t-105 -40.09 -53.03 2.48 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -174.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -51.58 -43.02 62.31 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.046 0.45 . . . . 0.0 111.674 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 77.7 mtp -83.91 -24.54 30.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.468 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.592 ' CZ ' ' HA ' ' A' ' 74' ' ' VAL . 13.4 t80 -68.81 -38.21 79.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.676 -173.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 79' ' ' TRP . 3.3 t -61.17 -42.86 94.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.897 0.38 . . . . 0.0 111.407 -172.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.5 p -78.52 -13.94 59.59 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.465 0.65 . . . . 0.0 110.588 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.1 t -81.42 -31.41 33.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.651 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.428 ' HA ' ' HD2' ' A' ' 64' ' ' TYR . 43.5 t -86.52 131.67 34.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.736 0.779 . . . . 0.0 112.202 -175.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -119.37 -36.74 3.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.263 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -139.14 153.15 47.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.931 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.677 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 12.4 tp -130.5 127.39 39.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.234 0.54 . . . . 0.0 111.716 -174.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.415 ' HB3' ' CZ3' ' A' ' 71' ' ' TRP . 37.5 ttp180 -140.33 130.0 24.32 Favored 'General case' 0 C--N 1.31 -1.137 0 O-C-N 121.374 -0.829 . . . . 0.0 110.929 171.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.818 ' O ' ' HE1' ' A' ' 14' ' ' MET . 8.8 mt -109.41 132.15 58.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.601 ' HA ' ' CE ' ' A' ' 14' ' ' MET . 3.1 ptt? -139.09 141.23 38.16 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -168.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 0.1 OUTLIER -48.38 141.03 7.05 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.229 174.187 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.13 -28.5 49.5 Favored Glycine 0 CA--C 1.508 -0.405 0 CA-C-N 115.398 -0.819 . . . . 0.0 114.146 -169.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.2 t -66.38 -12.79 58.84 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.134 0.493 . . . . 0.0 111.301 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -101.76 -51.53 3.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.614 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.55 -23.81 66.27 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -172.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -57.03 -28.65 62.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.177 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.33 -37.01 22.37 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.638 -176.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.489 HD13 ' HE2' ' A' ' 92' ' ' MET . 2.2 pt? . . . . . 0 C--N 1.324 -0.521 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -173.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 41.0 m80 . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -122.35 77.65 1.43 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.381 0.61 . . . . 0.0 110.268 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.13 -1.58 3.64 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.275 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -126.44 72.3 1.32 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.293 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.1 t -129.31 114.87 33.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.03 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.605 ' HA2' ' CG ' ' A' ' 24' ' ' ASP . . . 71.75 90.95 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.78 -177.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.84 -48.48 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.539 -1.025 . . . . 0.0 110.539 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.82 HD13 ' CZ ' ' A' ' 26' ' ' ARG . 3.8 mp -94.71 106.23 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-O 121.411 0.625 . . . . 0.0 109.941 173.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -91.55 138.18 31.77 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.473 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.574 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -115.86 140.03 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -174.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.601 ' HA ' ' CD ' ' A' ' 22' ' ' LYS . 8.1 mptt -107.04 128.35 54.29 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.46 -0.791 . . . . 0.0 108.886 -174.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.766 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -124.65 133.3 69.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.474 0.654 . . . . 0.0 112.044 -169.791 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.5 m -131.9 155.5 47.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.583 -174.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 31.0 tpp -113.6 148.28 36.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.619 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -116.06 142.26 47.04 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.98 -32.57 3.74 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.457 ' O ' ' HG3' ' A' ' 14' ' ' MET . . . -133.2 142.66 45.22 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 171.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.99 124.76 7.55 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 121.924 1.749 . . . . 0.0 112.685 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.417 ' HB2' ' HB3' ' A' ' 14' ' ' MET . 68.0 m-85 -151.5 142.55 23.12 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.953 174.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.553 ' O ' ' HD2' ' A' ' 21' ' ' ARG . 5.1 mp -130.17 104.67 7.45 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.101 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.553 ' HD2' ' O ' ' A' ' 20' ' ' LEU . 3.2 mpt_? -126.43 164.1 21.86 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.316 176.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.601 ' CD ' ' HA ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -154.95 143.86 20.85 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.505 HD13 ' HH ' ' A' ' 28' ' ' TYR . 0.2 OUTLIER -153.54 174.01 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 O-C-N 123.34 0.4 . . . . 0.0 111.599 -175.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.605 ' CG ' ' HA2' ' A' ' 6' ' ' GLY . 6.4 t70 -115.17 146.96 40.87 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.184 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.489 ' HG ' ' CG2' ' A' ' 10' ' ' VAL . 70.5 mt -72.13 -40.27 68.22 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -175.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.82 ' CZ ' HD13 ' A' ' 8' ' ' ILE . 9.4 mpt_? -71.08 -30.9 67.14 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -173.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 24' ' ' ASP . 36.0 m -62.78 -2.86 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -170.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.505 ' HH ' HD13 ' A' ' 23' ' ' ILE . 55.2 m-85 -99.21 -27.65 13.7 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.914 0.388 . . . . 0.0 111.731 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.45 12.91 14.57 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.986 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.72 171.03 32.36 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.245 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -70.0 -29.83 67.01 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.8 p -56.71 -53.72 54.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.92 0.391 . . . . 0.0 111.17 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -73.25 -27.09 61.38 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.086 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 20.8 tp -58.26 -54.01 51.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.866 0.365 . . . . 0.0 110.144 175.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.412 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 96.0 mt -66.19 -38.52 88.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.841 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.469 ' HD3' ' O ' ' A' ' 36' ' ' LYS . 1.7 tmtp? -66.0 -33.92 76.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.352 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.678 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -63.5 -40.96 98.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.286 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.438 HD12 ' HG3' ' A' ' 62' ' ' PRO . 0.4 OUTLIER -62.56 -49.32 75.74 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.056 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 28.2 mt-10 -52.87 -33.66 50.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.111 175.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.553 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 38.4 m -73.03 -39.63 65.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.245 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.678 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 93.1 mmm -58.2 -55.65 32.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.311 -168.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -104.26 10.38 35.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.013 0.435 . . . . 0.0 111.111 -174.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.58 53.6 4.04 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.649 177.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 pp -154.78 -167.07 2.48 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 61.2 m -117.69 117.04 28.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.959 0.409 . . . . 0.0 111.638 -177.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.415 ' CD1' ' HB2' ' A' ' 60' ' ' TYR . 34.8 mm -85.76 135.44 24.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.329 175.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.9 143.56 33.69 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.497 173.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -73.38 172.9 10.38 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.122 0.487 . . . . 0.0 111.46 -174.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -76.42 79.14 3.15 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.777 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.5 m -59.29 123.21 15.99 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.05 -11.24 47.06 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -168.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.505 ' HD2' ' N ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -78.9 -49.79 12.28 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.025 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.505 ' N ' ' HD2' ' A' ' 52' ' ' ARG . 90.8 mt-10 -119.32 -29.16 5.23 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.756 -0.59 . . . . 0.0 112.076 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.498 ' O ' HD11 ' A' ' 73' ' ' LEU . . . 41.78 12.1 0.01 OUTLIER Glycine 0 C--O 1.216 -1.022 0 N-CA-C 117.067 1.587 . . . . 0.0 117.067 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.576 ' HA ' ' CD1' ' A' ' 73' ' ' LEU . 17.5 m-30 -124.26 1.1 8.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 119.493 1.647 . . . . 0.0 110.492 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.422 ' HD3' ' H ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -64.78 -52.94 54.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.787 -175.602 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.422 ' H ' ' HD3' ' A' ' 56' ' ' LYS . . . 59.1 7.87 5.54 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 116.286 -0.415 . . . . 0.0 113.84 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.5 t 65.9 -82.72 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.199 0.6 . . . . 0.0 110.179 -171.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 40.5 tt0 -117.16 -15.64 10.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.595 0.236 . . . . 0.0 110.821 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.463 ' CZ ' ' HG3' ' A' ' 93' ' ' LYS . 57.7 m-85 -136.63 126.04 25.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.764 0.316 . . . . 0.0 111.432 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.412 ' HB2' HD12 ' A' ' 73' ' ' LEU . . . -103.92 105.79 49.92 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.801 175.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.466 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 28.6 Cg_endo -64.55 120.71 8.07 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.008 1.805 . . . . 0.0 111.243 172.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 72' ' ' MET . 35.9 p -127.22 154.05 45.33 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.214 0.53 . . . . 0.0 110.24 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.637 ' OH ' ' HE1' ' A' ' 72' ' ' MET . 44.0 p90 -135.28 167.04 21.75 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.744 -175.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.525 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 33.6 tt0 -108.29 117.35 33.93 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.37 179.38 7.69 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.467 ' HD2' ' N ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -64.18 -25.88 68.27 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.467 ' N ' ' HD2' ' A' ' 67' ' ' LYS . 35.1 t70 -78.15 -18.4 55.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.22 0.533 . . . . 0.0 110.095 177.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.18 15.51 47.73 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.339 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -96.41 142.38 28.59 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.553 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 68.9 m95 -101.13 118.94 37.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.432 0.634 . . . . 0.0 110.828 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.637 ' HE1' ' OH ' ' A' ' 64' ' ' TYR . 45.1 mtm -125.4 171.75 10.19 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.414 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.576 ' CD1' ' HA ' ' A' ' 55' ' ' TYR . 7.5 tt -91.63 142.17 27.92 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.432 ' N ' HD21 ' A' ' 73' ' ' LEU . 19.7 m -58.85 143.06 13.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.103 -174.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.37 3.06 25.99 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.881 -173.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -80.23 -59.54 2.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.927 0.394 . . . . 0.0 110.712 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.429 HG13 ' HD2' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -96.55 153.25 38.88 Favored Pre-proline 0 N--CA 1.445 -0.717 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 175.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.429 ' HD2' HG13 ' A' ' 77' ' ' VAL . 7.5 Cg_exo -74.2 155.32 46.92 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.475 2.117 . . . . 0.0 110.791 176.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.696 ' O ' HG22 ' A' ' 83' ' ' VAL . 61.9 t-105 -46.38 -49.64 17.6 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.862 0.726 . . . . 0.0 112.695 -171.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -55.97 -42.18 75.9 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -171.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 78.8 mtp -83.53 -33.74 25.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.239 0.543 . . . . 0.0 110.472 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.605 ' HZ ' ' CD2' ' A' ' 64' ' ' TYR . 7.1 t80 -58.32 -50.93 71.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.95 -175.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 79' ' ' TRP . 2.1 t -60.64 -39.22 80.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.126 0.488 . . . . 0.0 111.307 -171.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.6 p -79.57 -11.7 59.87 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -175.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.5 p -108.8 -28.65 9.08 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -174.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 40.4 t -66.14 136.42 55.91 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.026 0.441 . . . . 0.0 111.051 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.485 ' HZ3' ' HB3' ' A' ' 87' ' ' LYS . 7.6 mtpm? -116.86 -40.5 3.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.739 -175.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.525 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 69.9 mtt180 -137.59 161.89 35.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.198 -175.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.766 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 6.5 tp -133.76 122.97 24.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.752 -172.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -139.7 119.67 13.52 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 121.829 -0.545 . . . . 0.0 110.508 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.427 HG22 ' HA ' ' A' ' 62' ' ' PRO . 10.3 mt -116.74 135.14 58.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.427 ' HA ' ' SD ' ' A' ' 14' ' ' MET . 25.5 ptt? -159.25 162.95 36.21 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.336 0.589 . . . . 0.0 112.357 -174.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 36.4 mttt -56.93 146.78 25.61 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.062 -1.426 . . . . 0.0 113.086 -176.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -60.3 -30.09 70.31 Favored Glycine 0 CA--C 1.507 -0.454 0 CA-C-N 114.125 -1.398 . . . . 0.0 113.726 -174.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.452 HG21 ' HB3' ' A' ' 93' ' ' LYS . 1.5 t -56.78 -26.09 56.82 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.161 0.505 . . . . 0.0 111.337 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -102.67 -34.78 8.93 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.167 0.508 . . . . 0.0 110.346 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.08 -23.4 67.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.578 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.453 ' HA ' ' HB3' ' A' ' 106' ' ' SER . 16.0 pttp -62.39 -19.53 63.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.962 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -71.77 -40.61 57.94 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.39 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.51 11.53 37.76 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 122.599 -0.354 . . . . 0.0 110.87 -178.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.7 71.83 0.68 Allowed Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 173.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 59.1 m -55.21 105.2 0.15 Allowed 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.618 0.767 . . . . 0.0 112.554 -175.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 72.99 65.92 2.16 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 114.439 -1.255 . . . . 0.0 113.054 172.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 42.8 t 59.98 92.19 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.54 0.686 . . . . 0.0 110.324 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -140.86 -50.35 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.455 -0.879 . . . . 0.0 113.089 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.453 ' HB3' ' HA ' ' A' ' 98' ' ' LYS . 8.5 t -132.54 116.98 17.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.858 0.329 . . . . 0.0 111.338 -173.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.177 -0.916 . . . . 0.0 112.17 171.892 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 74.3 t60 . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.698 0.285 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -82.92 74.58 9.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.816 0.341 . . . . 0.0 111.705 -174.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 53.7 61.53 3.05 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.502 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.2 t70 63.28 108.71 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.415 0.686 . . . . 0.0 111.653 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.1 m -84.05 158.16 3.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.373 -176.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 148.97 153.25 5.95 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.117 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.93 -25.94 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.073 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 3.2 mp -114.06 104.5 17.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.184 0.516 . . . . 0.0 109.985 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -115.07 118.56 33.72 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.231 -172.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.569 ' CG2' ' HB2' ' A' ' 89' ' ' LEU . 4.1 m -116.25 162.51 14.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.165 -177.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.52 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 18.8 ptmt -104.07 134.33 47.52 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.702 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -126.47 128.08 70.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.607 0.717 . . . . 0.0 111.322 -177.003 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.3 t -122.56 155.2 36.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.763 175.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.727 ' SD ' ' HB ' ' A' ' 91' ' ' ILE . 68.6 mmm -103.18 141.92 35.04 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.847 0.356 . . . . 0.0 111.052 -177.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -110.44 125.02 52.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.024 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.34 -32.75 6.89 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -177.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.05 142.98 42.21 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 172.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.89 122.87 6.5 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 121.554 1.503 . . . . 0.0 112.355 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.478 ' HB2' ' CG ' ' A' ' 14' ' ' MET . 75.4 m-85 -153.43 151.68 30.17 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.044 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -127.81 105.56 8.52 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.008 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.481 ' C ' ' HG2' ' A' ' 22' ' ' LYS . 31.8 mmt180 -127.97 156.1 43.22 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' A' ' 11' ' ' LYS . 4.9 mmtm -147.81 130.18 15.71 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.0 pt -140.95 173.31 9.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.66 0.743 . . . . 0.0 112.168 -174.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.639 ' OD1' ' HG2' ' A' ' 26' ' ' ARG . 7.3 t70 -113.62 126.94 55.83 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.687 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.403 ' HB3' HG12 ' A' ' 83' ' ' VAL . 6.8 mp -70.8 -39.85 72.86 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.697 -174.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.639 ' HG2' ' OD1' ' A' ' 24' ' ' ASP . 8.4 ptm180 -77.66 -23.51 49.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.83 -167.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 24' ' ' ASP . 29.8 m -65.34 -16.12 19.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -176.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -84.74 -27.88 26.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.13 0.49 . . . . 0.0 110.909 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.93 14.3 30.31 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.24 -0.891 . . . . 0.0 113.688 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.07 168.5 32.02 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -70.4 -34.24 72.31 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.1 m -59.05 -51.18 71.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.846 0.355 . . . . 0.0 111.386 -175.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -72.99 -33.71 65.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.797 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.1 tp -55.82 -55.78 28.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.156 0.503 . . . . 0.0 110.796 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.7 mt -66.8 -35.48 80.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.08 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.447 ' HD3' ' C ' ' A' ' 36' ' ' LYS . 13.1 tmtt? -63.27 -43.38 98.09 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.526 -177.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.445 ' O ' ' HB ' ' A' ' 40' ' ' THR . . . -57.71 -42.31 83.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.829 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.431 ' H ' ' HG ' ' A' ' 38' ' ' LEU . 1.3 mt -65.56 -53.3 43.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.841 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.412 ' HG2' ' H ' ' A' ' 46' ' ' ILE . 40.7 mt-10 -52.01 -28.74 18.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.694 175.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.445 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 33.6 m -76.48 -45.13 32.4 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.542 175.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.408 ' HG3' ' O ' ' A' ' 37' ' ' ALA . 30.6 mtm -58.91 -55.03 40.45 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -170.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.21 9.15 36.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.249 0.547 . . . . 0.0 111.125 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? 55.24 48.81 18.54 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.792 173.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 pp -141.53 178.86 7.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.7 m -95.73 122.13 38.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.213 0.53 . . . . 0.0 112.237 -173.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.412 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 49.1 mm -102.47 135.05 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.5 174.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.448 ' HA3' ' NZ ' ' A' ' 56' ' ' LYS . . . -89.32 164.96 32.33 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.744 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.4 176.94 8.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.277 0.561 . . . . 0.0 112.009 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -78.18 93.91 4.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.755 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.56 ' N ' ' HA2' ' A' ' 54' ' ' GLY . 2.1 t -49.78 138.98 13.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.05 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -73.87 -13.28 60.89 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.131 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.53 ' HD3' ' HG3' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -104.23 -44.5 4.95 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.064 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.53 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 24.4 mt-10 -118.26 -28.41 5.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.472 0.578 . . . . 0.0 111.555 175.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.56 ' HA2' ' N ' ' A' ' 50' ' ' SER . . . 54.06 11.15 2.1 Favored Glycine 0 C--O 1.219 -0.81 0 CA-C-N 114.699 -1.137 . . . . 0.0 115.216 -178.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.428 ' HB3' HD11 ' A' ' 100' ' ' LEU . 18.5 m-85 -125.54 4.09 7.6 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 118.473 1.136 . . . . 0.0 111.247 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.448 ' HD3' ' H ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -58.74 -37.71 76.8 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -176.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.448 ' H ' ' HD3' ' A' ' 56' ' ' LYS . . . 60.86 -4.94 0.22 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 114.252 0.461 . . . . 0.0 114.252 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.428 ' H ' ' C ' ' A' ' 56' ' ' LYS . 48.8 m 69.26 -79.33 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.189 0.596 . . . . 0.0 109.892 -172.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 33.2 tt0 -118.57 -19.52 8.73 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.107 172.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.4 ' CD1' ' HE3' ' A' ' 14' ' ' MET . 24.4 m-85 -143.43 126.13 16.03 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.066 0.46 . . . . 0.0 110.974 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.445 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . . . -103.01 104.45 40.09 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.06 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.478 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 33.9 Cg_endo -67.99 121.16 8.15 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 121.714 1.609 . . . . 0.0 111.263 172.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.421 HG23 HD22 ' A' ' 100' ' ' LEU . 82.2 p -125.54 160.05 30.52 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.519 -176.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.672 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.7 p90 -121.57 164.1 17.81 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.604 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.497 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 41.3 tt0 -103.42 115.64 30.91 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 14.1 t70 -84.03 -169.25 2.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.007 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.486 ' H ' ' CG ' ' A' ' 66' ' ' ASP . 1.4 mtmp? -66.65 -45.73 78.03 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.647 0.26 . . . . 0.0 111.474 -173.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.53 -3.76 51.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.194 0.521 . . . . 0.0 110.861 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.27 24.27 19.64 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.166 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -76.18 138.81 40.92 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.558 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 90.7 m95 -115.16 113.05 23.44 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 123.405 0.441 . . . . 0.0 109.952 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.427 ' HA ' ' CD1' ' A' ' 100' ' ' LEU . 32.5 mtm -142.36 169.45 17.56 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 176.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.535 HD22 ' O ' ' A' ' 54' ' ' GLY . 2.3 tp -62.88 152.89 35.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.282 0.563 . . . . 0.0 111.204 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.74 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 99.2 t -77.55 127.78 38.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.443 174.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.57 1.68 27.56 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -170.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -63.03 -48.3 79.32 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.482 HG23 ' CD2' ' A' ' 82' ' ' PHE . 3.2 m -113.88 156.8 43.34 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.86 133.11 33.31 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.965 2.443 . . . . 0.0 113.606 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.546 ' O ' HG22 ' A' ' 83' ' ' VAL . 73.2 t-105 -40.03 -53.31 2.4 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.444 1.097 . . . . 0.0 113.552 -173.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -52.51 -42.78 64.61 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -175.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 68.1 mtm -83.75 -27.48 28.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.111 0.482 . . . . 0.0 110.545 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.74 ' CZ ' ' HA ' ' A' ' 74' ' ' VAL . 9.2 t80 -63.16 -45.49 91.59 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.502 -174.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 79' ' ' TRP . 4.7 t -61.14 -42.34 92.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.302 -171.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.7 p -78.58 -19.45 52.74 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.094 0.473 . . . . 0.0 110.985 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.8 t -83.83 -21.73 31.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.302 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.672 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 36.2 t -90.93 133.47 35.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.161 0.505 . . . . 0.0 111.182 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 13.7 pttp -121.91 -29.52 4.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.738 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.497 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 60.2 mtt180 -139.51 167.28 22.46 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 176.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.702 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 10.8 tp -136.86 138.17 40.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.299 0.571 . . . . 0.0 111.527 -173.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -139.22 129.3 25.17 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.832 0.349 . . . . 0.0 110.146 170.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.727 ' HB ' ' SD ' ' A' ' 14' ' ' MET . 13.4 mt -111.65 138.28 40.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 175.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.1 ptt? -155.9 147.55 22.93 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -170.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 21.0 ttpt -50.83 147.88 4.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 113.591 -1.641 . . . . 0.0 112.828 -175.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.53 -27.98 70.53 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 114.698 -1.137 . . . . 0.0 113.276 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.524 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 44.3 p -68.49 -16.08 63.77 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.91 0.386 . . . . 0.0 111.08 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -101.88 -2.57 29.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.453 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.405 ' HA ' HD21 ' A' ' 100' ' ' LEU . . . -59.61 -29.97 68.36 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -172.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.524 ' HE3' ' O ' ' A' ' 95' ' ' THR . 0.0 OUTLIER -59.6 -23.66 63.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.769 0.318 . . . . 0.0 110.874 178.434 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.52 -22.01 78.93 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 116.101 -0.5 . . . . 0.0 113.195 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.455 ' HG ' ' N ' ' A' ' 101' ' ' GLY . 1.0 OUTLIER -103.58 -24.72 13.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.355 0.598 . . . . 0.0 110.756 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.455 ' N ' ' HG ' ' A' ' 100' ' ' LEU . . . -100.91 48.23 1.16 Allowed Glycine 0 CA--C 1.493 -1.299 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.31 -176.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 66.9 m -79.62 4.19 16.75 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.944 -0.628 . . . . 0.0 111.716 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.02 -57.02 1.42 Allowed Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.887 176.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.9 p -85.64 10.79 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 122.083 0.944 . . . . 0.0 110.655 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 56.8 49.55 69.86 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.285 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.2 t -57.35 145.37 32.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.779 0.324 . . . . 0.0 110.25 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.635 -0.698 . . . . 0.0 110.649 -176.021 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.557 0.217 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -105.93 91.52 3.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.525 0.202 . . . . 0.0 110.505 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.78 53.1 7.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.352 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.0 t70 68.27 155.3 0.11 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.335 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.1 t -91.21 75.44 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.586 0.708 . . . . 0.0 109.338 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 137.04 172.56 12.57 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.969 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 154.62 -38.81 0.66 Allowed Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 176.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.488 ' CD1' ' HD2' ' A' ' 26' ' ' ARG . 3.9 mp -92.26 106.3 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-O 121.218 0.532 . . . . 0.0 109.983 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -90.04 134.8 34.03 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.95 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.533 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -116.25 139.74 41.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.443 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -104.55 135.07 46.66 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -124.39 127.41 73.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.691 0.758 . . . . 0.0 111.472 -172.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.8 p -115.57 155.84 26.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.69 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.443 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 27.4 tpp -110.05 145.08 37.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.624 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -111.89 140.35 46.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.597 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.74 -32.44 4.54 Favored Glycine 0 C--O 1.229 -0.157 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.443 ' O ' ' HG3' ' A' ' 14' ' ' MET . . . -133.94 143.71 48.58 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 172.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.97 122.21 6.17 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 121.391 1.394 . . . . 0.0 112.262 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -153.29 143.16 22.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.766 174.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.5 mt -127.65 106.95 9.5 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.84 0.353 . . . . 0.0 110.368 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.583 ' O ' HG12 ' A' ' 12' ' ' VAL . 10.3 mmm180 -124.07 155.49 38.25 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.459 ' HD2' ' C ' ' A' ' 21' ' ' ARG . 2.5 mptp? -143.76 144.39 31.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.796 0.332 . . . . 0.0 110.551 175.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.407 ' HB ' ' HH ' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -146.87 176.06 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.979 -178.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.48 ' O ' HG21 ' A' ' 27' ' ' VAL . 9.0 t70 -111.32 132.68 54.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.273 0.559 . . . . 0.0 110.275 -175.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.454 HD23 ' HB3' ' A' ' 86' ' ' CYS . 16.6 tp -69.27 -34.31 74.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.733 -172.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.488 ' HD2' ' CD1' ' A' ' 8' ' ' ILE . 65.8 mtp180 -79.47 -32.07 42.53 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -171.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 24' ' ' ASP . 33.6 m -68.81 -0.81 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -169.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.504 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 27.0 m-85 -85.64 -28.7 24.58 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.28 177.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.86 14.86 5.8 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.328 -0.851 . . . . 0.0 114.168 177.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.21 175.94 28.71 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.633 -176.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -69.18 -31.63 70.39 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -176.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.9 p -59.69 -56.11 25.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.733 0.301 . . . . 0.0 111.44 -175.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 28' ' ' TYR . 47.1 mt-10 -73.98 -25.83 60.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.59 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.64 -56.37 23.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.233 0.54 . . . . 0.0 110.115 174.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.4 mt -69.77 -36.63 75.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.81 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 36' ' ' LYS . 68.0 mmtt -71.62 -31.29 66.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.561 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.668 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -58.59 -42.65 88.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.881 176.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.488 HD13 ' HG3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -58.24 -52.93 63.51 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.598 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 39.0 mt-10 -52.3 -30.22 27.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.896 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.556 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 53.8 m -73.95 -44.89 53.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.135 177.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.668 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 74.5 mmm -57.07 -57.13 13.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.707 -169.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -102.17 8.6 40.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.119 0.485 . . . . 0.0 110.922 -175.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.28 47.72 16.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.633 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 3.0 pp -145.51 -179.31 6.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.705 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 m -111.61 98.21 7.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -171.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.418 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 37.5 mm -65.51 127.66 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.988 172.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.5 149.59 43.82 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.891 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -68.21 162.7 24.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.117 0.484 . . . . 0.0 111.803 -174.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.53 ' CZ ' HD12 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -65.95 89.73 0.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.891 179.007 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.416 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 30.8 t -62.89 146.88 51.85 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.707 0.765 . . . . 0.0 109.849 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -76.37 -16.32 59.75 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.603 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.556 ' HD3' ' HG3' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -82.03 -56.3 4.04 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -172.457 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.556 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 39.5 mt-10 -121.34 -29.64 4.43 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.732 0.777 . . . . 0.0 109.687 165.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.523 ' O ' HD13 ' A' ' 73' ' ' LEU . . . 46.73 8.76 0.03 OUTLIER Glycine 0 C--O 1.214 -1.115 0 CA-C-N 113.317 -1.765 . . . . 0.0 116.216 -177.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.587 ' CD1' ' HA2' ' A' ' 105' ' ' GLY . 11.1 m-85 -114.78 6.49 15.55 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 118.171 0.986 . . . . 0.0 110.992 -176.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.453 ' HG2' ' H ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -63.85 -39.07 93.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.647 177.324 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 60' ' ' TYR . . . 58.31 22.19 49.97 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.78 176.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.453 ' H ' ' HG2' ' A' ' 56' ' ' LYS . 20.4 t 69.27 -86.19 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -165.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -119.75 -16.61 8.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.694 0.283 . . . . 0.0 110.971 169.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.514 ' O ' ' HA3' ' A' ' 57' ' ' GLY . 30.3 m-85 -122.27 125.79 46.78 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -174.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -100.92 105.33 37.68 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.936 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.488 ' HG3' HD13 ' A' ' 38' ' ' LEU . 61.0 Cg_endo -72.8 119.65 6.2 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.986 1.791 . . . . 0.0 111.231 175.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 72' ' ' MET . 71.2 p -128.78 165.49 20.84 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.766 -175.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.544 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 4.3 p90 -137.8 164.74 28.16 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.683 0.278 . . . . 0.0 110.349 -176.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.474 ' OE1' ' HD3' ' A' ' 88' ' ' ARG . 29.5 tt0 -100.24 113.92 26.96 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.89 177.48 8.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.715 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.0 mtmm -48.72 -44.14 37.96 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.117 0.567 . . . . 0.0 111.888 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -81.86 -15.99 52.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.114 0.483 . . . . 0.0 110.74 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.99 23.86 16.56 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.57 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -95.27 143.64 26.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.544 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 67.3 m95 -110.1 114.96 28.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.065 0.46 . . . . 0.0 111.516 -173.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.524 ' HE2' ' CE1' ' A' ' 64' ' ' TYR . 2.1 mpp? -127.37 179.3 5.54 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 174.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.53 HD12 ' CZ ' ' A' ' 49' ' ' TYR . 10.8 mt -64.0 153.22 37.93 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.54 0.686 . . . . 0.0 111.531 176.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.4 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 22.9 m -77.14 137.83 21.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.855 175.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.73 8.26 80.18 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.624 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.35 -54.03 43.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.664 0.268 . . . . 0.0 111.212 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.463 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 12.4 m -98.82 155.52 36.57 Favored Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 4.2 Cg_endo -46.95 132.82 17.8 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.487 2.791 . . . . 0.0 113.326 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.528 ' O ' HG22 ' A' ' 83' ' ' VAL . 70.0 t-105 -43.41 -51.88 6.28 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -171.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -54.63 -42.66 71.48 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.628 0.251 . . . . 0.0 111.637 -174.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 57.2 ttp -84.03 -22.73 31.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.998 0.428 . . . . 0.0 110.547 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.427 ' CD2' HG22 ' A' ' 77' ' ' VAL . 11.4 t80 -66.29 -45.93 78.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.038 -177.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 79' ' ' TRP . 3.5 t -61.37 -37.28 77.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.115 0.483 . . . . 0.0 110.944 -174.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.5 p -79.46 -12.34 59.88 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.334 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.3 m -95.17 -31.32 13.58 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.454 ' HB3' HD23 ' A' ' 25' ' ' LEU . 44.6 t -80.5 130.31 35.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.762 0.791 . . . . 0.0 111.457 -175.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.459 ' HZ3' ' HB3' ' A' ' 87' ' ' LYS . 9.2 mtpm? -118.21 -40.66 2.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.674 -176.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.474 ' HD3' ' OE1' ' A' ' 65' ' ' GLU . 51.6 mtp180 -140.14 163.54 32.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.084 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.696 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 5.6 tp -130.02 137.65 50.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.879 0.371 . . . . 0.0 110.826 -171.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -139.31 115.03 10.04 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.826 175.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.1 mt -111.25 133.92 55.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 171.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.494 ' C ' ' HD1' ' A' ' 60' ' ' TYR . 21.9 ptt? -159.19 161.46 36.15 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -169.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -56.96 141.22 46.16 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.696 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.69 -22.07 45.38 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.957 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.2 t -63.63 -20.22 65.5 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.002 0.43 . . . . 0.0 111.01 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -101.25 -39.03 7.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.08 0.467 . . . . 0.0 109.887 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.44 -25.76 67.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.004 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.5 ' HA ' ' HB3' ' A' ' 106' ' ' SER . 13.4 ptmm? -65.25 -23.28 67.02 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.37 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.91 -38.1 36.9 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.911 -0.661 . . . . 0.0 113.112 -177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -103.59 11.89 35.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.748 0.308 . . . . 0.0 111.65 -174.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.34 81.96 0.37 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.599 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 24.1 p -121.92 128.35 51.45 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.24 0.543 . . . . 0.0 110.55 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.21 68.85 1.17 Allowed Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.478 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.7 t 60.45 57.51 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.988 0.899 . . . . 0.0 108.789 -172.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.587 ' HA2' ' CD1' ' A' ' 55' ' ' TYR . . . -130.74 -168.5 12.25 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.649 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.5 ' HB3' ' HA ' ' A' ' 98' ' ' LYS . 11.5 t -75.36 131.73 40.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.982 0.42 . . . . 0.0 110.254 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.1 m170 . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.648 -0.692 . . . . 0.0 110.579 -175.585 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 39.0 m80 . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 120.462 0.172 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -79.31 59.99 3.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.286 0.565 . . . . 0.0 111.424 -173.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 175.94 -51.51 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.337 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -92.12 26.88 2.34 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.11 -173.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.75 153.04 33.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 176.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.546 ' O ' ' HD3' ' A' ' 26' ' ' ARG . . . 122.71 -177.72 16.47 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.284 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 140.21 -40.93 1.34 Allowed Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -176.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 mp -125.11 107.58 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 114.229 -0.986 . . . . 0.0 109.129 170.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -103.18 141.2 36.28 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.571 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.566 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.9 OUTLIER -131.15 152.88 38.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.235 0.54 . . . . 0.0 109.927 -179.029 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -118.72 141.46 48.6 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -125.57 126.88 71.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.61 0.719 . . . . 0.0 111.313 -174.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.6 m -117.41 155.6 29.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.366 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.692 ' SD ' ' HA ' ' A' ' 92' ' ' MET . 25.7 tpp -99.69 151.98 20.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.888 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -119.06 122.46 42.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.079 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.63 -31.94 8.15 Favored Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 14' ' ' MET . . . -134.64 149.15 70.04 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 173.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.18 121.75 5.88 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.019 1.146 . . . . 0.0 112.222 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.515 ' HB2' ' CB ' ' A' ' 14' ' ' MET . 56.6 m-85 -153.09 142.89 22.05 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.557 175.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.444 HD22 ' C ' ' A' ' 19' ' ' TYR . 3.1 mm? -129.53 106.71 8.94 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.14 0.495 . . . . 0.0 111.12 -176.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.513 ' O ' HG11 ' A' ' 12' ' ' VAL . 37.3 mmt180 -125.52 155.85 39.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.808 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.511 ' HD2' ' C ' ' A' ' 21' ' ' ARG . 2.5 mptp? -146.96 137.2 23.49 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.507 HD13 ' CD2' ' A' ' 89' ' ' LEU . 1.9 pt -140.95 174.11 8.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.576 0.703 . . . . 0.0 111.87 -176.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.527 ' O ' HG21 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -113.16 124.8 53.4 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.036 -0.983 . . . . 0.0 108.956 -177.155 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.453 ' HB2' ' CG2' ' A' ' 10' ' ' VAL . 11.8 tp -71.62 -45.58 61.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -165.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.546 ' HD3' ' O ' ' A' ' 6' ' ' GLY . 2.8 ptm180 -79.98 -16.37 55.33 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -171.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.527 HG21 ' O ' ' A' ' 24' ' ' ASP . 19.1 m -75.68 -0.74 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -169.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.448 ' OH ' ' HB ' ' A' ' 23' ' ' ILE . 30.5 m-85 -96.12 -28.93 14.36 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.926 0.394 . . . . 0.0 111.341 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.16 14.21 17.68 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.859 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.31 167.31 33.61 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.876 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -69.23 -34.14 74.38 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 p -57.21 -55.22 37.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.569 0.223 . . . . 0.0 111.159 -176.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -70.3 -29.95 66.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.105 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.5 tp -59.09 -55.6 33.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.187 0.518 . . . . 0.0 109.959 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.532 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 56.4 mt -67.31 -38.13 84.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.259 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 36' ' ' LYS . 62.9 mmtt -69.66 -31.96 70.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.657 -177.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 40' ' ' THR . . . -60.54 -41.82 95.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.076 0.465 . . . . 0.0 110.387 176.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.503 ' HB2' HG13 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -63.37 -54.61 34.17 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 23.6 mt-10 -52.11 -29.8 23.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.938 176.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 24.6 m -71.71 -41.89 68.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.205 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.602 ' HE2' ' CZ ' ' A' ' 42' ' ' PHE . 71.8 mtm -66.51 -55.03 17.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -171.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.602 ' CZ ' ' HE2' ' A' ' 41' ' ' MET . 0.1 OUTLIER -100.46 10.53 41.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.159 0.504 . . . . 0.0 111.929 -173.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp 55.27 47.92 20.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.622 174.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.8 pp -143.08 -176.37 4.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.007 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 63.4 m -108.18 99.86 9.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.042 0.449 . . . . 0.0 111.713 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.503 HG13 ' HB2' ' A' ' 38' ' ' LEU . 34.2 mm -76.77 123.18 32.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 172.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.02 155.52 53.58 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.013 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -71.01 171.27 11.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.296 0.57 . . . . 0.0 111.249 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -79.3 85.66 5.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.542 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.8 m -56.66 135.64 54.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.383 173.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -72.13 -25.73 61.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.282 0.563 . . . . 0.0 110.399 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.599 ' HD2' ' N ' ' A' ' 53' ' ' GLU . 3.4 ppt_? -68.24 -52.98 27.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.367 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.599 ' N ' ' HD2' ' A' ' 52' ' ' ARG . 47.6 mt-10 -122.84 -29.23 4.01 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.634 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.583 ' O ' HD12 ' A' ' 73' ' ' LEU . . . 42.21 10.87 0.01 OUTLIER Glycine 0 C--O 1.218 -0.872 0 N-CA-C 116.303 1.281 . . . . 0.0 116.303 -174.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.415 ' HD1' ' HB3' ' A' ' 73' ' ' LEU . 9.7 m-85 -126.25 6.57 7.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 118.672 1.236 . . . . 0.0 110.269 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -67.12 -31.21 71.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.5 -175.29 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 58' ' ' SER . . . 65.56 -12.74 0.31 Allowed Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.527 -0.761 . . . . 0.0 114.727 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.438 ' H ' ' C ' ' A' ' 56' ' ' LYS . 40.0 m 71.77 -80.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -172.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -118.88 -23.75 6.84 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.656 170.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.432 ' HE1' ' SD ' ' A' ' 14' ' ' MET . 37.4 m-85 -134.79 124.51 25.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.008 0.432 . . . . 0.0 111.205 175.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.401 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . . . -105.46 105.3 51.92 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.681 177.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.479 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 43.8 Cg_endo -68.51 120.17 7.13 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.499 1.466 . . . . 0.0 110.993 174.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.3 p -124.7 168.45 13.16 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.078 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.52 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 3.6 p90 -143.77 165.32 28.0 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -176.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.442 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 40.4 tt0 -108.32 121.14 44.29 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.401 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.459 ' O ' ' HE3' ' A' ' 87' ' ' LYS . 14.9 t70 -84.15 -169.34 2.54 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.567 177.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.489 ' NZ ' ' HA ' ' A' ' 85' ' ' SER . 17.4 mmtm -62.36 -49.08 76.99 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.725 0.774 . . . . 0.0 109.82 -172.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -84.39 13.93 4.94 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.714 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.79 19.58 72.84 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.942 175.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -75.61 130.0 38.08 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.52 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 92.8 m95 -106.26 120.72 42.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.167 0.508 . . . . 0.0 110.69 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 46.5 mtm -138.5 170.27 16.32 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.583 HD12 ' O ' ' A' ' 54' ' ' GLY . 10.0 tt -79.08 141.57 37.25 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 16.2 m -66.81 130.11 31.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.649 0.738 . . . . 0.0 112.219 -174.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.87 4.56 26.08 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.807 -175.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.05 -59.43 5.43 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.612 0.244 . . . . 0.0 110.869 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.8 m -98.57 156.06 36.1 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -52.16 137.14 54.67 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.172 2.581 . . . . 0.0 112.975 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.547 ' O ' HG22 ' A' ' 83' ' ' VAL . 71.9 t-105 -43.78 -41.72 5.12 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.347 -174.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -58.74 -42.63 89.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.093 0.473 . . . . 0.0 111.063 -174.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 49.9 ttp -85.11 -27.66 26.11 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.589 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 74' ' ' VAL . 11.8 t80 -63.63 -40.71 97.57 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.162 -172.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 79' ' ' TRP . 2.8 t -60.86 -39.7 82.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.415 0.626 . . . . 0.0 110.942 -173.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.7 p -79.09 -10.85 59.94 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.314 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.489 ' HA ' ' NZ ' ' A' ' 67' ' ' LYS . 68.0 m -89.3 -31.39 17.86 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 30.3 t -90.75 123.91 34.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.176 0.512 . . . . 0.0 112.043 -175.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 66' ' ' ASP . 18.8 pttp -118.83 -22.9 7.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.594 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.442 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 84.5 mtt180 -140.23 151.16 44.94 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 174.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.62 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 3.6 tp -125.73 137.72 53.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.018 0.437 . . . . 0.0 111.114 -174.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -139.31 116.08 10.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.154 0.502 . . . . 0.0 110.948 172.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 22.1 mt -106.8 136.6 41.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 173.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.692 ' HA ' ' SD ' ' A' ' 14' ' ' MET . 19.9 ptt? -157.94 160.05 37.17 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -168.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -56.02 138.66 48.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 113.666 -1.606 . . . . 0.0 111.952 -177.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -61.99 -28.72 70.89 Favored Glycine 0 CA--C 1.505 -0.582 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.127 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.3 p -64.17 -20.31 65.91 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.195 -0.502 . . . . 0.0 111.124 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -100.53 -47.53 4.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.39 0.615 . . . . 0.0 110.103 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.96 -21.85 65.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.154 -176.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.652 ' HA ' ' SG ' ' A' ' 102' ' ' CYS . 0.1 OUTLIER -53.6 -29.74 39.09 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -175.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.58 -39.32 93.84 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.786 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.7 pp -103.97 -25.4 13.03 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -174.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -104.42 -48.73 1.1 Allowed Glycine 0 CA--C 1.492 -1.356 0 C-N-CA 120.34 -0.933 . . . . 0.0 112.111 -174.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.652 ' SG ' ' HA ' ' A' ' 98' ' ' LYS . 39.3 m -78.76 5.84 10.34 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.36 0.6 . . . . 0.0 110.821 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.51 33.44 5.49 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 168.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 p 34.73 73.84 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 113.165 -1.518 . . . . 0.0 113.125 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 130.16 73.98 0.13 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.552 174.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 25.4 t -63.91 105.35 0.83 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.77 0.319 . . . . 0.0 110.755 173.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.1 m170 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.369 -0.824 . . . . 0.0 109.767 177.446 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.447 ' H3 ' ' CG ' ' A' ' 4' ' ' ASP . 38.5 m-70 . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.788 0.328 . . . . 0.0 110.409 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -98.76 87.97 3.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.229 0.538 . . . . 0.0 110.68 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 71.95 -8.26 1.15 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.005 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.447 ' CG ' ' H3 ' ' A' ' 1' ' ' HIS . 8.4 p-10 -96.13 34.41 1.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.3 t 74.63 118.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.255 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 144.17 156.77 6.93 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.15 -21.69 0.29 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.75 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.504 ' CD1' ' HD2' ' A' ' 26' ' ' ARG . 3.3 mp -104.9 105.56 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 121.249 0.547 . . . . 0.0 109.674 177.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -102.9 130.77 50.06 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.439 -172.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.481 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 2.1 t -121.12 150.75 24.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.639 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -105.95 135.13 47.95 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.692 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -124.93 125.94 70.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.449 0.642 . . . . 0.0 110.874 -175.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 p -114.76 148.19 38.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.493 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 79.0 mmm -104.73 165.84 10.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.791 -177.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -131.75 141.7 49.58 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.99 -33.19 4.32 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.887 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.12 140.09 33.77 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-O 120.805 0.336 . . . . 0.0 110.796 173.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.3 127.77 9.29 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.925 2.416 . . . . 0.0 112.729 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -149.52 172.46 14.95 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.08 103.88 5.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.818 0.818 . . . . 0.0 110.423 170.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.456 ' O ' HG11 ' A' ' 12' ' ' VAL . 39.7 mmt180 -127.68 136.63 51.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.1 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.453 ' HD2' ' C ' ' A' ' 21' ' ' ARG . 2.6 mptp? -144.42 141.27 29.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 171.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.53 HD13 ' CD2' ' A' ' 89' ' ' LEU . 3.4 pt -140.86 174.11 8.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.028 0.442 . . . . 0.0 112.142 -175.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -110.45 126.47 54.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.103 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.479 ' CD2' ' HB3' ' A' ' 86' ' ' CYS . 10.8 tp -69.84 -43.06 72.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.833 -170.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.504 ' HD2' ' CD1' ' A' ' 8' ' ' ILE . 11.5 ptm180 -80.28 -25.82 39.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.047 0.451 . . . . 0.0 110.719 -171.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -49.71 -21.81 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 124.491 1.116 . . . . 0.0 113.767 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -86.73 -28.23 23.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.972 0.415 . . . . 0.0 111.805 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.5 13.75 46.14 Favored Glycine 0 CA--C 1.519 0.293 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.414 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 161.4 176.92 34.02 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.171 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.582 ' CE1' ' HA2' ' A' ' 75' ' ' GLY . 38.3 m-85 -69.49 -30.78 68.72 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -177.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.4 m -58.68 -54.76 43.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.671 0.272 . . . . 0.0 111.414 -174.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -73.59 -28.91 62.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.801 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.441 HD23 ' HB ' ' A' ' 74' ' ' VAL . 14.2 tp -58.31 -55.32 36.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.433 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.471 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 79.7 mt -67.12 -36.79 82.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.89 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.502 ' HA ' ' OE1' ' A' ' 39' ' ' GLU . 1.5 tmtp? -64.8 -33.89 77.06 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.499 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.703 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -67.64 -37.5 82.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.298 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.49 HD12 ' HG3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -63.52 -48.84 75.9 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.495 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.606 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 51.1 mt-10 -51.34 -33.27 28.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.574 173.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.545 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 21.1 m -74.37 -34.82 63.46 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.424 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.703 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 47.0 mmm -63.39 -57.86 8.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.131 -170.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -107.73 11.67 28.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.257 0.551 . . . . 0.0 111.101 -174.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp 61.7 50.53 4.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.72 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 2.4 pp -152.83 176.1 12.17 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.384 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.9 m -102.46 105.32 15.86 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -174.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.482 HD13 ' CB ' ' A' ' 38' ' ' LEU . 2.3 mt -89.2 120.89 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.601 169.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.46 165.86 54.55 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.558 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -66.02 172.37 3.78 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.725 0.774 . . . . 0.0 112.557 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -74.72 86.18 2.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.489 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 74.5 m -55.56 129.09 37.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.424 173.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -31.19 72.3 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.042 -171.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -50.47 28.43 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -174.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 105' ' ' GLY . 20.1 tt0 -119.68 -28.66 5.22 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.223 0.535 . . . . 0.0 111.068 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.546 ' O ' HD21 ' A' ' 73' ' ' LEU . . . 45.23 12.06 0.03 OUTLIER Glycine 0 C--O 1.218 -0.896 0 N-CA-C 117.102 1.601 . . . . 0.0 117.102 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.419 ' HD1' ' O ' ' A' ' 54' ' ' GLY . 17.3 m-30 -124.74 15.04 8.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 119.617 1.709 . . . . 0.0 111.144 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.44 ' HG2' ' H ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -74.44 -38.51 62.99 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.805 -177.042 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.09 7.74 5.36 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 115.797 -0.638 . . . . 0.0 114.436 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.44 ' H ' ' HG2' ' A' ' 56' ' ' LYS . 32.4 m 63.83 -83.87 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 122.733 0.413 . . . . 0.0 110.08 -171.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 39.3 tt0 -118.58 -14.52 9.62 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.681 0.277 . . . . 0.0 110.824 172.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -139.96 125.35 19.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.828 0.347 . . . . 0.0 111.036 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -100.53 103.7 25.69 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.798 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.49 ' HG3' HD12 ' A' ' 38' ' ' LEU . 57.2 Cg_endo -74.18 121.9 7.2 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.92 1.747 . . . . 0.0 111.638 174.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.2 p -124.91 157.27 36.4 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.038 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.69 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 3.4 p90 -129.23 164.5 23.33 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.468 ' CG ' ' HA2' ' A' ' 69' ' ' GLY . 43.9 tt0 -101.14 120.15 39.79 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.81 -168.72 2.31 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.355 0.41 . . . . 0.0 111.022 -176.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -57.67 -44.09 85.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.458 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -82.86 -14.65 53.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.285 0.564 . . . . 0.0 110.403 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.468 ' HA2' ' CG ' ' A' ' 65' ' ' GLU . . . 96.27 29.3 8.5 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.89 176.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -96.41 160.5 14.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.931 0.365 . . . . 0.0 110.11 172.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.69 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 39.6 m95 -122.46 114.1 20.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.902 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.444 ' HE1' ' CE1' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -131.44 174.33 10.18 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 171.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.546 HD21 ' O ' ' A' ' 54' ' ' GLY . 1.0 OUTLIER -62.59 157.33 20.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.75 0.786 . . . . 0.0 111.091 -178.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.441 ' HB ' HD23 ' A' ' 34' ' ' LEU . 31.4 m -76.26 134.54 28.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.101 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.582 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 109.96 0.67 30.22 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -171.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -56.57 -56.1 25.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.415 -0.392 . . . . 0.0 111.158 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 m -112.74 152.32 44.67 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.33 136.83 19.3 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.424 2.749 . . . . 0.0 113.203 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.517 ' O ' HG22 ' A' ' 83' ' ' VAL . 73.2 t-105 -43.21 -48.08 6.48 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 123.954 0.784 . . . . 0.0 113.107 -171.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -53.53 -43.08 68.06 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.2 0.312 . . . . 0.0 111.635 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 58.8 mtm -84.26 -25.33 29.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.963 0.411 . . . . 0.0 110.502 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -64.29 -44.84 90.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.423 -174.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 79' ' ' TRP . 2.5 t -61.68 -41.43 90.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.092 0.472 . . . . 0.0 111.023 -173.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.5 p -79.47 -15.46 57.74 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.569 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 65.8 m -91.19 -31.66 16.09 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 41.5 t -73.68 135.59 43.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.484 0.659 . . . . 0.0 111.048 -177.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -118.24 -44.17 2.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.324 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -140.15 163.38 32.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.712 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.692 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 2.0 tp -128.14 135.5 49.85 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.921 0.391 . . . . 0.0 110.702 -172.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -139.11 123.04 17.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.801 0.334 . . . . 0.0 110.868 175.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 14' ' ' MET . 6.1 mt -120.41 137.95 52.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 15.3 ptt? -156.65 158.64 37.37 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.213 0.53 . . . . 0.0 112.368 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 7.2 tttp -53.07 149.2 6.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.189 -1.368 . . . . 0.0 112.178 -175.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.67 -28.09 70.94 Favored Glycine 0 CA--C 1.505 -0.576 0 CA-C-N 114.842 -1.072 . . . . 0.0 113.348 -171.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.1 p -68.04 -20.04 64.95 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.963 0.411 . . . . 0.0 111.003 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -97.98 -9.18 26.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.937 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.682 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -60.57 -22.94 64.22 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.904 -176.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.22 -21.86 65.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.934 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.84 -4.43 63.47 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.626 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 97' ' ' ALA . 4.5 pp -101.3 -23.12 14.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.386 0.593 . . . . 0.0 110.584 178.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -106.36 -58.44 0.61 Allowed Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 48.5 t 57.78 91.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.763 -0.719 . . . . 0.0 111.831 176.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.55 -66.27 3.45 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.006 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.2 p -70.94 110.4 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-O 121.735 0.779 . . . . 0.0 109.515 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.515 ' O ' ' HG3' ' A' ' 53' ' ' GLU . . . 82.84 -78.8 1.97 Allowed Glycine 0 C--N 1.311 -0.823 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.863 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.6 t -76.5 132.41 39.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.021 0.438 . . . . 0.0 110.403 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.434 ' CD2' ' N ' ' A' ' 107' ' ' HIS . 1.2 p80 . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.486 -0.769 . . . . 0.0 110.108 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 121.037 0.446 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 2' ' ' GLU . 0.3 OUTLIER -84.21 77.97 9.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.276 0.56 . . . . 0.0 109.499 177.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.49 -174.77 0.17 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.601 -171.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.7 t70 59.69 41.58 18.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 122.287 1.041 . . . . 0.0 109.38 -176.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -90.28 91.22 3.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.929 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 121.42 -167.24 14.25 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.091 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.495 ' HA2' ' NH1' ' A' ' 26' ' ' ARG . . . -141.06 37.21 1.67 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.491 HD11 ' N ' ' A' ' 8' ' ' ILE . 3.3 mp -87.54 114.45 26.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.036 0.446 . . . . 0.0 110.44 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -98.72 132.46 44.08 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.098 174.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.606 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -118.19 138.76 47.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.496 0.665 . . . . 0.0 110.707 -178.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -104.54 133.94 48.57 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.707 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -125.7 124.85 67.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.746 0.784 . . . . 0.0 111.044 -173.053 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 p -112.13 155.3 24.13 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.119 -174.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.68 ' SD ' ' HA ' ' A' ' 92' ' ' MET . 31.8 tpp -110.78 135.31 51.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.659 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.48 137.98 40.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.435 177.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.75 -33.17 5.15 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.035 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.91 141.63 39.15 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 120.619 0.247 . . . . 0.0 111.085 173.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.92 126.71 8.14 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.707 2.272 . . . . 0.0 112.661 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -151.99 166.68 30.79 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.477 ' C ' ' HD2' ' A' ' 21' ' ' ARG . 78.2 mt -125.14 103.86 8.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.05 0.452 . . . . 0.0 110.255 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.487 ' C ' ' HD2' ' A' ' 22' ' ' LYS . 3.6 mpt_? -127.2 134.15 50.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.735 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.487 ' HD2' ' C ' ' A' ' 21' ' ' ARG . 2.4 mptp? -144.1 141.42 30.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 172.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -144.11 174.48 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.135 0.493 . . . . 0.0 112.044 -175.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.452 ' HB3' ' HE ' ' A' ' 26' ' ' ARG . 1.1 m-20 -109.71 126.76 54.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.65 -175.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.504 HD22 HG21 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -69.4 -36.62 76.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.925 0.869 . . . . 0.0 110.117 -175.196 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.495 ' NH1' ' HA2' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -79.54 -19.22 50.04 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.932 -1.031 . . . . 0.0 113.294 -168.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 24' ' ' ASP . 34.0 m -80.63 -3.96 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -170.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.483 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 25.8 m-85 -85.06 -30.12 24.35 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.22 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.7 14.15 6.93 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.788 -0.642 . . . . 0.0 114.354 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.29 165.78 24.24 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.735 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.556 ' CE1' ' HA2' ' A' ' 75' ' ' GLY . 15.2 m-85 -60.91 -36.12 78.46 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.7 p -62.54 -54.36 40.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.682 0.277 . . . . 0.0 110.961 -175.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -67.67 -27.33 66.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.076 -178.706 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.424 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 8.6 tp -62.47 -56.75 15.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.285 174.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.445 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 81.5 mt -67.63 -39.87 84.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.63 -176.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -71.2 -32.54 68.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.271 -175.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.699 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -59.9 -39.79 86.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.778 0.323 . . . . 0.0 110.7 177.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.459 HD13 ' HG3' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -68.87 -50.48 49.41 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.307 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 35.3 mt-10 -52.27 -28.86 20.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.58 173.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.563 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 17.5 m -74.06 -41.02 62.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.258 175.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.699 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 71.9 mmm -54.85 -55.98 24.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.023 -172.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -102.0 9.69 40.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 -177.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.17 44.21 19.37 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.95 174.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 pp -144.51 -171.8 3.67 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 m -113.72 121.14 43.18 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.876 0.369 . . . . 0.0 111.31 -175.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.41 ' CD1' ' HB2' ' A' ' 60' ' ' TYR . 40.8 mm -84.57 -22.77 7.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 122.335 1.064 . . . . 0.0 109.738 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.03 -164.58 31.2 Favored Glycine 0 C--N 1.31 -0.889 0 CA-C-N 114.071 -1.422 . . . . 0.0 112.574 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -92.02 162.4 14.39 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.412 ' CD1' HD21 ' A' ' 73' ' ' LEU . 60.4 t80 -80.43 75.72 7.27 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 171.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 m -49.05 128.97 17.14 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.804 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -68.06 -17.82 64.5 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.049 -173.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.526 ' HD2' ' N ' ' A' ' 53' ' ' GLU . 3.0 ppt_? -74.58 -51.95 13.14 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.526 ' N ' ' HD2' ' A' ' 52' ' ' ARG . 50.9 mt-10 -122.57 -29.95 3.98 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 119.934 -0.707 . . . . 0.0 112.728 176.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.689 ' O ' HD11 ' A' ' 73' ' ' LEU . . . 48.97 12.9 0.26 Allowed Glycine 0 C--O 1.218 -0.855 0 N-CA-C 115.288 0.875 . . . . 0.0 115.288 -175.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.556 ' CE2' ' HB3' ' A' ' 106' ' ' SER . 11.6 m-85 -124.8 10.04 8.29 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.535 1.167 . . . . 0.0 110.608 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.488 ' HZ1' ' HB2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -61.38 -51.37 69.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.428 -179.024 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.16 3.04 4.53 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 115.079 0.792 . . . . 0.0 115.079 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.2 t 67.86 -86.99 0.03 OUTLIER 'General case' 0 C--O 1.234 0.238 0 CA-C-N 117.357 0.579 . . . . 0.0 110.037 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -117.65 -6.84 11.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.741 0.305 . . . . 0.0 110.501 175.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.428 ' HE1' ' SD ' ' A' ' 14' ' ' MET . 70.3 m-85 -143.17 124.49 14.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.611 0.243 . . . . 0.0 111.354 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.2 105.06 47.46 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.619 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 42.8 Cg_endo -68.98 120.93 7.78 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.992 1.795 . . . . 0.0 111.009 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 72' ' ' MET . 77.0 p -129.92 165.67 21.61 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.478 -175.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.746 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.4 p90 -136.51 164.66 27.66 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -178.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.475 ' CG ' ' HA2' ' A' ' 69' ' ' GLY . 33.3 tt0 -104.53 121.63 43.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.711 0.291 . . . . 0.0 110.361 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.505 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 25.5 t70 -84.51 -170.87 3.32 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.519 175.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.505 ' H ' ' CG ' ' A' ' 66' ' ' ASP . 13.3 mmtm -65.46 -34.41 78.22 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.643 0.735 . . . . 0.0 109.349 -175.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -72.26 -18.52 61.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.083 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.475 ' HA2' ' CG ' ' A' ' 65' ' ' GLU . . . 92.58 11.98 58.75 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.639 -175.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -86.95 144.11 27.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.639 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 64.0 m95 -112.11 115.67 29.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.048 0.451 . . . . 0.0 110.983 -176.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.413 ' O ' ' HA ' ' A' ' 63' ' ' THR . 49.8 mtm -121.54 161.09 22.96 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.689 HD11 ' O ' ' A' ' 54' ' ' GLY . 9.5 tt -71.05 141.42 50.89 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.487 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 17.2 m -66.87 129.57 31.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.655 0.741 . . . . 0.0 112.166 -174.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.556 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 111.3 6.93 25.21 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.513 -174.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -71.57 -56.91 4.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.513 0.197 . . . . 0.0 111.302 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.49 HG23 ' CD2' ' A' ' 82' ' ' PHE . 12.6 m -98.34 155.11 37.25 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.469 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 5.1 Cg_endo -46.94 131.89 17.14 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.668 2.912 . . . . 0.0 113.667 -176.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.471 ' O ' HG22 ' A' ' 83' ' ' VAL . 72.9 t-105 -43.16 -54.28 4.55 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.68 -172.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -51.41 -42.04 61.17 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.587 0.554 . . . . 0.0 111.542 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 57.4 ttp -83.37 -31.86 26.51 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.807 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.49 ' CD2' HG23 ' A' ' 77' ' ' VAL . 6.3 t80 -58.23 -46.66 85.5 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.68 -174.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 79' ' ' TRP . 2.8 t -60.54 -48.18 89.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.342 -170.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.8 p -78.87 -14.37 59.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.55 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.6 t -85.97 -25.18 26.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.12 -175.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.746 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 40.4 t -79.22 131.15 36.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.751 0.31 . . . . 0.0 110.922 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 13.5 ptmm? -116.03 -23.94 8.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.694 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.414 ' HD3' ' OE1' ' A' ' 65' ' ' GLU . 62.1 mtp180 -140.81 154.67 46.33 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 176.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.707 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 9.6 tp -127.51 133.37 49.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.114 -176.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.431 ' HB2' ' CZ3' ' A' ' 71' ' ' TRP . 2.6 ttm180 -139.47 117.78 12.01 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.289 -0.565 . . . . 0.0 111.096 174.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.419 HG21 ' HA ' ' A' ' 62' ' ' PRO . 4.1 mt -116.1 133.55 62.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 170.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.68 ' HA ' ' SD ' ' A' ' 14' ' ' MET . 14.6 ptt? -158.13 161.13 37.9 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.212 0.53 . . . . 0.0 112.122 -170.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -53.94 141.81 26.58 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.727 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.4 -27.29 57.96 Favored Glycine 0 CA--C 1.505 -0.582 0 CA-C-N 114.437 -1.256 . . . . 0.0 113.092 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 59.1 p -60.21 -25.96 66.01 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.469 0.652 . . . . 0.0 110.779 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -101.11 -49.41 4.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.8 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.87 -21.15 66.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.635 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.485 ' HA ' ' HB3' ' A' ' 102' ' ' CYS . 14.7 ptmm? -53.63 -32.41 51.25 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.55 -38.43 90.49 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.727 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.82 5.53 28.61 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -175.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.35 -77.25 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 119.572 -1.299 . . . . 0.0 114.135 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.485 ' HB3' ' HA ' ' A' ' 98' ' ' LYS . 44.3 t -57.71 97.46 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.798 0.808 . . . . 0.0 111.669 -172.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 106.17 60.57 0.61 Allowed Glycine 0 N--CA 1.435 -1.409 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.492 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.9 m 32.7 61.27 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.186 0.995 . . . . 0.0 112.528 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -111.21 -6.23 25.98 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.205 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.556 ' HB3' ' CE2' ' A' ' 55' ' ' TYR . 16.7 t -94.76 -168.42 1.82 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 . . . . . 0 C--O 1.246 0.89 0 CA-C-O 118.419 -0.8 . . . . 0.0 110.235 -177.771 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.988 0.423 . . . . 0.0 110.65 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -98.52 97.89 9.14 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.644 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 61.61 77.62 0.32 Allowed 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.889 0.743 . . . . 0.0 110.217 -175.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.56 121.66 11.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.774 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 p -76.87 105.37 5.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.941 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.422 ' HA2' ' CG ' ' A' ' 24' ' ' ASP . . . 91.48 155.39 31.68 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.367 -174.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 169.25 -27.8 0.13 Allowed Glycine 0 N--CA 1.442 -0.923 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.432 ' N ' HD12 ' A' ' 8' ' ' ILE . 4.1 mp -117.37 105.51 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 174.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -97.76 142.51 29.44 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.068 -170.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.58 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -118.49 145.21 24.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.085 179.463 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.5 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 48.9 mttm -102.07 128.35 48.56 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -125.2 126.5 70.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.874 0.845 . . . . 0.0 111.377 -176.486 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.6 m -117.28 151.05 37.76 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.81 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.557 ' SD ' ' HB ' ' A' ' 91' ' ' ILE . 69.2 mmm -101.31 160.48 14.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.757 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -134.41 146.5 49.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.352 -0.386 . . . . 0.0 109.988 175.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.78 -34.62 3.84 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -174.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.62 138.38 28.19 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 169.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -76.72 125.5 8.22 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.419 2.079 . . . . 0.0 112.735 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.469 ' HB2' ' CG ' ' A' ' 14' ' ' MET . 93.2 m-85 -152.17 165.5 34.61 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.709 174.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.34 105.88 5.57 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 177.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.524 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 10.8 mmm180 -125.86 155.51 41.06 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.691 -176.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 21' ' ' ARG . 5.5 mmtm -148.08 140.55 24.43 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 174.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 pt -145.66 173.49 3.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.09 0.471 . . . . 0.0 111.397 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.482 ' O ' HG21 ' A' ' 27' ' ' VAL . 9.9 t70 -115.83 140.85 48.82 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.399 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.558 HD12 ' SG ' ' A' ' 86' ' ' CYS . 15.6 mt -73.61 -47.71 38.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.166 -173.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -82.33 -11.56 58.52 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -169.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 24' ' ' ASP . 35.8 m -63.94 -17.87 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 120.867 0.365 . . . . 0.0 111.283 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -84.02 -28.1 27.9 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.085 0.469 . . . . 0.0 110.893 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.77 15.92 36.28 Favored Glycine 0 CA--C 1.519 0.302 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.384 175.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.05 175.68 31.29 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.777 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -69.5 -30.56 68.46 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -176.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.8 p -60.08 -54.93 40.17 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.553 -174.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -71.5 -28.43 63.9 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.508 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.407 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 20.8 tp -58.13 -55.66 32.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.185 0.516 . . . . 0.0 109.844 174.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.453 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 63.0 mt -67.58 -37.05 82.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.333 -177.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -70.72 -32.19 69.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.241 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.691 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -62.24 -42.46 99.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.761 176.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.453 ' CD1' ' HA ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -61.89 -50.37 72.48 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.744 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 45.5 mt-10 -51.76 -30.66 23.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.828 173.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.55 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 26.5 m -76.2 -43.03 44.24 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.65 178.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.691 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 63.9 mmm -54.79 -57.87 9.83 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -168.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.668 ' CZ ' HG21 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -107.14 10.31 30.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.223 -177.168 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.8 mptt 62.51 42.55 8.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.101 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.744 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 1.2 pp -149.45 168.82 22.39 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 175.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.0 m -93.81 104.18 16.27 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -165.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.9 mm -97.64 148.97 5.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 170.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.52 -168.88 38.35 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.302 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 45.37 83.02 0.03 OUTLIER 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.1 0.96 . . . . 0.0 113.526 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 73' ' ' LEU . 30.2 t80 -66.4 86.4 0.11 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 167.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 t -65.61 151.18 47.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.388 0.613 . . . . 0.0 110.837 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -73.3 -16.13 61.38 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.021 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.581 ' HD3' ' HG3' ' A' ' 53' ' ' GLU . 1.2 tmt_? -80.42 -54.73 5.43 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.581 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 33.1 mt-10 -121.53 -29.11 4.47 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.338 171.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 43.01 10.99 0.01 OUTLIER Glycine 0 C--O 1.218 -0.9 0 CA-C-N 114.213 -1.358 . . . . 0.0 116.325 -175.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.507 ' CE1' ' HB3' ' A' ' 72' ' ' MET . 19.4 m-85 -128.64 16.69 6.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 119.222 1.511 . . . . 0.0 111.529 178.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.449 ' H ' ' HG3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -70.57 -37.14 73.95 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.979 -172.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.415 ' N ' ' HE3' ' A' ' 56' ' ' LYS . . . 58.35 19.32 39.69 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.806 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.3 t 63.77 -82.9 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -169.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 40.0 tt0 -119.28 -20.16 8.03 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.611 173.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.436 ' CE1' ' HG3' ' A' ' 93' ' ' LYS . 37.3 m-85 -131.89 125.98 33.05 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.993 0.425 . . . . 0.0 111.395 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -105.85 105.28 52.67 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.129 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.44 ' HG3' HD13 ' A' ' 38' ' ' LEU . 28.4 Cg_endo -72.24 120.33 6.71 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 121.443 1.428 . . . . 0.0 111.166 173.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 72' ' ' MET . 61.0 p -124.64 150.85 45.6 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.228 -176.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 5.2 p90 -117.74 161.85 19.03 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.506 ' HB2' ' CZ2' ' A' ' 71' ' ' TRP . 42.0 tt0 -100.37 118.82 37.4 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 173.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.21 -178.31 6.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.965 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 mtmm -51.37 -42.9 61.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.789 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -86.38 -15.93 38.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.949 0.404 . . . . 0.0 111.018 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.02 29.37 8.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.799 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -94.56 148.25 22.45 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 172.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.538 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 65.9 m95 -115.86 114.37 24.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.958 0.409 . . . . 0.0 110.576 -178.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.507 ' HB3' ' CE1' ' A' ' 55' ' ' TYR . 17.4 mtm -135.86 177.89 7.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.484 ' HG ' ' HA ' ' A' ' 55' ' ' TYR . 6.0 mt -62.34 151.4 36.81 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.642 0.734 . . . . 0.0 110.532 177.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.9 m -78.03 135.09 26.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.47 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.4 8.03 50.54 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.4 -173.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.92 -53.26 49.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.687 0.28 . . . . 0.0 111.255 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.467 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 12.9 m -103.63 157.51 33.73 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 6.4 Cg_endo -48.74 127.04 15.72 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.333 2.689 . . . . 0.0 113.226 -178.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.572 ' O ' HG23 ' A' ' 83' ' ' VAL . 70.6 t-105 -40.85 -46.09 2.65 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 113.848 -1.524 . . . . 0.0 113.811 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.2 -42.95 82.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.713 0.292 . . . . 0.0 111.272 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.2 tmm? -83.88 -27.33 28.72 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.458 ' CD2' HG21 ' A' ' 77' ' ' VAL . 9.2 t80 -60.01 -50.98 71.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.649 -174.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 79' ' ' TRP . 3.8 t -59.75 -36.77 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.129 0.49 . . . . 0.0 111.371 -170.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.2 p -79.1 -11.33 59.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.502 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.6 t -101.5 -19.96 15.3 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.795 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.558 ' SG ' HD12 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -86.1 117.48 24.97 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.302 0.572 . . . . 0.0 110.513 179.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 9.6 ptmm? -118.06 -25.52 6.67 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.572 -174.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -139.78 158.41 44.14 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.62 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 6.6 tp -134.31 131.02 37.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.237 0.541 . . . . 0.0 110.741 -175.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -138.36 123.98 19.69 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.993 0.425 . . . . 0.0 110.654 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.668 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 10.6 mt -114.08 136.61 50.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -158.45 160.79 37.17 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.722 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 52.6 mttt -52.72 149.41 6.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.703 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -61.81 -25.93 66.37 Favored Glycine 0 CA--C 1.504 -0.612 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.731 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.9 t -75.16 -13.36 60.45 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.172 0.51 . . . . 0.0 110.715 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -101.52 -46.74 4.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.99 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.73 -23.87 63.47 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -57.15 -38.11 73.04 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.681 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.82 -37.05 93.68 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.229 -0.51 . . . . 0.0 113.458 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -104.55 11.94 33.72 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -175.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -71.83 65.79 1.14 Allowed Glycine 0 CA--C 1.509 -0.332 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.122 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 61.5 m -90.91 25.96 2.25 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.037 0.446 . . . . 0.0 111.563 -176.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.5 ' HA3' ' OH ' ' A' ' 55' ' ' TYR . . . -95.39 -73.81 1.2 Allowed Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.054 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.5 m -101.24 19.14 3.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.254 0.549 . . . . 0.0 111.12 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.96 80.33 0.48 Allowed Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.125 -0.943 . . . . 0.0 114.154 174.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.1 t -89.95 104.42 16.99 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.439 -0.447 . . . . 0.0 109.9 173.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 . . . . . 0 C--O 1.245 0.858 0 CA-C-O 118.569 -0.729 . . . . 0.0 110.264 179.604 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 . . . . . 0 N--CA 1.484 1.237 0 CA-C-O 120.882 0.372 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -103.26 99.87 9.74 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.057 0.456 . . . . 0.0 110.523 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -113.43 -2.5 13.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.199 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -93.91 141.95 27.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.904 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.9 t 61.79 86.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 121.501 0.667 . . . . 0.0 109.316 -172.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.96 143.69 12.24 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -172.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 178.17 -11.51 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.436 HD13 ' HD3' ' A' ' 26' ' ' ARG . 2.0 mp -112.25 104.17 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -92.71 129.08 38.75 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.05 -174.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.579 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -114.33 142.31 27.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.465 -175.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.614 ' HA ' ' HD2' ' A' ' 22' ' ' LYS . 47.6 mtmt -98.22 127.89 44.4 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.728 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -124.54 126.87 72.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.369 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.5 m -112.93 141.48 46.72 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.852 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.449 ' HG3' ' CD2' ' A' ' 19' ' ' TYR . 73.2 mmm -97.75 122.69 41.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.041 0.448 . . . . 0.0 110.807 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.99 130.99 51.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.389 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.32 -33.45 6.52 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.882 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.19 141.31 33.84 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.48 125.11 7.43 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.356 2.037 . . . . 0.0 113.171 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.449 ' CD2' ' HG3' ' A' ' 14' ' ' MET . 97.8 m-85 -152.65 169.48 22.61 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.486 ' C ' ' HD2' ' A' ' 21' ' ' ARG . 56.0 mt -137.75 102.05 4.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.047 0.451 . . . . 0.0 110.195 169.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.486 ' HD2' ' C ' ' A' ' 20' ' ' LEU . 3.6 mpt_? -129.56 138.67 51.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.285 174.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.614 ' HD2' ' HA ' ' A' ' 11' ' ' LYS . 35.3 mmtm -132.46 142.75 49.38 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 169.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 pt -143.33 174.01 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -172.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.436 ' OD1' HG11 ' A' ' 27' ' ' VAL . 3.8 t70 -115.37 143.97 44.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.754 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.516 HD22 ' SG ' ' A' ' 86' ' ' CYS . 40.7 mt -71.62 -44.0 65.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.287 0.565 . . . . 0.0 111.576 -175.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.518 ' HG2' HG11 ' A' ' 83' ' ' VAL . 40.6 mtm180 -80.16 -22.97 41.42 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -165.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.436 HG11 ' OD1' ' A' ' 24' ' ' ASP . 28.1 m -61.11 -12.97 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -92.47 -28.5 16.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.191 0.52 . . . . 0.0 111.079 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.7 14.77 23.63 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.26 -0.882 . . . . 0.0 113.889 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.35 174.35 34.03 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.379 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -69.36 -33.4 73.02 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.9 m -57.96 -53.75 54.7 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.297 -175.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -74.49 -27.17 60.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.286 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.7 tp -60.13 -55.28 35.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.176 0.512 . . . . 0.0 110.483 175.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.486 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 77.5 mt -66.2 -35.13 79.64 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.549 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -68.45 -33.41 74.14 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.464 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.688 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -64.94 -38.5 91.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.152 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.486 ' CD1' ' HA ' ' A' ' 35' ' ' LEU . 0.5 OUTLIER -61.82 -49.91 74.41 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.043 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.703 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 41.1 mt-10 -53.25 -29.12 31.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.922 173.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.545 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 33.7 m -76.29 -42.62 44.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.475 176.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.688 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 44.2 mmm -55.0 -57.02 13.38 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.141 -169.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.462 ' C ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -109.7 7.36 24.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.081 179.586 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 0.0 OUTLIER 61.19 40.84 14.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.963 174.26 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.703 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 2.2 pp -141.34 162.41 35.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.125 176.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.3 m -85.39 103.4 14.26 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -166.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.425 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 12.1 mm -89.22 151.09 3.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 168.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -115.91 -162.03 13.06 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 121.359 -0.448 . . . . 0.0 112.76 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -89.56 171.84 9.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.764 0.792 . . . . 0.0 112.233 -174.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.457 ' CE2' ' HB2' ' A' ' 73' ' ' LEU . 41.4 t80 -72.62 81.3 1.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.292 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 54' ' ' GLY . 14.0 m -57.79 107.82 0.5 Allowed 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.356 175.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -55.74 -26.66 46.63 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -166.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.616 ' HD2' ' N ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -58.2 -49.28 77.62 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -176.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.616 ' N ' ' HD2' ' A' ' 52' ' ' ARG . 48.6 mt-10 -119.51 -26.98 5.64 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.702 0.763 . . . . 0.0 110.252 172.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 50' ' ' SER . . . 54.28 10.04 1.76 Allowed Glycine 0 C--O 1.213 -1.164 0 CA-C-N 113.913 -1.494 . . . . 0.0 115.695 177.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.58 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 19.0 m-85 -127.7 14.96 7.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 119.25 1.525 . . . . 0.0 112.355 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.712 ' HD3' ' N ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -74.66 -45.47 44.37 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.457 171.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.712 ' N ' ' HD3' ' A' ' 56' ' ' LYS . . . 58.38 -27.79 0.02 OUTLIER Glycine 0 CA--C 1.529 0.916 0 CA-C-N 115.246 -0.888 . . . . 0.0 114.485 -172.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.605 ' H ' ' C ' ' A' ' 56' ' ' LYS . 26.8 t 150.09 -138.75 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -175.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 31.2 tt0 -83.83 -5.48 59.21 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 166.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.421 ' HB2' ' CD1' ' A' ' 46' ' ' ILE . 32.1 m-85 -133.96 130.51 37.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.233 173.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.512 ' HB3' HD23 ' A' ' 73' ' ' LEU . . . -115.51 105.59 51.83 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.28 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.466 ' O ' HD22 ' A' ' 73' ' ' LEU . 32.7 Cg_endo -69.7 120.39 7.19 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 121.952 1.768 . . . . 0.0 112.08 174.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 72' ' ' MET . 38.3 p -123.73 159.51 29.28 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.436 -176.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.555 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 5.0 p90 -135.24 166.25 23.55 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.05 -177.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.548 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 44.1 tt0 -111.58 124.8 53.04 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.565 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.465 ' OD2' ' HG2' ' A' ' 67' ' ' LYS . 23.2 t70 -88.81 -179.81 6.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.968 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.465 ' HG2' ' OD2' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -63.91 -28.58 69.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.508 0.671 . . . . 0.0 110.229 179.26 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -68.11 -18.57 64.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.412 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.57 11.57 71.17 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -95.3 149.56 21.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.149 -0.525 . . . . 0.0 110.111 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.555 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 36.0 m95 -119.82 132.79 55.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.028 -176.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.548 ' HE3' ' CE1' ' A' ' 64' ' ' TYR . 2.0 mpp? -143.11 -179.73 6.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 171.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.58 ' HG ' ' HA ' ' A' ' 55' ' ' TYR . 4.8 mt -63.06 154.14 31.77 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.893 0.854 . . . . 0.0 110.996 175.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.539 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 57.9 t -78.69 122.2 33.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.866 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.06 -1.18 28.45 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -171.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.34 -46.58 79.88 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.994 0.426 . . . . 0.0 110.313 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.404 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 16.0 m -108.62 154.94 41.35 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 173.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 10.9 Cg_endo -54.59 136.57 70.94 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.88 2.387 . . . . 0.0 113.098 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.483 ' O ' HG21 ' A' ' 83' ' ' VAL . 65.1 t-105 -40.64 -48.39 2.91 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 124.096 0.872 . . . . 0.0 112.978 -173.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -53.52 -42.22 67.18 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.782 -177.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 77.2 mtp -82.67 -23.08 34.37 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.262 0.553 . . . . 0.0 110.374 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.539 ' CZ ' ' HA ' ' A' ' 74' ' ' VAL . 7.4 t80 -70.51 -46.49 63.56 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.02 -171.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.518 HG11 ' HG2' ' A' ' 26' ' ' ARG . 3.4 t -61.32 -38.57 80.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.193 0.52 . . . . 0.0 111.478 -171.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.9 p -78.76 -12.52 60.03 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.029 -175.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.2 p -106.52 -31.43 8.52 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.516 ' SG ' HD22 ' A' ' 25' ' ' LEU . 34.0 t -71.92 116.27 12.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.268 0.556 . . . . 0.0 110.978 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -119.38 -19.43 8.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.063 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.548 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 55.9 mtt180 -139.34 156.63 46.89 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 174.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.728 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 5.7 tp -136.12 134.44 38.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.992 0.425 . . . . 0.0 111.247 -173.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.0 ttp180 -140.51 123.58 16.6 Favored 'General case' 0 C--N 1.318 -0.778 0 O-C-N 122.011 -0.431 . . . . 0.0 111.227 168.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.408 HD13 HG23 ' A' ' 91' ' ' ILE . 4.4 mt -106.43 136.03 42.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 168.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -159.0 163.34 36.52 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.15 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 34.0 mtpt -48.55 140.71 7.76 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 124.25 0.969 . . . . 0.0 112.756 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -58.86 -36.33 86.78 Favored Glycine 0 CA--C 1.505 -0.547 0 CA-C-N 113.689 -1.596 . . . . 0.0 113.713 -168.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.405 ' HA ' ' HD3' ' A' ' 98' ' ' LYS . 38.9 p -60.55 -19.86 58.59 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.072 0.463 . . . . 0.0 111.807 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -97.5 -43.56 7.2 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.723 -174.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.58 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -71.16 -29.42 65.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.483 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 95' ' ' THR . 15.1 ptmm? -69.72 -6.86 34.7 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.597 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.96 -7.18 50.9 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.413 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 97' ' ' ALA . 4.0 pp -103.4 -8.23 20.37 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 122.496 -0.414 . . . . 0.0 110.929 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -28.21 95.24 0.01 OUTLIER Glycine 0 C--N 1.336 0.554 0 O-C-N 124.826 1.329 . . . . 0.0 115.25 -171.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 5.4 p 42.02 55.05 3.93 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.7 0.8 . . . . 0.0 112.344 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.62 49.37 2.17 Favored Glycine 0 N--CA 1.436 -1.31 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.079 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.7 t 51.89 55.53 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.671 -0.764 . . . . 0.0 111.272 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -162.71 68.87 0.22 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.482 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.2 t -83.43 58.63 4.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.994 0.426 . . . . 0.0 110.586 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 . . . . . 0 C--O 1.245 0.863 0 CA-C-O 118.463 -0.779 . . . . 0.0 110.293 179.007 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.42 ' O ' ' HB1' ' A' ' 3' ' ' ALA . 36.5 tt0 -97.23 69.43 2.29 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 2' ' ' GLU . . . 77.92 142.99 0.08 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.034 -165.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -68.53 130.39 42.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -172.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 6' ' ' GLY . 21.9 t 67.61 167.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.695 177.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.548 ' HA3' ' HE ' ' A' ' 26' ' ' ARG . . . -170.92 175.76 44.53 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.406 177.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -139.24 26.9 2.67 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.453 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.6 mt -70.12 111.88 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.757 0.313 . . . . 0.0 110.243 175.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -89.59 139.24 30.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.69 -176.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -118.55 148.31 21.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 176.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.54 ' HA ' ' HD2' ' A' ' 22' ' ' LYS . 56.3 mtmt -107.29 130.25 54.79 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.705 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -126.4 129.41 71.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.971 -176.359 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.4 m -109.51 146.64 34.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.639 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.543 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 23.1 tpp -97.53 125.2 42.09 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.854 175.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.5 140.65 37.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.913 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.1 -33.66 4.79 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.683 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.543 ' O ' ' HG3' ' A' ' 14' ' ' MET . . . -134.75 140.2 34.61 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 120.661 0.267 . . . . 0.0 110.556 171.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.49 125.08 7.41 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.428 2.085 . . . . 0.0 112.759 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -153.19 168.17 26.85 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 123.048 0.539 . . . . 0.0 109.944 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.42 98.69 4.15 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.664 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 1.6 ptp180 -134.33 123.0 23.45 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.391 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.664 ' HD3' ' O ' ' A' ' 21' ' ' ARG . 60.7 mmtt -120.43 157.19 29.86 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 117.973 0.351 . . . . 0.0 110.602 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -144.99 172.57 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 120.868 0.366 . . . . 0.0 111.849 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.602 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -112.96 130.66 56.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.225 0.536 . . . . 0.0 110.225 -173.029 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.5 tp -70.11 -45.5 66.79 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -169.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.548 ' HE ' ' HA3' ' A' ' 6' ' ' GLY . 17.4 mtp180 -79.41 -10.86 59.89 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -173.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 24' ' ' ASP . 20.8 m -84.27 -0.55 5.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.521 -0.471 . . . . 0.0 112.246 -173.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.622 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 23.3 m-85 -84.12 -31.09 25.43 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.583 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 44.75 48.21 9.11 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.745 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.89 172.99 13.81 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.135 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -70.07 -29.85 66.95 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -176.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.5 m -59.36 -53.73 54.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.749 0.309 . . . . 0.0 111.37 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.622 ' HB2' ' O ' ' A' ' 28' ' ' TYR . 49.2 mm-40 -73.67 -29.74 62.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.521 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.4 tp -55.22 -56.64 17.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.103 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.6 mt -68.94 -38.74 79.66 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.592 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -67.8 -33.09 74.14 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.276 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.659 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -61.4 -41.47 97.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.54 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.474 HD11 ' HG3' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -65.58 -46.51 79.15 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.132 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 43.6 mt-10 -51.29 -32.71 25.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.441 174.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.536 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 50.2 m -73.79 -41.83 61.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.154 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.659 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 55.9 mmm -56.71 -56.66 18.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.635 -169.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.0 9.12 38.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.083 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.9 mttt 62.04 40.93 11.61 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.618 174.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 3.0 pp -145.01 174.14 11.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.157 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.1 m -102.99 100.78 10.74 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -171.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.434 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 31.5 mm -69.82 139.48 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 168.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.36 -162.3 34.11 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.293 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.58 167.3 12.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.025 0.44 . . . . 0.0 110.839 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.713 ' CE1' HD11 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -63.89 93.03 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.362 172.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.407 ' HB2' ' HA2' ' A' ' 54' ' ' GLY . 1.5 m -61.85 134.06 56.23 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.7 -23.96 60.94 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -168.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.675 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -82.15 -51.5 7.91 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.104 -0.638 . . . . 0.0 112.412 -174.019 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.675 ' N ' ' HD3' ' A' ' 52' ' ' ARG . 60.8 mt-10 -121.3 -31.22 4.13 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 118.956 0.798 . . . . 0.0 110.712 168.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.688 ' O ' HD12 ' A' ' 73' ' ' LEU . . . 38.08 7.78 0.0 OUTLIER Glycine 0 C--O 1.221 -0.701 0 CA-C-N 113.535 -1.666 . . . . 0.0 116.269 -168.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.507 ' CE1' ' HG ' ' A' ' 73' ' ' LEU . 3.8 m-30 -96.24 3.6 52.99 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 118.507 1.154 . . . . 0.0 110.753 -171.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.643 ' C ' ' H ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -69.51 -36.17 76.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.923 168.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 60' ' ' TYR . . . 59.52 -24.11 0.03 OUTLIER Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.321 -0.854 . . . . 0.0 114.399 -174.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.643 ' H ' ' C ' ' A' ' 56' ' ' LYS . 44.4 t 146.91 -89.75 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 -176.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -118.44 -3.15 10.96 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 161.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.47 ' O ' ' HA3' ' A' ' 57' ' ' GLY . 46.9 m-85 -137.47 130.05 29.86 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.748 -175.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 55' ' ' TYR . . . -101.67 104.46 34.89 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.129 176.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.566 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 60.3 Cg_endo -73.06 121.5 7.32 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.093 1.862 . . . . 0.0 111.496 172.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.6 p -132.52 164.17 27.21 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.03 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 5.0 p90 -141.61 165.68 26.82 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.52 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 30.7 tt0 -104.98 122.81 46.62 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.734 175.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.08 179.51 7.25 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.378 0.424 . . . . 0.0 110.781 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.0 mtmm -48.61 -46.95 40.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.044 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -86.6 -10.91 52.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.978 0.418 . . . . 0.0 111.382 -174.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.11 29.5 8.45 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.644 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -93.1 148.84 21.67 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 171.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.493 ' CZ2' ' HB2' ' A' ' 65' ' ' GLU . 66.2 m95 -119.16 113.85 21.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.806 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -130.23 -179.65 5.37 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 171.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.713 HD11 ' CE1' ' A' ' 49' ' ' TYR . 76.7 mt -65.62 156.27 33.3 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.344 0.592 . . . . 0.0 111.089 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.407 ' HA ' ' HZ ' ' A' ' 82' ' ' PHE . 30.2 m -75.87 128.98 37.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.494 176.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.46 8.21 56.36 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.412 -173.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.67 -61.22 2.57 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.596 0.236 . . . . 0.0 111.454 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.415 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 16.1 m -98.87 161.85 23.53 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.402 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 85.4 Cg_exo -46.25 131.96 14.94 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.189 2.593 . . . . 0.0 113.217 177.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.542 ' O ' HG23 ' A' ' 83' ' ' VAL . 66.9 t-105 -47.59 -42.19 23.38 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.816 -173.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -59.11 -42.45 90.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.946 0.403 . . . . 0.0 111.335 -176.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 73.7 mtm -82.39 -21.89 35.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.202 0.525 . . . . 0.0 109.982 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.407 ' HZ ' ' HA ' ' A' ' 74' ' ' VAL . 6.7 t80 -65.7 -55.34 17.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.348 -175.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 79' ' ' TRP . 3.0 t -61.1 -38.14 78.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.153 -171.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.7 p -76.21 -10.2 59.22 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.733 -175.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.5 m -102.7 -19.15 14.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.313 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 74.0 m -76.18 112.8 13.02 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.249 0.547 . . . . 0.0 111.823 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -118.08 -26.59 6.34 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.022 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.52 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 71.9 mtt180 -139.73 154.86 47.55 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.705 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 8.5 tp -131.67 138.35 48.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.489 -175.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.441 ' HD3' ' SD ' ' A' ' 92' ' ' MET . 10.8 ttm180 -141.11 121.45 13.97 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.243 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.0 mt -120.2 134.26 64.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 168.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.441 ' SD ' ' HD3' ' A' ' 90' ' ' ARG . 23.5 ptt? -158.96 164.31 35.71 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 123.319 0.387 . . . . 0.0 111.863 -172.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -47.11 129.46 12.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.991 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -65.51 -31.56 80.58 Favored Glycine 0 CA--C 1.506 -0.469 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.795 -172.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.8 p -66.98 -23.27 65.92 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.165 -0.518 . . . . 0.0 111.633 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -100.03 -18.23 17.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.813 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.576 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -71.18 -22.22 62.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.47 0.652 . . . . 0.0 110.303 176.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -57.33 -26.07 60.35 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.504 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.85 -33.76 85.08 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.86 -176.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 97' ' ' ALA . 3.6 pp -78.92 -21.94 46.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.624 0.712 . . . . 0.0 111.868 -175.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.437 ' N ' HD12 ' A' ' 100' ' ' LEU . . . 29.72 64.69 0.14 Allowed Glycine 0 N--CA 1.468 0.796 0 O-C-N 124.363 1.04 . . . . 0.0 114.372 177.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.464 ' SG ' HD11 ' A' ' 100' ' ' LEU . 70.9 m -95.07 101.56 13.32 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.319 0.581 . . . . 0.0 111.598 -175.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.74 -117.2 10.41 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.672 175.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.0 t -82.07 74.53 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.424 0.63 . . . . 0.0 109.537 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 53' ' ' GLU . . . -137.15 -142.9 4.48 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 177.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 t -75.02 110.26 9.17 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 24.0 m170 . . . . . 0 C--O 1.249 1.073 0 O-C-N 123.899 0.749 . . . . 0.0 110.618 -174.923 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.821 0.343 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -94.97 69.43 3.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.731 0.777 . . . . 0.0 110.045 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -153.39 111.16 3.56 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.936 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -85.65 148.71 25.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.414 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.5 m -104.0 39.68 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.776 -175.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.41 102.18 1.07 Allowed Glycine 0 CA--C 1.504 -0.637 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.112 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.29 -7.83 63.37 Favored Glycine 0 C--N 1.308 -0.991 0 CA-C-N 114.658 -0.771 . . . . 0.0 111.804 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.451 HD12 ' HD2' ' A' ' 26' ' ' ARG . 2.7 mp -82.23 110.05 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.049 0.452 . . . . 0.0 110.151 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -111.14 116.31 30.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.564 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.544 ' CG2' ' HB2' ' A' ' 89' ' ' LEU . 2.9 m -116.37 151.95 18.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -94.86 133.02 39.04 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.131 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.677 ' HB ' ' HB3' ' A' ' 89' ' ' LEU . 1.5 p -148.39 122.45 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 O-C-N 124.037 0.836 . . . . 0.0 110.844 173.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.507 ' HB2' ' N ' ' A' ' 21' ' ' ARG . 7.5 t -160.03 112.41 2.06 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.482 163.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.818 ' HE1' ' O ' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -168.02 141.54 3.3 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 118.282 -1.367 . . . . 0.0 113.888 175.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.406 ' HB2' ' OH ' ' A' ' 60' ' ' TYR . 4.2 p-10 -140.58 76.75 1.57 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.341 0.591 . . . . 0.0 111.619 162.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.505 ' H ' ' CE ' ' A' ' 14' ' ' MET . . . 88.81 -30.71 5.28 Favored Glycine 0 C--O 1.229 -0.174 0 C-N-CA 121.371 -0.442 . . . . 0.0 112.115 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.515 ' O ' ' HG2' ' A' ' 14' ' ' MET . . . -121.21 150.29 53.53 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 177.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.73 129.75 15.99 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.439 2.093 . . . . 0.0 113.736 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 13' ' ' SER . 49.5 m-85 -134.67 172.71 12.56 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.9 mt -136.26 104.14 5.54 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.212 0.529 . . . . 0.0 112.425 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.507 ' N ' ' HB2' ' A' ' 13' ' ' SER . 0.2 OUTLIER -129.91 173.21 10.9 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 167.319 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -137.85 148.93 45.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 118.979 0.809 . . . . 0.0 111.418 175.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.477 HD13 ' CD2' ' A' ' 89' ' ' LEU . 8.8 pt -129.41 175.09 11.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.861 170.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.497 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.6 OUTLIER -109.53 124.64 51.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -176.421 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.447 HD23 HG12 ' A' ' 83' ' ' VAL . 3.2 tp -72.18 -44.85 62.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.073 -167.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.451 ' HD2' HD12 ' A' ' 8' ' ' ILE . 47.2 mtp180 -79.4 -22.63 44.05 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -172.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 24' ' ' ASP . 20.7 m -65.49 -11.23 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.834 0.349 . . . . 0.0 111.719 -172.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -84.48 -27.26 27.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.006 0.431 . . . . 0.0 110.564 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.26 14.73 20.18 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 114.95 -1.023 . . . . 0.0 113.78 173.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.36 169.82 30.47 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 -176.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -70.49 -32.66 70.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -175.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.0 m -59.27 -53.86 53.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.661 0.267 . . . . 0.0 111.226 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -73.42 -30.1 63.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.726 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.446 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 9.8 tp -59.6 -55.53 33.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.38 177.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.594 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 54.1 mt -66.37 -35.99 81.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.137 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -64.39 -33.8 76.7 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.275 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.576 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -72.43 -32.56 66.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.955 0.407 . . . . 0.0 111.036 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.594 ' CD1' ' HA ' ' A' ' 35' ' ' LEU . 2.2 mt -66.9 -51.65 52.77 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.52 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -52.39 -32.43 38.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.884 173.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.568 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 20.5 m -71.37 -34.22 70.25 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.619 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.576 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 73.2 mmm -64.59 -56.71 12.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.783 0.325 . . . . 0.0 111.852 -170.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.41 12.93 25.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.09 0.472 . . . . 0.0 112.119 -177.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.8 mmtm 62.17 53.68 2.85 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.278 170.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 pp -150.28 -172.66 4.23 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.325 -0.235 . . . . 0.0 110.774 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.0 m -100.08 128.04 46.22 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -174.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.535 HG13 ' HB2' ' A' ' 38' ' ' LEU . 41.5 mm -105.16 133.39 49.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.007 174.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.517 ' HA3' ' OG ' ' A' ' 58' ' ' SER . . . -92.09 140.18 15.03 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.228 -0.987 . . . . 0.0 111.235 171.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.17 -179.42 1.95 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.46 0.647 . . . . 0.0 111.896 -173.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -73.56 82.05 1.5 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.661 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 54' ' ' GLY . 3.2 m -64.64 115.8 5.58 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.338 173.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.11 -18.6 37.05 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -169.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.588 ' HD3' ' HG3' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -69.42 -49.27 56.76 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -177.264 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.588 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 44.1 mt-10 -120.11 -27.54 5.29 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.678 0.751 . . . . 0.0 111.238 174.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.502 ' O ' HD22 ' A' ' 73' ' ' LEU . . . 46.29 8.27 0.02 OUTLIER Glycine 0 C--O 1.219 -0.813 0 CA-C-N 113.787 -1.551 . . . . 0.0 116.8 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.474 ' HA ' HD13 ' A' ' 73' ' ' LEU . 12.9 m-85 -127.81 9.24 6.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 119.286 1.543 . . . . 0.0 111.223 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.717 ' HE3' ' N ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -74.42 -24.56 59.11 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.996 -171.636 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.717 ' N ' ' HE3' ' A' ' 56' ' ' LYS . . . 59.88 -8.07 0.06 OUTLIER Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.283 -0.871 . . . . 0.0 114.551 -175.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.517 ' OG ' ' HA3' ' A' ' 47' ' ' GLY . 16.1 m 69.13 -72.44 0.1 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -171.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 33.2 tt0 -119.9 -27.87 5.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.096 166.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.416 ' HB2' HD12 ' A' ' 46' ' ' ILE . 11.1 m-85 -134.86 124.98 25.89 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 120.906 0.384 . . . . 0.0 111.001 176.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.446 ' HB2' ' CD1' ' A' ' 73' ' ' LEU . . . -102.46 105.93 46.34 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.202 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.558 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 38.1 Cg_endo -69.69 119.69 6.6 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.936 1.757 . . . . 0.0 111.335 174.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.588 ' OG1' ' HE1' ' A' ' 92' ' ' MET . 43.4 p -126.07 162.12 26.05 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.175 0.512 . . . . 0.0 110.767 -176.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.627 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 3.5 p90 -132.84 165.18 25.19 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.307 -177.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.418 ' HB2' ' CZ2' ' A' ' 71' ' ' TRP . 30.9 tt0 -108.42 115.77 30.72 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.46 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.552 ' OD2' ' HG2' ' A' ' 67' ' ' LYS . 17.7 t70 -80.53 -176.8 5.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.819 176.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.552 ' HG2' ' OD2' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -62.83 -39.37 94.12 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -171.33 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.428 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . 20.6 t70 -83.0 -0.98 51.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.18 0.514 . . . . 0.0 110.602 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.41 24.39 28.84 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.177 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.428 ' OD2' ' HB3' ' A' ' 68' ' ' ASP . 20.1 m-20 -81.52 129.0 34.5 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.627 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 71.7 m95 -110.3 113.79 26.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.019 0.438 . . . . 0.0 110.813 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 63' ' ' THR . 25.6 mtm -134.81 176.48 8.61 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' A' ' 62' ' ' PRO . 1.2 tp -68.66 154.89 41.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.498 0.665 . . . . 0.0 111.04 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.592 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 3.7 m -77.83 124.38 36.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.136 175.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.94 3.5 28.17 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -172.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.13 -56.65 15.02 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.037 0.446 . . . . 0.0 109.93 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.443 HG22 ' CD2' ' A' ' 82' ' ' PHE . 6.3 m -100.98 154.68 37.0 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 173.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 11.0 Cg_endo -54.45 136.86 71.15 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.879 2.386 . . . . 0.0 113.075 -176.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.481 ' O ' HG22 ' A' ' 83' ' ' VAL . 69.9 t-105 -40.09 -53.03 2.48 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -174.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -51.58 -43.02 62.31 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.046 0.45 . . . . 0.0 111.674 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 77.7 mtp -83.91 -24.54 30.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.468 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.592 ' CZ ' ' HA ' ' A' ' 74' ' ' VAL . 13.4 t80 -68.81 -38.21 79.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.676 -173.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 79' ' ' TRP . 3.3 t -61.17 -42.86 94.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.897 0.38 . . . . 0.0 111.407 -172.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.5 p -78.52 -13.94 59.59 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.465 0.65 . . . . 0.0 110.588 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.1 t -81.42 -31.41 33.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.651 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.428 ' HA ' ' HD2' ' A' ' 64' ' ' TYR . 43.5 t -86.52 131.67 34.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.736 0.779 . . . . 0.0 112.202 -175.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -119.37 -36.74 3.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.263 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -139.14 153.15 47.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.931 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.677 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 12.4 tp -130.5 127.39 39.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.234 0.54 . . . . 0.0 111.716 -174.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.415 ' HB3' ' CZ3' ' A' ' 71' ' ' TRP . 37.5 ttp180 -140.33 130.0 24.32 Favored 'General case' 0 C--N 1.31 -1.137 0 O-C-N 121.374 -0.829 . . . . 0.0 110.929 171.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.818 ' O ' ' HE1' ' A' ' 14' ' ' MET . 8.8 mt -109.41 132.15 58.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.601 ' HA ' ' CE ' ' A' ' 14' ' ' MET . 3.1 ptt? -139.09 141.23 38.16 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -168.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 0.1 OUTLIER -48.38 141.03 7.05 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.229 174.187 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.13 -28.5 49.5 Favored Glycine 0 CA--C 1.508 -0.405 0 CA-C-N 115.398 -0.819 . . . . 0.0 114.146 -169.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.2 t -66.38 -12.79 58.84 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.134 0.493 . . . . 0.0 111.301 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -101.76 -51.53 3.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.614 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.55 -23.81 66.27 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -172.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -57.03 -28.65 62.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.177 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.33 -37.01 22.37 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.638 -176.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.489 HD13 ' HE2' ' A' ' 92' ' ' MET . 2.2 pt? -105.2 14.44 29.06 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -173.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.78 68.15 0.3 Allowed Glycine 0 CA--C 1.521 0.415 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.597 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 6.9 p -83.51 93.16 7.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.703 0.763 . . . . 0.0 111.091 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -179.52 -66.29 0.07 OUTLIER Glycine 0 N--CA 1.428 -1.854 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.785 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.2 t -113.62 11.33 8.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.63 0.728 . . . . 0.0 110.487 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 58.76 65.39 3.52 Favored Glycine 0 N--CA 1.453 -0.171 0 CA-C-N 114.821 -1.081 . . . . 0.0 112.823 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.445 ' CB ' ' HB2' ' A' ' 55' ' ' TYR . 8.5 t -73.81 127.96 34.24 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -177.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.9 m170 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.55 -0.738 . . . . 0.0 110.237 -178.345 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.028 0 N-CA-C 110.539 -1.025 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.826 HD13 ' CZ ' ' A' ' 26' ' ' ARG . 3.8 mp -94.71 106.23 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-O 121.411 0.625 . . . . 0.0 109.941 173.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -91.55 138.18 31.77 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.473 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.58 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -115.86 140.03 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -174.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.633 ' HA ' ' CD ' ' A' ' 22' ' ' LYS . 8.1 mptt -107.04 128.35 54.29 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.46 -0.791 . . . . 0.0 108.886 -174.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.771 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -124.65 133.3 69.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.474 0.654 . . . . 0.0 112.044 -169.791 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.5 m -131.9 155.5 47.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.583 -174.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.467 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 31.0 tpp -113.6 148.28 36.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.619 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -116.06 142.26 47.04 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.98 -32.57 3.74 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.467 ' O ' ' HG3' ' A' ' 14' ' ' MET . . . -133.2 142.66 45.22 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 171.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.99 124.76 7.55 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 121.924 1.749 . . . . 0.0 112.685 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.435 ' HB2' ' HB3' ' A' ' 14' ' ' MET . 68.0 m-85 -151.5 142.55 23.12 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.953 174.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.563 ' O ' ' HD2' ' A' ' 21' ' ' ARG . 5.1 mp -130.17 104.67 7.45 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.101 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.563 ' HD2' ' O ' ' A' ' 20' ' ' LEU . 3.2 mpt_? -126.43 164.1 21.86 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.316 176.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.633 ' CD ' ' HA ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -154.95 143.86 20.85 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.538 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -153.54 174.01 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 O-C-N 123.34 0.4 . . . . 0.0 111.599 -175.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.443 ' O ' HG22 ' A' ' 27' ' ' VAL . 6.4 t70 -115.17 146.96 40.87 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.184 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.494 ' HG ' ' CG2' ' A' ' 10' ' ' VAL . 70.5 mt -72.13 -40.27 68.22 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -175.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.826 ' CZ ' HD13 ' A' ' 8' ' ' ILE . 9.4 mpt_? -71.08 -30.9 67.14 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -173.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 24' ' ' ASP . 36.0 m -62.78 -2.86 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -170.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -99.21 -27.65 13.7 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.914 0.388 . . . . 0.0 111.731 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.45 12.91 14.57 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.986 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.72 171.03 32.36 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.245 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -70.0 -29.83 67.01 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.8 p -56.71 -53.72 54.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.92 0.391 . . . . 0.0 111.17 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -73.25 -27.09 61.38 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.086 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 20.8 tp -58.26 -54.01 51.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.866 0.365 . . . . 0.0 110.144 175.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 96.0 mt -66.19 -38.52 88.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.841 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.473 ' HD3' ' O ' ' A' ' 36' ' ' LYS . 1.7 tmtp? -66.0 -33.92 76.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.352 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.679 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -63.5 -40.96 98.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.286 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.502 ' H ' ' HG ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -62.56 -49.32 75.74 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.056 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.457 ' HG2' ' H ' ' A' ' 46' ' ' ILE . 28.2 mt-10 -52.87 -33.66 50.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.111 175.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.56 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 38.4 m -73.03 -39.63 65.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.245 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.679 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 93.1 mmm -58.2 -55.65 32.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.311 -168.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -104.26 10.38 35.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.013 0.435 . . . . 0.0 111.111 -174.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.58 53.6 4.04 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.649 177.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 pp -154.78 -167.07 2.48 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 61.2 m -117.69 117.04 28.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.959 0.409 . . . . 0.0 111.638 -177.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.457 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 34.8 mm -85.76 135.44 24.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.329 175.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.9 143.56 33.69 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.497 173.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -73.38 172.9 10.38 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.122 0.487 . . . . 0.0 111.46 -174.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.632 ' HD1' HD22 ' A' ' 73' ' ' LEU . 44.5 t80 -76.42 79.14 3.15 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.777 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.5 m -59.29 123.21 15.99 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.05 -11.24 47.06 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -168.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.498 ' HD2' ' HG3' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -78.9 -49.79 12.28 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.025 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.498 ' HG3' ' HD2' ' A' ' 52' ' ' ARG . 90.8 mt-10 -119.32 -29.16 5.23 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.756 -0.59 . . . . 0.0 112.076 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.554 ' O ' HD13 ' A' ' 73' ' ' LEU . . . 41.78 12.1 0.01 OUTLIER Glycine 0 C--O 1.216 -1.022 0 N-CA-C 117.067 1.587 . . . . 0.0 117.067 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.738 ' HA ' HD13 ' A' ' 73' ' ' LEU . 17.5 m-30 -124.26 1.1 8.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 119.493 1.647 . . . . 0.0 110.492 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.422 ' HD3' ' H ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -64.78 -52.94 54.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.787 -175.602 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 60' ' ' TYR . . . 59.1 7.87 5.54 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 116.286 -0.415 . . . . 0.0 113.84 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.5 t 65.9 -82.72 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.199 0.6 . . . . 0.0 110.179 -171.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 40.5 tt0 -117.16 -15.64 10.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.595 0.236 . . . . 0.0 110.821 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.476 ' CZ ' ' HG3' ' A' ' 93' ' ' LYS . 57.7 m-85 -136.63 126.04 25.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.764 0.316 . . . . 0.0 111.432 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.638 ' HB1' HD12 ' A' ' 73' ' ' LEU . . . -103.92 105.79 49.92 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.801 175.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.505 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 28.6 Cg_endo -64.55 120.71 8.07 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.008 1.805 . . . . 0.0 111.243 172.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.619 HG21 HD11 ' A' ' 100' ' ' LEU . 35.9 p -127.22 154.05 45.33 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.214 0.53 . . . . 0.0 110.24 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.598 ' CD2' ' HZ ' ' A' ' 82' ' ' PHE . 44.0 p90 -135.28 167.04 21.75 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.744 -175.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.531 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 33.6 tt0 -108.29 117.35 33.93 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.37 179.38 7.69 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.475 ' HD2' ' N ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -64.18 -25.88 68.27 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.358 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.475 ' N ' ' HD2' ' A' ' 67' ' ' LYS . 35.1 t70 -78.15 -18.4 55.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.22 0.533 . . . . 0.0 110.095 177.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.18 15.51 47.73 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.339 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -96.41 142.38 28.59 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.557 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 68.9 m95 -101.13 118.94 37.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.432 0.634 . . . . 0.0 110.828 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.435 ' O ' ' HA ' ' A' ' 63' ' ' THR . 45.1 mtm -125.4 171.75 10.19 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.414 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.738 HD13 ' HA ' ' A' ' 55' ' ' TYR . 7.5 tt -91.63 142.17 27.92 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.481 ' N ' HD23 ' A' ' 73' ' ' LEU . 19.7 m -58.85 143.06 13.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.103 -174.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.37 3.06 25.99 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.881 -173.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -80.23 -59.54 2.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.927 0.394 . . . . 0.0 110.712 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.576 HG12 ' HD2' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -96.55 153.25 38.88 Favored Pre-proline 0 N--CA 1.445 -0.717 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 175.788 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.576 ' HD2' HG12 ' A' ' 77' ' ' VAL . 7.5 Cg_exo -74.2 155.32 46.92 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.475 2.117 . . . . 0.0 110.791 176.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.722 ' O ' HG23 ' A' ' 83' ' ' VAL . 61.9 t-105 -46.38 -49.64 17.6 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.862 0.726 . . . . 0.0 112.695 -171.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -55.97 -42.18 75.9 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -171.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 78.8 mtp -83.53 -33.74 25.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.239 0.543 . . . . 0.0 110.472 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.598 ' HZ ' ' CD2' ' A' ' 64' ' ' TYR . 7.1 t80 -58.32 -50.93 71.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.95 -175.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 79' ' ' TRP . 2.1 t -60.64 -39.22 80.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.126 0.488 . . . . 0.0 111.307 -171.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.6 p -79.57 -11.7 59.87 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -175.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.5 p -108.8 -28.65 9.08 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -174.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 40.4 t -66.14 136.42 55.91 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.026 0.441 . . . . 0.0 111.051 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -116.86 -40.5 3.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.739 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.531 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 69.9 mtt180 -137.59 161.89 35.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.198 -175.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.771 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 6.5 tp -133.76 122.97 24.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.752 -172.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -139.7 119.67 13.52 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 121.829 -0.545 . . . . 0.0 110.508 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.421 HG23 ' HA ' ' A' ' 62' ' ' PRO . 10.3 mt -116.74 135.14 58.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.429 ' HA ' ' SD ' ' A' ' 14' ' ' MET . 25.5 ptt? -159.25 162.95 36.21 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.336 0.589 . . . . 0.0 112.357 -174.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 36.4 mttt -56.93 146.78 25.61 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.062 -1.426 . . . . 0.0 113.086 -176.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' A' ' 97' ' ' ALA . . . -60.3 -30.09 70.31 Favored Glycine 0 CA--C 1.507 -0.454 0 CA-C-N 114.125 -1.398 . . . . 0.0 113.726 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.498 HG22 ' HB3' ' A' ' 93' ' ' LYS . 1.5 t -56.78 -26.09 56.82 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.161 0.505 . . . . 0.0 111.337 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -102.67 -34.78 8.93 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.167 0.508 . . . . 0.0 110.346 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.407 ' HB3' ' HA2' ' A' ' 94' ' ' GLY . . . -63.08 -23.4 67.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.578 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.44 ' HE3' ' O ' ' A' ' 95' ' ' THR . 16.0 pttp -62.39 -19.53 63.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.962 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -71.77 -40.61 57.94 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.39 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.619 HD11 HG21 ' A' ' 63' ' ' THR . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.352 0 O-C-N 122.599 -0.354 . . . . 0.0 110.87 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.747 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 3.2 mp -114.06 104.5 17.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.184 0.516 . . . . 0.0 109.985 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -115.07 118.56 33.72 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.231 -172.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.597 ' CG2' ' HB2' ' A' ' 89' ' ' LEU . 4.1 m -116.25 162.51 14.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.165 -177.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.555 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 18.8 ptmt -104.07 134.33 47.52 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -126.47 128.08 70.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.607 0.717 . . . . 0.0 111.322 -177.003 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.3 t -122.56 155.2 36.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.763 175.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.739 ' SD ' ' HB ' ' A' ' 91' ' ' ILE . 68.6 mmm -103.18 141.92 35.04 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.847 0.356 . . . . 0.0 111.052 -177.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 92' ' ' MET . 11.0 t70 -110.44 125.02 52.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.024 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.34 -32.75 6.89 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -177.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.05 142.98 42.21 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 172.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.89 122.87 6.5 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 121.554 1.503 . . . . 0.0 112.355 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.482 ' HB2' ' CG ' ' A' ' 14' ' ' MET . 75.4 m-85 -153.43 151.68 30.17 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.044 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -127.81 105.56 8.52 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.008 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.481 ' C ' ' HG2' ' A' ' 22' ' ' LYS . 31.8 mmt180 -127.97 156.1 43.22 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.555 ' HD3' ' HA ' ' A' ' 11' ' ' LYS . 4.9 mmtm -147.81 130.18 15.71 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.415 HD11 ' CD2' ' A' ' 89' ' ' LEU . 4.0 pt -140.95 173.31 9.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.66 0.743 . . . . 0.0 112.168 -174.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.653 ' OD1' ' HG2' ' A' ' 26' ' ' ARG . 7.3 t70 -113.62 126.94 55.83 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.687 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.472 ' HB3' HG13 ' A' ' 83' ' ' VAL . 6.8 mp -70.8 -39.85 72.86 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.697 -174.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.653 ' HG2' ' OD1' ' A' ' 24' ' ' ASP . 8.4 ptm180 -77.66 -23.51 49.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.83 -167.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 24' ' ' ASP . 29.8 m -65.34 -16.12 19.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -176.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -84.74 -27.88 26.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.13 0.49 . . . . 0.0 110.909 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.93 14.3 30.31 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.24 -0.891 . . . . 0.0 113.688 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.07 168.5 32.02 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.412 ' CE1' ' HA2' ' A' ' 75' ' ' GLY . 43.3 m-85 -70.4 -34.24 72.31 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -175.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.1 m -59.05 -51.18 71.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.846 0.355 . . . . 0.0 111.386 -175.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -72.99 -33.71 65.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.797 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.1 tp -55.82 -55.78 28.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.156 0.503 . . . . 0.0 110.796 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.7 mt -66.8 -35.48 80.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.08 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.453 ' HD3' ' C ' ' A' ' 36' ' ' LYS . 13.1 tmtt? -63.27 -43.38 98.09 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.526 -177.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.45 ' O ' ' HB ' ' A' ' 40' ' ' THR . . . -57.71 -42.31 83.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.829 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.444 ' H ' ' HG ' ' A' ' 38' ' ' LEU . 1.3 mt -65.56 -53.3 43.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.841 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.457 ' HG2' ' H ' ' A' ' 46' ' ' ILE . 40.7 mt-10 -52.01 -28.74 18.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.694 175.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 33.6 m -76.48 -45.13 32.4 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.542 175.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.435 ' HG3' ' O ' ' A' ' 37' ' ' ALA . 30.6 mtm -58.91 -55.03 40.45 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -170.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.21 9.15 36.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.249 0.547 . . . . 0.0 111.125 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? 55.24 48.81 18.54 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.792 173.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 pp -141.53 178.86 7.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.7 m -95.73 122.13 38.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.213 0.53 . . . . 0.0 112.237 -173.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.457 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 49.1 mm -102.47 135.05 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.5 174.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.453 ' HA3' ' NZ ' ' A' ' 56' ' ' LYS . . . -89.32 164.96 32.33 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.744 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.4 176.94 8.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.277 0.561 . . . . 0.0 112.009 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -78.18 93.91 4.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.755 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.571 ' N ' ' HA2' ' A' ' 54' ' ' GLY . 2.1 t -49.78 138.98 13.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.05 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -73.87 -13.28 60.89 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.131 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.536 ' HD3' ' HG3' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -104.23 -44.5 4.95 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.064 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.536 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 24.4 mt-10 -118.26 -28.41 5.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.472 0.578 . . . . 0.0 111.555 175.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.571 ' HA2' ' N ' ' A' ' 50' ' ' SER . . . 54.06 11.15 2.1 Favored Glycine 0 C--O 1.219 -0.81 0 CA-C-N 114.699 -1.137 . . . . 0.0 115.216 -178.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.442 ' HB3' HD11 ' A' ' 100' ' ' LEU . 18.5 m-85 -125.54 4.09 7.6 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 118.473 1.136 . . . . 0.0 111.247 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.497 ' HD3' ' H ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -58.74 -37.71 76.8 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -176.771 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.497 ' H ' ' HD3' ' A' ' 56' ' ' LYS . . . 60.86 -4.94 0.22 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 114.252 0.461 . . . . 0.0 114.252 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.415 ' H ' ' HE2' ' A' ' 56' ' ' LYS . 48.8 m 69.26 -79.33 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.189 0.596 . . . . 0.0 109.892 -172.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 33.2 tt0 -118.57 -19.52 8.73 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.107 172.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -143.43 126.13 16.03 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.066 0.46 . . . . 0.0 110.974 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.434 ' HB1' ' CD1' ' A' ' 73' ' ' LEU . . . -103.01 104.45 40.09 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.06 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.477 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 33.9 Cg_endo -67.99 121.16 8.15 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 121.714 1.609 . . . . 0.0 111.263 172.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.436 HG21 HD22 ' A' ' 100' ' ' LEU . 82.2 p -125.54 160.05 30.52 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.519 -176.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.689 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.7 p90 -121.57 164.1 17.81 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.604 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.492 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 41.3 tt0 -103.42 115.64 30.91 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 14.1 t70 -84.03 -169.25 2.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.007 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.448 ' H ' ' CG ' ' A' ' 66' ' ' ASP . 1.4 mtmp? -66.65 -45.73 78.03 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.647 0.26 . . . . 0.0 111.474 -173.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.53 -3.76 51.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.194 0.521 . . . . 0.0 110.861 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.27 24.27 19.64 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.166 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -76.18 138.81 40.92 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.568 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 90.7 m95 -115.16 113.05 23.44 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 123.405 0.441 . . . . 0.0 109.952 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.433 ' HA ' ' CD1' ' A' ' 100' ' ' LEU . 32.5 mtm -142.36 169.45 17.56 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 176.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 62' ' ' PRO . 2.3 tp -62.88 152.89 35.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.282 0.563 . . . . 0.0 111.204 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.753 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 99.2 t -77.55 127.78 38.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.443 174.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.412 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 111.57 1.68 27.56 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -170.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -63.03 -48.3 79.32 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.571 HG22 ' CD2' ' A' ' 82' ' ' PHE . 3.2 m -113.88 156.8 43.34 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.86 133.11 33.31 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.965 2.443 . . . . 0.0 113.606 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.565 ' O ' HG23 ' A' ' 83' ' ' VAL . 73.2 t-105 -40.03 -53.31 2.4 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.444 1.097 . . . . 0.0 113.552 -173.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -52.51 -42.78 64.61 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -175.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 68.1 mtm -83.75 -27.48 28.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.111 0.482 . . . . 0.0 110.545 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.753 ' CZ ' ' HA ' ' A' ' 74' ' ' VAL . 9.2 t80 -63.16 -45.49 91.59 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.502 -174.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 79' ' ' TRP . 4.7 t -61.14 -42.34 92.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.302 -171.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.7 p -78.58 -19.45 52.74 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.094 0.473 . . . . 0.0 110.985 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.8 t -83.83 -21.73 31.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.302 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.689 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 36.2 t -90.93 133.47 35.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.161 0.505 . . . . 0.0 111.182 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 13.7 pttp -121.91 -29.52 4.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.738 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.492 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 60.2 mtt180 -139.51 167.28 22.46 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 176.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.712 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 10.8 tp -136.86 138.17 40.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.299 0.571 . . . . 0.0 111.527 -173.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -139.22 129.3 25.17 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.832 0.349 . . . . 0.0 110.146 170.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.739 ' HB ' ' SD ' ' A' ' 14' ' ' MET . 13.4 mt -111.65 138.28 40.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 175.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.467 ' HE1' ' HB3' ' A' ' 100' ' ' LEU . 9.1 ptt? -155.9 147.55 22.93 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -170.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 21.0 ttpt -50.83 147.88 4.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 113.591 -1.641 . . . . 0.0 112.828 -175.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.53 -27.98 70.53 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 114.698 -1.137 . . . . 0.0 113.276 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.526 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 44.3 p -68.49 -16.08 63.77 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.91 0.386 . . . . 0.0 111.08 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -101.88 -2.57 29.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.453 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.574 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -59.61 -29.97 68.36 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -172.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.526 ' HE3' ' O ' ' A' ' 95' ' ' THR . 0.0 OUTLIER -59.6 -23.66 63.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.769 0.318 . . . . 0.0 110.874 178.434 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.52 -22.01 78.93 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 116.101 -0.5 . . . . 0.0 113.195 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.574 HD23 ' HA ' ' A' ' 97' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 121.355 0.598 . . . . 0.0 110.756 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.93 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.495 ' CD1' ' HD2' ' A' ' 26' ' ' ARG . 3.9 mp -92.26 106.3 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-O 121.218 0.532 . . . . 0.0 109.983 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -90.04 134.8 34.03 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.95 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.537 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -116.25 139.74 41.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.443 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -104.55 135.07 46.66 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.706 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -124.39 127.41 73.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.691 0.758 . . . . 0.0 111.472 -172.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.8 p -115.57 155.84 26.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.69 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.456 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 27.4 tpp -110.05 145.08 37.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.624 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -111.89 140.35 46.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.597 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.74 -32.44 4.54 Favored Glycine 0 C--O 1.229 -0.157 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 14' ' ' MET . . . -133.94 143.71 48.58 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 172.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.97 122.21 6.17 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 121.391 1.394 . . . . 0.0 112.262 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -153.29 143.16 22.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.766 174.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.5 mt -127.65 106.95 9.5 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.84 0.353 . . . . 0.0 110.368 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.554 ' O ' HG13 ' A' ' 12' ' ' VAL . 10.3 mmm180 -124.07 155.49 38.25 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.446 ' HD2' ' C ' ' A' ' 21' ' ' ARG . 2.5 mptp? -143.76 144.39 31.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.796 0.332 . . . . 0.0 110.551 175.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -146.87 176.06 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.979 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.485 ' O ' HG22 ' A' ' 27' ' ' VAL . 9.0 t70 -111.32 132.68 54.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.273 0.559 . . . . 0.0 110.275 -175.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.551 HD21 ' HB3' ' A' ' 86' ' ' CYS . 16.6 tp -69.27 -34.31 74.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.733 -172.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.495 ' HD2' ' CD1' ' A' ' 8' ' ' ILE . 65.8 mtp180 -79.47 -32.07 42.53 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -171.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 24' ' ' ASP . 33.6 m -68.81 -0.81 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -169.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.513 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 27.0 m-85 -85.64 -28.7 24.58 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.28 177.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.86 14.86 5.8 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.328 -0.851 . . . . 0.0 114.168 177.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.21 175.94 28.71 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.633 -176.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.4 ' OH ' ' HA ' ' A' ' 78' ' ' PRO . 25.1 m-85 -69.18 -31.63 70.39 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -176.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.9 p -59.69 -56.11 25.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.733 0.301 . . . . 0.0 111.44 -175.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' A' ' 28' ' ' TYR . 47.1 mt-10 -73.98 -25.83 60.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.59 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.64 -56.37 23.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.233 0.54 . . . . 0.0 110.115 174.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.4 mt -69.77 -36.63 75.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.81 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.458 ' HA ' ' HD3' ' A' ' 36' ' ' LYS . 68.0 mmtt -71.62 -31.29 66.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.561 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.684 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -58.59 -42.65 88.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.881 176.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.656 HD13 ' HG3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -58.24 -52.93 63.51 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.598 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 39.0 mt-10 -52.3 -30.22 27.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.896 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.559 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 53.8 m -73.95 -44.89 53.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.135 177.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.684 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 74.5 mmm -57.07 -57.13 13.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.707 -169.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -102.17 8.6 40.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.119 0.485 . . . . 0.0 110.922 -175.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.28 47.72 16.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.633 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 3.0 pp -145.51 -179.31 6.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.705 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 m -111.61 98.21 7.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -171.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.457 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 37.5 mm -65.51 127.66 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.988 172.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.5 149.59 43.82 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.891 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -68.21 162.7 24.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.117 0.484 . . . . 0.0 111.803 -174.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.541 ' CZ ' HD12 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -65.95 89.73 0.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.891 179.007 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.427 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 30.8 t -62.89 146.88 51.85 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.707 0.765 . . . . 0.0 109.849 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -76.37 -16.32 59.75 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.603 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.555 ' HD3' ' HG3' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -82.03 -56.3 4.04 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -172.457 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.555 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 39.5 mt-10 -121.34 -29.64 4.43 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.732 0.777 . . . . 0.0 109.687 165.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.532 ' O ' HD11 ' A' ' 73' ' ' LEU . . . 46.73 8.76 0.03 OUTLIER Glycine 0 C--O 1.214 -1.115 0 CA-C-N 113.317 -1.765 . . . . 0.0 116.216 -177.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.485 ' HD1' ' O ' ' A' ' 53' ' ' GLU . 11.1 m-85 -114.78 6.49 15.55 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 118.171 0.986 . . . . 0.0 110.992 -176.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.507 ' HG2' ' H ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -63.85 -39.07 93.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.647 177.324 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 60' ' ' TYR . . . 58.31 22.19 49.97 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.78 176.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.507 ' H ' ' HG2' ' A' ' 56' ' ' LYS . 20.4 t 69.27 -86.19 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -165.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -119.75 -16.61 8.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.694 0.283 . . . . 0.0 110.971 169.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.525 ' O ' ' HA3' ' A' ' 57' ' ' GLY . 30.3 m-85 -122.27 125.79 46.78 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -174.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -100.92 105.33 37.68 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.936 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.656 ' HG3' HD13 ' A' ' 38' ' ' LEU . 61.0 Cg_endo -72.8 119.65 6.2 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.986 1.791 . . . . 0.0 111.231 175.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 72' ' ' MET . 71.2 p -128.78 165.49 20.84 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.766 -175.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.549 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 4.3 p90 -137.8 164.74 28.16 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.683 0.278 . . . . 0.0 110.349 -176.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.482 ' OE1' ' HD3' ' A' ' 88' ' ' ARG . 29.5 tt0 -100.24 113.92 26.96 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.89 177.48 8.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.715 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.0 mtmm -48.72 -44.14 37.96 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.117 0.567 . . . . 0.0 111.888 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -81.86 -15.99 52.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.114 0.483 . . . . 0.0 110.74 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.99 23.86 16.56 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.57 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -95.27 143.64 26.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.549 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 67.3 m95 -110.1 114.96 28.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.065 0.46 . . . . 0.0 111.516 -173.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.425 ' O ' ' HA ' ' A' ' 63' ' ' THR . 2.1 mpp? -127.37 179.3 5.54 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 174.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.541 HD12 ' CZ ' ' A' ' 49' ' ' TYR . 10.8 mt -64.0 153.22 37.93 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.54 0.686 . . . . 0.0 111.531 176.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.406 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 22.9 m -77.14 137.83 21.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.855 175.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.73 8.26 80.18 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.624 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.35 -54.03 43.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.664 0.268 . . . . 0.0 111.212 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.542 HG22 ' CD2' ' A' ' 82' ' ' PHE . 12.4 m -98.82 155.52 36.57 Favored Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 4.2 Cg_endo -46.95 132.82 17.8 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.487 2.791 . . . . 0.0 113.326 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.548 ' O ' HG23 ' A' ' 83' ' ' VAL . 70.0 t-105 -43.41 -51.88 6.28 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -171.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -54.63 -42.66 71.48 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.628 0.251 . . . . 0.0 111.637 -174.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 57.2 ttp -84.03 -22.73 31.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.998 0.428 . . . . 0.0 110.547 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.542 ' CD2' HG22 ' A' ' 77' ' ' VAL . 11.4 t80 -66.29 -45.93 78.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.038 -177.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 79' ' ' TRP . 3.5 t -61.37 -37.28 77.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.115 0.483 . . . . 0.0 110.944 -174.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.5 p -79.46 -12.34 59.88 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.334 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.3 m -95.17 -31.32 13.58 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.551 ' HB3' HD21 ' A' ' 25' ' ' LEU . 44.6 t -80.5 130.31 35.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.762 0.791 . . . . 0.0 111.457 -175.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -118.21 -40.66 2.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.674 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.482 ' HD3' ' OE1' ' A' ' 65' ' ' GLU . 51.6 mtp180 -140.14 163.54 32.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.084 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.706 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 5.6 tp -130.02 137.65 50.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.879 0.371 . . . . 0.0 110.826 -171.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.406 ' HD2' ' SD ' ' A' ' 92' ' ' MET . 12.9 ttm180 -139.31 115.03 10.04 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.826 175.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.1 mt -111.25 133.92 55.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 171.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.495 ' C ' ' HD1' ' A' ' 60' ' ' TYR . 21.9 ptt? -159.19 161.46 36.15 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -169.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -56.96 141.22 46.16 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.696 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.69 -22.07 45.38 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.957 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.2 t -63.63 -20.22 65.5 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.002 0.43 . . . . 0.0 111.01 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -101.25 -39.03 7.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.08 0.467 . . . . 0.0 109.887 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.44 -25.76 67.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.004 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -65.25 -23.28 67.02 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.37 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.91 -38.1 36.9 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.911 -0.661 . . . . 0.0 113.112 -177.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.472 HD23 ' H ' ' A' ' 100' ' ' LEU . 1.3 pt? . . . . . 0 C--N 1.326 -0.416 0 CA-C-O 120.748 0.308 . . . . 0.0 111.65 -174.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.947 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 mp -125.11 107.58 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 114.229 -0.986 . . . . 0.0 109.129 170.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -103.18 141.2 36.28 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.571 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.598 HG21 HD13 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -131.15 152.88 38.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.235 0.54 . . . . 0.0 109.927 -179.029 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -118.72 141.46 48.6 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -125.57 126.88 71.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.61 0.719 . . . . 0.0 111.313 -174.839 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.6 m -117.41 155.6 29.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.366 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.695 ' SD ' ' HA ' ' A' ' 92' ' ' MET . 25.7 tpp -99.69 151.98 20.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.888 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -119.06 122.46 42.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.079 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.63 -31.94 8.15 Favored Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.43 ' O ' ' HG3' ' A' ' 14' ' ' MET . . . -134.64 149.15 70.04 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 173.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.18 121.75 5.88 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.019 1.146 . . . . 0.0 112.222 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.526 ' HB2' ' CB ' ' A' ' 14' ' ' MET . 56.6 m-85 -153.09 142.89 22.05 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.557 175.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.453 HD22 ' C ' ' A' ' 19' ' ' TYR . 3.1 mm? -129.53 106.71 8.94 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.14 0.495 . . . . 0.0 111.12 -176.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.504 ' C ' ' HD2' ' A' ' 22' ' ' LYS . 37.3 mmt180 -125.52 155.85 39.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.808 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.504 ' HD2' ' C ' ' A' ' 21' ' ' ARG . 2.5 mptp? -146.96 137.2 23.49 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.533 HD11 ' CD2' ' A' ' 89' ' ' LEU . 1.9 pt -140.95 174.11 8.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.576 0.703 . . . . 0.0 111.87 -176.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.536 ' O ' HG22 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -113.16 124.8 53.4 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.036 -0.983 . . . . 0.0 108.956 -177.155 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.598 HD13 HG21 ' A' ' 10' ' ' VAL . 11.8 tp -71.62 -45.58 61.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -165.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -79.98 -16.37 55.33 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -171.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 24' ' ' ASP . 19.1 m -75.68 -0.74 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -169.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.461 ' OH ' ' HB ' ' A' ' 23' ' ' ILE . 30.5 m-85 -96.12 -28.93 14.36 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.926 0.394 . . . . 0.0 111.341 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.16 14.21 17.68 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.859 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.31 167.31 33.61 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.876 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -69.23 -34.14 74.38 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 p -57.21 -55.22 37.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.569 0.223 . . . . 0.0 111.159 -176.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -70.3 -29.95 66.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.105 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.5 tp -59.09 -55.6 33.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.187 0.518 . . . . 0.0 109.959 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.54 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 56.4 mt -67.31 -38.13 84.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.259 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 36' ' ' LYS . 62.9 mmtt -69.66 -31.96 70.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.657 -177.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.471 ' O ' ' HB ' ' A' ' 40' ' ' THR . . . -60.54 -41.82 95.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.076 0.465 . . . . 0.0 110.387 176.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.541 ' HB2' HG13 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -63.37 -54.61 34.17 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.805 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.54 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 23.6 mt-10 -52.11 -29.8 23.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.938 176.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 24.6 m -71.71 -41.89 68.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.205 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.533 ' HE3' ' CZ ' ' A' ' 42' ' ' PHE . 71.8 mtm -66.51 -55.03 17.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -171.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.533 ' CZ ' ' HE3' ' A' ' 41' ' ' MET . 0.1 OUTLIER -100.46 10.53 41.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.159 0.504 . . . . 0.0 111.929 -173.611 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp 55.27 47.92 20.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.622 174.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.41 ' CD2' ' HB2' ' A' ' 42' ' ' PHE . 2.8 pp -143.08 -176.37 4.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.007 -177.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 63.4 m -108.18 99.86 9.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.042 0.449 . . . . 0.0 111.713 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.541 HG13 ' HB2' ' A' ' 38' ' ' LEU . 34.2 mm -76.77 123.18 32.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 172.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.02 155.52 53.58 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.013 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -71.01 171.27 11.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.296 0.57 . . . . 0.0 111.249 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.579 ' HD1' HD22 ' A' ' 73' ' ' LEU . 28.2 t80 -79.3 85.66 5.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.542 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.8 m -56.66 135.64 54.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.383 173.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -72.13 -25.73 61.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.282 0.563 . . . . 0.0 110.399 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.588 ' HD2' ' N ' ' A' ' 53' ' ' GLU . 3.4 ppt_? -68.24 -52.98 27.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.367 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.588 ' N ' ' HD2' ' A' ' 52' ' ' ARG . 47.6 mt-10 -122.84 -29.23 4.01 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.634 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.598 ' O ' HD13 ' A' ' 73' ' ' LEU . . . 42.21 10.87 0.01 OUTLIER Glycine 0 C--O 1.218 -0.872 0 N-CA-C 116.303 1.281 . . . . 0.0 116.303 -174.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.455 ' HD1' ' HB3' ' A' ' 73' ' ' LEU . 9.7 m-85 -126.25 6.57 7.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 118.672 1.236 . . . . 0.0 110.269 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.479 ' HG2' ' H ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -67.12 -31.21 71.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.5 -175.29 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 58' ' ' SER . . . 65.56 -12.74 0.31 Allowed Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.527 -0.761 . . . . 0.0 114.727 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.479 ' H ' ' HG2' ' A' ' 56' ' ' LYS . 40.0 m 71.77 -80.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -172.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -118.88 -23.75 6.84 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.656 170.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.424 ' HE1' ' SD ' ' A' ' 14' ' ' MET . 37.4 m-85 -134.79 124.51 25.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.008 0.432 . . . . 0.0 111.205 175.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.431 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . . . -105.46 105.3 51.92 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.681 177.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.516 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 43.8 Cg_endo -68.51 120.17 7.13 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.499 1.466 . . . . 0.0 110.993 174.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.3 p -124.7 168.45 13.16 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.078 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 3.6 p90 -143.77 165.32 28.0 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -176.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.436 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 40.4 tt0 -108.32 121.14 44.29 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.401 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.479 ' O ' ' HE3' ' A' ' 87' ' ' LYS . 14.9 t70 -84.15 -169.34 2.54 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.567 177.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.484 ' NZ ' ' HA ' ' A' ' 85' ' ' SER . 17.4 mmtm -62.36 -49.08 76.99 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.725 0.774 . . . . 0.0 109.82 -172.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -84.39 13.93 4.94 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.714 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.79 19.58 72.84 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.942 175.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -75.61 130.0 38.08 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.526 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 92.8 m95 -106.26 120.72 42.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.167 0.508 . . . . 0.0 110.69 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 46.5 mtm -138.5 170.27 16.32 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.598 HD13 ' O ' ' A' ' 54' ' ' GLY . 10.0 tt -79.08 141.57 37.25 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 16.2 m -66.81 130.11 31.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.649 0.738 . . . . 0.0 112.219 -174.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.87 4.56 26.08 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.807 -175.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.05 -59.43 5.43 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.612 0.244 . . . . 0.0 110.869 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.8 m -98.57 156.06 36.1 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -52.16 137.14 54.67 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.172 2.581 . . . . 0.0 112.975 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.593 ' O ' HG23 ' A' ' 83' ' ' VAL . 71.9 t-105 -43.78 -41.72 5.12 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.347 -174.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -58.74 -42.63 89.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.093 0.473 . . . . 0.0 111.063 -174.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 49.9 ttp -85.11 -27.66 26.11 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.589 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 74' ' ' VAL . 11.8 t80 -63.63 -40.71 97.57 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.162 -172.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 79' ' ' TRP . 2.8 t -60.86 -39.7 82.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.415 0.626 . . . . 0.0 110.942 -173.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.7 p -79.09 -10.85 59.94 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.314 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.484 ' HA ' ' NZ ' ' A' ' 67' ' ' LYS . 68.0 m -89.3 -31.39 17.86 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 30.3 t -90.75 123.91 34.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.176 0.512 . . . . 0.0 112.043 -175.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.479 ' HE3' ' O ' ' A' ' 66' ' ' ASP . 18.8 pttp -118.83 -22.9 7.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.594 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.436 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 84.5 mtt180 -140.23 151.16 44.94 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 174.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.63 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 3.6 tp -125.73 137.72 53.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.018 0.437 . . . . 0.0 111.114 -174.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -139.31 116.08 10.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.154 0.502 . . . . 0.0 110.948 172.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.435 HD12 ' HZ ' ' A' ' 42' ' ' PHE . 22.1 mt -106.8 136.6 41.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 173.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.695 ' HA ' ' SD ' ' A' ' 14' ' ' MET . 19.9 ptt? -157.94 160.05 37.17 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -168.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -56.02 138.66 48.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 113.666 -1.606 . . . . 0.0 111.952 -177.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -61.99 -28.72 70.89 Favored Glycine 0 CA--C 1.505 -0.582 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.127 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.3 p -64.17 -20.31 65.91 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.195 -0.502 . . . . 0.0 111.124 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -100.53 -47.53 4.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.39 0.615 . . . . 0.0 110.103 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.96 -21.85 65.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.154 -176.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.6 -29.74 39.09 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -175.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.58 -39.32 93.84 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.786 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 C--N 1.328 -0.361 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -174.94 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.676 0 N-CA-C 111.75 -0.54 . . . . 0.0 111.75 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.51 ' CD1' ' HD2' ' A' ' 26' ' ' ARG . 3.3 mp -104.9 105.56 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 121.249 0.547 . . . . 0.0 109.674 177.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -102.9 130.77 50.06 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.439 -172.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.622 HG21 HD13 ' A' ' 25' ' ' LEU . 2.1 t -121.12 150.75 24.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.639 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -105.95 135.13 47.95 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.7 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -124.93 125.94 70.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.449 0.642 . . . . 0.0 110.874 -175.669 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 p -114.76 148.19 38.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.493 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.512 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 79.0 mmm -104.73 165.84 10.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.791 -177.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -131.75 141.7 49.58 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.99 -33.19 4.32 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.887 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.12 140.09 33.77 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-O 120.805 0.336 . . . . 0.0 110.796 173.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.3 127.77 9.29 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.925 2.416 . . . . 0.0 112.729 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -149.52 172.46 14.95 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.08 103.88 5.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.818 0.818 . . . . 0.0 110.423 170.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.449 ' C ' ' HD2' ' A' ' 22' ' ' LYS . 39.7 mmt180 -127.68 136.63 51.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.1 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.449 ' HD2' ' C ' ' A' ' 21' ' ' ARG . 2.6 mptp? -144.42 141.27 29.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 171.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.537 HD11 ' CD2' ' A' ' 89' ' ' LEU . 3.4 pt -140.86 174.11 8.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.028 0.442 . . . . 0.0 112.142 -175.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -110.45 126.47 54.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.103 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.622 HD13 HG21 ' A' ' 10' ' ' VAL . 10.8 tp -69.84 -43.06 72.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.833 -170.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.51 ' HD2' ' CD1' ' A' ' 8' ' ' ILE . 11.5 ptm180 -80.28 -25.82 39.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.047 0.451 . . . . 0.0 110.719 -171.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -49.71 -21.81 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 124.491 1.116 . . . . 0.0 113.767 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -86.73 -28.23 23.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.972 0.415 . . . . 0.0 111.805 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.5 13.75 46.14 Favored Glycine 0 CA--C 1.519 0.293 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.414 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 161.4 176.92 34.02 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.171 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.597 ' CE1' ' HA2' ' A' ' 75' ' ' GLY . 38.3 m-85 -69.49 -30.78 68.72 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -177.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.4 m -58.68 -54.76 43.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.671 0.272 . . . . 0.0 111.414 -174.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -73.59 -28.91 62.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.801 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.467 HD21 ' HB ' ' A' ' 74' ' ' VAL . 14.2 tp -58.31 -55.32 36.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.433 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.498 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 79.7 mt -67.12 -36.79 82.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.89 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.514 ' HA ' ' OE1' ' A' ' 39' ' ' GLU . 1.5 tmtp? -64.8 -33.89 77.06 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.499 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.711 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -67.64 -37.5 82.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.298 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.685 HD13 ' HG3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -63.52 -48.84 75.9 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.495 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 51.1 mt-10 -51.34 -33.27 28.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.574 173.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.549 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 21.1 m -74.37 -34.82 63.46 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.424 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.711 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 47.0 mmm -63.39 -57.86 8.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.131 -170.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.567 ' HE1' HD11 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -107.73 11.67 28.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.257 0.551 . . . . 0.0 111.101 -174.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp 61.7 50.53 4.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.72 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.615 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 2.4 pp -152.83 176.1 12.17 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.384 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.9 m -102.46 105.32 15.86 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -174.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.567 HD11 ' HE1' ' A' ' 42' ' ' PHE . 2.3 mt -89.2 120.89 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.601 169.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.46 165.86 54.55 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.558 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -66.02 172.37 3.78 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.725 0.774 . . . . 0.0 112.557 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.407 ' CD1' ' HB3' ' A' ' 73' ' ' LEU . 70.0 t80 -74.72 86.18 2.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.489 177.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 74.5 m -55.56 129.09 37.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.424 173.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -64.93 -31.19 72.3 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.042 -171.228 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -50.47 28.43 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -174.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.405 ' HG2' ' H ' ' A' ' 55' ' ' TYR . 20.1 tt0 -119.68 -28.66 5.22 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.223 0.535 . . . . 0.0 111.068 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.545 ' O ' HD22 ' A' ' 73' ' ' LEU . . . 45.23 12.06 0.03 OUTLIER Glycine 0 C--O 1.218 -0.896 0 N-CA-C 117.102 1.601 . . . . 0.0 117.102 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.434 ' HA ' HD13 ' A' ' 73' ' ' LEU . 17.3 m-30 -124.74 15.04 8.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 119.617 1.709 . . . . 0.0 111.144 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.494 ' HG2' ' H ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -74.44 -38.51 62.99 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.805 -177.042 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.09 7.74 5.36 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 115.797 -0.638 . . . . 0.0 114.436 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.494 ' H ' ' HG2' ' A' ' 56' ' ' LYS . 32.4 m 63.83 -83.87 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 122.733 0.413 . . . . 0.0 110.08 -171.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 39.3 tt0 -118.58 -14.52 9.62 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.681 0.277 . . . . 0.0 110.824 172.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -139.96 125.35 19.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.828 0.347 . . . . 0.0 111.036 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -100.53 103.7 25.69 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.798 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.685 ' HG3' HD13 ' A' ' 38' ' ' LEU . 57.2 Cg_endo -74.18 121.9 7.2 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.92 1.747 . . . . 0.0 111.638 174.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.43 HG21 HD13 ' A' ' 100' ' ' LEU . 63.2 p -124.91 157.27 36.4 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.038 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.689 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 3.4 p90 -129.23 164.5 23.33 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.48 ' CG ' ' HA2' ' A' ' 69' ' ' GLY . 43.9 tt0 -101.14 120.15 39.79 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.81 -168.72 2.31 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.355 0.41 . . . . 0.0 111.022 -176.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -57.67 -44.09 85.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.458 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -82.86 -14.65 53.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.285 0.564 . . . . 0.0 110.403 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.48 ' HA2' ' CG ' ' A' ' 65' ' ' GLU . . . 96.27 29.3 8.5 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.89 176.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -96.41 160.5 14.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.931 0.365 . . . . 0.0 110.11 172.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.689 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 39.6 m95 -122.46 114.1 20.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.902 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -131.44 174.33 10.18 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 171.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.545 HD22 ' O ' ' A' ' 54' ' ' GLY . 1.0 OUTLIER -62.59 157.33 20.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.75 0.786 . . . . 0.0 111.091 -178.515 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.467 ' HB ' HD21 ' A' ' 34' ' ' LEU . 31.4 m -76.26 134.54 28.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.101 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.597 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 109.96 0.67 30.22 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -171.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -56.57 -56.1 25.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.415 -0.392 . . . . 0.0 111.158 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 m -112.74 152.32 44.67 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.33 136.83 19.3 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.424 2.749 . . . . 0.0 113.203 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.552 ' O ' HG23 ' A' ' 83' ' ' VAL . 73.2 t-105 -43.21 -48.08 6.48 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 123.954 0.784 . . . . 0.0 113.107 -171.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -53.53 -43.08 68.06 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.2 0.312 . . . . 0.0 111.635 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 58.8 mtm -84.26 -25.33 29.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.963 0.411 . . . . 0.0 110.502 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -64.29 -44.84 90.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.423 -174.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 79' ' ' TRP . 2.5 t -61.68 -41.43 90.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.092 0.472 . . . . 0.0 111.023 -173.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.5 p -79.47 -15.46 57.74 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.569 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 65.8 m -91.19 -31.66 16.09 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.557 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 41.5 t -73.68 135.59 43.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.484 0.659 . . . . 0.0 111.048 -177.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -118.24 -44.17 2.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.324 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -140.15 163.38 32.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.712 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.7 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 2.0 tp -128.14 135.5 49.85 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.921 0.391 . . . . 0.0 110.702 -172.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -139.11 123.04 17.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.801 0.334 . . . . 0.0 110.868 175.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 14' ' ' MET . 6.1 mt -120.41 137.95 52.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 15.3 ptt? -156.65 158.64 37.37 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.213 0.53 . . . . 0.0 112.368 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 7.2 tttp -53.07 149.2 6.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.189 -1.368 . . . . 0.0 112.178 -175.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.67 -28.09 70.94 Favored Glycine 0 CA--C 1.505 -0.576 0 CA-C-N 114.842 -1.072 . . . . 0.0 113.348 -171.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.1 p -68.04 -20.04 64.95 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.963 0.411 . . . . 0.0 111.003 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -97.98 -9.18 26.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.937 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.684 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -60.57 -22.94 64.22 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.904 -176.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.22 -21.86 65.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.934 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.84 -4.43 63.47 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.626 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.684 ' HG ' ' O ' ' A' ' 97' ' ' ALA . 4.5 pp . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 117.386 0.593 . . . . 0.0 110.584 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.505 ' HA2' ' NH1' ' A' ' 26' ' ' ARG . . . . . . . . 0 N--CA 1.447 -0.605 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.3 mp -87.54 114.45 26.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.036 0.446 . . . . 0.0 110.44 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -98.72 132.46 44.08 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.098 174.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.617 HG21 HD22 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -118.19 138.76 47.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.496 0.665 . . . . 0.0 110.707 -178.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -104.54 133.94 48.57 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.715 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -125.7 124.85 67.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.746 0.784 . . . . 0.0 111.044 -173.053 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 p -112.13 155.3 24.13 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.119 -174.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.685 ' SD ' ' HA ' ' A' ' 92' ' ' MET . 31.8 tpp -110.78 135.31 51.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.659 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.48 137.98 40.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.435 177.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.75 -33.17 5.15 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.035 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.91 141.63 39.15 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 120.619 0.247 . . . . 0.0 111.085 173.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.92 126.71 8.14 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.707 2.272 . . . . 0.0 112.661 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -151.99 166.68 30.79 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.483 ' C ' ' HD2' ' A' ' 21' ' ' ARG . 78.2 mt -125.14 103.86 8.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.05 0.452 . . . . 0.0 110.255 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.483 ' HD2' ' C ' ' A' ' 20' ' ' LEU . 3.6 mpt_? -127.2 134.15 50.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.735 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.478 ' HD2' ' C ' ' A' ' 21' ' ' ARG . 2.4 mptp? -144.1 141.42 30.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 172.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -144.11 174.48 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.135 0.493 . . . . 0.0 112.044 -175.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.497 ' HB3' ' HE ' ' A' ' 26' ' ' ARG . 1.1 m-20 -109.71 126.76 54.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.65 -175.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.617 HD22 HG21 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -69.4 -36.62 76.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.925 0.869 . . . . 0.0 110.117 -175.196 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.505 ' NH1' ' HA2' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -79.54 -19.22 50.04 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.932 -1.031 . . . . 0.0 113.294 -168.849 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 24' ' ' ASP . 34.0 m -80.63 -3.96 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -170.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.494 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 25.8 m-85 -85.06 -30.12 24.35 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.22 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.7 14.15 6.93 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.788 -0.642 . . . . 0.0 114.354 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.29 165.78 24.24 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.735 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.572 ' CE1' ' HA2' ' A' ' 75' ' ' GLY . 15.2 m-85 -60.91 -36.12 78.46 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.7 p -62.54 -54.36 40.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.682 0.277 . . . . 0.0 110.961 -175.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -67.67 -27.33 66.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.076 -178.706 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 74' ' ' VAL . 8.6 tp -62.47 -56.75 15.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.285 174.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.453 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 81.5 mt -67.63 -39.87 84.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.63 -176.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -71.2 -32.54 68.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.271 -175.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.708 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -59.9 -39.79 86.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.778 0.323 . . . . 0.0 110.7 177.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.5 HD13 ' HG3' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -68.87 -50.48 49.41 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.307 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 35.3 mt-10 -52.27 -28.86 20.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.58 173.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.571 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 17.5 m -74.06 -41.02 62.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.258 175.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.708 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 71.9 mmm -54.85 -55.98 24.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.023 -172.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.519 ' HZ ' HG21 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -102.0 9.69 40.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 -177.173 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.17 44.21 19.37 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.95 174.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 pp -144.51 -171.8 3.67 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 m -113.72 121.14 43.18 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.876 0.369 . . . . 0.0 111.31 -175.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.435 ' CD1' ' HB2' ' A' ' 60' ' ' TYR . 40.8 mm -84.57 -22.77 7.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 122.335 1.064 . . . . 0.0 109.738 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.03 -164.58 31.2 Favored Glycine 0 C--N 1.31 -0.889 0 CA-C-N 114.071 -1.422 . . . . 0.0 112.574 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -92.02 162.4 14.39 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.464 ' CD1' HD22 ' A' ' 73' ' ' LEU . 60.4 t80 -80.43 75.72 7.27 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 171.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 m -49.05 128.97 17.14 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.804 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -68.06 -17.82 64.5 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.049 -173.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.519 ' HD2' ' N ' ' A' ' 53' ' ' GLU . 3.0 ppt_? -74.58 -51.95 13.14 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.519 ' N ' ' HD2' ' A' ' 52' ' ' ARG . 50.9 mt-10 -122.57 -29.95 3.98 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 119.934 -0.707 . . . . 0.0 112.728 176.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.693 ' O ' HD13 ' A' ' 73' ' ' LEU . . . 48.97 12.9 0.26 Allowed Glycine 0 C--O 1.218 -0.855 0 N-CA-C 115.288 0.875 . . . . 0.0 115.288 -175.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.508 ' HA ' HD13 ' A' ' 73' ' ' LEU . 11.6 m-85 -124.8 10.04 8.29 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.535 1.167 . . . . 0.0 110.608 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.475 ' NZ ' ' HB2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -61.38 -51.37 69.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.428 -179.024 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.16 3.04 4.53 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 115.079 0.792 . . . . 0.0 115.079 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.2 t 67.86 -86.99 0.03 OUTLIER 'General case' 0 C--O 1.234 0.238 0 CA-C-N 117.357 0.579 . . . . 0.0 110.037 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -117.65 -6.84 11.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.741 0.305 . . . . 0.0 110.501 175.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.435 ' HB2' ' CD1' ' A' ' 46' ' ' ILE . 70.3 m-85 -143.17 124.49 14.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.611 0.243 . . . . 0.0 111.354 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.411 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . . . -104.2 105.06 47.46 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.653 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 42.8 Cg_endo -68.98 120.93 7.78 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.992 1.795 . . . . 0.0 111.009 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 72' ' ' MET . 77.0 p -129.92 165.67 21.61 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.478 -175.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.759 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.4 p90 -136.51 164.66 27.66 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -178.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.479 ' CG ' ' HA2' ' A' ' 69' ' ' GLY . 33.3 tt0 -104.53 121.63 43.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.711 0.291 . . . . 0.0 110.361 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 25.5 t70 -84.51 -170.87 3.32 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.519 175.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.463 ' H ' ' CG ' ' A' ' 66' ' ' ASP . 13.3 mmtm -65.46 -34.41 78.22 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.643 0.735 . . . . 0.0 109.349 -175.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -72.26 -18.52 61.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.083 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.479 ' HA2' ' CG ' ' A' ' 65' ' ' GLU . . . 92.58 11.98 58.75 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.639 -175.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -86.95 144.11 27.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.646 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 64.0 m95 -112.11 115.67 29.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.048 0.451 . . . . 0.0 110.983 -176.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.416 ' O ' ' HA ' ' A' ' 63' ' ' THR . 49.8 mtm -121.54 161.09 22.96 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.693 HD13 ' O ' ' A' ' 54' ' ' GLY . 9.5 tt -71.05 141.42 50.89 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 17.2 m -66.87 129.57 31.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.655 0.741 . . . . 0.0 112.166 -174.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.572 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 111.3 6.93 25.21 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.513 -174.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -71.57 -56.91 4.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.513 0.197 . . . . 0.0 111.302 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.583 HG22 ' CD2' ' A' ' 82' ' ' PHE . 12.6 m -98.34 155.11 37.25 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.484 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 5.1 Cg_endo -46.94 131.89 17.14 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.668 2.912 . . . . 0.0 113.667 -176.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.491 ' O ' HG23 ' A' ' 83' ' ' VAL . 72.9 t-105 -43.16 -54.28 4.55 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.68 -172.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -51.41 -42.04 61.17 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.587 0.554 . . . . 0.0 111.542 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 57.4 ttp -83.37 -31.86 26.51 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.807 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.583 ' CD2' HG22 ' A' ' 77' ' ' VAL . 6.3 t80 -58.23 -46.66 85.5 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.68 -174.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 79' ' ' TRP . 2.8 t -60.54 -48.18 89.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.342 -170.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.8 p -78.87 -14.37 59.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.55 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.6 t -85.97 -25.18 26.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.12 -175.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.759 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 40.4 t -79.22 131.15 36.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.751 0.31 . . . . 0.0 110.922 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 13.5 ptmm? -116.03 -23.94 8.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.694 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.426 ' HD3' ' OE1' ' A' ' 65' ' ' GLU . 62.1 mtp180 -140.81 154.67 46.33 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 176.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.715 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 9.6 tp -127.51 133.37 49.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.114 -176.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.451 ' HD2' ' SD ' ' A' ' 92' ' ' MET . 2.6 ttm180 -139.47 117.78 12.01 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.289 -0.565 . . . . 0.0 111.096 174.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.519 HG21 ' HZ ' ' A' ' 42' ' ' PHE . 4.1 mt -116.1 133.55 62.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 170.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.685 ' HA ' ' SD ' ' A' ' 14' ' ' MET . 14.6 ptt? -158.13 161.13 37.9 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.212 0.53 . . . . 0.0 112.122 -170.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -53.94 141.81 26.58 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.727 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.4 -27.29 57.96 Favored Glycine 0 CA--C 1.505 -0.582 0 CA-C-N 114.437 -1.256 . . . . 0.0 113.092 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 59.1 p -60.21 -25.96 66.01 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.469 0.652 . . . . 0.0 110.779 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -101.11 -49.41 4.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.8 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.437 ' HA ' ' HE3' ' A' ' 92' ' ' MET . . . -63.87 -21.15 66.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.635 -175.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -53.63 -32.41 51.25 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.55 -38.43 90.49 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.727 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.413 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -175.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.923 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.424 HG22 HD12 ' A' ' 25' ' ' LEU . 4.1 mp -117.37 105.51 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 174.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -97.76 142.51 29.44 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.068 -170.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.59 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -118.49 145.21 24.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.085 179.463 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.529 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 48.9 mttm -102.07 128.35 48.56 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -125.2 126.5 70.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.874 0.845 . . . . 0.0 111.377 -176.486 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.6 m -117.28 151.05 37.76 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.81 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.568 ' SD ' ' HB ' ' A' ' 91' ' ' ILE . 69.2 mmm -101.31 160.48 14.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.757 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -134.41 146.5 49.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.352 -0.386 . . . . 0.0 109.988 175.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.78 -34.62 3.84 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -174.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.62 138.38 28.19 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 169.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -76.72 125.5 8.22 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.419 2.079 . . . . 0.0 112.735 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.474 ' HB2' ' CG ' ' A' ' 14' ' ' MET . 93.2 m-85 -152.17 165.5 34.61 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.709 174.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.34 105.88 5.57 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 177.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.54 ' HB2' HG22 ' A' ' 12' ' ' VAL . 10.8 mmm180 -125.86 155.51 41.06 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.691 -176.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.529 ' HD3' ' HA ' ' A' ' 11' ' ' LYS . 5.5 mmtm -148.08 140.55 24.43 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 174.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 pt -145.66 173.49 3.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.09 0.471 . . . . 0.0 111.397 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.49 ' O ' HG22 ' A' ' 27' ' ' VAL . 9.9 t70 -115.83 140.85 48.82 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.399 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.51 HD13 ' SG ' ' A' ' 86' ' ' CYS . 15.6 mt -73.61 -47.71 38.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.166 -173.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -82.33 -11.56 58.52 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -169.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 24' ' ' ASP . 35.8 m -63.94 -17.87 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 120.867 0.365 . . . . 0.0 111.283 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -84.02 -28.1 27.9 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.085 0.469 . . . . 0.0 110.893 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.77 15.92 36.28 Favored Glycine 0 CA--C 1.519 0.302 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.384 175.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.05 175.68 31.29 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.777 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -69.5 -30.56 68.46 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -176.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.8 p -60.08 -54.93 40.17 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.553 -174.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -71.5 -28.43 63.9 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.508 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.416 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 20.8 tp -58.13 -55.66 32.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.185 0.516 . . . . 0.0 109.844 174.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.478 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 63.0 mt -67.58 -37.05 82.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.333 -177.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -70.72 -32.19 69.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.241 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.709 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -62.24 -42.46 99.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.761 176.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.495 HD13 ' HG3' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -61.89 -50.37 72.48 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.707 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.752 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 45.5 mt-10 -51.76 -30.66 23.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.828 173.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.555 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 26.5 m -76.2 -43.03 44.24 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.65 178.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.709 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 63.9 mmm -54.79 -57.87 9.83 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -168.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.671 ' CZ ' HG21 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -107.14 10.31 30.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.223 -177.168 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.8 mptt 62.51 42.55 8.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.101 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.752 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 1.2 pp -149.45 168.82 22.39 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 175.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.0 m -93.81 104.18 16.27 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -165.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.434 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 3.9 mm -97.64 148.97 5.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 170.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.52 -168.88 38.35 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.302 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 45.37 83.02 0.03 OUTLIER 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.1 0.96 . . . . 0.0 113.526 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.441 ' CE2' ' HB2' ' A' ' 73' ' ' LEU . 30.2 t80 -66.4 86.4 0.11 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 167.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 t -65.61 151.18 47.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.388 0.613 . . . . 0.0 110.837 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -73.3 -16.13 61.38 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.021 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.592 ' HD3' ' HG3' ' A' ' 53' ' ' GLU . 1.2 tmt_? -80.42 -54.73 5.43 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.592 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 33.1 mt-10 -121.53 -29.11 4.47 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.338 171.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 43.01 10.99 0.01 OUTLIER Glycine 0 C--O 1.218 -0.9 0 CA-C-N 114.213 -1.358 . . . . 0.0 116.325 -175.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.513 ' CE1' ' HB3' ' A' ' 72' ' ' MET . 19.4 m-85 -128.64 16.69 6.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 119.222 1.511 . . . . 0.0 111.529 178.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.447 ' HE3' ' N ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -70.57 -37.14 73.95 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.979 -172.834 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.447 ' N ' ' HE3' ' A' ' 56' ' ' LYS . . . 58.35 19.32 39.69 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.806 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.3 t 63.77 -82.9 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -169.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.605 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 40.0 tt0 -119.28 -20.16 8.03 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.611 173.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.447 ' CE1' ' HG3' ' A' ' 93' ' ' LYS . 37.3 m-85 -131.89 125.98 33.05 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.993 0.425 . . . . 0.0 111.395 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -105.85 105.28 52.67 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.129 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.495 ' HG3' HD13 ' A' ' 38' ' ' LEU . 28.4 Cg_endo -72.24 120.33 6.71 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 121.443 1.428 . . . . 0.0 111.166 173.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 72' ' ' MET . 61.0 p -124.64 150.85 45.6 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.228 -176.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 5.2 p90 -117.74 161.85 19.03 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.503 ' HB2' ' CZ2' ' A' ' 71' ' ' TRP . 42.0 tt0 -100.37 118.82 37.4 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 173.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.21 -178.31 6.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.965 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 mtmm -51.37 -42.9 61.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.789 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -86.38 -15.93 38.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.949 0.404 . . . . 0.0 111.018 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.02 29.37 8.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.799 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -94.56 148.25 22.45 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 172.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.546 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 65.9 m95 -115.86 114.37 24.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.958 0.409 . . . . 0.0 110.576 -178.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.513 ' HB3' ' CE1' ' A' ' 55' ' ' TYR . 17.4 mtm -135.86 177.89 7.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.483 ' HG ' ' HA ' ' A' ' 55' ' ' TYR . 6.0 mt -62.34 151.4 36.81 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.642 0.734 . . . . 0.0 110.532 177.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.9 m -78.03 135.09 26.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.47 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.4 8.03 50.54 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.4 -173.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.92 -53.26 49.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.687 0.28 . . . . 0.0 111.255 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.525 HG22 ' CD2' ' A' ' 82' ' ' PHE . 12.9 m -103.63 157.51 33.73 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.489 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 6.4 Cg_endo -48.74 127.04 15.72 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.333 2.689 . . . . 0.0 113.226 -178.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.61 ' O ' HG23 ' A' ' 83' ' ' VAL . 70.6 t-105 -40.85 -46.09 2.65 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 113.848 -1.524 . . . . 0.0 113.811 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.2 -42.95 82.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.713 0.292 . . . . 0.0 111.272 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.2 tmm? -83.88 -27.33 28.72 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.525 ' CD2' HG22 ' A' ' 77' ' ' VAL . 9.2 t80 -60.01 -50.98 71.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.649 -174.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 79' ' ' TRP . 3.8 t -59.75 -36.77 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.129 0.49 . . . . 0.0 111.371 -170.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.2 p -79.1 -11.33 59.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.502 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.6 t -101.5 -19.96 15.3 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.795 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.51 ' SG ' HD13 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -86.1 117.48 24.97 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.302 0.572 . . . . 0.0 110.513 179.412 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 9.6 ptmm? -118.06 -25.52 6.67 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.572 -174.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -139.78 158.41 44.14 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.63 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 6.6 tp -134.31 131.02 37.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.237 0.541 . . . . 0.0 110.741 -175.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -138.36 123.98 19.69 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.993 0.425 . . . . 0.0 110.654 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.671 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 10.6 mt -114.08 136.61 50.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -158.45 160.79 37.17 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.722 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 52.6 mttt -52.72 149.41 6.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.703 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -61.81 -25.93 66.37 Favored Glycine 0 CA--C 1.504 -0.612 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.731 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.44 HG22 ' HB3' ' A' ' 93' ' ' LYS . 9.9 t -75.16 -13.36 60.45 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.172 0.51 . . . . 0.0 110.715 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -101.52 -46.74 4.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.99 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.73 -23.87 63.47 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -57.15 -38.11 73.04 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.681 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.82 -37.05 93.68 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.229 -0.51 . . . . 0.0 113.458 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.426 HD23 ' H ' ' A' ' 100' ' ' LEU . 1.1 pt? . . . . . 0 C--N 1.327 -0.388 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -175.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.467 HD13 ' HD3' ' A' ' 26' ' ' ARG . 2.0 mp -112.25 104.17 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -92.71 129.08 38.75 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.05 -174.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.594 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -114.33 142.31 27.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.465 -175.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.694 ' HA ' ' HD2' ' A' ' 22' ' ' LYS . 47.6 mtmt -98.22 127.89 44.4 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.736 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -124.54 126.87 72.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.369 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.4 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 20.5 m -112.93 141.48 46.72 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.852 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.46 ' HG3' ' CD2' ' A' ' 19' ' ' TYR . 73.2 mmm -97.75 122.69 41.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.041 0.448 . . . . 0.0 110.807 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.99 130.99 51.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.389 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.32 -33.45 6.52 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.882 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.19 141.31 33.84 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.48 125.11 7.43 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.356 2.037 . . . . 0.0 113.171 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.46 ' CD2' ' HG3' ' A' ' 14' ' ' MET . 97.8 m-85 -152.65 169.48 22.61 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.495 ' C ' ' HD2' ' A' ' 21' ' ' ARG . 56.0 mt -137.75 102.05 4.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.047 0.451 . . . . 0.0 110.195 169.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.495 ' HD2' ' C ' ' A' ' 20' ' ' LEU . 3.6 mpt_? -129.56 138.67 51.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.285 174.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.694 ' HD2' ' HA ' ' A' ' 11' ' ' LYS . 35.3 mmtm -132.46 142.75 49.38 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 169.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 pt -143.33 174.01 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -172.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.444 ' OD1' HG13 ' A' ' 27' ' ' VAL . 3.8 t70 -115.37 143.97 44.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.754 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.455 HD21 ' SG ' ' A' ' 86' ' ' CYS . 40.7 mt -71.62 -44.0 65.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.287 0.565 . . . . 0.0 111.576 -175.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.556 ' HG2' HG11 ' A' ' 83' ' ' VAL . 40.6 mtm180 -80.16 -22.97 41.42 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -165.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.444 HG13 ' OD1' ' A' ' 24' ' ' ASP . 28.1 m -61.11 -12.97 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -92.47 -28.5 16.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.191 0.52 . . . . 0.0 111.079 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.7 14.77 23.63 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.26 -0.882 . . . . 0.0 113.889 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.35 174.35 34.03 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.379 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -69.36 -33.4 73.02 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.9 m -57.96 -53.75 54.7 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.297 -175.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -74.49 -27.17 60.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.286 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.7 tp -60.13 -55.28 35.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.176 0.512 . . . . 0.0 110.483 175.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.509 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 77.5 mt -66.2 -35.13 79.64 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.549 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -68.45 -33.41 74.14 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.464 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.706 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -64.94 -38.5 91.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.152 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.596 HD13 ' HG3' ' A' ' 62' ' ' PRO . 0.5 OUTLIER -61.82 -49.91 74.41 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.043 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.711 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 41.1 mt-10 -53.25 -29.12 31.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.922 173.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.551 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 33.7 m -76.29 -42.62 44.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.475 176.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.706 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 44.2 mmm -55.0 -57.02 13.38 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.141 -169.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.616 ' HZ ' HG21 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -109.7 7.36 24.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.081 179.586 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 0.0 OUTLIER 61.19 40.84 14.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.963 174.26 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.711 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 2.2 pp -141.34 162.41 35.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.125 176.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.3 m -85.39 103.4 14.26 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -166.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.464 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 12.1 mm -89.22 151.09 3.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 168.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -115.91 -162.03 13.06 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 121.359 -0.448 . . . . 0.0 112.76 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -89.56 171.84 9.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.764 0.792 . . . . 0.0 112.233 -174.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.481 ' CE2' ' HB2' ' A' ' 73' ' ' LEU . 41.4 t80 -72.62 81.3 1.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.292 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 54' ' ' GLY . 14.0 m -57.79 107.82 0.5 Allowed 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.356 175.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -55.74 -26.66 46.63 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -166.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.614 ' HD2' ' N ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -58.2 -49.28 77.62 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -176.284 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.614 ' N ' ' HD2' ' A' ' 52' ' ' ARG . 48.6 mt-10 -119.51 -26.98 5.64 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.702 0.763 . . . . 0.0 110.252 172.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 50' ' ' SER . . . 54.28 10.04 1.76 Allowed Glycine 0 C--O 1.213 -1.164 0 CA-C-N 113.913 -1.494 . . . . 0.0 115.695 177.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.598 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 19.0 m-85 -127.7 14.96 7.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 119.25 1.525 . . . . 0.0 112.355 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.721 ' HD3' ' N ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -74.66 -45.47 44.37 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.457 171.364 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.721 ' N ' ' HD3' ' A' ' 56' ' ' LYS . . . 58.38 -27.79 0.02 OUTLIER Glycine 0 CA--C 1.529 0.916 0 CA-C-N 115.246 -0.888 . . . . 0.0 114.485 -172.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.584 ' H ' ' C ' ' A' ' 56' ' ' LYS . 26.8 t 150.09 -138.75 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -175.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.594 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 31.2 tt0 -83.83 -5.48 59.21 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 166.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.445 ' HB2' ' CD1' ' A' ' 46' ' ' ILE . 32.1 m-85 -133.96 130.51 37.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.233 173.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.734 ' HB1' HD21 ' A' ' 73' ' ' LEU . . . -115.51 105.59 51.83 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.28 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.596 ' HG3' HD13 ' A' ' 38' ' ' LEU . 32.7 Cg_endo -69.7 120.39 7.19 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 121.952 1.768 . . . . 0.0 112.08 174.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 72' ' ' MET . 38.3 p -123.73 159.51 29.28 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.436 -176.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 5.0 p90 -135.24 166.25 23.55 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.05 -177.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.55 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 44.1 tt0 -111.58 124.8 53.04 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.565 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.468 ' OD2' ' HG2' ' A' ' 67' ' ' LYS . 23.2 t70 -88.81 -179.81 6.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.968 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.468 ' HG2' ' OD2' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -63.91 -28.58 69.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.508 0.671 . . . . 0.0 110.229 179.26 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -68.11 -18.57 64.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.412 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.57 11.57 71.17 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -95.3 149.56 21.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.149 -0.525 . . . . 0.0 110.111 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.559 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 36.0 m95 -119.82 132.79 55.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.028 -176.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.426 ' HE2' ' CE1' ' A' ' 64' ' ' TYR . 2.0 mpp? -143.11 -179.73 6.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 171.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.734 HD21 ' HB1' ' A' ' 61' ' ' ALA . 4.8 mt -63.06 154.14 31.77 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.893 0.854 . . . . 0.0 110.996 175.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.554 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 57.9 t -78.69 122.2 33.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.866 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.06 -1.18 28.45 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -171.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.34 -46.58 79.88 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.994 0.426 . . . . 0.0 110.313 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.419 HG22 ' CD2' ' A' ' 82' ' ' PHE . 16.0 m -108.62 154.94 41.35 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 173.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 10.9 Cg_endo -54.59 136.57 70.94 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.88 2.387 . . . . 0.0 113.098 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.516 ' O ' HG23 ' A' ' 83' ' ' VAL . 65.1 t-105 -40.64 -48.39 2.91 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 124.096 0.872 . . . . 0.0 112.978 -173.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -53.52 -42.22 67.18 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.782 -177.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 77.2 mtp -82.67 -23.08 34.37 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.262 0.553 . . . . 0.0 110.374 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.554 ' CZ ' ' HA ' ' A' ' 74' ' ' VAL . 7.4 t80 -70.51 -46.49 63.56 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.02 -171.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.556 HG11 ' HG2' ' A' ' 26' ' ' ARG . 3.4 t -61.32 -38.57 80.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.193 0.52 . . . . 0.0 111.478 -171.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.9 p -78.76 -12.52 60.03 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.029 -175.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.2 p -106.52 -31.43 8.52 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 34.0 t -71.92 116.27 12.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.268 0.556 . . . . 0.0 110.978 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -119.38 -19.43 8.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.063 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.55 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 55.9 mtt180 -139.34 156.63 46.89 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 174.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.736 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 5.7 tp -136.12 134.44 38.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.992 0.425 . . . . 0.0 111.247 -173.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 13' ' ' SER . 24.0 ttp180 -140.51 123.58 16.6 Favored 'General case' 0 C--N 1.318 -0.778 0 O-C-N 122.011 -0.431 . . . . 0.0 111.227 168.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.616 HG21 ' HZ ' ' A' ' 42' ' ' PHE . 4.4 mt -106.43 136.03 42.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 168.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -159.0 163.34 36.52 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.15 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 34.0 mtpt -48.55 140.71 7.76 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 124.25 0.969 . . . . 0.0 112.756 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -58.86 -36.33 86.78 Favored Glycine 0 CA--C 1.505 -0.547 0 CA-C-N 113.689 -1.596 . . . . 0.0 113.713 -168.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.44 ' HA ' ' HD3' ' A' ' 98' ' ' LYS . 38.9 p -60.55 -19.86 58.59 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.072 0.463 . . . . 0.0 111.807 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -97.5 -43.56 7.2 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.723 -174.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.59 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -71.16 -29.42 65.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.483 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 95' ' ' THR . 15.1 ptmm? -69.72 -6.86 34.7 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.597 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.96 -7.18 50.9 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.413 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 97' ' ' ALA . 4.0 pp . . . . . 0 CA--C 1.514 -0.415 0 O-C-N 122.496 -0.414 . . . . 0.0 110.929 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.685 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.6 mt -70.12 111.88 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.757 0.313 . . . . 0.0 110.243 175.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -89.59 139.24 30.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.69 -176.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.599 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -118.55 148.31 21.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 176.332 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.573 ' HA ' ' HD2' ' A' ' 22' ' ' LYS . 56.3 mtmt -107.29 130.25 54.79 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.715 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -126.4 129.41 71.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.971 -176.359 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.4 m -109.51 146.64 34.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.639 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.555 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 23.1 tpp -97.53 125.2 42.09 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.854 175.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.5 140.65 37.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.913 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.1 -33.66 4.79 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.683 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.555 ' O ' ' HG3' ' A' ' 14' ' ' MET . . . -134.75 140.2 34.61 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 120.661 0.267 . . . . 0.0 110.556 171.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.49 125.08 7.41 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.428 2.085 . . . . 0.0 112.759 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -153.19 168.17 26.85 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 123.048 0.539 . . . . 0.0 109.944 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.42 98.69 4.15 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.67 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 1.6 ptp180 -134.33 123.0 23.45 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.391 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.67 ' HD3' ' O ' ' A' ' 21' ' ' ARG . 60.7 mmtt -120.43 157.19 29.86 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 117.973 0.351 . . . . 0.0 110.602 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -144.99 172.57 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 120.868 0.366 . . . . 0.0 111.849 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.601 ' O ' HG22 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -112.96 130.66 56.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.225 0.536 . . . . 0.0 110.225 -173.029 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.54 HD21 ' HB2' ' A' ' 86' ' ' CYS . 16.5 tp -70.11 -45.5 66.79 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -169.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 26' ' ' ARG . 17.4 mtp180 -79.41 -10.86 59.89 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -173.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.601 HG22 ' O ' ' A' ' 24' ' ' ASP . 20.8 m -84.27 -0.55 5.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.521 -0.471 . . . . 0.0 112.246 -173.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.63 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 23.3 m-85 -84.12 -31.09 25.43 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.583 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 44.75 48.21 9.11 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.745 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.89 172.99 13.81 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.135 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -70.07 -29.85 66.95 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -176.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.5 m -59.36 -53.73 54.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.749 0.309 . . . . 0.0 111.37 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.63 ' HB2' ' O ' ' A' ' 28' ' ' TYR . 49.2 mm-40 -73.67 -29.74 62.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.521 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.4 tp -55.22 -56.64 17.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.103 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.401 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 53.6 mt -68.94 -38.74 79.66 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.592 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -67.8 -33.09 74.14 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.276 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.674 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -61.4 -41.47 97.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.54 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.506 ' H ' ' HG ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -65.58 -46.51 79.15 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.132 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 43.6 mt-10 -51.29 -32.71 25.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.441 174.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.539 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 50.2 m -73.79 -41.83 61.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.154 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.674 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 55.9 mmm -56.71 -56.66 18.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.635 -169.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.644 ' HZ ' HG21 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -103.0 9.12 38.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.083 -176.626 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.9 mttt 62.04 40.93 11.61 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.618 174.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 3.0 pp -145.01 174.14 11.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.157 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.1 m -102.99 100.78 10.74 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -171.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.495 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 31.5 mm -69.82 139.48 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 168.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.36 -162.3 34.11 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.293 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.58 167.3 12.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.025 0.44 . . . . 0.0 110.839 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.765 ' CE1' HD12 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -63.89 93.03 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.362 172.834 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.416 ' HB2' ' HA2' ' A' ' 54' ' ' GLY . 1.5 m -61.85 134.06 56.23 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.7 -23.96 60.94 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -168.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.667 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -82.15 -51.5 7.91 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.104 -0.638 . . . . 0.0 112.412 -174.019 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.667 ' N ' ' HD3' ' A' ' 52' ' ' ARG . 60.8 mt-10 -121.3 -31.22 4.13 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 118.956 0.798 . . . . 0.0 110.712 168.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.716 ' O ' HD11 ' A' ' 73' ' ' LEU . . . 38.08 7.78 0.0 OUTLIER Glycine 0 C--O 1.221 -0.701 0 CA-C-N 113.535 -1.666 . . . . 0.0 116.269 -168.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.5 ' CE1' ' HG ' ' A' ' 73' ' ' LEU . 3.8 m-30 -96.24 3.6 52.99 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 118.507 1.154 . . . . 0.0 110.753 -171.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.616 ' C ' ' H ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -69.51 -36.17 76.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.923 168.693 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.499 ' H ' ' HD3' ' A' ' 56' ' ' LYS . . . 59.52 -24.11 0.03 OUTLIER Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.321 -0.854 . . . . 0.0 114.399 -174.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.616 ' H ' ' C ' ' A' ' 56' ' ' LYS . 44.4 t 146.91 -89.75 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 -176.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -118.44 -3.15 10.96 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 161.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.476 ' O ' ' HA3' ' A' ' 57' ' ' GLY . 46.9 m-85 -137.47 130.05 29.86 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.748 -175.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 55' ' ' TYR . . . -101.67 104.46 34.89 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.129 176.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.566 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 60.3 Cg_endo -73.06 121.5 7.32 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.093 1.862 . . . . 0.0 111.496 172.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.6 p -132.52 164.17 27.21 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.03 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 5.0 p90 -141.61 165.68 26.82 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.532 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 30.7 tt0 -104.98 122.81 46.62 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.734 175.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.08 179.51 7.25 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.378 0.424 . . . . 0.0 110.781 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.0 mtmm -48.61 -46.95 40.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.044 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -86.6 -10.91 52.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.978 0.418 . . . . 0.0 111.382 -174.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.11 29.5 8.45 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.644 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -93.1 148.84 21.67 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 171.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.494 ' CZ2' ' HB2' ' A' ' 65' ' ' GLU . 66.2 m95 -119.16 113.85 21.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.806 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -130.23 -179.65 5.37 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 171.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.765 HD12 ' CE1' ' A' ' 49' ' ' TYR . 76.7 mt -65.62 156.27 33.3 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.344 0.592 . . . . 0.0 111.089 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 62' ' ' PRO . 30.2 m -75.87 128.98 37.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.494 176.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.46 8.21 56.36 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.412 -173.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.67 -61.22 2.57 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.596 0.236 . . . . 0.0 111.454 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.446 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 16.1 m -98.87 161.85 23.53 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.402 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.446 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 85.4 Cg_exo -46.25 131.96 14.94 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.189 2.593 . . . . 0.0 113.217 177.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.582 ' O ' HG23 ' A' ' 83' ' ' VAL . 66.9 t-105 -47.59 -42.19 23.38 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.816 -173.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -59.11 -42.45 90.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.946 0.403 . . . . 0.0 111.335 -176.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 73.7 mtm -82.39 -21.89 35.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.202 0.525 . . . . 0.0 109.982 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.449 ' HZ ' ' HA ' ' A' ' 74' ' ' VAL . 6.7 t80 -65.7 -55.34 17.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.348 -175.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 79' ' ' TRP . 3.0 t -61.1 -38.14 78.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.153 -171.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.7 p -76.21 -10.2 59.22 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.733 -175.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.5 m -102.7 -19.15 14.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.313 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.54 ' HB2' HD21 ' A' ' 25' ' ' LEU . 74.0 m -76.18 112.8 13.02 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.249 0.547 . . . . 0.0 111.823 -175.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -118.08 -26.59 6.34 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.022 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.532 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 71.9 mtt180 -139.73 154.86 47.55 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.715 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 8.5 tp -131.67 138.35 48.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.489 -175.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.462 ' HD3' ' SD ' ' A' ' 92' ' ' MET . 10.8 ttm180 -141.11 121.45 13.97 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.243 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.644 HG21 ' HZ ' ' A' ' 42' ' ' PHE . 4.0 mt -120.2 134.26 64.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 168.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.462 ' SD ' ' HD3' ' A' ' 90' ' ' ARG . 23.5 ptt? -158.96 164.31 35.71 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 123.319 0.387 . . . . 0.0 111.863 -172.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -47.11 129.46 12.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.991 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -65.51 -31.56 80.58 Favored Glycine 0 CA--C 1.506 -0.469 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.795 -172.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.8 p -66.98 -23.27 65.92 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.165 -0.518 . . . . 0.0 111.633 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -100.03 -18.23 17.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.813 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.582 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -71.18 -22.22 62.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.47 0.652 . . . . 0.0 110.303 176.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -57.33 -26.07 60.35 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.504 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.85 -33.76 85.08 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.86 -176.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 97' ' ' ALA . 3.6 pp . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 117.624 0.712 . . . . 0.0 111.868 -175.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.455 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.481 HD13 ' HD2' ' A' ' 26' ' ' ARG . 2.7 mp -82.23 110.05 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.049 0.452 . . . . 0.0 110.151 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -111.14 116.31 30.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.564 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.566 ' CG2' ' HB2' ' A' ' 89' ' ' LEU . 2.9 m -116.37 151.95 18.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 17.0 ptpt -94.86 133.02 39.04 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.131 -176.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.699 ' HB ' ' HB3' ' A' ' 89' ' ' LEU . 1.5 p -148.39 122.45 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 O-C-N 124.037 0.836 . . . . 0.0 110.844 173.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.528 ' HB2' ' N ' ' A' ' 21' ' ' ARG . 7.5 t -160.03 112.41 2.06 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.482 163.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.773 ' HE2' ' O ' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -168.02 141.54 3.3 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 118.282 -1.367 . . . . 0.0 113.888 175.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.431 ' HB2' ' OH ' ' A' ' 60' ' ' TYR . 4.2 p-10 -140.58 76.75 1.57 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.341 0.591 . . . . 0.0 111.619 162.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.522 ' H ' ' CE ' ' A' ' 14' ' ' MET . . . 88.81 -30.71 5.28 Favored Glycine 0 C--O 1.229 -0.174 0 C-N-CA 121.371 -0.442 . . . . 0.0 112.115 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.549 ' O ' ' HG2' ' A' ' 14' ' ' MET . . . -121.21 150.29 53.53 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 177.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.73 129.75 15.99 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.439 2.093 . . . . 0.0 113.736 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' A' ' 13' ' ' SER . 49.5 m-85 -134.67 172.71 12.56 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.9 mt -136.26 104.14 5.54 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.212 0.529 . . . . 0.0 112.425 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.533 ' HA ' ' HE ' ' A' ' 21' ' ' ARG . 0.2 OUTLIER -129.91 173.21 10.9 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 167.319 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 11' ' ' LYS . 0.7 OUTLIER -137.85 148.93 45.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 118.979 0.809 . . . . 0.0 111.418 175.218 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.498 HD11 ' CD2' ' A' ' 89' ' ' LEU . 8.8 pt -129.41 175.09 11.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.861 170.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.504 ' O ' HG22 ' A' ' 27' ' ' VAL . 0.6 OUTLIER -109.53 124.64 51.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -176.421 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.538 HD23 HG13 ' A' ' 83' ' ' VAL . 3.2 tp -72.18 -44.85 62.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.073 -167.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.49 ' HG2' HG11 ' A' ' 83' ' ' VAL . 47.2 mtp180 -79.4 -22.63 44.05 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -172.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 24' ' ' ASP . 20.7 m -65.49 -11.23 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.834 0.349 . . . . 0.0 111.719 -172.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.402 ' CD2' HD12 ' A' ' 34' ' ' LEU . 23.5 m-85 -84.48 -27.26 27.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.006 0.431 . . . . 0.0 110.564 178.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.26 14.73 20.18 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 114.95 -1.023 . . . . 0.0 113.78 173.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.36 169.82 30.47 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 -176.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -70.49 -32.66 70.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -175.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.0 m -59.27 -53.86 53.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.661 0.267 . . . . 0.0 111.226 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -73.42 -30.1 63.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.726 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.461 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 9.8 tp -59.6 -55.53 33.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.38 177.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.615 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 54.1 mt -66.37 -35.99 81.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.137 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -64.39 -33.8 76.7 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.275 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.588 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -72.43 -32.56 66.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.955 0.407 . . . . 0.0 111.036 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.615 ' CD1' ' HA ' ' A' ' 35' ' ' LEU . 2.2 mt -66.9 -51.65 52.77 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.52 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -52.39 -32.43 38.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.884 173.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.574 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 20.5 m -71.37 -34.22 70.25 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.619 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.588 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 73.2 mmm -64.59 -56.71 12.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.783 0.325 . . . . 0.0 111.852 -170.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.41 12.93 25.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.09 0.472 . . . . 0.0 112.119 -177.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.406 ' HD3' ' O ' ' A' ' 40' ' ' THR . 22.8 mmtm 62.17 53.68 2.85 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.278 170.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 pp -150.28 -172.66 4.23 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.325 -0.235 . . . . 0.0 110.774 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.0 m -100.08 128.04 46.22 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -174.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.584 HG13 ' HB2' ' A' ' 38' ' ' LEU . 41.5 mm -105.16 133.39 49.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.007 174.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.537 ' HA3' ' OG ' ' A' ' 58' ' ' SER . . . -92.09 140.18 15.03 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.228 -0.987 . . . . 0.0 111.235 171.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.17 -179.42 1.95 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.46 0.647 . . . . 0.0 111.896 -173.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -73.56 82.05 1.5 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.661 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 54' ' ' GLY . 3.2 m -64.64 115.8 5.58 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.338 173.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.11 -18.6 37.05 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -169.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.611 ' HD3' ' HG3' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -69.42 -49.27 56.76 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -177.264 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.611 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 44.1 mt-10 -120.11 -27.54 5.29 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.678 0.751 . . . . 0.0 111.238 174.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.476 ' O ' HD22 ' A' ' 73' ' ' LEU . . . 46.29 8.27 0.02 OUTLIER Glycine 0 C--O 1.219 -0.813 0 CA-C-N 113.787 -1.551 . . . . 0.0 116.8 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.493 ' HA ' HD13 ' A' ' 73' ' ' LEU . 12.9 m-85 -127.81 9.24 6.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 119.286 1.543 . . . . 0.0 111.223 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.744 ' HE3' ' N ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -74.42 -24.56 59.11 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.996 -171.636 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.744 ' N ' ' HE3' ' A' ' 56' ' ' LYS . . . 59.88 -8.07 0.06 OUTLIER Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.283 -0.871 . . . . 0.0 114.551 -175.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.537 ' OG ' ' HA3' ' A' ' 47' ' ' GLY . 16.1 m 69.13 -72.44 0.1 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -171.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 33.2 tt0 -119.9 -27.87 5.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.096 166.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.45 ' HB2' HD13 ' A' ' 46' ' ' ILE . 11.1 m-85 -134.86 124.98 25.89 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 120.906 0.384 . . . . 0.0 111.001 176.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.443 ' HB1' ' CD1' ' A' ' 73' ' ' LEU . . . -102.46 105.93 46.34 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.202 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.554 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 38.1 Cg_endo -69.69 119.69 6.6 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.936 1.757 . . . . 0.0 111.335 174.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 72' ' ' MET . 43.4 p -126.07 162.12 26.05 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.175 0.512 . . . . 0.0 110.767 -176.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.635 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 3.5 p90 -132.84 165.18 25.19 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.307 -177.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.418 ' HB2' ' CZ2' ' A' ' 71' ' ' TRP . 30.9 tt0 -108.42 115.77 30.72 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.46 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.559 ' OD2' ' HG2' ' A' ' 67' ' ' LYS . 17.7 t70 -80.53 -176.8 5.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.819 176.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.559 ' HG2' ' OD2' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -62.83 -39.37 94.12 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -171.33 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.442 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . 20.6 t70 -83.0 -0.98 51.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.18 0.514 . . . . 0.0 110.602 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.41 24.39 28.84 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.177 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.442 ' OD2' ' HB3' ' A' ' 68' ' ' ASP . 20.1 m-20 -81.52 129.0 34.5 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.635 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 71.7 m95 -110.3 113.79 26.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.019 0.438 . . . . 0.0 110.813 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.431 ' O ' ' HA ' ' A' ' 63' ' ' THR . 25.6 mtm -134.81 176.48 8.61 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.554 ' HA ' ' O ' ' A' ' 62' ' ' PRO . 1.2 tp -68.66 154.89 41.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.498 0.665 . . . . 0.0 111.04 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.604 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 3.7 m -77.83 124.38 36.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.136 175.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.94 3.5 28.17 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -172.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.13 -56.65 15.02 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.037 0.446 . . . . 0.0 109.93 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.533 HG22 ' CD2' ' A' ' 82' ' ' PHE . 6.3 m -100.98 154.68 37.0 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 173.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.431 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 11.0 Cg_endo -54.45 136.86 71.15 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.879 2.386 . . . . 0.0 113.075 -176.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.515 ' O ' HG23 ' A' ' 83' ' ' VAL . 69.9 t-105 -40.09 -53.03 2.48 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -174.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -51.58 -43.02 62.31 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.046 0.45 . . . . 0.0 111.674 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 77.7 mtp -83.91 -24.54 30.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.468 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' A' ' 74' ' ' VAL . 13.4 t80 -68.81 -38.21 79.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.676 -173.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.538 HG13 HD23 ' A' ' 25' ' ' LEU . 3.3 t -61.17 -42.86 94.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.897 0.38 . . . . 0.0 111.407 -172.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.5 p -78.52 -13.94 59.59 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.465 0.65 . . . . 0.0 110.588 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.1 t -81.42 -31.41 33.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.651 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.448 ' HA ' ' HD2' ' A' ' 64' ' ' TYR . 43.5 t -86.52 131.67 34.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.736 0.779 . . . . 0.0 112.202 -175.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -119.37 -36.74 3.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.263 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -139.14 153.15 47.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.931 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.699 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 12.4 tp -130.5 127.39 39.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.234 0.54 . . . . 0.0 111.716 -174.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.433 ' HB3' ' CZ3' ' A' ' 71' ' ' TRP . 37.5 ttp180 -140.33 130.0 24.32 Favored 'General case' 0 C--N 1.31 -1.137 0 O-C-N 121.374 -0.829 . . . . 0.0 110.929 171.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.773 ' O ' ' HE2' ' A' ' 14' ' ' MET . 8.8 mt -109.41 132.15 58.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.636 ' HE3' HD21 ' A' ' 100' ' ' LEU . 3.1 ptt? -139.09 141.23 38.16 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -168.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 0.1 OUTLIER -48.38 141.03 7.05 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.229 174.187 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.13 -28.5 49.5 Favored Glycine 0 CA--C 1.508 -0.405 0 CA-C-N 115.398 -0.819 . . . . 0.0 114.146 -169.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.2 t -66.38 -12.79 58.84 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.134 0.493 . . . . 0.0 111.301 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -101.76 -51.53 3.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.614 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.55 -23.81 66.27 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -172.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -57.03 -28.65 62.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.177 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.33 -37.01 22.37 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.638 -176.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.636 HD21 ' HE3' ' A' ' 92' ' ' MET . 2.2 pt? . . . . . 0 C--N 1.324 -0.521 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -173.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 41.0 m80 . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -122.35 77.65 1.43 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.381 0.61 . . . . 0.0 110.268 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.13 -1.58 3.64 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.275 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -126.44 72.3 1.32 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.293 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.439 ' HA ' ' HB3' ' A' ' 26' ' ' ARG . 96.1 t -129.31 114.87 33.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.03 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.595 ' HA2' ' CG ' ' A' ' 24' ' ' ASP . . . 71.75 90.95 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.78 -177.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.84 -48.48 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.539 -1.025 . . . . 0.0 110.539 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.826 HD13 ' CZ ' ' A' ' 26' ' ' ARG . 3.8 mp -94.71 106.23 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-O 121.411 0.625 . . . . 0.0 109.941 173.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -91.55 138.18 31.77 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.473 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.58 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -115.86 140.03 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -174.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.633 ' HA ' ' CD ' ' A' ' 22' ' ' LYS . 8.1 mptt -107.04 128.35 54.29 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.46 -0.791 . . . . 0.0 108.886 -174.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.771 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -124.65 133.3 69.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.474 0.654 . . . . 0.0 112.044 -169.791 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.5 m -131.9 155.5 47.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.583 -174.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.467 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 31.0 tpp -113.6 148.28 36.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.619 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -116.06 142.26 47.04 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.98 -32.57 3.74 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.467 ' O ' ' HG3' ' A' ' 14' ' ' MET . . . -133.2 142.66 45.22 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 171.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.99 124.76 7.55 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 121.924 1.749 . . . . 0.0 112.685 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.435 ' HB2' ' HB3' ' A' ' 14' ' ' MET . 68.0 m-85 -151.5 142.55 23.12 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.953 174.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.563 ' O ' ' HD2' ' A' ' 21' ' ' ARG . 5.1 mp -130.17 104.67 7.45 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.101 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.563 ' HD2' ' O ' ' A' ' 20' ' ' LEU . 3.2 mpt_? -126.43 164.1 21.86 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.316 176.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.633 ' CD ' ' HA ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -154.95 143.86 20.85 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.538 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -153.54 174.01 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 O-C-N 123.34 0.4 . . . . 0.0 111.599 -175.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.595 ' CG ' ' HA2' ' A' ' 6' ' ' GLY . 6.4 t70 -115.17 146.96 40.87 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.184 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.494 ' HG ' ' CG2' ' A' ' 10' ' ' VAL . 70.5 mt -72.13 -40.27 68.22 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -175.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.826 ' CZ ' HD13 ' A' ' 8' ' ' ILE . 9.4 mpt_? -71.08 -30.9 67.14 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -173.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 24' ' ' ASP . 36.0 m -62.78 -2.86 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -170.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -99.21 -27.65 13.7 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.914 0.388 . . . . 0.0 111.731 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.45 12.91 14.57 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.986 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.72 171.03 32.36 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.245 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -70.0 -29.83 67.01 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.8 p -56.71 -53.72 54.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.92 0.391 . . . . 0.0 111.17 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -73.25 -27.09 61.38 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.086 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 20.8 tp -58.26 -54.01 51.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.866 0.365 . . . . 0.0 110.144 175.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 96.0 mt -66.19 -38.52 88.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.841 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.473 ' HD3' ' O ' ' A' ' 36' ' ' LYS . 1.7 tmtp? -66.0 -33.92 76.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.352 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.679 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -63.5 -40.96 98.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.286 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.502 ' H ' ' HG ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -62.56 -49.32 75.74 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.056 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.457 ' HG2' ' H ' ' A' ' 46' ' ' ILE . 28.2 mt-10 -52.87 -33.66 50.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.111 175.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.56 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 38.4 m -73.03 -39.63 65.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.245 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.679 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 93.1 mmm -58.2 -55.65 32.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.311 -168.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -104.26 10.38 35.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.013 0.435 . . . . 0.0 111.111 -174.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.58 53.6 4.04 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.649 177.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 pp -154.78 -167.07 2.48 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 61.2 m -117.69 117.04 28.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.959 0.409 . . . . 0.0 111.638 -177.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.457 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 34.8 mm -85.76 135.44 24.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.329 175.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.9 143.56 33.69 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.497 173.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -73.38 172.9 10.38 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.122 0.487 . . . . 0.0 111.46 -174.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.632 ' HD1' HD22 ' A' ' 73' ' ' LEU . 44.5 t80 -76.42 79.14 3.15 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.777 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.5 m -59.29 123.21 15.99 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.05 -11.24 47.06 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -168.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.498 ' HD2' ' HG3' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -78.9 -49.79 12.28 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.025 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.498 ' HG3' ' HD2' ' A' ' 52' ' ' ARG . 90.8 mt-10 -119.32 -29.16 5.23 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.756 -0.59 . . . . 0.0 112.076 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.554 ' O ' HD13 ' A' ' 73' ' ' LEU . . . 41.78 12.1 0.01 OUTLIER Glycine 0 C--O 1.216 -1.022 0 N-CA-C 117.067 1.587 . . . . 0.0 117.067 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.738 ' HA ' HD13 ' A' ' 73' ' ' LEU . 17.5 m-30 -124.26 1.1 8.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 119.493 1.647 . . . . 0.0 110.492 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.422 ' HD3' ' H ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -64.78 -52.94 54.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.787 -175.602 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 60' ' ' TYR . . . 59.1 7.87 5.54 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 116.286 -0.415 . . . . 0.0 113.84 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.5 t 65.9 -82.72 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.199 0.6 . . . . 0.0 110.179 -171.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 40.5 tt0 -117.16 -15.64 10.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.595 0.236 . . . . 0.0 110.821 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.476 ' CZ ' ' HG3' ' A' ' 93' ' ' LYS . 57.7 m-85 -136.63 126.04 25.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.764 0.316 . . . . 0.0 111.432 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.638 ' HB1' HD12 ' A' ' 73' ' ' LEU . . . -103.92 105.79 49.92 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.801 175.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.505 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 28.6 Cg_endo -64.55 120.71 8.07 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.008 1.805 . . . . 0.0 111.243 172.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.619 HG21 HD11 ' A' ' 100' ' ' LEU . 35.9 p -127.22 154.05 45.33 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.214 0.53 . . . . 0.0 110.24 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.598 ' CD2' ' HZ ' ' A' ' 82' ' ' PHE . 44.0 p90 -135.28 167.04 21.75 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.744 -175.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.531 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 33.6 tt0 -108.29 117.35 33.93 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.37 179.38 7.69 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.475 ' HD2' ' N ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -64.18 -25.88 68.27 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.358 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.475 ' N ' ' HD2' ' A' ' 67' ' ' LYS . 35.1 t70 -78.15 -18.4 55.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.22 0.533 . . . . 0.0 110.095 177.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.18 15.51 47.73 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.339 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -96.41 142.38 28.59 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.557 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 68.9 m95 -101.13 118.94 37.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.432 0.634 . . . . 0.0 110.828 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.435 ' O ' ' HA ' ' A' ' 63' ' ' THR . 45.1 mtm -125.4 171.75 10.19 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.414 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.738 HD13 ' HA ' ' A' ' 55' ' ' TYR . 7.5 tt -91.63 142.17 27.92 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.481 ' N ' HD23 ' A' ' 73' ' ' LEU . 19.7 m -58.85 143.06 13.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.103 -174.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.37 3.06 25.99 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.881 -173.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -80.23 -59.54 2.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.927 0.394 . . . . 0.0 110.712 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.576 HG12 ' HD2' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -96.55 153.25 38.88 Favored Pre-proline 0 N--CA 1.445 -0.717 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 175.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.576 ' HD2' HG12 ' A' ' 77' ' ' VAL . 7.5 Cg_exo -74.2 155.32 46.92 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.475 2.117 . . . . 0.0 110.791 176.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.722 ' O ' HG23 ' A' ' 83' ' ' VAL . 61.9 t-105 -46.38 -49.64 17.6 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.862 0.726 . . . . 0.0 112.695 -171.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -55.97 -42.18 75.9 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -171.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 78.8 mtp -83.53 -33.74 25.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.239 0.543 . . . . 0.0 110.472 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.598 ' HZ ' ' CD2' ' A' ' 64' ' ' TYR . 7.1 t80 -58.32 -50.93 71.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.95 -175.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 79' ' ' TRP . 2.1 t -60.64 -39.22 80.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.126 0.488 . . . . 0.0 111.307 -171.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.6 p -79.57 -11.7 59.87 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -175.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.5 p -108.8 -28.65 9.08 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -174.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 40.4 t -66.14 136.42 55.91 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.026 0.441 . . . . 0.0 111.051 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -116.86 -40.5 3.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.739 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.531 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 69.9 mtt180 -137.59 161.89 35.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.198 -175.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.771 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 6.5 tp -133.76 122.97 24.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.752 -172.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -139.7 119.67 13.52 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 121.829 -0.545 . . . . 0.0 110.508 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.421 HG23 ' HA ' ' A' ' 62' ' ' PRO . 10.3 mt -116.74 135.14 58.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.429 ' HA ' ' SD ' ' A' ' 14' ' ' MET . 25.5 ptt? -159.25 162.95 36.21 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.336 0.589 . . . . 0.0 112.357 -174.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 36.4 mttt -56.93 146.78 25.61 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.062 -1.426 . . . . 0.0 113.086 -176.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' A' ' 97' ' ' ALA . . . -60.3 -30.09 70.31 Favored Glycine 0 CA--C 1.507 -0.454 0 CA-C-N 114.125 -1.398 . . . . 0.0 113.726 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.498 HG22 ' HB3' ' A' ' 93' ' ' LYS . 1.5 t -56.78 -26.09 56.82 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.161 0.505 . . . . 0.0 111.337 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -102.67 -34.78 8.93 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.167 0.508 . . . . 0.0 110.346 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.407 ' HB3' ' HA2' ' A' ' 94' ' ' GLY . . . -63.08 -23.4 67.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.578 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.457 ' HA ' ' HB3' ' A' ' 106' ' ' SER . 16.0 pttp -62.39 -19.53 63.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.962 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -71.77 -40.61 57.94 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.39 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.619 HD11 HG21 ' A' ' 63' ' ' THR . 0.9 OUTLIER -102.51 11.53 37.76 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 122.599 -0.354 . . . . 0.0 110.87 -178.404 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.7 71.83 0.68 Allowed Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 173.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 59.1 m -55.21 105.2 0.15 Allowed 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.618 0.767 . . . . 0.0 112.554 -175.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 72.99 65.92 2.16 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 114.439 -1.255 . . . . 0.0 113.054 172.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 42.8 t 59.98 92.19 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.54 0.686 . . . . 0.0 110.324 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -140.86 -50.35 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.455 -0.879 . . . . 0.0 113.089 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.457 ' HB3' ' HA ' ' A' ' 98' ' ' LYS . 8.5 t -132.54 116.98 17.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.858 0.329 . . . . 0.0 111.338 -173.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.177 -0.916 . . . . 0.0 112.17 171.892 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.698 0.285 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -82.92 74.58 9.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.816 0.341 . . . . 0.0 111.705 -174.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 53.7 61.53 3.05 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.502 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.2 t70 63.28 108.71 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.415 0.686 . . . . 0.0 111.653 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.1 m -84.05 158.16 3.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.373 -176.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 148.97 153.25 5.95 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.117 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.93 -25.94 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.073 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 3.2 mp -114.06 104.5 17.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.184 0.516 . . . . 0.0 109.985 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -115.07 118.56 33.72 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.231 -172.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.597 ' CG2' ' HB2' ' A' ' 89' ' ' LEU . 4.1 m -116.25 162.51 14.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.165 -177.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.555 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 18.8 ptmt -104.07 134.33 47.52 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -126.47 128.08 70.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.607 0.717 . . . . 0.0 111.322 -177.003 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.3 t -122.56 155.2 36.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.763 175.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.739 ' SD ' ' HB ' ' A' ' 91' ' ' ILE . 68.6 mmm -103.18 141.92 35.04 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.847 0.356 . . . . 0.0 111.052 -177.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 92' ' ' MET . 11.0 t70 -110.44 125.02 52.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.024 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.34 -32.75 6.89 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -177.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.05 142.98 42.21 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 172.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.89 122.87 6.5 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 121.554 1.503 . . . . 0.0 112.355 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.482 ' HB2' ' CG ' ' A' ' 14' ' ' MET . 75.4 m-85 -153.43 151.68 30.17 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.044 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -127.81 105.56 8.52 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.008 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.481 ' C ' ' HG2' ' A' ' 22' ' ' LYS . 31.8 mmt180 -127.97 156.1 43.22 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.555 ' HD3' ' HA ' ' A' ' 11' ' ' LYS . 4.9 mmtm -147.81 130.18 15.71 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.415 HD11 ' CD2' ' A' ' 89' ' ' LEU . 4.0 pt -140.95 173.31 9.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.66 0.743 . . . . 0.0 112.168 -174.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.653 ' OD1' ' HG2' ' A' ' 26' ' ' ARG . 7.3 t70 -113.62 126.94 55.83 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.687 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.472 ' HB3' HG13 ' A' ' 83' ' ' VAL . 6.8 mp -70.8 -39.85 72.86 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.697 -174.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.653 ' HG2' ' OD1' ' A' ' 24' ' ' ASP . 8.4 ptm180 -77.66 -23.51 49.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.83 -167.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 24' ' ' ASP . 29.8 m -65.34 -16.12 19.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -176.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -84.74 -27.88 26.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.13 0.49 . . . . 0.0 110.909 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.93 14.3 30.31 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.24 -0.891 . . . . 0.0 113.688 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.07 168.5 32.02 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.412 ' CE1' ' HA2' ' A' ' 75' ' ' GLY . 43.3 m-85 -70.4 -34.24 72.31 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -175.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.1 m -59.05 -51.18 71.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.846 0.355 . . . . 0.0 111.386 -175.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -72.99 -33.71 65.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.797 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.1 tp -55.82 -55.78 28.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.156 0.503 . . . . 0.0 110.796 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.7 mt -66.8 -35.48 80.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.08 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.453 ' HD3' ' C ' ' A' ' 36' ' ' LYS . 13.1 tmtt? -63.27 -43.38 98.09 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.526 -177.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.45 ' O ' ' HB ' ' A' ' 40' ' ' THR . . . -57.71 -42.31 83.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.829 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.444 ' H ' ' HG ' ' A' ' 38' ' ' LEU . 1.3 mt -65.56 -53.3 43.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.841 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.457 ' HG2' ' H ' ' A' ' 46' ' ' ILE . 40.7 mt-10 -52.01 -28.74 18.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.694 175.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 33.6 m -76.48 -45.13 32.4 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.542 175.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.435 ' HG3' ' O ' ' A' ' 37' ' ' ALA . 30.6 mtm -58.91 -55.03 40.45 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -170.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.21 9.15 36.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.249 0.547 . . . . 0.0 111.125 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? 55.24 48.81 18.54 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.792 173.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 pp -141.53 178.86 7.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.7 m -95.73 122.13 38.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.213 0.53 . . . . 0.0 112.237 -173.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.457 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 49.1 mm -102.47 135.05 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.5 174.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.453 ' HA3' ' NZ ' ' A' ' 56' ' ' LYS . . . -89.32 164.96 32.33 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.744 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.4 176.94 8.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.277 0.561 . . . . 0.0 112.009 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -78.18 93.91 4.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.755 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.571 ' N ' ' HA2' ' A' ' 54' ' ' GLY . 2.1 t -49.78 138.98 13.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.05 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -73.87 -13.28 60.89 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.131 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.536 ' HD3' ' HG3' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -104.23 -44.5 4.95 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.064 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.536 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 24.4 mt-10 -118.26 -28.41 5.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.472 0.578 . . . . 0.0 111.555 175.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.571 ' HA2' ' N ' ' A' ' 50' ' ' SER . . . 54.06 11.15 2.1 Favored Glycine 0 C--O 1.219 -0.81 0 CA-C-N 114.699 -1.137 . . . . 0.0 115.216 -178.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.442 ' HB3' HD11 ' A' ' 100' ' ' LEU . 18.5 m-85 -125.54 4.09 7.6 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 118.473 1.136 . . . . 0.0 111.247 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.497 ' HD3' ' H ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -58.74 -37.71 76.8 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -176.771 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.497 ' H ' ' HD3' ' A' ' 56' ' ' LYS . . . 60.86 -4.94 0.22 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 114.252 0.461 . . . . 0.0 114.252 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.415 ' H ' ' HE2' ' A' ' 56' ' ' LYS . 48.8 m 69.26 -79.33 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.189 0.596 . . . . 0.0 109.892 -172.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 33.2 tt0 -118.57 -19.52 8.73 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.107 172.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -143.43 126.13 16.03 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.066 0.46 . . . . 0.0 110.974 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.434 ' HB1' ' CD1' ' A' ' 73' ' ' LEU . . . -103.01 104.45 40.09 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.06 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.477 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 33.9 Cg_endo -67.99 121.16 8.15 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 121.714 1.609 . . . . 0.0 111.263 172.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.436 HG21 HD22 ' A' ' 100' ' ' LEU . 82.2 p -125.54 160.05 30.52 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.519 -176.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.689 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.7 p90 -121.57 164.1 17.81 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.604 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.492 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 41.3 tt0 -103.42 115.64 30.91 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 14.1 t70 -84.03 -169.25 2.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.007 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.448 ' H ' ' CG ' ' A' ' 66' ' ' ASP . 1.4 mtmp? -66.65 -45.73 78.03 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.647 0.26 . . . . 0.0 111.474 -173.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.53 -3.76 51.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.194 0.521 . . . . 0.0 110.861 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.27 24.27 19.64 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.166 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -76.18 138.81 40.92 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.568 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 90.7 m95 -115.16 113.05 23.44 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 123.405 0.441 . . . . 0.0 109.952 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.433 ' HA ' ' CD1' ' A' ' 100' ' ' LEU . 32.5 mtm -142.36 169.45 17.56 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 176.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 62' ' ' PRO . 2.3 tp -62.88 152.89 35.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.282 0.563 . . . . 0.0 111.204 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.753 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 99.2 t -77.55 127.78 38.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.443 174.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.412 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 111.57 1.68 27.56 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -170.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -63.03 -48.3 79.32 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.571 HG22 ' CD2' ' A' ' 82' ' ' PHE . 3.2 m -113.88 156.8 43.34 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.86 133.11 33.31 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.965 2.443 . . . . 0.0 113.606 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.565 ' O ' HG23 ' A' ' 83' ' ' VAL . 73.2 t-105 -40.03 -53.31 2.4 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.444 1.097 . . . . 0.0 113.552 -173.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -52.51 -42.78 64.61 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -175.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 68.1 mtm -83.75 -27.48 28.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.111 0.482 . . . . 0.0 110.545 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.753 ' CZ ' ' HA ' ' A' ' 74' ' ' VAL . 9.2 t80 -63.16 -45.49 91.59 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.502 -174.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 79' ' ' TRP . 4.7 t -61.14 -42.34 92.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.302 -171.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.7 p -78.58 -19.45 52.74 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.094 0.473 . . . . 0.0 110.985 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.8 t -83.83 -21.73 31.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.302 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.689 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 36.2 t -90.93 133.47 35.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.161 0.505 . . . . 0.0 111.182 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 13.7 pttp -121.91 -29.52 4.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.738 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.492 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 60.2 mtt180 -139.51 167.28 22.46 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 176.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.712 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 10.8 tp -136.86 138.17 40.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.299 0.571 . . . . 0.0 111.527 -173.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -139.22 129.3 25.17 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.832 0.349 . . . . 0.0 110.146 170.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.739 ' HB ' ' SD ' ' A' ' 14' ' ' MET . 13.4 mt -111.65 138.28 40.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 175.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.467 ' HE1' ' HB3' ' A' ' 100' ' ' LEU . 9.1 ptt? -155.9 147.55 22.93 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -170.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 21.0 ttpt -50.83 147.88 4.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 113.591 -1.641 . . . . 0.0 112.828 -175.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.53 -27.98 70.53 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 114.698 -1.137 . . . . 0.0 113.276 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.526 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 44.3 p -68.49 -16.08 63.77 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.91 0.386 . . . . 0.0 111.08 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -101.88 -2.57 29.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.453 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.574 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -59.61 -29.97 68.36 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -172.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.526 ' HE3' ' O ' ' A' ' 95' ' ' THR . 0.0 OUTLIER -59.6 -23.66 63.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.769 0.318 . . . . 0.0 110.874 178.434 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.52 -22.01 78.93 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 116.101 -0.5 . . . . 0.0 113.195 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.574 HD23 ' HA ' ' A' ' 97' ' ' ALA . 1.0 OUTLIER -103.58 -24.72 13.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.355 0.598 . . . . 0.0 110.756 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.455 ' N ' ' HG ' ' A' ' 100' ' ' LEU . . . -100.91 48.23 1.16 Allowed Glycine 0 CA--C 1.493 -1.299 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.31 -176.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 66.9 m -79.62 4.19 16.75 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.944 -0.628 . . . . 0.0 111.716 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.02 -57.02 1.42 Allowed Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.887 176.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.9 p -85.64 10.79 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 122.083 0.944 . . . . 0.0 110.655 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 56.8 49.55 69.86 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.285 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.2 t -57.35 145.37 32.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.779 0.324 . . . . 0.0 110.25 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.635 -0.698 . . . . 0.0 110.649 -176.021 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.557 0.217 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -105.93 91.52 3.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.525 0.202 . . . . 0.0 110.505 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.78 53.1 7.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.352 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.0 t70 68.27 155.3 0.11 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.335 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.1 t -91.21 75.44 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.586 0.708 . . . . 0.0 109.338 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 137.04 172.56 12.57 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.969 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 154.62 -38.81 0.66 Allowed Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 176.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.495 ' CD1' ' HD2' ' A' ' 26' ' ' ARG . 3.9 mp -92.26 106.3 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-O 121.218 0.532 . . . . 0.0 109.983 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -90.04 134.8 34.03 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.95 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.537 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -116.25 139.74 41.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.443 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -104.55 135.07 46.66 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.706 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -124.39 127.41 73.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.691 0.758 . . . . 0.0 111.472 -172.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.8 p -115.57 155.84 26.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.69 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.456 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 27.4 tpp -110.05 145.08 37.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.624 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -111.89 140.35 46.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.597 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.74 -32.44 4.54 Favored Glycine 0 C--O 1.229 -0.157 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 14' ' ' MET . . . -133.94 143.71 48.58 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 172.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.97 122.21 6.17 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 121.391 1.394 . . . . 0.0 112.262 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -153.29 143.16 22.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.766 174.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.5 mt -127.65 106.95 9.5 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.84 0.353 . . . . 0.0 110.368 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.554 ' O ' HG13 ' A' ' 12' ' ' VAL . 10.3 mmm180 -124.07 155.49 38.25 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.446 ' HD2' ' C ' ' A' ' 21' ' ' ARG . 2.5 mptp? -143.76 144.39 31.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.796 0.332 . . . . 0.0 110.551 175.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -146.87 176.06 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.979 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.485 ' O ' HG22 ' A' ' 27' ' ' VAL . 9.0 t70 -111.32 132.68 54.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.273 0.559 . . . . 0.0 110.275 -175.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.551 HD21 ' HB3' ' A' ' 86' ' ' CYS . 16.6 tp -69.27 -34.31 74.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.733 -172.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.495 ' HD2' ' CD1' ' A' ' 8' ' ' ILE . 65.8 mtp180 -79.47 -32.07 42.53 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -171.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 24' ' ' ASP . 33.6 m -68.81 -0.81 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -169.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.513 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 27.0 m-85 -85.64 -28.7 24.58 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.28 177.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.86 14.86 5.8 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.328 -0.851 . . . . 0.0 114.168 177.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.21 175.94 28.71 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.633 -176.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.4 ' OH ' ' HA ' ' A' ' 78' ' ' PRO . 25.1 m-85 -69.18 -31.63 70.39 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -176.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.9 p -59.69 -56.11 25.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.733 0.301 . . . . 0.0 111.44 -175.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' A' ' 28' ' ' TYR . 47.1 mt-10 -73.98 -25.83 60.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.59 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.64 -56.37 23.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.233 0.54 . . . . 0.0 110.115 174.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.4 mt -69.77 -36.63 75.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.81 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.458 ' HA ' ' HD3' ' A' ' 36' ' ' LYS . 68.0 mmtt -71.62 -31.29 66.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.561 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.684 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -58.59 -42.65 88.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.881 176.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.656 HD13 ' HG3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -58.24 -52.93 63.51 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.598 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 39.0 mt-10 -52.3 -30.22 27.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.896 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.559 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 53.8 m -73.95 -44.89 53.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.135 177.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.684 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 74.5 mmm -57.07 -57.13 13.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.707 -169.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -102.17 8.6 40.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.119 0.485 . . . . 0.0 110.922 -175.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.28 47.72 16.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.633 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 3.0 pp -145.51 -179.31 6.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.705 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 m -111.61 98.21 7.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -171.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.457 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 37.5 mm -65.51 127.66 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.988 172.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.5 149.59 43.82 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.891 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -68.21 162.7 24.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.117 0.484 . . . . 0.0 111.803 -174.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.541 ' CZ ' HD12 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -65.95 89.73 0.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.891 179.007 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.427 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 30.8 t -62.89 146.88 51.85 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.707 0.765 . . . . 0.0 109.849 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -76.37 -16.32 59.75 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.603 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.555 ' HD3' ' HG3' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -82.03 -56.3 4.04 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -172.457 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.555 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 39.5 mt-10 -121.34 -29.64 4.43 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.732 0.777 . . . . 0.0 109.687 165.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.532 ' O ' HD11 ' A' ' 73' ' ' LEU . . . 46.73 8.76 0.03 OUTLIER Glycine 0 C--O 1.214 -1.115 0 CA-C-N 113.317 -1.765 . . . . 0.0 116.216 -177.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.605 ' CD1' ' HA2' ' A' ' 105' ' ' GLY . 11.1 m-85 -114.78 6.49 15.55 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 118.171 0.986 . . . . 0.0 110.992 -176.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.507 ' HG2' ' H ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -63.85 -39.07 93.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.647 177.324 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 60' ' ' TYR . . . 58.31 22.19 49.97 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.78 176.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.507 ' H ' ' HG2' ' A' ' 56' ' ' LYS . 20.4 t 69.27 -86.19 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -165.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -119.75 -16.61 8.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.694 0.283 . . . . 0.0 110.971 169.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.525 ' O ' ' HA3' ' A' ' 57' ' ' GLY . 30.3 m-85 -122.27 125.79 46.78 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -174.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -100.92 105.33 37.68 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.936 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.656 ' HG3' HD13 ' A' ' 38' ' ' LEU . 61.0 Cg_endo -72.8 119.65 6.2 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.986 1.791 . . . . 0.0 111.231 175.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 72' ' ' MET . 71.2 p -128.78 165.49 20.84 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.766 -175.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.549 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 4.3 p90 -137.8 164.74 28.16 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.683 0.278 . . . . 0.0 110.349 -176.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.482 ' OE1' ' HD3' ' A' ' 88' ' ' ARG . 29.5 tt0 -100.24 113.92 26.96 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.89 177.48 8.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.715 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.0 mtmm -48.72 -44.14 37.96 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.117 0.567 . . . . 0.0 111.888 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -81.86 -15.99 52.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.114 0.483 . . . . 0.0 110.74 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.99 23.86 16.56 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.57 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -95.27 143.64 26.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.549 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 67.3 m95 -110.1 114.96 28.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.065 0.46 . . . . 0.0 111.516 -173.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.425 ' O ' ' HA ' ' A' ' 63' ' ' THR . 2.1 mpp? -127.37 179.3 5.54 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 174.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.541 HD12 ' CZ ' ' A' ' 49' ' ' TYR . 10.8 mt -64.0 153.22 37.93 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.54 0.686 . . . . 0.0 111.531 176.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.406 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 22.9 m -77.14 137.83 21.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.855 175.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.73 8.26 80.18 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.624 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.35 -54.03 43.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.664 0.268 . . . . 0.0 111.212 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.542 HG22 ' CD2' ' A' ' 82' ' ' PHE . 12.4 m -98.82 155.52 36.57 Favored Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 4.2 Cg_endo -46.95 132.82 17.8 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.487 2.791 . . . . 0.0 113.326 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.548 ' O ' HG23 ' A' ' 83' ' ' VAL . 70.0 t-105 -43.41 -51.88 6.28 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -171.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -54.63 -42.66 71.48 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.628 0.251 . . . . 0.0 111.637 -174.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 57.2 ttp -84.03 -22.73 31.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.998 0.428 . . . . 0.0 110.547 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.542 ' CD2' HG22 ' A' ' 77' ' ' VAL . 11.4 t80 -66.29 -45.93 78.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.038 -177.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 79' ' ' TRP . 3.5 t -61.37 -37.28 77.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.115 0.483 . . . . 0.0 110.944 -174.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.5 p -79.46 -12.34 59.88 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.334 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.3 m -95.17 -31.32 13.58 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.551 ' HB3' HD21 ' A' ' 25' ' ' LEU . 44.6 t -80.5 130.31 35.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.762 0.791 . . . . 0.0 111.457 -175.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -118.21 -40.66 2.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.674 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.482 ' HD3' ' OE1' ' A' ' 65' ' ' GLU . 51.6 mtp180 -140.14 163.54 32.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.084 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.706 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 5.6 tp -130.02 137.65 50.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.879 0.371 . . . . 0.0 110.826 -171.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.406 ' HD2' ' SD ' ' A' ' 92' ' ' MET . 12.9 ttm180 -139.31 115.03 10.04 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.826 175.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.1 mt -111.25 133.92 55.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 171.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.495 ' C ' ' HD1' ' A' ' 60' ' ' TYR . 21.9 ptt? -159.19 161.46 36.15 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -169.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -56.96 141.22 46.16 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.696 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.69 -22.07 45.38 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.957 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.2 t -63.63 -20.22 65.5 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.002 0.43 . . . . 0.0 111.01 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -101.25 -39.03 7.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.08 0.467 . . . . 0.0 109.887 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.44 -25.76 67.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.004 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.507 ' HA ' ' HB3' ' A' ' 106' ' ' SER . 13.4 ptmm? -65.25 -23.28 67.02 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.37 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.91 -38.1 36.9 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.911 -0.661 . . . . 0.0 113.112 -177.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.472 HD23 ' H ' ' A' ' 100' ' ' LEU . 1.3 pt? -103.59 11.89 35.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.748 0.308 . . . . 0.0 111.65 -174.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.34 81.96 0.37 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.599 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 24.1 p -121.92 128.35 51.45 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.24 0.543 . . . . 0.0 110.55 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.21 68.85 1.17 Allowed Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.478 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.7 t 60.45 57.51 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.988 0.899 . . . . 0.0 108.789 -172.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.605 ' HA2' ' CD1' ' A' ' 55' ' ' TYR . . . -130.74 -168.5 12.25 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.649 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.507 ' HB3' ' HA ' ' A' ' 98' ' ' LYS . 11.5 t -75.36 131.73 40.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.982 0.42 . . . . 0.0 110.254 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.1 m170 . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.648 -0.692 . . . . 0.0 110.579 -175.585 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 39.0 m80 . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 120.462 0.172 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -79.31 59.99 3.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.286 0.565 . . . . 0.0 111.424 -173.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 175.94 -51.51 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.337 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -92.12 26.88 2.34 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.11 -173.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.75 153.04 33.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 176.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.558 ' O ' ' HD3' ' A' ' 26' ' ' ARG . . . 122.71 -177.72 16.47 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.284 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 140.21 -40.93 1.34 Allowed Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -176.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 mp -125.11 107.58 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 114.229 -0.986 . . . . 0.0 109.129 170.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -103.18 141.2 36.28 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.571 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.598 HG21 HD13 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -131.15 152.88 38.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.235 0.54 . . . . 0.0 109.927 -179.029 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -118.72 141.46 48.6 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -125.57 126.88 71.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.61 0.719 . . . . 0.0 111.313 -174.839 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.6 m -117.41 155.6 29.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.366 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.695 ' SD ' ' HA ' ' A' ' 92' ' ' MET . 25.7 tpp -99.69 151.98 20.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.888 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -119.06 122.46 42.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.079 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.63 -31.94 8.15 Favored Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.43 ' O ' ' HG3' ' A' ' 14' ' ' MET . . . -134.64 149.15 70.04 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 173.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.18 121.75 5.88 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.019 1.146 . . . . 0.0 112.222 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.526 ' HB2' ' CB ' ' A' ' 14' ' ' MET . 56.6 m-85 -153.09 142.89 22.05 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.557 175.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.453 HD22 ' C ' ' A' ' 19' ' ' TYR . 3.1 mm? -129.53 106.71 8.94 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.14 0.495 . . . . 0.0 111.12 -176.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.504 ' C ' ' HD2' ' A' ' 22' ' ' LYS . 37.3 mmt180 -125.52 155.85 39.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.808 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.504 ' HD2' ' C ' ' A' ' 21' ' ' ARG . 2.5 mptp? -146.96 137.2 23.49 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.533 HD11 ' CD2' ' A' ' 89' ' ' LEU . 1.9 pt -140.95 174.11 8.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.576 0.703 . . . . 0.0 111.87 -176.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.536 ' O ' HG22 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -113.16 124.8 53.4 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.036 -0.983 . . . . 0.0 108.956 -177.155 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.598 HD13 HG21 ' A' ' 10' ' ' VAL . 11.8 tp -71.62 -45.58 61.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -165.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.558 ' HD3' ' O ' ' A' ' 6' ' ' GLY . 2.8 ptm180 -79.98 -16.37 55.33 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -171.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 24' ' ' ASP . 19.1 m -75.68 -0.74 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -169.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.461 ' OH ' ' HB ' ' A' ' 23' ' ' ILE . 30.5 m-85 -96.12 -28.93 14.36 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.926 0.394 . . . . 0.0 111.341 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.16 14.21 17.68 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.859 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.31 167.31 33.61 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.876 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -69.23 -34.14 74.38 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 p -57.21 -55.22 37.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.569 0.223 . . . . 0.0 111.159 -176.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -70.3 -29.95 66.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.105 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.5 tp -59.09 -55.6 33.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.187 0.518 . . . . 0.0 109.959 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.54 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 56.4 mt -67.31 -38.13 84.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.259 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 36' ' ' LYS . 62.9 mmtt -69.66 -31.96 70.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.657 -177.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.471 ' O ' ' HB ' ' A' ' 40' ' ' THR . . . -60.54 -41.82 95.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.076 0.465 . . . . 0.0 110.387 176.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.541 ' HB2' HG13 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -63.37 -54.61 34.17 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.805 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.54 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 23.6 mt-10 -52.11 -29.8 23.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.938 176.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 24.6 m -71.71 -41.89 68.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.205 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.533 ' HE3' ' CZ ' ' A' ' 42' ' ' PHE . 71.8 mtm -66.51 -55.03 17.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -171.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.533 ' CZ ' ' HE3' ' A' ' 41' ' ' MET . 0.1 OUTLIER -100.46 10.53 41.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.159 0.504 . . . . 0.0 111.929 -173.611 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp 55.27 47.92 20.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.622 174.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.41 ' CD2' ' HB2' ' A' ' 42' ' ' PHE . 2.8 pp -143.08 -176.37 4.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.007 -177.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 63.4 m -108.18 99.86 9.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.042 0.449 . . . . 0.0 111.713 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.541 HG13 ' HB2' ' A' ' 38' ' ' LEU . 34.2 mm -76.77 123.18 32.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 172.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.02 155.52 53.58 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.013 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -71.01 171.27 11.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.296 0.57 . . . . 0.0 111.249 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.579 ' HD1' HD22 ' A' ' 73' ' ' LEU . 28.2 t80 -79.3 85.66 5.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.542 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.8 m -56.66 135.64 54.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.383 173.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -72.13 -25.73 61.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.282 0.563 . . . . 0.0 110.399 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.588 ' HD2' ' N ' ' A' ' 53' ' ' GLU . 3.4 ppt_? -68.24 -52.98 27.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.367 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.588 ' N ' ' HD2' ' A' ' 52' ' ' ARG . 47.6 mt-10 -122.84 -29.23 4.01 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.634 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.598 ' O ' HD13 ' A' ' 73' ' ' LEU . . . 42.21 10.87 0.01 OUTLIER Glycine 0 C--O 1.218 -0.872 0 N-CA-C 116.303 1.281 . . . . 0.0 116.303 -174.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.455 ' HD1' ' HB3' ' A' ' 73' ' ' LEU . 9.7 m-85 -126.25 6.57 7.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 118.672 1.236 . . . . 0.0 110.269 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.479 ' HG2' ' H ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -67.12 -31.21 71.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.5 -175.29 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 58' ' ' SER . . . 65.56 -12.74 0.31 Allowed Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.527 -0.761 . . . . 0.0 114.727 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.479 ' H ' ' HG2' ' A' ' 56' ' ' LYS . 40.0 m 71.77 -80.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -172.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -118.88 -23.75 6.84 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.656 170.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.424 ' HE1' ' SD ' ' A' ' 14' ' ' MET . 37.4 m-85 -134.79 124.51 25.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.008 0.432 . . . . 0.0 111.205 175.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.431 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . . . -105.46 105.3 51.92 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.681 177.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.516 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 43.8 Cg_endo -68.51 120.17 7.13 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.499 1.466 . . . . 0.0 110.993 174.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.3 p -124.7 168.45 13.16 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.078 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 3.6 p90 -143.77 165.32 28.0 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -176.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.436 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 40.4 tt0 -108.32 121.14 44.29 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.401 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.479 ' O ' ' HE3' ' A' ' 87' ' ' LYS . 14.9 t70 -84.15 -169.34 2.54 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.567 177.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.484 ' NZ ' ' HA ' ' A' ' 85' ' ' SER . 17.4 mmtm -62.36 -49.08 76.99 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.725 0.774 . . . . 0.0 109.82 -172.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -84.39 13.93 4.94 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.714 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.79 19.58 72.84 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.942 175.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -75.61 130.0 38.08 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.526 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 92.8 m95 -106.26 120.72 42.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.167 0.508 . . . . 0.0 110.69 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 46.5 mtm -138.5 170.27 16.32 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.598 HD13 ' O ' ' A' ' 54' ' ' GLY . 10.0 tt -79.08 141.57 37.25 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 16.2 m -66.81 130.11 31.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.649 0.738 . . . . 0.0 112.219 -174.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.87 4.56 26.08 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.807 -175.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.05 -59.43 5.43 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.612 0.244 . . . . 0.0 110.869 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.8 m -98.57 156.06 36.1 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -52.16 137.14 54.67 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.172 2.581 . . . . 0.0 112.975 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.593 ' O ' HG23 ' A' ' 83' ' ' VAL . 71.9 t-105 -43.78 -41.72 5.12 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.347 -174.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -58.74 -42.63 89.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.093 0.473 . . . . 0.0 111.063 -174.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 49.9 ttp -85.11 -27.66 26.11 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.589 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 74' ' ' VAL . 11.8 t80 -63.63 -40.71 97.57 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.162 -172.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 79' ' ' TRP . 2.8 t -60.86 -39.7 82.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.415 0.626 . . . . 0.0 110.942 -173.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.7 p -79.09 -10.85 59.94 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.314 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.484 ' HA ' ' NZ ' ' A' ' 67' ' ' LYS . 68.0 m -89.3 -31.39 17.86 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 30.3 t -90.75 123.91 34.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.176 0.512 . . . . 0.0 112.043 -175.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.479 ' HE3' ' O ' ' A' ' 66' ' ' ASP . 18.8 pttp -118.83 -22.9 7.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.594 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.436 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 84.5 mtt180 -140.23 151.16 44.94 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 174.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.63 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 3.6 tp -125.73 137.72 53.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.018 0.437 . . . . 0.0 111.114 -174.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -139.31 116.08 10.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.154 0.502 . . . . 0.0 110.948 172.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.435 HD12 ' HZ ' ' A' ' 42' ' ' PHE . 22.1 mt -106.8 136.6 41.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 173.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.695 ' HA ' ' SD ' ' A' ' 14' ' ' MET . 19.9 ptt? -157.94 160.05 37.17 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -168.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -56.02 138.66 48.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 113.666 -1.606 . . . . 0.0 111.952 -177.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -61.99 -28.72 70.89 Favored Glycine 0 CA--C 1.505 -0.582 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.127 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.3 p -64.17 -20.31 65.91 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.195 -0.502 . . . . 0.0 111.124 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -100.53 -47.53 4.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.39 0.615 . . . . 0.0 110.103 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.96 -21.85 65.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.154 -176.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.652 ' HA ' ' SG ' ' A' ' 102' ' ' CYS . 0.1 OUTLIER -53.6 -29.74 39.09 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -175.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.58 -39.32 93.84 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.786 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.7 pp -103.97 -25.4 13.03 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -174.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -104.42 -48.73 1.1 Allowed Glycine 0 CA--C 1.492 -1.356 0 C-N-CA 120.34 -0.933 . . . . 0.0 112.111 -174.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.652 ' SG ' ' HA ' ' A' ' 98' ' ' LYS . 39.3 m -78.76 5.84 10.34 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.36 0.6 . . . . 0.0 110.821 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.51 33.44 5.49 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 168.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 p 34.73 73.84 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 113.165 -1.518 . . . . 0.0 113.125 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 130.16 73.98 0.13 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.552 174.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 25.4 t -63.91 105.35 0.83 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.77 0.319 . . . . 0.0 110.755 173.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.1 m170 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.369 -0.824 . . . . 0.0 109.767 177.446 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.424 ' H3 ' ' CG ' ' A' ' 4' ' ' ASP . 38.5 m-70 . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.788 0.328 . . . . 0.0 110.409 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -98.76 87.97 3.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.229 0.538 . . . . 0.0 110.68 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 71.95 -8.26 1.15 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.005 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.424 ' CG ' ' H3 ' ' A' ' 1' ' ' HIS . 8.4 p-10 -96.13 34.41 1.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 27' ' ' VAL . 84.3 t 74.63 118.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.255 -175.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 144.17 156.77 6.93 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.15 -21.69 0.29 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.75 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.51 ' CD1' ' HD2' ' A' ' 26' ' ' ARG . 3.3 mp -104.9 105.56 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 121.249 0.547 . . . . 0.0 109.674 177.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -102.9 130.77 50.06 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.439 -172.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.622 HG21 HD13 ' A' ' 25' ' ' LEU . 2.1 t -121.12 150.75 24.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.639 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -105.95 135.13 47.95 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.7 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -124.93 125.94 70.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.449 0.642 . . . . 0.0 110.874 -175.669 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 p -114.76 148.19 38.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.493 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.512 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 79.0 mmm -104.73 165.84 10.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.791 -177.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -131.75 141.7 49.58 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.99 -33.19 4.32 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.887 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.12 140.09 33.77 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-O 120.805 0.336 . . . . 0.0 110.796 173.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.3 127.77 9.29 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.925 2.416 . . . . 0.0 112.729 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -149.52 172.46 14.95 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.08 103.88 5.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.818 0.818 . . . . 0.0 110.423 170.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.449 ' C ' ' HD2' ' A' ' 22' ' ' LYS . 39.7 mmt180 -127.68 136.63 51.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.1 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.449 ' HD2' ' C ' ' A' ' 21' ' ' ARG . 2.6 mptp? -144.42 141.27 29.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 171.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.537 HD11 ' CD2' ' A' ' 89' ' ' LEU . 3.4 pt -140.86 174.11 8.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.028 0.442 . . . . 0.0 112.142 -175.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -110.45 126.47 54.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.103 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.622 HD13 HG21 ' A' ' 10' ' ' VAL . 10.8 tp -69.84 -43.06 72.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.833 -170.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.51 ' HD2' ' CD1' ' A' ' 8' ' ' ILE . 11.5 ptm180 -80.28 -25.82 39.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.047 0.451 . . . . 0.0 110.719 -171.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.437 ' HA ' HG12 ' A' ' 5' ' ' VAL . 0.5 OUTLIER -49.71 -21.81 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 124.491 1.116 . . . . 0.0 113.767 -179.002 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -86.73 -28.23 23.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.972 0.415 . . . . 0.0 111.805 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.5 13.75 46.14 Favored Glycine 0 CA--C 1.519 0.293 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.414 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 161.4 176.92 34.02 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.171 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.597 ' CE1' ' HA2' ' A' ' 75' ' ' GLY . 38.3 m-85 -69.49 -30.78 68.72 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -177.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.4 m -58.68 -54.76 43.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.671 0.272 . . . . 0.0 111.414 -174.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -73.59 -28.91 62.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.801 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.467 HD21 ' HB ' ' A' ' 74' ' ' VAL . 14.2 tp -58.31 -55.32 36.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.433 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.498 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 79.7 mt -67.12 -36.79 82.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.89 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.514 ' HA ' ' OE1' ' A' ' 39' ' ' GLU . 1.5 tmtp? -64.8 -33.89 77.06 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.499 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.711 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -67.64 -37.5 82.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.298 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.685 HD13 ' HG3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -63.52 -48.84 75.9 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.495 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 51.1 mt-10 -51.34 -33.27 28.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.574 173.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.549 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 21.1 m -74.37 -34.82 63.46 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.424 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.711 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 47.0 mmm -63.39 -57.86 8.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.131 -170.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.567 ' HE1' HD11 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -107.73 11.67 28.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.257 0.551 . . . . 0.0 111.101 -174.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp 61.7 50.53 4.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.72 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.615 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 2.4 pp -152.83 176.1 12.17 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.384 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.9 m -102.46 105.32 15.86 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -174.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.567 HD11 ' HE1' ' A' ' 42' ' ' PHE . 2.3 mt -89.2 120.89 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.601 169.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.46 165.86 54.55 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.558 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -66.02 172.37 3.78 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.725 0.774 . . . . 0.0 112.557 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.407 ' CD1' ' HB3' ' A' ' 73' ' ' LEU . 70.0 t80 -74.72 86.18 2.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.489 177.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 74.5 m -55.56 129.09 37.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.424 173.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -64.93 -31.19 72.3 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.042 -171.228 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -50.47 28.43 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -174.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 105' ' ' GLY . 20.1 tt0 -119.68 -28.66 5.22 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.223 0.535 . . . . 0.0 111.068 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.545 ' O ' HD22 ' A' ' 73' ' ' LEU . . . 45.23 12.06 0.03 OUTLIER Glycine 0 C--O 1.218 -0.896 0 N-CA-C 117.102 1.601 . . . . 0.0 117.102 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.434 ' HA ' HD13 ' A' ' 73' ' ' LEU . 17.3 m-30 -124.74 15.04 8.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 119.617 1.709 . . . . 0.0 111.144 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.494 ' HG2' ' H ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -74.44 -38.51 62.99 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.805 -177.042 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.09 7.74 5.36 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 115.797 -0.638 . . . . 0.0 114.436 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.494 ' H ' ' HG2' ' A' ' 56' ' ' LYS . 32.4 m 63.83 -83.87 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 122.733 0.413 . . . . 0.0 110.08 -171.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 39.3 tt0 -118.58 -14.52 9.62 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.681 0.277 . . . . 0.0 110.824 172.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -139.96 125.35 19.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.828 0.347 . . . . 0.0 111.036 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -100.53 103.7 25.69 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.798 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.685 ' HG3' HD13 ' A' ' 38' ' ' LEU . 57.2 Cg_endo -74.18 121.9 7.2 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.92 1.747 . . . . 0.0 111.638 174.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.43 HG21 HD13 ' A' ' 100' ' ' LEU . 63.2 p -124.91 157.27 36.4 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.038 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.689 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 3.4 p90 -129.23 164.5 23.33 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.48 ' CG ' ' HA2' ' A' ' 69' ' ' GLY . 43.9 tt0 -101.14 120.15 39.79 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.81 -168.72 2.31 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.355 0.41 . . . . 0.0 111.022 -176.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -57.67 -44.09 85.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.458 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -82.86 -14.65 53.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.285 0.564 . . . . 0.0 110.403 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.48 ' HA2' ' CG ' ' A' ' 65' ' ' GLU . . . 96.27 29.3 8.5 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.89 176.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -96.41 160.5 14.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.931 0.365 . . . . 0.0 110.11 172.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.689 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 39.6 m95 -122.46 114.1 20.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.902 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -131.44 174.33 10.18 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 171.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.545 HD22 ' O ' ' A' ' 54' ' ' GLY . 1.0 OUTLIER -62.59 157.33 20.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.75 0.786 . . . . 0.0 111.091 -178.515 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.467 ' HB ' HD21 ' A' ' 34' ' ' LEU . 31.4 m -76.26 134.54 28.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.101 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.597 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 109.96 0.67 30.22 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -171.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -56.57 -56.1 25.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.415 -0.392 . . . . 0.0 111.158 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 m -112.74 152.32 44.67 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.33 136.83 19.3 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.424 2.749 . . . . 0.0 113.203 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.552 ' O ' HG23 ' A' ' 83' ' ' VAL . 73.2 t-105 -43.21 -48.08 6.48 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 123.954 0.784 . . . . 0.0 113.107 -171.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -53.53 -43.08 68.06 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.2 0.312 . . . . 0.0 111.635 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 58.8 mtm -84.26 -25.33 29.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.963 0.411 . . . . 0.0 110.502 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -64.29 -44.84 90.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.423 -174.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 79' ' ' TRP . 2.5 t -61.68 -41.43 90.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.092 0.472 . . . . 0.0 111.023 -173.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.5 p -79.47 -15.46 57.74 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.569 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 65.8 m -91.19 -31.66 16.09 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.557 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 41.5 t -73.68 135.59 43.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.484 0.659 . . . . 0.0 111.048 -177.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -118.24 -44.17 2.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.324 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -140.15 163.38 32.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.712 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.7 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 2.0 tp -128.14 135.5 49.85 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.921 0.391 . . . . 0.0 110.702 -172.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -139.11 123.04 17.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.801 0.334 . . . . 0.0 110.868 175.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 14' ' ' MET . 6.1 mt -120.41 137.95 52.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 15.3 ptt? -156.65 158.64 37.37 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.213 0.53 . . . . 0.0 112.368 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 7.2 tttp -53.07 149.2 6.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.189 -1.368 . . . . 0.0 112.178 -175.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.67 -28.09 70.94 Favored Glycine 0 CA--C 1.505 -0.576 0 CA-C-N 114.842 -1.072 . . . . 0.0 113.348 -171.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.1 p -68.04 -20.04 64.95 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.963 0.411 . . . . 0.0 111.003 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -97.98 -9.18 26.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.937 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.684 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -60.57 -22.94 64.22 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.904 -176.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.22 -21.86 65.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.934 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.84 -4.43 63.47 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.626 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.684 ' HG ' ' O ' ' A' ' 97' ' ' ALA . 4.5 pp -101.3 -23.12 14.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.386 0.593 . . . . 0.0 110.584 178.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -106.36 -58.44 0.61 Allowed Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 48.5 t 57.78 91.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.763 -0.719 . . . . 0.0 111.831 176.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.55 -66.27 3.45 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.006 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.2 p -70.94 110.4 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-O 121.735 0.779 . . . . 0.0 109.515 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' A' ' 53' ' ' GLU . . . 82.84 -78.8 1.97 Allowed Glycine 0 C--N 1.311 -0.823 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.863 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.6 t -76.5 132.41 39.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.021 0.438 . . . . 0.0 110.403 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.434 ' CD2' ' N ' ' A' ' 107' ' ' HIS . 1.2 p80 . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.486 -0.769 . . . . 0.0 110.108 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 121.037 0.446 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 0.3 OUTLIER -84.21 77.97 9.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.276 0.56 . . . . 0.0 109.499 177.614 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.49 -174.77 0.17 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.601 -171.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.4 ' H ' ' HA ' ' A' ' 27' ' ' VAL . 38.7 t70 59.69 41.58 18.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 122.287 1.041 . . . . 0.0 109.38 -176.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -90.28 91.22 3.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.929 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 121.42 -167.24 14.25 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.091 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.505 ' HA2' ' NH1' ' A' ' 26' ' ' ARG . . . -141.06 37.21 1.67 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.3 mp -87.54 114.45 26.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.036 0.446 . . . . 0.0 110.44 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -98.72 132.46 44.08 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.098 174.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.617 HG21 HD22 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -118.19 138.76 47.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.496 0.665 . . . . 0.0 110.707 -178.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -104.54 133.94 48.57 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.715 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -125.7 124.85 67.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.746 0.784 . . . . 0.0 111.044 -173.053 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 p -112.13 155.3 24.13 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.119 -174.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.685 ' SD ' ' HA ' ' A' ' 92' ' ' MET . 31.8 tpp -110.78 135.31 51.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.659 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.48 137.98 40.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.435 177.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.75 -33.17 5.15 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.035 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.91 141.63 39.15 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 120.619 0.247 . . . . 0.0 111.085 173.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.92 126.71 8.14 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.707 2.272 . . . . 0.0 112.661 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -151.99 166.68 30.79 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.483 ' C ' ' HD2' ' A' ' 21' ' ' ARG . 78.2 mt -125.14 103.86 8.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.05 0.452 . . . . 0.0 110.255 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.483 ' HD2' ' C ' ' A' ' 20' ' ' LEU . 3.6 mpt_? -127.2 134.15 50.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.735 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.478 ' HD2' ' C ' ' A' ' 21' ' ' ARG . 2.4 mptp? -144.1 141.42 30.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 172.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -144.11 174.48 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.135 0.493 . . . . 0.0 112.044 -175.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.497 ' HB3' ' HE ' ' A' ' 26' ' ' ARG . 1.1 m-20 -109.71 126.76 54.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.65 -175.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.617 HD22 HG21 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -69.4 -36.62 76.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.925 0.869 . . . . 0.0 110.117 -175.196 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.505 ' NH1' ' HA2' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -79.54 -19.22 50.04 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.932 -1.031 . . . . 0.0 113.294 -168.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 24' ' ' ASP . 34.0 m -80.63 -3.96 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -170.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.494 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 25.8 m-85 -85.06 -30.12 24.35 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.22 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.7 14.15 6.93 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.788 -0.642 . . . . 0.0 114.354 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.29 165.78 24.24 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.735 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.572 ' CE1' ' HA2' ' A' ' 75' ' ' GLY . 15.2 m-85 -60.91 -36.12 78.46 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.7 p -62.54 -54.36 40.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.682 0.277 . . . . 0.0 110.961 -175.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -67.67 -27.33 66.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.076 -178.706 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 74' ' ' VAL . 8.6 tp -62.47 -56.75 15.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.285 174.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.453 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 81.5 mt -67.63 -39.87 84.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.63 -176.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -71.2 -32.54 68.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.271 -175.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.708 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -59.9 -39.79 86.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.778 0.323 . . . . 0.0 110.7 177.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.5 HD13 ' HG3' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -68.87 -50.48 49.41 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.307 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 35.3 mt-10 -52.27 -28.86 20.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.58 173.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.571 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 17.5 m -74.06 -41.02 62.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.258 175.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.708 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 71.9 mmm -54.85 -55.98 24.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.023 -172.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.519 ' HZ ' HG21 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -102.0 9.69 40.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 -177.173 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.17 44.21 19.37 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.95 174.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 pp -144.51 -171.8 3.67 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 m -113.72 121.14 43.18 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.876 0.369 . . . . 0.0 111.31 -175.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.435 ' CD1' ' HB2' ' A' ' 60' ' ' TYR . 40.8 mm -84.57 -22.77 7.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 122.335 1.064 . . . . 0.0 109.738 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.03 -164.58 31.2 Favored Glycine 0 C--N 1.31 -0.889 0 CA-C-N 114.071 -1.422 . . . . 0.0 112.574 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -92.02 162.4 14.39 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.464 ' CD1' HD22 ' A' ' 73' ' ' LEU . 60.4 t80 -80.43 75.72 7.27 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 171.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 m -49.05 128.97 17.14 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.804 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -68.06 -17.82 64.5 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.049 -173.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.519 ' HD2' ' N ' ' A' ' 53' ' ' GLU . 3.0 ppt_? -74.58 -51.95 13.14 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.519 ' N ' ' HD2' ' A' ' 52' ' ' ARG . 50.9 mt-10 -122.57 -29.95 3.98 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 119.934 -0.707 . . . . 0.0 112.728 176.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.693 ' O ' HD13 ' A' ' 73' ' ' LEU . . . 48.97 12.9 0.26 Allowed Glycine 0 C--O 1.218 -0.855 0 N-CA-C 115.288 0.875 . . . . 0.0 115.288 -175.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.572 ' CE2' ' HB3' ' A' ' 106' ' ' SER . 11.6 m-85 -124.8 10.04 8.29 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.535 1.167 . . . . 0.0 110.608 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.475 ' NZ ' ' HB2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -61.38 -51.37 69.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.428 -179.024 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.16 3.04 4.53 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 115.079 0.792 . . . . 0.0 115.079 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.2 t 67.86 -86.99 0.03 OUTLIER 'General case' 0 C--O 1.234 0.238 0 CA-C-N 117.357 0.579 . . . . 0.0 110.037 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -117.65 -6.84 11.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.741 0.305 . . . . 0.0 110.501 175.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.435 ' HB2' ' CD1' ' A' ' 46' ' ' ILE . 70.3 m-85 -143.17 124.49 14.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.611 0.243 . . . . 0.0 111.354 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.411 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . . . -104.2 105.06 47.46 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.653 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 42.8 Cg_endo -68.98 120.93 7.78 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.992 1.795 . . . . 0.0 111.009 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 72' ' ' MET . 77.0 p -129.92 165.67 21.61 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.478 -175.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.759 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.4 p90 -136.51 164.66 27.66 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -178.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.479 ' CG ' ' HA2' ' A' ' 69' ' ' GLY . 33.3 tt0 -104.53 121.63 43.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.711 0.291 . . . . 0.0 110.361 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 25.5 t70 -84.51 -170.87 3.32 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.519 175.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.463 ' H ' ' CG ' ' A' ' 66' ' ' ASP . 13.3 mmtm -65.46 -34.41 78.22 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.643 0.735 . . . . 0.0 109.349 -175.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -72.26 -18.52 61.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.083 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.479 ' HA2' ' CG ' ' A' ' 65' ' ' GLU . . . 92.58 11.98 58.75 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.639 -175.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -86.95 144.11 27.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.646 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 64.0 m95 -112.11 115.67 29.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.048 0.451 . . . . 0.0 110.983 -176.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.416 ' O ' ' HA ' ' A' ' 63' ' ' THR . 49.8 mtm -121.54 161.09 22.96 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.693 HD13 ' O ' ' A' ' 54' ' ' GLY . 9.5 tt -71.05 141.42 50.89 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 17.2 m -66.87 129.57 31.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.655 0.741 . . . . 0.0 112.166 -174.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.572 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 111.3 6.93 25.21 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.513 -174.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -71.57 -56.91 4.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.513 0.197 . . . . 0.0 111.302 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.583 HG22 ' CD2' ' A' ' 82' ' ' PHE . 12.6 m -98.34 155.11 37.25 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.484 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 5.1 Cg_endo -46.94 131.89 17.14 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.668 2.912 . . . . 0.0 113.667 -176.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.491 ' O ' HG23 ' A' ' 83' ' ' VAL . 72.9 t-105 -43.16 -54.28 4.55 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.68 -172.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -51.41 -42.04 61.17 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.587 0.554 . . . . 0.0 111.542 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 57.4 ttp -83.37 -31.86 26.51 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.807 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.583 ' CD2' HG22 ' A' ' 77' ' ' VAL . 6.3 t80 -58.23 -46.66 85.5 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.68 -174.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 79' ' ' TRP . 2.8 t -60.54 -48.18 89.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.342 -170.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.8 p -78.87 -14.37 59.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.55 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.6 t -85.97 -25.18 26.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.12 -175.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.759 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 40.4 t -79.22 131.15 36.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.751 0.31 . . . . 0.0 110.922 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 13.5 ptmm? -116.03 -23.94 8.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.694 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.426 ' HD3' ' OE1' ' A' ' 65' ' ' GLU . 62.1 mtp180 -140.81 154.67 46.33 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 176.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.715 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 9.6 tp -127.51 133.37 49.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.114 -176.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.451 ' HD2' ' SD ' ' A' ' 92' ' ' MET . 2.6 ttm180 -139.47 117.78 12.01 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.289 -0.565 . . . . 0.0 111.096 174.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.519 HG21 ' HZ ' ' A' ' 42' ' ' PHE . 4.1 mt -116.1 133.55 62.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 170.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.685 ' HA ' ' SD ' ' A' ' 14' ' ' MET . 14.6 ptt? -158.13 161.13 37.9 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.212 0.53 . . . . 0.0 112.122 -170.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -53.94 141.81 26.58 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.727 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.4 -27.29 57.96 Favored Glycine 0 CA--C 1.505 -0.582 0 CA-C-N 114.437 -1.256 . . . . 0.0 113.092 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 59.1 p -60.21 -25.96 66.01 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.469 0.652 . . . . 0.0 110.779 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -101.11 -49.41 4.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.8 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.437 ' HA ' ' HE3' ' A' ' 92' ' ' MET . . . -63.87 -21.15 66.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.635 -175.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.489 ' HA ' ' HB3' ' A' ' 102' ' ' CYS . 14.7 ptmm? -53.63 -32.41 51.25 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.55 -38.43 90.49 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.727 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.82 5.53 28.61 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -175.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.35 -77.25 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 119.572 -1.299 . . . . 0.0 114.135 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.489 ' HB3' ' HA ' ' A' ' 98' ' ' LYS . 44.3 t -57.71 97.46 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.798 0.808 . . . . 0.0 111.669 -172.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 106.17 60.57 0.61 Allowed Glycine 0 N--CA 1.435 -1.409 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.492 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.9 m 32.7 61.27 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.186 0.995 . . . . 0.0 112.528 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -111.21 -6.23 25.98 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.205 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.572 ' HB3' ' CE2' ' A' ' 55' ' ' TYR . 16.7 t -94.76 -168.42 1.82 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 . . . . . 0 C--O 1.246 0.89 0 CA-C-O 118.419 -0.8 . . . . 0.0 110.235 -177.771 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.988 0.423 . . . . 0.0 110.65 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -98.52 97.89 9.14 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.644 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 61.61 77.62 0.32 Allowed 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.889 0.743 . . . . 0.0 110.217 -175.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.56 121.66 11.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.774 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 p -76.87 105.37 5.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.941 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.427 ' HA2' ' CG ' ' A' ' 24' ' ' ASP . . . 91.48 155.39 31.68 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.367 -174.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 169.25 -27.8 0.13 Allowed Glycine 0 N--CA 1.442 -0.923 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.424 HG22 HD12 ' A' ' 25' ' ' LEU . 4.1 mp -117.37 105.51 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 174.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -97.76 142.51 29.44 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.068 -170.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.59 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -118.49 145.21 24.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.085 179.463 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.529 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 48.9 mttm -102.07 128.35 48.56 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -125.2 126.5 70.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.874 0.845 . . . . 0.0 111.377 -176.486 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.6 m -117.28 151.05 37.76 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.81 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.568 ' SD ' ' HB ' ' A' ' 91' ' ' ILE . 69.2 mmm -101.31 160.48 14.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.757 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -134.41 146.5 49.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.352 -0.386 . . . . 0.0 109.988 175.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.78 -34.62 3.84 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -174.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.62 138.38 28.19 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 169.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -76.72 125.5 8.22 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.419 2.079 . . . . 0.0 112.735 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.474 ' HB2' ' CG ' ' A' ' 14' ' ' MET . 93.2 m-85 -152.17 165.5 34.61 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.709 174.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.34 105.88 5.57 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 177.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.54 ' HB2' HG22 ' A' ' 12' ' ' VAL . 10.8 mmm180 -125.86 155.51 41.06 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.691 -176.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.529 ' HD3' ' HA ' ' A' ' 11' ' ' LYS . 5.5 mmtm -148.08 140.55 24.43 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 174.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 pt -145.66 173.49 3.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.09 0.471 . . . . 0.0 111.397 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.49 ' O ' HG22 ' A' ' 27' ' ' VAL . 9.9 t70 -115.83 140.85 48.82 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.399 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.51 HD13 ' SG ' ' A' ' 86' ' ' CYS . 15.6 mt -73.61 -47.71 38.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.166 -173.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.409 ' HE ' ' C ' ' A' ' 6' ' ' GLY . 31.1 ptt180 -82.33 -11.56 58.52 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -169.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 24' ' ' ASP . 35.8 m -63.94 -17.87 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 120.867 0.365 . . . . 0.0 111.283 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -84.02 -28.1 27.9 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.085 0.469 . . . . 0.0 110.893 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.77 15.92 36.28 Favored Glycine 0 CA--C 1.519 0.302 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.384 175.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.05 175.68 31.29 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.777 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -69.5 -30.56 68.46 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -176.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.8 p -60.08 -54.93 40.17 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.553 -174.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -71.5 -28.43 63.9 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.508 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.416 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 20.8 tp -58.13 -55.66 32.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.185 0.516 . . . . 0.0 109.844 174.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.478 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 63.0 mt -67.58 -37.05 82.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.333 -177.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -70.72 -32.19 69.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.241 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.709 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -62.24 -42.46 99.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.761 176.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.495 HD13 ' HG3' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -61.89 -50.37 72.48 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.707 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.752 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 45.5 mt-10 -51.76 -30.66 23.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.828 173.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.555 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 26.5 m -76.2 -43.03 44.24 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.65 178.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.709 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 63.9 mmm -54.79 -57.87 9.83 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -168.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.671 ' CZ ' HG21 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -107.14 10.31 30.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.223 -177.168 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.8 mptt 62.51 42.55 8.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.101 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.752 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 1.2 pp -149.45 168.82 22.39 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 175.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.0 m -93.81 104.18 16.27 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -165.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.434 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 3.9 mm -97.64 148.97 5.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 170.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.52 -168.88 38.35 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.302 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 45.37 83.02 0.03 OUTLIER 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.1 0.96 . . . . 0.0 113.526 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.441 ' CE2' ' HB2' ' A' ' 73' ' ' LEU . 30.2 t80 -66.4 86.4 0.11 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 167.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 t -65.61 151.18 47.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.388 0.613 . . . . 0.0 110.837 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -73.3 -16.13 61.38 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.021 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.592 ' HD3' ' HG3' ' A' ' 53' ' ' GLU . 1.2 tmt_? -80.42 -54.73 5.43 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.592 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 33.1 mt-10 -121.53 -29.11 4.47 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.338 171.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 43.01 10.99 0.01 OUTLIER Glycine 0 C--O 1.218 -0.9 0 CA-C-N 114.213 -1.358 . . . . 0.0 116.325 -175.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.513 ' CE1' ' HB3' ' A' ' 72' ' ' MET . 19.4 m-85 -128.64 16.69 6.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 119.222 1.511 . . . . 0.0 111.529 178.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.447 ' HE3' ' N ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -70.57 -37.14 73.95 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.979 -172.834 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.447 ' N ' ' HE3' ' A' ' 56' ' ' LYS . . . 58.35 19.32 39.69 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.806 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.3 t 63.77 -82.9 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -169.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.605 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 40.0 tt0 -119.28 -20.16 8.03 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.611 173.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.447 ' CE1' ' HG3' ' A' ' 93' ' ' LYS . 37.3 m-85 -131.89 125.98 33.05 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.993 0.425 . . . . 0.0 111.395 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -105.85 105.28 52.67 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.129 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.495 ' HG3' HD13 ' A' ' 38' ' ' LEU . 28.4 Cg_endo -72.24 120.33 6.71 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 121.443 1.428 . . . . 0.0 111.166 173.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 72' ' ' MET . 61.0 p -124.64 150.85 45.6 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.228 -176.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 5.2 p90 -117.74 161.85 19.03 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.503 ' HB2' ' CZ2' ' A' ' 71' ' ' TRP . 42.0 tt0 -100.37 118.82 37.4 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 173.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.21 -178.31 6.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.965 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 mtmm -51.37 -42.9 61.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.789 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -86.38 -15.93 38.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.949 0.404 . . . . 0.0 111.018 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.02 29.37 8.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.799 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -94.56 148.25 22.45 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 172.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.546 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 65.9 m95 -115.86 114.37 24.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.958 0.409 . . . . 0.0 110.576 -178.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.513 ' HB3' ' CE1' ' A' ' 55' ' ' TYR . 17.4 mtm -135.86 177.89 7.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.483 ' HG ' ' HA ' ' A' ' 55' ' ' TYR . 6.0 mt -62.34 151.4 36.81 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.642 0.734 . . . . 0.0 110.532 177.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.9 m -78.03 135.09 26.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.47 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.4 8.03 50.54 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.4 -173.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.92 -53.26 49.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.687 0.28 . . . . 0.0 111.255 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.525 HG22 ' CD2' ' A' ' 82' ' ' PHE . 12.9 m -103.63 157.51 33.73 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.489 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 6.4 Cg_endo -48.74 127.04 15.72 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.333 2.689 . . . . 0.0 113.226 -178.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.61 ' O ' HG23 ' A' ' 83' ' ' VAL . 70.6 t-105 -40.85 -46.09 2.65 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 113.848 -1.524 . . . . 0.0 113.811 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.2 -42.95 82.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.713 0.292 . . . . 0.0 111.272 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.2 tmm? -83.88 -27.33 28.72 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.525 ' CD2' HG22 ' A' ' 77' ' ' VAL . 9.2 t80 -60.01 -50.98 71.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.649 -174.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 79' ' ' TRP . 3.8 t -59.75 -36.77 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.129 0.49 . . . . 0.0 111.371 -170.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.2 p -79.1 -11.33 59.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.502 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.6 t -101.5 -19.96 15.3 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.795 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.51 ' SG ' HD13 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -86.1 117.48 24.97 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.302 0.572 . . . . 0.0 110.513 179.412 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 9.6 ptmm? -118.06 -25.52 6.67 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.572 -174.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -139.78 158.41 44.14 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.63 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 6.6 tp -134.31 131.02 37.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.237 0.541 . . . . 0.0 110.741 -175.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -138.36 123.98 19.69 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.993 0.425 . . . . 0.0 110.654 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.671 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 10.6 mt -114.08 136.61 50.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -158.45 160.79 37.17 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.722 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 52.6 mttt -52.72 149.41 6.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.703 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -61.81 -25.93 66.37 Favored Glycine 0 CA--C 1.504 -0.612 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.731 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.44 HG22 ' HB3' ' A' ' 93' ' ' LYS . 9.9 t -75.16 -13.36 60.45 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.172 0.51 . . . . 0.0 110.715 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -101.52 -46.74 4.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.99 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.73 -23.87 63.47 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -57.15 -38.11 73.04 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.681 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.82 -37.05 93.68 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.229 -0.51 . . . . 0.0 113.458 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.426 HD23 ' H ' ' A' ' 100' ' ' LEU . 1.1 pt? -104.55 11.94 33.72 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -175.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -71.83 65.79 1.14 Allowed Glycine 0 CA--C 1.509 -0.332 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.122 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 61.5 m -90.91 25.96 2.25 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.037 0.446 . . . . 0.0 111.563 -176.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.499 ' HA3' ' OH ' ' A' ' 55' ' ' TYR . . . -95.39 -73.81 1.2 Allowed Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.054 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.5 m -101.24 19.14 3.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.254 0.549 . . . . 0.0 111.12 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.96 80.33 0.48 Allowed Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.125 -0.943 . . . . 0.0 114.154 174.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.1 t -89.95 104.42 16.99 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.439 -0.447 . . . . 0.0 109.9 173.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 . . . . . 0 C--O 1.245 0.858 0 CA-C-O 118.569 -0.729 . . . . 0.0 110.264 179.604 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 . . . . . 0 N--CA 1.484 1.237 0 CA-C-O 120.882 0.372 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -103.26 99.87 9.74 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.057 0.456 . . . . 0.0 110.523 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -113.43 -2.5 13.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.199 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -93.91 141.95 27.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.904 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.9 t 61.79 86.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 121.501 0.667 . . . . 0.0 109.316 -172.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.405 ' HA2' ' OD1' ' A' ' 24' ' ' ASP . . . 104.96 143.69 12.24 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -172.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.436 ' H ' ' H ' ' A' ' 8' ' ' ILE . . . 178.17 -11.51 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.467 HD13 ' HD3' ' A' ' 26' ' ' ARG . 2.0 mp -112.25 104.17 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -92.71 129.08 38.75 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.05 -174.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.594 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -114.33 142.31 27.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.465 -175.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.694 ' HA ' ' HD2' ' A' ' 22' ' ' LYS . 47.6 mtmt -98.22 127.89 44.4 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.736 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -124.54 126.87 72.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.369 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.4 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 20.5 m -112.93 141.48 46.72 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.852 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.46 ' HG3' ' CD2' ' A' ' 19' ' ' TYR . 73.2 mmm -97.75 122.69 41.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.041 0.448 . . . . 0.0 110.807 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.99 130.99 51.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.389 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.32 -33.45 6.52 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.882 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.19 141.31 33.84 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.48 125.11 7.43 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.356 2.037 . . . . 0.0 113.171 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.46 ' CD2' ' HG3' ' A' ' 14' ' ' MET . 97.8 m-85 -152.65 169.48 22.61 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.495 ' C ' ' HD2' ' A' ' 21' ' ' ARG . 56.0 mt -137.75 102.05 4.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.047 0.451 . . . . 0.0 110.195 169.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.495 ' HD2' ' C ' ' A' ' 20' ' ' LEU . 3.6 mpt_? -129.56 138.67 51.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.285 174.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.694 ' HD2' ' HA ' ' A' ' 11' ' ' LYS . 35.3 mmtm -132.46 142.75 49.38 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 169.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 pt -143.33 174.01 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -172.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.444 ' OD1' HG13 ' A' ' 27' ' ' VAL . 3.8 t70 -115.37 143.97 44.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.754 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.455 HD21 ' SG ' ' A' ' 86' ' ' CYS . 40.7 mt -71.62 -44.0 65.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.287 0.565 . . . . 0.0 111.576 -175.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.556 ' HG2' HG11 ' A' ' 83' ' ' VAL . 40.6 mtm180 -80.16 -22.97 41.42 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -165.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.444 HG13 ' OD1' ' A' ' 24' ' ' ASP . 28.1 m -61.11 -12.97 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -92.47 -28.5 16.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.191 0.52 . . . . 0.0 111.079 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.7 14.77 23.63 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.26 -0.882 . . . . 0.0 113.889 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.35 174.35 34.03 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.379 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -69.36 -33.4 73.02 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.9 m -57.96 -53.75 54.7 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.297 -175.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -74.49 -27.17 60.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.286 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.7 tp -60.13 -55.28 35.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.176 0.512 . . . . 0.0 110.483 175.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.509 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 77.5 mt -66.2 -35.13 79.64 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.549 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -68.45 -33.41 74.14 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.464 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.706 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -64.94 -38.5 91.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.152 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.596 HD13 ' HG3' ' A' ' 62' ' ' PRO . 0.5 OUTLIER -61.82 -49.91 74.41 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.043 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.711 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 41.1 mt-10 -53.25 -29.12 31.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.922 173.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.551 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 33.7 m -76.29 -42.62 44.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.475 176.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.706 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 44.2 mmm -55.0 -57.02 13.38 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.141 -169.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.616 ' HZ ' HG21 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -109.7 7.36 24.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.081 179.586 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 0.0 OUTLIER 61.19 40.84 14.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.963 174.26 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.711 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 2.2 pp -141.34 162.41 35.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.125 176.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.3 m -85.39 103.4 14.26 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -166.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.464 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 12.1 mm -89.22 151.09 3.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 168.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -115.91 -162.03 13.06 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 121.359 -0.448 . . . . 0.0 112.76 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -89.56 171.84 9.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.764 0.792 . . . . 0.0 112.233 -174.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.481 ' CE2' ' HB2' ' A' ' 73' ' ' LEU . 41.4 t80 -72.62 81.3 1.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.292 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 54' ' ' GLY . 14.0 m -57.79 107.82 0.5 Allowed 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.356 175.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -55.74 -26.66 46.63 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -166.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.614 ' HD2' ' N ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -58.2 -49.28 77.62 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -176.284 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.614 ' N ' ' HD2' ' A' ' 52' ' ' ARG . 48.6 mt-10 -119.51 -26.98 5.64 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.702 0.763 . . . . 0.0 110.252 172.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 50' ' ' SER . . . 54.28 10.04 1.76 Allowed Glycine 0 C--O 1.213 -1.164 0 CA-C-N 113.913 -1.494 . . . . 0.0 115.695 177.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.598 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 19.0 m-85 -127.7 14.96 7.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 119.25 1.525 . . . . 0.0 112.355 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.721 ' HD3' ' N ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -74.66 -45.47 44.37 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.457 171.364 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.721 ' N ' ' HD3' ' A' ' 56' ' ' LYS . . . 58.38 -27.79 0.02 OUTLIER Glycine 0 CA--C 1.529 0.916 0 CA-C-N 115.246 -0.888 . . . . 0.0 114.485 -172.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.584 ' H ' ' C ' ' A' ' 56' ' ' LYS . 26.8 t 150.09 -138.75 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -175.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.594 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 31.2 tt0 -83.83 -5.48 59.21 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 166.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.445 ' HB2' ' CD1' ' A' ' 46' ' ' ILE . 32.1 m-85 -133.96 130.51 37.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.233 173.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.734 ' HB1' HD21 ' A' ' 73' ' ' LEU . . . -115.51 105.59 51.83 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.28 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.596 ' HG3' HD13 ' A' ' 38' ' ' LEU . 32.7 Cg_endo -69.7 120.39 7.19 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 121.952 1.768 . . . . 0.0 112.08 174.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 72' ' ' MET . 38.3 p -123.73 159.51 29.28 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.436 -176.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 5.0 p90 -135.24 166.25 23.55 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.05 -177.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.55 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 44.1 tt0 -111.58 124.8 53.04 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.565 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.468 ' OD2' ' HG2' ' A' ' 67' ' ' LYS . 23.2 t70 -88.81 -179.81 6.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.968 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.468 ' HG2' ' OD2' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -63.91 -28.58 69.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.508 0.671 . . . . 0.0 110.229 179.26 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -68.11 -18.57 64.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.412 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.57 11.57 71.17 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -95.3 149.56 21.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.149 -0.525 . . . . 0.0 110.111 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.559 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 36.0 m95 -119.82 132.79 55.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.028 -176.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.426 ' HE2' ' CE1' ' A' ' 64' ' ' TYR . 2.0 mpp? -143.11 -179.73 6.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 171.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.734 HD21 ' HB1' ' A' ' 61' ' ' ALA . 4.8 mt -63.06 154.14 31.77 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.893 0.854 . . . . 0.0 110.996 175.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.554 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 57.9 t -78.69 122.2 33.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.866 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.06 -1.18 28.45 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -171.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.34 -46.58 79.88 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.994 0.426 . . . . 0.0 110.313 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.419 HG22 ' CD2' ' A' ' 82' ' ' PHE . 16.0 m -108.62 154.94 41.35 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 173.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 10.9 Cg_endo -54.59 136.57 70.94 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.88 2.387 . . . . 0.0 113.098 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.516 ' O ' HG23 ' A' ' 83' ' ' VAL . 65.1 t-105 -40.64 -48.39 2.91 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 124.096 0.872 . . . . 0.0 112.978 -173.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -53.52 -42.22 67.18 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.782 -177.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 77.2 mtp -82.67 -23.08 34.37 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.262 0.553 . . . . 0.0 110.374 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.554 ' CZ ' ' HA ' ' A' ' 74' ' ' VAL . 7.4 t80 -70.51 -46.49 63.56 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.02 -171.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.556 HG11 ' HG2' ' A' ' 26' ' ' ARG . 3.4 t -61.32 -38.57 80.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.193 0.52 . . . . 0.0 111.478 -171.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.9 p -78.76 -12.52 60.03 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.029 -175.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.2 p -106.52 -31.43 8.52 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 34.0 t -71.92 116.27 12.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.268 0.556 . . . . 0.0 110.978 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -119.38 -19.43 8.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.063 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.55 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 55.9 mtt180 -139.34 156.63 46.89 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 174.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.736 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 5.7 tp -136.12 134.44 38.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.992 0.425 . . . . 0.0 111.247 -173.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 13' ' ' SER . 24.0 ttp180 -140.51 123.58 16.6 Favored 'General case' 0 C--N 1.318 -0.778 0 O-C-N 122.011 -0.431 . . . . 0.0 111.227 168.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.616 HG21 ' HZ ' ' A' ' 42' ' ' PHE . 4.4 mt -106.43 136.03 42.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 168.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -159.0 163.34 36.52 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.15 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 34.0 mtpt -48.55 140.71 7.76 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 124.25 0.969 . . . . 0.0 112.756 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -58.86 -36.33 86.78 Favored Glycine 0 CA--C 1.505 -0.547 0 CA-C-N 113.689 -1.596 . . . . 0.0 113.713 -168.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.44 ' HA ' ' HD3' ' A' ' 98' ' ' LYS . 38.9 p -60.55 -19.86 58.59 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.072 0.463 . . . . 0.0 111.807 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -97.5 -43.56 7.2 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.723 -174.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.59 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -71.16 -29.42 65.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.483 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 95' ' ' THR . 15.1 ptmm? -69.72 -6.86 34.7 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.597 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.96 -7.18 50.9 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.413 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 97' ' ' ALA . 4.0 pp -103.4 -8.23 20.37 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 122.496 -0.414 . . . . 0.0 110.929 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -28.21 95.24 0.01 OUTLIER Glycine 0 C--N 1.336 0.554 0 O-C-N 124.826 1.329 . . . . 0.0 115.25 -171.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 5.4 p 42.02 55.05 3.93 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.7 0.8 . . . . 0.0 112.344 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.62 49.37 2.17 Favored Glycine 0 N--CA 1.436 -1.31 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.079 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.7 t 51.89 55.53 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.671 -0.764 . . . . 0.0 111.272 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -162.71 68.87 0.22 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.482 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.2 t -83.43 58.63 4.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.994 0.426 . . . . 0.0 110.586 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 . . . . . 0 C--O 1.245 0.863 0 CA-C-O 118.463 -0.779 . . . . 0.0 110.293 179.007 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 36.5 tt0 -97.23 69.43 2.29 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 2' ' ' GLU . . . 77.92 142.99 0.08 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.034 -165.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -68.53 130.39 42.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -172.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 6' ' ' GLY . 21.9 t 67.61 167.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.695 177.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.531 ' HA3' ' HE ' ' A' ' 26' ' ' ARG . . . -170.92 175.76 44.53 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.406 177.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -139.24 26.9 2.67 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.453 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.6 mt -70.12 111.88 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.757 0.313 . . . . 0.0 110.243 175.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -89.59 139.24 30.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.69 -176.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.599 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -118.55 148.31 21.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 176.332 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.573 ' HA ' ' HD2' ' A' ' 22' ' ' LYS . 56.3 mtmt -107.29 130.25 54.79 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.715 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -126.4 129.41 71.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.971 -176.359 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.4 m -109.51 146.64 34.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.639 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.555 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 23.1 tpp -97.53 125.2 42.09 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.854 175.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.5 140.65 37.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.913 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.1 -33.66 4.79 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.683 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.555 ' O ' ' HG3' ' A' ' 14' ' ' MET . . . -134.75 140.2 34.61 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 120.661 0.267 . . . . 0.0 110.556 171.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.49 125.08 7.41 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.428 2.085 . . . . 0.0 112.759 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -153.19 168.17 26.85 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 123.048 0.539 . . . . 0.0 109.944 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.42 98.69 4.15 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.67 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 1.6 ptp180 -134.33 123.0 23.45 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.391 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.67 ' HD3' ' O ' ' A' ' 21' ' ' ARG . 60.7 mmtt -120.43 157.19 29.86 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 117.973 0.351 . . . . 0.0 110.602 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -144.99 172.57 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 120.868 0.366 . . . . 0.0 111.849 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.601 ' O ' HG22 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -112.96 130.66 56.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.225 0.536 . . . . 0.0 110.225 -173.029 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.54 HD21 ' HB2' ' A' ' 86' ' ' CYS . 16.5 tp -70.11 -45.5 66.79 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -169.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.531 ' HE ' ' HA3' ' A' ' 6' ' ' GLY . 17.4 mtp180 -79.41 -10.86 59.89 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -173.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.601 HG22 ' O ' ' A' ' 24' ' ' ASP . 20.8 m -84.27 -0.55 5.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.521 -0.471 . . . . 0.0 112.246 -173.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.63 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 23.3 m-85 -84.12 -31.09 25.43 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.583 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 44.75 48.21 9.11 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.745 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.89 172.99 13.81 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.135 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -70.07 -29.85 66.95 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -176.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.5 m -59.36 -53.73 54.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.749 0.309 . . . . 0.0 111.37 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.63 ' HB2' ' O ' ' A' ' 28' ' ' TYR . 49.2 mm-40 -73.67 -29.74 62.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.521 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.4 tp -55.22 -56.64 17.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.103 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.401 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 53.6 mt -68.94 -38.74 79.66 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.592 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -67.8 -33.09 74.14 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.276 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.674 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -61.4 -41.47 97.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.54 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.506 ' H ' ' HG ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -65.58 -46.51 79.15 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.132 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 43.6 mt-10 -51.29 -32.71 25.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.441 174.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.539 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 50.2 m -73.79 -41.83 61.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.154 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.674 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 55.9 mmm -56.71 -56.66 18.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.635 -169.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.644 ' HZ ' HG21 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -103.0 9.12 38.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.083 -176.626 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.9 mttt 62.04 40.93 11.61 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.618 174.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 3.0 pp -145.01 174.14 11.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.157 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.1 m -102.99 100.78 10.74 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -171.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.495 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 31.5 mm -69.82 139.48 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 168.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.36 -162.3 34.11 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.293 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.58 167.3 12.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.025 0.44 . . . . 0.0 110.839 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.765 ' CE1' HD12 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -63.89 93.03 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.362 172.834 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.416 ' HB2' ' HA2' ' A' ' 54' ' ' GLY . 1.5 m -61.85 134.06 56.23 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.7 -23.96 60.94 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -168.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.667 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -82.15 -51.5 7.91 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.104 -0.638 . . . . 0.0 112.412 -174.019 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.667 ' N ' ' HD3' ' A' ' 52' ' ' ARG . 60.8 mt-10 -121.3 -31.22 4.13 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 118.956 0.798 . . . . 0.0 110.712 168.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.716 ' O ' HD11 ' A' ' 73' ' ' LEU . . . 38.08 7.78 0.0 OUTLIER Glycine 0 C--O 1.221 -0.701 0 CA-C-N 113.535 -1.666 . . . . 0.0 116.269 -168.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.5 ' CE1' ' HG ' ' A' ' 73' ' ' LEU . 3.8 m-30 -96.24 3.6 52.99 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 118.507 1.154 . . . . 0.0 110.753 -171.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.616 ' C ' ' H ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -69.51 -36.17 76.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.923 168.693 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.499 ' H ' ' HD3' ' A' ' 56' ' ' LYS . . . 59.52 -24.11 0.03 OUTLIER Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.321 -0.854 . . . . 0.0 114.399 -174.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.616 ' H ' ' C ' ' A' ' 56' ' ' LYS . 44.4 t 146.91 -89.75 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 -176.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -118.44 -3.15 10.96 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 161.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.476 ' O ' ' HA3' ' A' ' 57' ' ' GLY . 46.9 m-85 -137.47 130.05 29.86 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.748 -175.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 55' ' ' TYR . . . -101.67 104.46 34.89 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.129 176.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.566 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 60.3 Cg_endo -73.06 121.5 7.32 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.093 1.862 . . . . 0.0 111.496 172.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.6 p -132.52 164.17 27.21 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.03 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 5.0 p90 -141.61 165.68 26.82 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.532 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 30.7 tt0 -104.98 122.81 46.62 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.734 175.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.08 179.51 7.25 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.378 0.424 . . . . 0.0 110.781 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.0 mtmm -48.61 -46.95 40.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.044 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -86.6 -10.91 52.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.978 0.418 . . . . 0.0 111.382 -174.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.11 29.5 8.45 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.644 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -93.1 148.84 21.67 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 171.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.494 ' CZ2' ' HB2' ' A' ' 65' ' ' GLU . 66.2 m95 -119.16 113.85 21.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.806 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -130.23 -179.65 5.37 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 171.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.765 HD12 ' CE1' ' A' ' 49' ' ' TYR . 76.7 mt -65.62 156.27 33.3 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.344 0.592 . . . . 0.0 111.089 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 62' ' ' PRO . 30.2 m -75.87 128.98 37.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.494 176.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.46 8.21 56.36 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.412 -173.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.67 -61.22 2.57 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.596 0.236 . . . . 0.0 111.454 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.446 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 16.1 m -98.87 161.85 23.53 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.402 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.446 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 85.4 Cg_exo -46.25 131.96 14.94 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.189 2.593 . . . . 0.0 113.217 177.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.582 ' O ' HG23 ' A' ' 83' ' ' VAL . 66.9 t-105 -47.59 -42.19 23.38 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.816 -173.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -59.11 -42.45 90.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.946 0.403 . . . . 0.0 111.335 -176.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 73.7 mtm -82.39 -21.89 35.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.202 0.525 . . . . 0.0 109.982 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.449 ' HZ ' ' HA ' ' A' ' 74' ' ' VAL . 6.7 t80 -65.7 -55.34 17.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.348 -175.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 79' ' ' TRP . 3.0 t -61.1 -38.14 78.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.153 -171.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.7 p -76.21 -10.2 59.22 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.733 -175.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.5 m -102.7 -19.15 14.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.313 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.54 ' HB2' HD21 ' A' ' 25' ' ' LEU . 74.0 m -76.18 112.8 13.02 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.249 0.547 . . . . 0.0 111.823 -175.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -118.08 -26.59 6.34 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.022 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.532 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 71.9 mtt180 -139.73 154.86 47.55 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.715 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 8.5 tp -131.67 138.35 48.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.489 -175.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.462 ' HD3' ' SD ' ' A' ' 92' ' ' MET . 10.8 ttm180 -141.11 121.45 13.97 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.243 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.644 HG21 ' HZ ' ' A' ' 42' ' ' PHE . 4.0 mt -120.2 134.26 64.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 168.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.462 ' SD ' ' HD3' ' A' ' 90' ' ' ARG . 23.5 ptt? -158.96 164.31 35.71 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 123.319 0.387 . . . . 0.0 111.863 -172.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -47.11 129.46 12.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.991 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -65.51 -31.56 80.58 Favored Glycine 0 CA--C 1.506 -0.469 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.795 -172.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.8 p -66.98 -23.27 65.92 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.165 -0.518 . . . . 0.0 111.633 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -100.03 -18.23 17.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.813 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.582 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -71.18 -22.22 62.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.47 0.652 . . . . 0.0 110.303 176.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -57.33 -26.07 60.35 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.504 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.85 -33.76 85.08 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.86 -176.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 97' ' ' ALA . 3.6 pp -78.92 -21.94 46.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.624 0.712 . . . . 0.0 111.868 -175.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.447 ' N ' HD12 ' A' ' 100' ' ' LEU . . . 29.72 64.69 0.14 Allowed Glycine 0 N--CA 1.468 0.796 0 O-C-N 124.363 1.04 . . . . 0.0 114.372 177.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.469 ' SG ' HD13 ' A' ' 100' ' ' LEU . 70.9 m -95.07 101.56 13.32 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.319 0.581 . . . . 0.0 111.598 -175.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.74 -117.2 10.41 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.672 175.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.0 t -82.07 74.53 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.424 0.63 . . . . 0.0 109.537 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 53' ' ' GLU . . . -137.15 -142.9 4.48 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 177.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 t -75.02 110.26 9.17 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 24.0 m170 . . . . . 0 C--O 1.249 1.073 0 O-C-N 123.899 0.749 . . . . 0.0 110.618 -174.923 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.821 0.343 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -94.97 69.43 3.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.731 0.777 . . . . 0.0 110.045 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -153.39 111.16 3.56 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.936 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -85.65 148.71 25.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.414 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.5 m -104.0 39.68 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.776 -175.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.41 102.18 1.07 Allowed Glycine 0 CA--C 1.504 -0.637 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.112 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.29 -7.83 63.37 Favored Glycine 0 C--N 1.308 -0.991 0 CA-C-N 114.658 -0.771 . . . . 0.0 111.804 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.481 HD13 ' HD2' ' A' ' 26' ' ' ARG . 2.7 mp -82.23 110.05 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.049 0.452 . . . . 0.0 110.151 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -111.14 116.31 30.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.564 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.566 ' CG2' ' HB2' ' A' ' 89' ' ' LEU . 2.9 m -116.37 151.95 18.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 17.0 ptpt -94.86 133.02 39.04 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.131 -176.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.699 ' HB ' ' HB3' ' A' ' 89' ' ' LEU . 1.5 p -148.39 122.45 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 O-C-N 124.037 0.836 . . . . 0.0 110.844 173.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.528 ' HB2' ' N ' ' A' ' 21' ' ' ARG . 7.5 t -160.03 112.41 2.06 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.482 163.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.773 ' HE2' ' O ' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -168.02 141.54 3.3 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 118.282 -1.367 . . . . 0.0 113.888 175.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.431 ' HB2' ' OH ' ' A' ' 60' ' ' TYR . 4.2 p-10 -140.58 76.75 1.57 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.341 0.591 . . . . 0.0 111.619 162.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.522 ' H ' ' CE ' ' A' ' 14' ' ' MET . . . 88.81 -30.71 5.28 Favored Glycine 0 C--O 1.229 -0.174 0 C-N-CA 121.371 -0.442 . . . . 0.0 112.115 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.549 ' O ' ' HG2' ' A' ' 14' ' ' MET . . . -121.21 150.29 53.53 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 177.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.73 129.75 15.99 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.439 2.093 . . . . 0.0 113.736 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' A' ' 13' ' ' SER . 49.5 m-85 -134.67 172.71 12.56 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.9 mt -136.26 104.14 5.54 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.212 0.529 . . . . 0.0 112.425 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.533 ' HA ' ' HE ' ' A' ' 21' ' ' ARG . 0.2 OUTLIER -129.91 173.21 10.9 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 167.319 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 11' ' ' LYS . 0.7 OUTLIER -137.85 148.93 45.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 118.979 0.809 . . . . 0.0 111.418 175.218 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.498 HD11 ' CD2' ' A' ' 89' ' ' LEU . 8.8 pt -129.41 175.09 11.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.861 170.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.504 ' O ' HG22 ' A' ' 27' ' ' VAL . 0.6 OUTLIER -109.53 124.64 51.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -176.421 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.538 HD23 HG13 ' A' ' 83' ' ' VAL . 3.2 tp -72.18 -44.85 62.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.073 -167.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.49 ' HG2' HG11 ' A' ' 83' ' ' VAL . 47.2 mtp180 -79.4 -22.63 44.05 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -172.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 24' ' ' ASP . 20.7 m -65.49 -11.23 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.834 0.349 . . . . 0.0 111.719 -172.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.402 ' CD2' HD12 ' A' ' 34' ' ' LEU . 23.5 m-85 -84.48 -27.26 27.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.006 0.431 . . . . 0.0 110.564 178.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.26 14.73 20.18 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 114.95 -1.023 . . . . 0.0 113.78 173.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.36 169.82 30.47 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 -176.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -70.49 -32.66 70.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -175.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.0 m -59.27 -53.86 53.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.661 0.267 . . . . 0.0 111.226 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -73.42 -30.1 63.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.726 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.461 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 9.8 tp -59.6 -55.53 33.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.38 177.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.615 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 54.1 mt -66.37 -35.99 81.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.137 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -64.39 -33.8 76.7 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.275 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.588 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -72.43 -32.56 66.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.955 0.407 . . . . 0.0 111.036 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.615 ' CD1' ' HA ' ' A' ' 35' ' ' LEU . 2.2 mt -66.9 -51.65 52.77 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.52 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -52.39 -32.43 38.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.884 173.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.574 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 20.5 m -71.37 -34.22 70.25 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.619 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.588 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 73.2 mmm -64.59 -56.71 12.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.783 0.325 . . . . 0.0 111.852 -170.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.41 12.93 25.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.09 0.472 . . . . 0.0 112.119 -177.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.406 ' HD3' ' O ' ' A' ' 40' ' ' THR . 22.8 mmtm 62.17 53.68 2.85 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.278 170.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 pp -150.28 -172.66 4.23 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.325 -0.235 . . . . 0.0 110.774 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.0 m -100.08 128.04 46.22 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -174.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.584 HG13 ' HB2' ' A' ' 38' ' ' LEU . 41.5 mm -105.16 133.39 49.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.007 174.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.537 ' HA3' ' OG ' ' A' ' 58' ' ' SER . . . -92.09 140.18 15.03 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.228 -0.987 . . . . 0.0 111.235 171.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.17 -179.42 1.95 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.46 0.647 . . . . 0.0 111.896 -173.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -73.56 82.05 1.5 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.661 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 54' ' ' GLY . 3.2 m -64.64 115.8 5.58 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.338 173.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.11 -18.6 37.05 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -169.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.611 ' HD3' ' HG3' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -69.42 -49.27 56.76 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -177.264 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.611 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 44.1 mt-10 -120.11 -27.54 5.29 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.678 0.751 . . . . 0.0 111.238 174.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.476 ' O ' HD22 ' A' ' 73' ' ' LEU . . . 46.29 8.27 0.02 OUTLIER Glycine 0 C--O 1.219 -0.813 0 CA-C-N 113.787 -1.551 . . . . 0.0 116.8 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.493 ' HA ' HD13 ' A' ' 73' ' ' LEU . 12.9 m-85 -127.81 9.24 6.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 119.286 1.543 . . . . 0.0 111.223 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.744 ' HE3' ' N ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -74.42 -24.56 59.11 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.996 -171.636 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.744 ' N ' ' HE3' ' A' ' 56' ' ' LYS . . . 59.88 -8.07 0.06 OUTLIER Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.283 -0.871 . . . . 0.0 114.551 -175.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.537 ' OG ' ' HA3' ' A' ' 47' ' ' GLY . 16.1 m 69.13 -72.44 0.1 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -171.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 33.2 tt0 -119.9 -27.87 5.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.096 166.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.45 ' HB2' HD13 ' A' ' 46' ' ' ILE . 11.1 m-85 -134.86 124.98 25.89 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 120.906 0.384 . . . . 0.0 111.001 176.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.443 ' HB1' ' CD1' ' A' ' 73' ' ' LEU . . . -102.46 105.93 46.34 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.202 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.554 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 38.1 Cg_endo -69.69 119.69 6.6 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.936 1.757 . . . . 0.0 111.335 174.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 72' ' ' MET . 43.4 p -126.07 162.12 26.05 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.175 0.512 . . . . 0.0 110.767 -176.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.635 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 3.5 p90 -132.84 165.18 25.19 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.307 -177.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.418 ' HB2' ' CZ2' ' A' ' 71' ' ' TRP . 30.9 tt0 -108.42 115.77 30.72 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.46 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.559 ' OD2' ' HG2' ' A' ' 67' ' ' LYS . 17.7 t70 -80.53 -176.8 5.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.819 176.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.559 ' HG2' ' OD2' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -62.83 -39.37 94.12 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -171.33 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.442 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . 20.6 t70 -83.0 -0.98 51.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.18 0.514 . . . . 0.0 110.602 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.41 24.39 28.84 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.177 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.442 ' OD2' ' HB3' ' A' ' 68' ' ' ASP . 20.1 m-20 -81.52 129.0 34.5 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.635 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 71.7 m95 -110.3 113.79 26.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.019 0.438 . . . . 0.0 110.813 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.431 ' O ' ' HA ' ' A' ' 63' ' ' THR . 25.6 mtm -134.81 176.48 8.61 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.554 ' HA ' ' O ' ' A' ' 62' ' ' PRO . 1.2 tp -68.66 154.89 41.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.498 0.665 . . . . 0.0 111.04 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.604 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 3.7 m -77.83 124.38 36.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.136 175.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.94 3.5 28.17 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -172.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.13 -56.65 15.02 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.037 0.446 . . . . 0.0 109.93 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.533 HG22 ' CD2' ' A' ' 82' ' ' PHE . 6.3 m -100.98 154.68 37.0 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 173.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.431 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 11.0 Cg_endo -54.45 136.86 71.15 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.879 2.386 . . . . 0.0 113.075 -176.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.515 ' O ' HG23 ' A' ' 83' ' ' VAL . 69.9 t-105 -40.09 -53.03 2.48 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -174.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -51.58 -43.02 62.31 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.046 0.45 . . . . 0.0 111.674 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 77.7 mtp -83.91 -24.54 30.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.468 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' A' ' 74' ' ' VAL . 13.4 t80 -68.81 -38.21 79.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.676 -173.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.538 HG13 HD23 ' A' ' 25' ' ' LEU . 3.3 t -61.17 -42.86 94.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.897 0.38 . . . . 0.0 111.407 -172.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.5 p -78.52 -13.94 59.59 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.465 0.65 . . . . 0.0 110.588 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.1 t -81.42 -31.41 33.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.651 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.448 ' HA ' ' HD2' ' A' ' 64' ' ' TYR . 43.5 t -86.52 131.67 34.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.736 0.779 . . . . 0.0 112.202 -175.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -119.37 -36.74 3.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.263 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -139.14 153.15 47.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.931 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.699 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 12.4 tp -130.5 127.39 39.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.234 0.54 . . . . 0.0 111.716 -174.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.433 ' HB3' ' CZ3' ' A' ' 71' ' ' TRP . 37.5 ttp180 -140.33 130.0 24.32 Favored 'General case' 0 C--N 1.31 -1.137 0 O-C-N 121.374 -0.829 . . . . 0.0 110.929 171.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.773 ' O ' ' HE2' ' A' ' 14' ' ' MET . 8.8 mt -109.41 132.15 58.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.636 ' HE3' HD21 ' A' ' 100' ' ' LEU . 3.1 ptt? -139.09 141.23 38.16 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -168.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 0.1 OUTLIER -48.38 141.03 7.05 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.229 174.187 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.13 -28.5 49.5 Favored Glycine 0 CA--C 1.508 -0.405 0 CA-C-N 115.398 -0.819 . . . . 0.0 114.146 -169.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.2 t -66.38 -12.79 58.84 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.134 0.493 . . . . 0.0 111.301 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -101.76 -51.53 3.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.614 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.55 -23.81 66.27 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -172.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -57.03 -28.65 62.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.177 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.33 -37.01 22.37 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.638 -176.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.636 HD21 ' HE3' ' A' ' 92' ' ' MET . 2.2 pt? -105.2 14.44 29.06 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -173.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.78 68.15 0.3 Allowed Glycine 0 CA--C 1.521 0.415 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.597 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 6.9 p -83.51 93.16 7.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.703 0.763 . . . . 0.0 111.091 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -179.52 -66.29 0.07 OUTLIER Glycine 0 N--CA 1.428 -1.854 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.785 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.2 t -113.62 11.33 8.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.63 0.728 . . . . 0.0 110.487 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 58.76 65.39 3.52 Favored Glycine 0 N--CA 1.453 -0.171 0 CA-C-N 114.821 -1.081 . . . . 0.0 112.823 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.457 ' CB ' ' HB2' ' A' ' 55' ' ' TYR . 8.5 t -73.81 127.96 34.24 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -177.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.9 m170 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.55 -0.738 . . . . 0.0 110.237 -178.345 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.028 0 N-CA-C 110.539 -1.025 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.826 HD13 ' CZ ' ' A' ' 26' ' ' ARG . 3.8 mp -94.71 106.23 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-O 121.411 0.625 . . . . 0.0 109.941 173.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -91.55 138.18 31.77 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.473 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.58 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -115.86 140.03 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -174.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.633 ' HA ' ' CD ' ' A' ' 22' ' ' LYS . 8.1 mptt -107.04 128.35 54.29 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.46 -0.791 . . . . 0.0 108.886 -174.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.771 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -124.65 133.3 69.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.474 0.654 . . . . 0.0 112.044 -169.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.5 m -131.9 155.5 47.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.583 -174.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.467 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 31.0 tpp -113.6 148.28 36.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.619 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -116.06 142.26 47.04 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.98 -32.57 3.74 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.467 ' O ' ' HG3' ' A' ' 14' ' ' MET . . . -133.2 142.66 45.22 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 171.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.99 124.76 7.55 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 121.924 1.749 . . . . 0.0 112.685 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.435 ' HB2' ' HB3' ' A' ' 14' ' ' MET . 68.0 m-85 -151.5 142.55 23.12 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.953 174.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.563 ' O ' ' HD2' ' A' ' 21' ' ' ARG . 5.1 mp -130.17 104.67 7.45 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.101 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.563 ' HD2' ' O ' ' A' ' 20' ' ' LEU . 3.2 mpt_? -126.43 164.1 21.86 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.316 176.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.633 ' CD ' ' HA ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -154.95 143.86 20.85 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -153.54 174.01 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 O-C-N 123.34 0.4 . . . . 0.0 111.599 -175.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.443 ' O ' HG22 ' A' ' 27' ' ' VAL . 6.4 t70 -115.17 146.96 40.87 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.184 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.494 ' HG ' ' CG2' ' A' ' 10' ' ' VAL . 70.5 mt -72.13 -40.27 68.22 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -175.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.826 ' CZ ' HD13 ' A' ' 8' ' ' ILE . 9.4 mpt_? -71.08 -30.9 67.14 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -173.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 24' ' ' ASP . 36.0 m -62.78 -2.86 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -170.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -99.21 -27.65 13.7 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.914 0.388 . . . . 0.0 111.731 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.45 12.91 14.57 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.986 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.72 171.03 32.36 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.245 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -70.0 -29.83 67.01 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.8 p -56.71 -53.72 54.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.92 0.391 . . . . 0.0 111.17 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -73.25 -27.09 61.38 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.086 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 20.8 tp -58.26 -54.01 51.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.866 0.365 . . . . 0.0 110.144 175.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 96.0 mt -66.19 -38.52 88.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.841 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.473 ' HD3' ' O ' ' A' ' 36' ' ' LYS . 1.7 tmtp? -66.0 -33.92 76.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.352 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.679 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -63.5 -40.96 98.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.286 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.502 ' H ' ' HG ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -62.56 -49.32 75.74 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.457 ' HG2' ' H ' ' A' ' 46' ' ' ILE . 28.2 mt-10 -52.87 -33.66 50.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.111 175.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.56 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 38.4 m -73.03 -39.63 65.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.245 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.679 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 93.1 mmm -58.2 -55.65 32.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.311 -168.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -104.26 10.38 35.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.013 0.435 . . . . 0.0 111.111 -174.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.58 53.6 4.04 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.649 177.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 pp -154.78 -167.07 2.48 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 61.2 m -117.69 117.04 28.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.959 0.409 . . . . 0.0 111.638 -177.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.457 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 34.8 mm -85.76 135.44 24.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.329 175.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.9 143.56 33.69 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.497 173.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -73.38 172.9 10.38 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.122 0.487 . . . . 0.0 111.46 -174.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.632 ' HD1' HD22 ' A' ' 73' ' ' LEU . 44.5 t80 -76.42 79.14 3.15 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.777 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.5 m -59.29 123.21 15.99 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.05 -11.24 47.06 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -168.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.498 ' HD2' ' HG3' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -78.9 -49.79 12.28 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.025 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.498 ' HG3' ' HD2' ' A' ' 52' ' ' ARG . 90.8 mt-10 -119.32 -29.16 5.23 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.756 -0.59 . . . . 0.0 112.076 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.554 ' O ' HD13 ' A' ' 73' ' ' LEU . . . 41.78 12.1 0.01 OUTLIER Glycine 0 C--O 1.216 -1.022 0 N-CA-C 117.067 1.587 . . . . 0.0 117.067 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.738 ' HA ' HD13 ' A' ' 73' ' ' LEU . 17.5 m-30 -124.26 1.1 8.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 119.493 1.647 . . . . 0.0 110.492 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.422 ' HD3' ' H ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -64.78 -52.94 54.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.787 -175.602 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 60' ' ' TYR . . . 59.1 7.87 5.54 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 116.286 -0.415 . . . . 0.0 113.84 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.5 t 65.9 -82.72 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.199 0.6 . . . . 0.0 110.179 -171.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 40.5 tt0 -117.16 -15.64 10.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.595 0.236 . . . . 0.0 110.821 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.476 ' CZ ' ' HG3' ' A' ' 93' ' ' LYS . 57.7 m-85 -136.63 126.04 25.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.764 0.316 . . . . 0.0 111.432 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.638 ' HB1' HD12 ' A' ' 73' ' ' LEU . . . -103.92 105.79 49.92 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.801 175.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.505 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 28.6 Cg_endo -64.55 120.71 8.07 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.008 1.805 . . . . 0.0 111.243 172.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.619 HG21 HD11 ' A' ' 100' ' ' LEU . 35.9 p -127.22 154.05 45.33 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.214 0.53 . . . . 0.0 110.24 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.598 ' CD2' ' HZ ' ' A' ' 82' ' ' PHE . 44.0 p90 -135.28 167.04 21.75 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.744 -175.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.531 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 33.6 tt0 -108.29 117.35 33.93 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.37 179.38 7.69 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.475 ' HD2' ' N ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -64.18 -25.88 68.27 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.475 ' N ' ' HD2' ' A' ' 67' ' ' LYS . 35.1 t70 -78.15 -18.4 55.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.22 0.533 . . . . 0.0 110.095 177.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.18 15.51 47.73 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.339 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -96.41 142.38 28.59 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.557 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 68.9 m95 -101.13 118.94 37.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.432 0.634 . . . . 0.0 110.828 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.435 ' O ' ' HA ' ' A' ' 63' ' ' THR . 45.1 mtm -125.4 171.75 10.19 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.414 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.738 HD13 ' HA ' ' A' ' 55' ' ' TYR . 7.5 tt -91.63 142.17 27.92 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.481 ' N ' HD23 ' A' ' 73' ' ' LEU . 19.7 m -58.85 143.06 13.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.103 -174.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.37 3.06 25.99 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.881 -173.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -80.23 -59.54 2.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.927 0.394 . . . . 0.0 110.712 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.576 HG12 ' HD2' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -96.55 153.25 38.88 Favored Pre-proline 0 N--CA 1.445 -0.717 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 175.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.576 ' HD2' HG12 ' A' ' 77' ' ' VAL . 7.5 Cg_exo -74.2 155.32 46.92 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.475 2.117 . . . . 0.0 110.791 176.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.722 ' O ' HG23 ' A' ' 83' ' ' VAL . 61.9 t-105 -46.38 -49.64 17.6 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.862 0.726 . . . . 0.0 112.695 -171.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -55.97 -42.18 75.9 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -171.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 78.8 mtp -83.53 -33.74 25.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.239 0.543 . . . . 0.0 110.472 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.598 ' HZ ' ' CD2' ' A' ' 64' ' ' TYR . 7.1 t80 -58.32 -50.93 71.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.95 -175.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 79' ' ' TRP . 2.1 t -60.64 -39.22 80.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.126 0.488 . . . . 0.0 111.307 -171.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.6 p -79.57 -11.7 59.87 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -175.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.5 p -108.8 -28.65 9.08 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -174.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 40.4 t -66.14 136.42 55.91 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.026 0.441 . . . . 0.0 111.051 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -116.86 -40.5 3.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.739 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.531 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 69.9 mtt180 -137.59 161.89 35.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.198 -175.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.771 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 6.5 tp -133.76 122.97 24.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.752 -172.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -139.7 119.67 13.52 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 121.829 -0.545 . . . . 0.0 110.508 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.421 HG23 ' HA ' ' A' ' 62' ' ' PRO . 10.3 mt -116.74 135.14 58.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.429 ' HA ' ' SD ' ' A' ' 14' ' ' MET . 25.5 ptt? -159.25 162.95 36.21 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.336 0.589 . . . . 0.0 112.357 -174.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 36.4 mttt -56.93 146.78 25.61 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.062 -1.426 . . . . 0.0 113.086 -176.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' A' ' 97' ' ' ALA . . . -60.3 -30.09 70.31 Favored Glycine 0 CA--C 1.507 -0.454 0 CA-C-N 114.125 -1.398 . . . . 0.0 113.726 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.498 HG22 ' HB3' ' A' ' 93' ' ' LYS . 1.5 t -56.78 -26.09 56.82 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.161 0.505 . . . . 0.0 111.337 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -102.67 -34.78 8.93 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.167 0.508 . . . . 0.0 110.346 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.407 ' HB3' ' HA2' ' A' ' 94' ' ' GLY . . . -63.08 -23.4 67.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.578 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.44 ' HE3' ' O ' ' A' ' 95' ' ' THR . 16.0 pttp -62.39 -19.53 63.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.962 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -71.77 -40.61 57.94 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.39 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.619 HD11 HG21 ' A' ' 63' ' ' THR . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.352 0 O-C-N 122.599 -0.354 . . . . 0.0 110.87 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.747 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 3.2 mp -114.06 104.5 17.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.184 0.516 . . . . 0.0 109.985 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -115.07 118.56 33.72 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.231 -172.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.597 ' CG2' ' HB2' ' A' ' 89' ' ' LEU . 4.1 m -116.25 162.51 14.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.165 -177.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.555 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 18.8 ptmt -104.07 134.33 47.52 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -126.47 128.08 70.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.607 0.717 . . . . 0.0 111.322 -177.003 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.3 t -122.56 155.2 36.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.763 175.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.739 ' SD ' ' HB ' ' A' ' 91' ' ' ILE . 68.6 mmm -103.18 141.92 35.04 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.847 0.356 . . . . 0.0 111.052 -177.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 92' ' ' MET . 11.0 t70 -110.44 125.02 52.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.024 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.34 -32.75 6.89 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -177.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.05 142.98 42.21 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 172.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.89 122.87 6.5 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 121.554 1.503 . . . . 0.0 112.355 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.482 ' HB2' ' CG ' ' A' ' 14' ' ' MET . 75.4 m-85 -153.43 151.68 30.17 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.044 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -127.81 105.56 8.52 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.008 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.481 ' C ' ' HG2' ' A' ' 22' ' ' LYS . 31.8 mmt180 -127.97 156.1 43.22 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.555 ' HD3' ' HA ' ' A' ' 11' ' ' LYS . 4.9 mmtm -147.81 130.18 15.71 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.415 HD11 ' CD2' ' A' ' 89' ' ' LEU . 4.0 pt -140.95 173.31 9.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.66 0.743 . . . . 0.0 112.168 -174.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.653 ' OD1' ' HG2' ' A' ' 26' ' ' ARG . 7.3 t70 -113.62 126.94 55.83 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.687 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.472 ' HB3' HG13 ' A' ' 83' ' ' VAL . 6.8 mp -70.8 -39.85 72.86 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.697 -174.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.653 ' HG2' ' OD1' ' A' ' 24' ' ' ASP . 8.4 ptm180 -77.66 -23.51 49.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.83 -167.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 24' ' ' ASP . 29.8 m -65.34 -16.12 19.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -176.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -84.74 -27.88 26.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.13 0.49 . . . . 0.0 110.909 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.93 14.3 30.31 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.24 -0.891 . . . . 0.0 113.688 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.07 168.5 32.02 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.412 ' CE1' ' HA2' ' A' ' 75' ' ' GLY . 43.3 m-85 -70.4 -34.24 72.31 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -175.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.1 m -59.05 -51.18 71.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.846 0.355 . . . . 0.0 111.386 -175.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -72.99 -33.71 65.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.797 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.1 tp -55.82 -55.78 28.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.156 0.503 . . . . 0.0 110.796 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.7 mt -66.8 -35.48 80.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.08 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.453 ' HD3' ' C ' ' A' ' 36' ' ' LYS . 13.1 tmtt? -63.27 -43.38 98.09 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.526 -177.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.45 ' O ' ' HB ' ' A' ' 40' ' ' THR . . . -57.71 -42.31 83.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.829 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.444 ' HG ' ' H ' ' A' ' 38' ' ' LEU . 1.3 mt -65.56 -53.3 43.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.841 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.457 ' HG2' ' H ' ' A' ' 46' ' ' ILE . 40.7 mt-10 -52.01 -28.74 18.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.694 175.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 33.6 m -76.48 -45.13 32.4 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.542 175.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.435 ' HG3' ' O ' ' A' ' 37' ' ' ALA . 30.6 mtm -58.91 -55.03 40.45 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -170.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.21 9.15 36.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.249 0.547 . . . . 0.0 111.125 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? 55.24 48.81 18.54 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.792 173.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 pp -141.53 178.86 7.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.7 m -95.73 122.13 38.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.213 0.53 . . . . 0.0 112.237 -173.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.457 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 49.1 mm -102.47 135.05 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.5 174.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.453 ' HA3' ' NZ ' ' A' ' 56' ' ' LYS . . . -89.32 164.96 32.33 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.744 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.4 176.94 8.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.277 0.561 . . . . 0.0 112.009 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -78.18 93.91 4.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.755 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.571 ' N ' ' HA2' ' A' ' 54' ' ' GLY . 2.1 t -49.78 138.98 13.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.05 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -73.87 -13.28 60.89 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.131 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.536 ' HD3' ' HG3' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -104.23 -44.5 4.95 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.064 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.536 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 24.4 mt-10 -118.26 -28.41 5.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.472 0.578 . . . . 0.0 111.555 175.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.571 ' HA2' ' N ' ' A' ' 50' ' ' SER . . . 54.06 11.15 2.1 Favored Glycine 0 C--O 1.219 -0.81 0 CA-C-N 114.699 -1.137 . . . . 0.0 115.216 -178.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.442 ' HB3' HD11 ' A' ' 100' ' ' LEU . 18.5 m-85 -125.54 4.09 7.6 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 118.473 1.136 . . . . 0.0 111.247 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.497 ' HD3' ' H ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -58.74 -37.71 76.8 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -176.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.497 ' H ' ' HD3' ' A' ' 56' ' ' LYS . . . 60.86 -4.94 0.22 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 114.252 0.461 . . . . 0.0 114.252 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.415 ' H ' ' HE2' ' A' ' 56' ' ' LYS . 48.8 m 69.26 -79.33 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.189 0.596 . . . . 0.0 109.892 -172.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 33.2 tt0 -118.57 -19.52 8.73 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.107 172.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -143.43 126.13 16.03 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.066 0.46 . . . . 0.0 110.974 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.434 ' HB1' ' CD1' ' A' ' 73' ' ' LEU . . . -103.01 104.45 40.09 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.06 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.477 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 33.9 Cg_endo -67.99 121.16 8.15 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 121.714 1.609 . . . . 0.0 111.263 172.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.436 HG21 HD22 ' A' ' 100' ' ' LEU . 82.2 p -125.54 160.05 30.52 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.519 -176.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.689 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.7 p90 -121.57 164.1 17.81 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.604 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.492 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 41.3 tt0 -103.42 115.64 30.91 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 14.1 t70 -84.03 -169.25 2.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.007 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.448 ' H ' ' CG ' ' A' ' 66' ' ' ASP . 1.4 mtmp? -66.65 -45.73 78.03 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.647 0.26 . . . . 0.0 111.474 -173.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.53 -3.76 51.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.194 0.521 . . . . 0.0 110.861 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.27 24.27 19.64 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.166 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -76.18 138.81 40.92 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.568 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 90.7 m95 -115.16 113.05 23.44 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 123.405 0.441 . . . . 0.0 109.952 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.433 ' HA ' ' CD1' ' A' ' 100' ' ' LEU . 32.5 mtm -142.36 169.45 17.56 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 176.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 62' ' ' PRO . 2.3 tp -62.88 152.89 35.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.282 0.563 . . . . 0.0 111.204 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.753 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 99.2 t -77.55 127.78 38.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.443 174.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.412 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 111.57 1.68 27.56 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -170.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -63.03 -48.3 79.32 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.571 HG22 ' CD2' ' A' ' 82' ' ' PHE . 3.2 m -113.88 156.8 43.34 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.86 133.11 33.31 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.965 2.443 . . . . 0.0 113.606 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.565 ' O ' HG23 ' A' ' 83' ' ' VAL . 73.2 t-105 -40.03 -53.31 2.4 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.444 1.097 . . . . 0.0 113.552 -173.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -52.51 -42.78 64.61 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -175.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 68.1 mtm -83.75 -27.48 28.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.111 0.482 . . . . 0.0 110.545 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.753 ' CZ ' ' HA ' ' A' ' 74' ' ' VAL . 9.2 t80 -63.16 -45.49 91.59 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.502 -174.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 79' ' ' TRP . 4.7 t -61.14 -42.34 92.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.302 -171.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.7 p -78.58 -19.45 52.74 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.094 0.473 . . . . 0.0 110.985 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.8 t -83.83 -21.73 31.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.302 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.689 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 36.2 t -90.93 133.47 35.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.161 0.505 . . . . 0.0 111.182 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 13.7 pttp -121.91 -29.52 4.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.738 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.492 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 60.2 mtt180 -139.51 167.28 22.46 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 176.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.712 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 10.8 tp -136.86 138.17 40.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.299 0.571 . . . . 0.0 111.527 -173.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -139.22 129.3 25.17 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.832 0.349 . . . . 0.0 110.146 170.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.739 ' HB ' ' SD ' ' A' ' 14' ' ' MET . 13.4 mt -111.65 138.28 40.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 175.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.467 ' HE1' ' HB3' ' A' ' 100' ' ' LEU . 9.1 ptt? -155.9 147.55 22.93 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -170.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 21.0 ttpt -50.83 147.88 4.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 113.591 -1.641 . . . . 0.0 112.828 -175.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.53 -27.98 70.53 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 114.698 -1.137 . . . . 0.0 113.276 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.526 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 44.3 p -68.49 -16.08 63.77 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.91 0.386 . . . . 0.0 111.08 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -101.88 -2.57 29.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.453 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.574 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -59.61 -29.97 68.36 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -172.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.526 ' HE3' ' O ' ' A' ' 95' ' ' THR . 0.0 OUTLIER -59.6 -23.66 63.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.769 0.318 . . . . 0.0 110.874 178.434 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.52 -22.01 78.93 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 116.101 -0.5 . . . . 0.0 113.195 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.574 HD23 ' HA ' ' A' ' 97' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 121.355 0.598 . . . . 0.0 110.756 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.93 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.495 ' CD1' ' HD2' ' A' ' 26' ' ' ARG . 3.9 mp -92.26 106.3 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-O 121.218 0.532 . . . . 0.0 109.983 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -90.04 134.8 34.03 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.95 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.537 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -116.25 139.74 41.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.443 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -104.55 135.07 46.66 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.706 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -124.39 127.41 73.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.691 0.758 . . . . 0.0 111.472 -172.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.8 p -115.57 155.84 26.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.69 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.456 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 27.4 tpp -110.05 145.08 37.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.624 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -111.89 140.35 46.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.597 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.74 -32.44 4.54 Favored Glycine 0 C--O 1.229 -0.157 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 14' ' ' MET . . . -133.94 143.71 48.58 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 172.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.97 122.21 6.17 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 121.391 1.394 . . . . 0.0 112.262 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -153.29 143.16 22.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.766 174.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.5 mt -127.65 106.95 9.5 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.84 0.353 . . . . 0.0 110.368 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.554 ' O ' HG13 ' A' ' 12' ' ' VAL . 10.3 mmm180 -124.07 155.49 38.25 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.446 ' HD2' ' C ' ' A' ' 21' ' ' ARG . 2.5 mptp? -143.76 144.39 31.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.796 0.332 . . . . 0.0 110.551 175.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -146.87 176.06 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.979 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.485 ' O ' HG22 ' A' ' 27' ' ' VAL . 9.0 t70 -111.32 132.68 54.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.273 0.559 . . . . 0.0 110.275 -175.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.551 HD21 ' HB3' ' A' ' 86' ' ' CYS . 16.6 tp -69.27 -34.31 74.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.733 -172.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.495 ' HD2' ' CD1' ' A' ' 8' ' ' ILE . 65.8 mtp180 -79.47 -32.07 42.53 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -171.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 24' ' ' ASP . 33.6 m -68.81 -0.81 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -169.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.513 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 27.0 m-85 -85.64 -28.7 24.58 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.28 177.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.86 14.86 5.8 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.328 -0.851 . . . . 0.0 114.168 177.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.21 175.94 28.71 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.633 -176.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.4 ' OH ' ' HA ' ' A' ' 78' ' ' PRO . 25.1 m-85 -69.18 -31.63 70.39 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -176.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.9 p -59.69 -56.11 25.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.733 0.301 . . . . 0.0 111.44 -175.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' A' ' 28' ' ' TYR . 47.1 mt-10 -73.98 -25.83 60.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.59 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.64 -56.37 23.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.233 0.54 . . . . 0.0 110.115 174.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.4 mt -69.77 -36.63 75.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.81 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.458 ' HA ' ' HD3' ' A' ' 36' ' ' LYS . 68.0 mmtt -71.62 -31.29 66.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.561 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.684 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -58.59 -42.65 88.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.881 176.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.656 HD13 ' HG3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -58.24 -52.93 63.51 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.598 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 39.0 mt-10 -52.3 -30.22 27.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.896 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.559 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 53.8 m -73.95 -44.89 53.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.135 177.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.684 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 74.5 mmm -57.07 -57.13 13.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.707 -169.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -102.17 8.6 40.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.119 0.485 . . . . 0.0 110.922 -175.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.28 47.72 16.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.633 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 3.0 pp -145.51 -179.31 6.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.705 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 m -111.61 98.21 7.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -171.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.457 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 37.5 mm -65.51 127.66 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.988 172.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.5 149.59 43.82 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.891 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -68.21 162.7 24.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.117 0.484 . . . . 0.0 111.803 -174.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.541 ' CZ ' HD12 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -65.95 89.73 0.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.891 179.007 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.427 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 30.8 t -62.89 146.88 51.85 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.707 0.765 . . . . 0.0 109.849 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -76.37 -16.32 59.75 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.603 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.555 ' HD3' ' HG3' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -82.03 -56.3 4.04 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -172.457 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.555 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 39.5 mt-10 -121.34 -29.64 4.43 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.732 0.777 . . . . 0.0 109.687 165.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.532 ' O ' HD11 ' A' ' 73' ' ' LEU . . . 46.73 8.76 0.03 OUTLIER Glycine 0 C--O 1.214 -1.115 0 CA-C-N 113.317 -1.765 . . . . 0.0 116.216 -177.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.485 ' HD1' ' O ' ' A' ' 53' ' ' GLU . 11.1 m-85 -114.78 6.49 15.55 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 118.171 0.986 . . . . 0.0 110.992 -176.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.507 ' HG2' ' H ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -63.85 -39.07 93.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.647 177.324 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 60' ' ' TYR . . . 58.31 22.19 49.97 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.78 176.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.507 ' H ' ' HG2' ' A' ' 56' ' ' LYS . 20.4 t 69.27 -86.19 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -165.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -119.75 -16.61 8.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.694 0.283 . . . . 0.0 110.971 169.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.525 ' O ' ' HA3' ' A' ' 57' ' ' GLY . 30.3 m-85 -122.27 125.79 46.78 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -174.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -100.92 105.33 37.68 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.936 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.656 ' HG3' HD13 ' A' ' 38' ' ' LEU . 61.0 Cg_endo -72.8 119.65 6.2 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.986 1.791 . . . . 0.0 111.231 175.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 72' ' ' MET . 71.2 p -128.78 165.49 20.84 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.766 -175.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.549 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 4.3 p90 -137.8 164.74 28.16 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.683 0.278 . . . . 0.0 110.349 -176.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.482 ' OE1' ' HD3' ' A' ' 88' ' ' ARG . 29.5 tt0 -100.24 113.92 26.96 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.89 177.48 8.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.715 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.0 mtmm -48.72 -44.14 37.96 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.117 0.567 . . . . 0.0 111.888 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -81.86 -15.99 52.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.114 0.483 . . . . 0.0 110.74 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.99 23.86 16.56 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.57 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -95.27 143.64 26.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.549 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 67.3 m95 -110.1 114.96 28.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.065 0.46 . . . . 0.0 111.516 -173.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.425 ' O ' ' HA ' ' A' ' 63' ' ' THR . 2.1 mpp? -127.37 179.3 5.54 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 174.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.541 HD12 ' CZ ' ' A' ' 49' ' ' TYR . 10.8 mt -64.0 153.22 37.93 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.54 0.686 . . . . 0.0 111.531 176.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.406 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 22.9 m -77.14 137.83 21.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.855 175.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.73 8.26 80.18 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.624 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.35 -54.03 43.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.664 0.268 . . . . 0.0 111.212 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.542 HG22 ' CD2' ' A' ' 82' ' ' PHE . 12.4 m -98.82 155.52 36.57 Favored Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 4.2 Cg_endo -46.95 132.82 17.8 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.487 2.791 . . . . 0.0 113.326 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.548 ' O ' HG23 ' A' ' 83' ' ' VAL . 70.0 t-105 -43.41 -51.88 6.28 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -171.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -54.63 -42.66 71.48 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.628 0.251 . . . . 0.0 111.637 -174.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 57.2 ttp -84.03 -22.73 31.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.998 0.428 . . . . 0.0 110.547 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.542 ' CD2' HG22 ' A' ' 77' ' ' VAL . 11.4 t80 -66.29 -45.93 78.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.038 -177.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 79' ' ' TRP . 3.5 t -61.37 -37.28 77.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.115 0.483 . . . . 0.0 110.944 -174.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.5 p -79.46 -12.34 59.88 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.334 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.3 m -95.17 -31.32 13.58 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.551 ' HB3' HD21 ' A' ' 25' ' ' LEU . 44.6 t -80.5 130.31 35.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.762 0.791 . . . . 0.0 111.457 -175.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -118.21 -40.66 2.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.674 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.482 ' HD3' ' OE1' ' A' ' 65' ' ' GLU . 51.6 mtp180 -140.14 163.54 32.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.084 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.706 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 5.6 tp -130.02 137.65 50.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.879 0.371 . . . . 0.0 110.826 -171.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.406 ' HD2' ' SD ' ' A' ' 92' ' ' MET . 12.9 ttm180 -139.31 115.03 10.04 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.826 175.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.1 mt -111.25 133.92 55.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 171.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.495 ' C ' ' HD1' ' A' ' 60' ' ' TYR . 21.9 ptt? -159.19 161.46 36.15 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -169.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -56.96 141.22 46.16 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.696 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.69 -22.07 45.38 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.957 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.2 t -63.63 -20.22 65.5 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.002 0.43 . . . . 0.0 111.01 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -101.25 -39.03 7.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.08 0.467 . . . . 0.0 109.887 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.44 -25.76 67.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.004 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -65.25 -23.28 67.02 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.37 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.91 -38.1 36.9 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.911 -0.661 . . . . 0.0 113.112 -177.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.472 ' H ' HD23 ' A' ' 100' ' ' LEU . 1.3 pt? . . . . . 0 C--N 1.326 -0.416 0 CA-C-O 120.748 0.308 . . . . 0.0 111.65 -174.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.947 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 mp -125.11 107.58 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 114.229 -0.986 . . . . 0.0 109.129 170.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -103.18 141.2 36.28 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.571 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.598 HG21 HD13 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -131.15 152.88 38.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.235 0.54 . . . . 0.0 109.927 -179.029 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -118.72 141.46 48.6 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -125.57 126.88 71.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.61 0.719 . . . . 0.0 111.313 -174.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.6 m -117.41 155.6 29.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.366 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.695 ' SD ' ' HA ' ' A' ' 92' ' ' MET . 25.7 tpp -99.69 151.98 20.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.888 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -119.06 122.46 42.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.079 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.63 -31.94 8.15 Favored Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.43 ' O ' ' HG3' ' A' ' 14' ' ' MET . . . -134.64 149.15 70.04 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 173.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.18 121.75 5.88 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.019 1.146 . . . . 0.0 112.222 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.526 ' HB2' ' CB ' ' A' ' 14' ' ' MET . 56.6 m-85 -153.09 142.89 22.05 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.557 175.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.453 HD22 ' C ' ' A' ' 19' ' ' TYR . 3.1 mm? -129.53 106.71 8.94 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.14 0.495 . . . . 0.0 111.12 -176.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.504 ' C ' ' HD2' ' A' ' 22' ' ' LYS . 37.3 mmt180 -125.52 155.85 39.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.808 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.504 ' HD2' ' C ' ' A' ' 21' ' ' ARG . 2.5 mptp? -146.96 137.2 23.49 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.533 HD11 ' CD2' ' A' ' 89' ' ' LEU . 1.9 pt -140.95 174.11 8.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.576 0.703 . . . . 0.0 111.87 -176.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.536 ' O ' HG22 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -113.16 124.8 53.4 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.036 -0.983 . . . . 0.0 108.956 -177.155 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.598 HD13 HG21 ' A' ' 10' ' ' VAL . 11.8 tp -71.62 -45.58 61.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -165.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -79.98 -16.37 55.33 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -171.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 24' ' ' ASP . 19.1 m -75.68 -0.74 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -169.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.461 ' OH ' ' HB ' ' A' ' 23' ' ' ILE . 30.5 m-85 -96.12 -28.93 14.36 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.926 0.394 . . . . 0.0 111.341 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.16 14.21 17.68 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.859 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.31 167.31 33.61 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.876 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -69.23 -34.14 74.38 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 p -57.21 -55.22 37.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.569 0.223 . . . . 0.0 111.159 -176.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -70.3 -29.95 66.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.105 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.5 tp -59.09 -55.6 33.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.187 0.518 . . . . 0.0 109.959 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.54 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 56.4 mt -67.31 -38.13 84.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.259 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 36' ' ' LYS . 62.9 mmtt -69.66 -31.96 70.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.657 -177.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.471 ' O ' ' HB ' ' A' ' 40' ' ' THR . . . -60.54 -41.82 95.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.076 0.465 . . . . 0.0 110.387 176.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.541 ' HB2' HG13 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -63.37 -54.61 34.17 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.54 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 23.6 mt-10 -52.11 -29.8 23.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.938 176.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 24.6 m -71.71 -41.89 68.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.205 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.533 ' HE3' ' CZ ' ' A' ' 42' ' ' PHE . 71.8 mtm -66.51 -55.03 17.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -171.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.533 ' CZ ' ' HE3' ' A' ' 41' ' ' MET . 0.1 OUTLIER -100.46 10.53 41.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.159 0.504 . . . . 0.0 111.929 -173.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp 55.27 47.92 20.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.622 174.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.41 ' CD2' ' HB2' ' A' ' 42' ' ' PHE . 2.8 pp -143.08 -176.37 4.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.007 -177.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 63.4 m -108.18 99.86 9.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.042 0.449 . . . . 0.0 111.713 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.541 HG13 ' HB2' ' A' ' 38' ' ' LEU . 34.2 mm -76.77 123.18 32.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 172.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.02 155.52 53.58 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.013 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -71.01 171.27 11.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.296 0.57 . . . . 0.0 111.249 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.579 ' HD1' HD22 ' A' ' 73' ' ' LEU . 28.2 t80 -79.3 85.66 5.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.542 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.8 m -56.66 135.64 54.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.383 173.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -72.13 -25.73 61.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.282 0.563 . . . . 0.0 110.399 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.588 ' HD2' ' N ' ' A' ' 53' ' ' GLU . 3.4 ppt_? -68.24 -52.98 27.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.367 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.588 ' N ' ' HD2' ' A' ' 52' ' ' ARG . 47.6 mt-10 -122.84 -29.23 4.01 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.634 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.598 ' O ' HD13 ' A' ' 73' ' ' LEU . . . 42.21 10.87 0.01 OUTLIER Glycine 0 C--O 1.218 -0.872 0 N-CA-C 116.303 1.281 . . . . 0.0 116.303 -174.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.455 ' HD1' ' HB3' ' A' ' 73' ' ' LEU . 9.7 m-85 -126.25 6.57 7.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 118.672 1.236 . . . . 0.0 110.269 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.479 ' HG2' ' H ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -67.12 -31.21 71.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.5 -175.29 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 58' ' ' SER . . . 65.56 -12.74 0.31 Allowed Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.527 -0.761 . . . . 0.0 114.727 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.479 ' H ' ' HG2' ' A' ' 56' ' ' LYS . 40.0 m 71.77 -80.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -172.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -118.88 -23.75 6.84 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.656 170.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.424 ' HE1' ' SD ' ' A' ' 14' ' ' MET . 37.4 m-85 -134.79 124.51 25.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.008 0.432 . . . . 0.0 111.205 175.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.431 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . . . -105.46 105.3 51.92 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.681 177.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.516 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 43.8 Cg_endo -68.51 120.17 7.13 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.499 1.466 . . . . 0.0 110.993 174.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.3 p -124.7 168.45 13.16 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.078 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 3.6 p90 -143.77 165.32 28.0 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -176.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.436 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 40.4 tt0 -108.32 121.14 44.29 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.401 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.479 ' O ' ' HE3' ' A' ' 87' ' ' LYS . 14.9 t70 -84.15 -169.34 2.54 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.567 177.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.484 ' NZ ' ' HA ' ' A' ' 85' ' ' SER . 17.4 mmtm -62.36 -49.08 76.99 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.725 0.774 . . . . 0.0 109.82 -172.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -84.39 13.93 4.94 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.714 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.79 19.58 72.84 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.942 175.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -75.61 130.0 38.08 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.526 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 92.8 m95 -106.26 120.72 42.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.167 0.508 . . . . 0.0 110.69 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 46.5 mtm -138.5 170.27 16.32 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.598 HD13 ' O ' ' A' ' 54' ' ' GLY . 10.0 tt -79.08 141.57 37.25 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 16.2 m -66.81 130.11 31.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.649 0.738 . . . . 0.0 112.219 -174.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.87 4.56 26.08 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.807 -175.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.05 -59.43 5.43 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.612 0.244 . . . . 0.0 110.869 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.8 m -98.57 156.06 36.1 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -52.16 137.14 54.67 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.172 2.581 . . . . 0.0 112.975 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.593 ' O ' HG23 ' A' ' 83' ' ' VAL . 71.9 t-105 -43.78 -41.72 5.12 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.347 -174.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -58.74 -42.63 89.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.093 0.473 . . . . 0.0 111.063 -174.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 49.9 ttp -85.11 -27.66 26.11 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.589 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 74' ' ' VAL . 11.8 t80 -63.63 -40.71 97.57 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.162 -172.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 79' ' ' TRP . 2.8 t -60.86 -39.7 82.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.415 0.626 . . . . 0.0 110.942 -173.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.7 p -79.09 -10.85 59.94 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.314 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.484 ' HA ' ' NZ ' ' A' ' 67' ' ' LYS . 68.0 m -89.3 -31.39 17.86 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 30.3 t -90.75 123.91 34.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.176 0.512 . . . . 0.0 112.043 -175.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.479 ' HE3' ' O ' ' A' ' 66' ' ' ASP . 18.8 pttp -118.83 -22.9 7.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.594 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.436 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 84.5 mtt180 -140.23 151.16 44.94 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 174.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.63 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 3.6 tp -125.73 137.72 53.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.018 0.437 . . . . 0.0 111.114 -174.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -139.31 116.08 10.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.154 0.502 . . . . 0.0 110.948 172.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.435 HD12 ' HZ ' ' A' ' 42' ' ' PHE . 22.1 mt -106.8 136.6 41.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 173.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.695 ' HA ' ' SD ' ' A' ' 14' ' ' MET . 19.9 ptt? -157.94 160.05 37.17 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -168.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -56.02 138.66 48.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 113.666 -1.606 . . . . 0.0 111.952 -177.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -61.99 -28.72 70.89 Favored Glycine 0 CA--C 1.505 -0.582 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.127 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.3 p -64.17 -20.31 65.91 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.195 -0.502 . . . . 0.0 111.124 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -100.53 -47.53 4.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.39 0.615 . . . . 0.0 110.103 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.96 -21.85 65.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.154 -176.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.6 -29.74 39.09 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -175.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.58 -39.32 93.84 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.786 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 C--N 1.328 -0.361 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -174.94 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.676 0 N-CA-C 111.75 -0.54 . . . . 0.0 111.75 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.51 ' CD1' ' HD2' ' A' ' 26' ' ' ARG . 3.3 mp -104.9 105.56 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 121.249 0.547 . . . . 0.0 109.674 177.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -102.9 130.77 50.06 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.439 -172.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.622 HG21 HD13 ' A' ' 25' ' ' LEU . 2.1 t -121.12 150.75 24.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.639 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -105.95 135.13 47.95 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.7 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -124.93 125.94 70.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.449 0.642 . . . . 0.0 110.874 -175.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 p -114.76 148.19 38.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.493 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.512 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 79.0 mmm -104.73 165.84 10.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.791 -177.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -131.75 141.7 49.58 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.99 -33.19 4.32 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.887 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.12 140.09 33.77 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-O 120.805 0.336 . . . . 0.0 110.796 173.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.3 127.77 9.29 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.925 2.416 . . . . 0.0 112.729 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -149.52 172.46 14.95 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.08 103.88 5.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.818 0.818 . . . . 0.0 110.423 170.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.449 ' C ' ' HD2' ' A' ' 22' ' ' LYS . 39.7 mmt180 -127.68 136.63 51.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.1 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.449 ' HD2' ' C ' ' A' ' 21' ' ' ARG . 2.6 mptp? -144.42 141.27 29.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 171.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.537 HD11 ' CD2' ' A' ' 89' ' ' LEU . 3.4 pt -140.86 174.11 8.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.028 0.442 . . . . 0.0 112.142 -175.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -110.45 126.47 54.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.103 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.622 HD13 HG21 ' A' ' 10' ' ' VAL . 10.8 tp -69.84 -43.06 72.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.833 -170.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.51 ' HD2' ' CD1' ' A' ' 8' ' ' ILE . 11.5 ptm180 -80.28 -25.82 39.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.047 0.451 . . . . 0.0 110.719 -171.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -49.71 -21.81 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 124.491 1.116 . . . . 0.0 113.767 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -86.73 -28.23 23.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.972 0.415 . . . . 0.0 111.805 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.5 13.75 46.14 Favored Glycine 0 CA--C 1.519 0.293 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.414 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 161.4 176.92 34.02 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.171 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.597 ' CE1' ' HA2' ' A' ' 75' ' ' GLY . 38.3 m-85 -69.49 -30.78 68.72 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -177.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.4 m -58.68 -54.76 43.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.671 0.272 . . . . 0.0 111.414 -174.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -73.59 -28.91 62.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.801 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.467 HD21 ' HB ' ' A' ' 74' ' ' VAL . 14.2 tp -58.31 -55.32 36.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.433 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.498 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 79.7 mt -67.12 -36.79 82.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.89 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.514 ' HA ' ' OE1' ' A' ' 39' ' ' GLU . 1.5 tmtp? -64.8 -33.89 77.06 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.499 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.711 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -67.64 -37.5 82.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.298 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.685 HD13 ' HG3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -63.52 -48.84 75.9 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.495 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 51.1 mt-10 -51.34 -33.27 28.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.574 173.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.549 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 21.1 m -74.37 -34.82 63.46 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.424 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.711 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 47.0 mmm -63.39 -57.86 8.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.131 -170.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.567 ' HE1' HD11 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -107.73 11.67 28.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.257 0.551 . . . . 0.0 111.101 -174.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp 61.7 50.53 4.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.72 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.615 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 2.4 pp -152.83 176.1 12.17 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.384 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.9 m -102.46 105.32 15.86 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -174.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.567 HD11 ' HE1' ' A' ' 42' ' ' PHE . 2.3 mt -89.2 120.89 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.601 169.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.46 165.86 54.55 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.558 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -66.02 172.37 3.78 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.725 0.774 . . . . 0.0 112.557 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.407 ' CD1' ' HB3' ' A' ' 73' ' ' LEU . 70.0 t80 -74.72 86.18 2.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.489 177.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 74.5 m -55.56 129.09 37.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.424 173.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.404 ' CD ' ' H ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -64.93 -31.19 72.3 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.042 -171.228 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -50.47 28.43 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -174.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.405 ' HG2' ' H ' ' A' ' 55' ' ' TYR . 20.1 tt0 -119.68 -28.66 5.22 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.223 0.535 . . . . 0.0 111.068 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.545 ' O ' HD22 ' A' ' 73' ' ' LEU . . . 45.23 12.06 0.03 OUTLIER Glycine 0 C--O 1.218 -0.896 0 N-CA-C 117.102 1.601 . . . . 0.0 117.102 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.434 ' HA ' HD13 ' A' ' 73' ' ' LEU . 17.3 m-30 -124.74 15.04 8.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 119.617 1.709 . . . . 0.0 111.144 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.494 ' HG2' ' H ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -74.44 -38.51 62.99 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.805 -177.042 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.09 7.74 5.36 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 115.797 -0.638 . . . . 0.0 114.436 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.494 ' H ' ' HG2' ' A' ' 56' ' ' LYS . 32.4 m 63.83 -83.87 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 122.733 0.413 . . . . 0.0 110.08 -171.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 39.3 tt0 -118.58 -14.52 9.62 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.681 0.277 . . . . 0.0 110.824 172.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -139.96 125.35 19.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.828 0.347 . . . . 0.0 111.036 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -100.53 103.7 25.69 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.798 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.685 ' HG3' HD13 ' A' ' 38' ' ' LEU . 57.2 Cg_endo -74.18 121.9 7.2 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.92 1.747 . . . . 0.0 111.638 174.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.43 HG21 HD13 ' A' ' 100' ' ' LEU . 63.2 p -124.91 157.27 36.4 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.038 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.689 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 3.4 p90 -129.23 164.5 23.33 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.48 ' CG ' ' HA2' ' A' ' 69' ' ' GLY . 43.9 tt0 -101.14 120.15 39.79 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.81 -168.72 2.31 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.355 0.41 . . . . 0.0 111.022 -176.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -57.67 -44.09 85.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.458 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -82.86 -14.65 53.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.285 0.564 . . . . 0.0 110.403 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.48 ' HA2' ' CG ' ' A' ' 65' ' ' GLU . . . 96.27 29.3 8.5 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.89 176.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -96.41 160.5 14.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.931 0.365 . . . . 0.0 110.11 172.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.689 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 39.6 m95 -122.46 114.1 20.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.902 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -131.44 174.33 10.18 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 171.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.545 HD22 ' O ' ' A' ' 54' ' ' GLY . 1.0 OUTLIER -62.59 157.33 20.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.75 0.786 . . . . 0.0 111.091 -178.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.467 ' HB ' HD21 ' A' ' 34' ' ' LEU . 31.4 m -76.26 134.54 28.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.101 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.597 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 109.96 0.67 30.22 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -171.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -56.57 -56.1 25.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.415 -0.392 . . . . 0.0 111.158 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 m -112.74 152.32 44.67 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.33 136.83 19.3 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.424 2.749 . . . . 0.0 113.203 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.552 ' O ' HG23 ' A' ' 83' ' ' VAL . 73.2 t-105 -43.21 -48.08 6.48 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 123.954 0.784 . . . . 0.0 113.107 -171.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -53.53 -43.08 68.06 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.2 0.312 . . . . 0.0 111.635 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 58.8 mtm -84.26 -25.33 29.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.963 0.411 . . . . 0.0 110.502 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -64.29 -44.84 90.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.423 -174.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 79' ' ' TRP . 2.5 t -61.68 -41.43 90.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.092 0.472 . . . . 0.0 111.023 -173.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.5 p -79.47 -15.46 57.74 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.569 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 65.8 m -91.19 -31.66 16.09 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.557 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 41.5 t -73.68 135.59 43.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.484 0.659 . . . . 0.0 111.048 -177.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -118.24 -44.17 2.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.324 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -140.15 163.38 32.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.712 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.7 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 2.0 tp -128.14 135.5 49.85 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.921 0.391 . . . . 0.0 110.702 -172.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -139.11 123.04 17.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.801 0.334 . . . . 0.0 110.868 175.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 14' ' ' MET . 6.1 mt -120.41 137.95 52.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 15.3 ptt? -156.65 158.64 37.37 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.213 0.53 . . . . 0.0 112.368 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 7.2 tttp -53.07 149.2 6.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.189 -1.368 . . . . 0.0 112.178 -175.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.67 -28.09 70.94 Favored Glycine 0 CA--C 1.505 -0.576 0 CA-C-N 114.842 -1.072 . . . . 0.0 113.348 -171.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.1 p -68.04 -20.04 64.95 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.963 0.411 . . . . 0.0 111.003 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -97.98 -9.18 26.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.937 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.684 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -60.57 -22.94 64.22 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.904 -176.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.22 -21.86 65.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.934 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.84 -4.43 63.47 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.626 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.684 ' HG ' ' O ' ' A' ' 97' ' ' ALA . 4.5 pp . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 117.386 0.593 . . . . 0.0 110.584 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.505 ' HA2' ' NH1' ' A' ' 26' ' ' ARG . . . . . . . . 0 N--CA 1.447 -0.605 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.3 mp -87.54 114.45 26.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.036 0.446 . . . . 0.0 110.44 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -98.72 132.46 44.08 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.098 174.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.617 HG21 HD22 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -118.19 138.76 47.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.496 0.665 . . . . 0.0 110.707 -178.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -104.54 133.94 48.57 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.715 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -125.7 124.85 67.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.746 0.784 . . . . 0.0 111.044 -173.053 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 p -112.13 155.3 24.13 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.119 -174.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.685 ' SD ' ' HA ' ' A' ' 92' ' ' MET . 31.8 tpp -110.78 135.31 51.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.659 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.48 137.98 40.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.435 177.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.75 -33.17 5.15 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.035 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.91 141.63 39.15 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 120.619 0.247 . . . . 0.0 111.085 173.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.92 126.71 8.14 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.707 2.272 . . . . 0.0 112.661 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -151.99 166.68 30.79 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.483 ' C ' ' HD2' ' A' ' 21' ' ' ARG . 78.2 mt -125.14 103.86 8.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.05 0.452 . . . . 0.0 110.255 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.483 ' HD2' ' C ' ' A' ' 20' ' ' LEU . 3.6 mpt_? -127.2 134.15 50.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.735 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.478 ' HD2' ' C ' ' A' ' 21' ' ' ARG . 2.4 mptp? -144.1 141.42 30.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 172.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -144.11 174.48 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.135 0.493 . . . . 0.0 112.044 -175.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.497 ' HB3' ' HE ' ' A' ' 26' ' ' ARG . 1.1 m-20 -109.71 126.76 54.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.65 -175.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.617 HD22 HG21 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -69.4 -36.62 76.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.925 0.869 . . . . 0.0 110.117 -175.196 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.505 ' NH1' ' HA2' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -79.54 -19.22 50.04 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.932 -1.031 . . . . 0.0 113.294 -168.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 24' ' ' ASP . 34.0 m -80.63 -3.96 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -170.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.494 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 25.8 m-85 -85.06 -30.12 24.35 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.22 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.7 14.15 6.93 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.788 -0.642 . . . . 0.0 114.354 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.29 165.78 24.24 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.735 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.572 ' CE1' ' HA2' ' A' ' 75' ' ' GLY . 15.2 m-85 -60.91 -36.12 78.46 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.7 p -62.54 -54.36 40.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.682 0.277 . . . . 0.0 110.961 -175.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -67.67 -27.33 66.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.076 -178.706 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 74' ' ' VAL . 8.6 tp -62.47 -56.75 15.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.285 174.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.453 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 81.5 mt -67.63 -39.87 84.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.63 -176.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -71.2 -32.54 68.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.271 -175.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.708 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -59.9 -39.79 86.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.778 0.323 . . . . 0.0 110.7 177.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.5 HD13 ' HG3' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -68.87 -50.48 49.41 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.307 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 35.3 mt-10 -52.27 -28.86 20.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.58 173.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.571 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 17.5 m -74.06 -41.02 62.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.258 175.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.708 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 71.9 mmm -54.85 -55.98 24.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.023 -172.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.519 ' HZ ' HG21 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -102.0 9.69 40.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 -177.173 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.17 44.21 19.37 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.95 174.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 pp -144.51 -171.8 3.67 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 m -113.72 121.14 43.18 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.876 0.369 . . . . 0.0 111.31 -175.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.435 ' CD1' ' HB2' ' A' ' 60' ' ' TYR . 40.8 mm -84.57 -22.77 7.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 122.335 1.064 . . . . 0.0 109.738 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.03 -164.58 31.2 Favored Glycine 0 C--N 1.31 -0.889 0 CA-C-N 114.071 -1.422 . . . . 0.0 112.574 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -92.02 162.4 14.39 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.464 ' CD1' HD22 ' A' ' 73' ' ' LEU . 60.4 t80 -80.43 75.72 7.27 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 171.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 m -49.05 128.97 17.14 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.804 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -68.06 -17.82 64.5 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.049 -173.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.519 ' HD2' ' N ' ' A' ' 53' ' ' GLU . 3.0 ppt_? -74.58 -51.95 13.14 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.519 ' N ' ' HD2' ' A' ' 52' ' ' ARG . 50.9 mt-10 -122.57 -29.95 3.98 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 119.934 -0.707 . . . . 0.0 112.728 176.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.693 ' O ' HD13 ' A' ' 73' ' ' LEU . . . 48.97 12.9 0.26 Allowed Glycine 0 C--O 1.218 -0.855 0 N-CA-C 115.288 0.875 . . . . 0.0 115.288 -175.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.508 ' HA ' HD13 ' A' ' 73' ' ' LEU . 11.6 m-85 -124.8 10.04 8.29 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.535 1.167 . . . . 0.0 110.608 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.475 ' HB2' ' NZ ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -61.38 -51.37 69.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.428 -179.024 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.16 3.04 4.53 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 115.079 0.792 . . . . 0.0 115.079 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.2 t 67.86 -86.99 0.03 OUTLIER 'General case' 0 C--O 1.234 0.238 0 CA-C-N 117.357 0.579 . . . . 0.0 110.037 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -117.65 -6.84 11.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.741 0.305 . . . . 0.0 110.501 175.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.435 ' HB2' ' CD1' ' A' ' 46' ' ' ILE . 70.3 m-85 -143.17 124.49 14.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.611 0.243 . . . . 0.0 111.354 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.411 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . . . -104.2 105.06 47.46 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.653 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 42.8 Cg_endo -68.98 120.93 7.78 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.992 1.795 . . . . 0.0 111.009 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 72' ' ' MET . 77.0 p -129.92 165.67 21.61 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.478 -175.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.759 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.4 p90 -136.51 164.66 27.66 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -178.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.479 ' CG ' ' HA2' ' A' ' 69' ' ' GLY . 33.3 tt0 -104.53 121.63 43.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.711 0.291 . . . . 0.0 110.361 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 25.5 t70 -84.51 -170.87 3.32 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.519 175.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.463 ' H ' ' CG ' ' A' ' 66' ' ' ASP . 13.3 mmtm -65.46 -34.41 78.22 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.643 0.735 . . . . 0.0 109.349 -175.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -72.26 -18.52 61.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.083 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.479 ' HA2' ' CG ' ' A' ' 65' ' ' GLU . . . 92.58 11.98 58.75 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.639 -175.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -86.95 144.11 27.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.646 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 64.0 m95 -112.11 115.67 29.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.048 0.451 . . . . 0.0 110.983 -176.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.416 ' O ' ' HA ' ' A' ' 63' ' ' THR . 49.8 mtm -121.54 161.09 22.96 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.693 HD13 ' O ' ' A' ' 54' ' ' GLY . 9.5 tt -71.05 141.42 50.89 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 17.2 m -66.87 129.57 31.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.655 0.741 . . . . 0.0 112.166 -174.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.572 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 111.3 6.93 25.21 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.513 -174.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -71.57 -56.91 4.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.513 0.197 . . . . 0.0 111.302 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.583 HG22 ' CD2' ' A' ' 82' ' ' PHE . 12.6 m -98.34 155.11 37.25 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.484 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 5.1 Cg_endo -46.94 131.89 17.14 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.668 2.912 . . . . 0.0 113.667 -176.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.491 ' O ' HG23 ' A' ' 83' ' ' VAL . 72.9 t-105 -43.16 -54.28 4.55 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.68 -172.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -51.41 -42.04 61.17 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.587 0.554 . . . . 0.0 111.542 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 57.4 ttp -83.37 -31.86 26.51 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.807 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.583 ' CD2' HG22 ' A' ' 77' ' ' VAL . 6.3 t80 -58.23 -46.66 85.5 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.68 -174.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 79' ' ' TRP . 2.8 t -60.54 -48.18 89.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.342 -170.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.8 p -78.87 -14.37 59.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.55 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.6 t -85.97 -25.18 26.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.12 -175.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.759 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 40.4 t -79.22 131.15 36.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.751 0.31 . . . . 0.0 110.922 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 13.5 ptmm? -116.03 -23.94 8.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.694 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.426 ' HD3' ' OE1' ' A' ' 65' ' ' GLU . 62.1 mtp180 -140.81 154.67 46.33 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 176.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.715 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 9.6 tp -127.51 133.37 49.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.114 -176.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.451 ' HD2' ' SD ' ' A' ' 92' ' ' MET . 2.6 ttm180 -139.47 117.78 12.01 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.289 -0.565 . . . . 0.0 111.096 174.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.519 HG21 ' HZ ' ' A' ' 42' ' ' PHE . 4.1 mt -116.1 133.55 62.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 170.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.685 ' HA ' ' SD ' ' A' ' 14' ' ' MET . 14.6 ptt? -158.13 161.13 37.9 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.212 0.53 . . . . 0.0 112.122 -170.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -53.94 141.81 26.58 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.727 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.4 -27.29 57.96 Favored Glycine 0 CA--C 1.505 -0.582 0 CA-C-N 114.437 -1.256 . . . . 0.0 113.092 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 59.1 p -60.21 -25.96 66.01 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.469 0.652 . . . . 0.0 110.779 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -101.11 -49.41 4.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.8 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.437 ' HA ' ' HE3' ' A' ' 92' ' ' MET . . . -63.87 -21.15 66.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.635 -175.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -53.63 -32.41 51.25 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.55 -38.43 90.49 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.727 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.413 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -175.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.923 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.424 HG22 HD12 ' A' ' 25' ' ' LEU . 4.1 mp -117.37 105.51 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 174.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -97.76 142.51 29.44 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.068 -170.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.59 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -118.49 145.21 24.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.085 179.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.529 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 48.9 mttm -102.07 128.35 48.56 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -125.2 126.5 70.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.874 0.845 . . . . 0.0 111.377 -176.486 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.6 m -117.28 151.05 37.76 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.81 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.568 ' SD ' ' HB ' ' A' ' 91' ' ' ILE . 69.2 mmm -101.31 160.48 14.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.757 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -134.41 146.5 49.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.352 -0.386 . . . . 0.0 109.988 175.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.78 -34.62 3.84 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -174.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.62 138.38 28.19 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 169.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -76.72 125.5 8.22 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.419 2.079 . . . . 0.0 112.735 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.474 ' HB2' ' CG ' ' A' ' 14' ' ' MET . 93.2 m-85 -152.17 165.5 34.61 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.709 174.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.34 105.88 5.57 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 177.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.54 ' HB2' HG22 ' A' ' 12' ' ' VAL . 10.8 mmm180 -125.86 155.51 41.06 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.691 -176.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.529 ' HD3' ' HA ' ' A' ' 11' ' ' LYS . 5.5 mmtm -148.08 140.55 24.43 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 174.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 pt -145.66 173.49 3.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.09 0.471 . . . . 0.0 111.397 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.49 ' O ' HG22 ' A' ' 27' ' ' VAL . 9.9 t70 -115.83 140.85 48.82 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.399 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.51 HD13 ' SG ' ' A' ' 86' ' ' CYS . 15.6 mt -73.61 -47.71 38.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.166 -173.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -82.33 -11.56 58.52 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -169.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 24' ' ' ASP . 35.8 m -63.94 -17.87 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 120.867 0.365 . . . . 0.0 111.283 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -84.02 -28.1 27.9 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.085 0.469 . . . . 0.0 110.893 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.77 15.92 36.28 Favored Glycine 0 CA--C 1.519 0.302 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.384 175.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.05 175.68 31.29 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.777 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -69.5 -30.56 68.46 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -176.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.8 p -60.08 -54.93 40.17 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.553 -174.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -71.5 -28.43 63.9 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.508 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.416 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 20.8 tp -58.13 -55.66 32.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.185 0.516 . . . . 0.0 109.844 174.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.478 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 63.0 mt -67.58 -37.05 82.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.333 -177.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -70.72 -32.19 69.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.241 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.709 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -62.24 -42.46 99.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.761 176.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.495 HD13 ' HG3' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -61.89 -50.37 72.48 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.752 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 45.5 mt-10 -51.76 -30.66 23.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.828 173.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.555 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 26.5 m -76.2 -43.03 44.24 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.65 178.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.709 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 63.9 mmm -54.79 -57.87 9.83 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -168.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.671 ' CZ ' HG21 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -107.14 10.31 30.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.223 -177.168 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.8 mptt 62.51 42.55 8.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.101 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.752 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 1.2 pp -149.45 168.82 22.39 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 175.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.0 m -93.81 104.18 16.27 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -165.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.434 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 3.9 mm -97.64 148.97 5.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 170.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.52 -168.88 38.35 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.302 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 45.37 83.02 0.03 OUTLIER 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.1 0.96 . . . . 0.0 113.526 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.441 ' CE2' ' HB2' ' A' ' 73' ' ' LEU . 30.2 t80 -66.4 86.4 0.11 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 167.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 t -65.61 151.18 47.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.388 0.613 . . . . 0.0 110.837 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -73.3 -16.13 61.38 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.021 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.592 ' HD3' ' HG3' ' A' ' 53' ' ' GLU . 1.2 tmt_? -80.42 -54.73 5.43 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.592 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 33.1 mt-10 -121.53 -29.11 4.47 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.338 171.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 43.01 10.99 0.01 OUTLIER Glycine 0 C--O 1.218 -0.9 0 CA-C-N 114.213 -1.358 . . . . 0.0 116.325 -175.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.513 ' CE1' ' HB3' ' A' ' 72' ' ' MET . 19.4 m-85 -128.64 16.69 6.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 119.222 1.511 . . . . 0.0 111.529 178.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.447 ' HE3' ' N ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -70.57 -37.14 73.95 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.979 -172.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.447 ' N ' ' HE3' ' A' ' 56' ' ' LYS . . . 58.35 19.32 39.69 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.806 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.3 t 63.77 -82.9 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -169.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.605 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 40.0 tt0 -119.28 -20.16 8.03 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.611 173.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.447 ' CE1' ' HG3' ' A' ' 93' ' ' LYS . 37.3 m-85 -131.89 125.98 33.05 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.993 0.425 . . . . 0.0 111.395 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -105.85 105.28 52.67 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.129 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.495 ' HG3' HD13 ' A' ' 38' ' ' LEU . 28.4 Cg_endo -72.24 120.33 6.71 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 121.443 1.428 . . . . 0.0 111.166 173.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 72' ' ' MET . 61.0 p -124.64 150.85 45.6 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.228 -176.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 5.2 p90 -117.74 161.85 19.03 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.503 ' HB2' ' CZ2' ' A' ' 71' ' ' TRP . 42.0 tt0 -100.37 118.82 37.4 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 173.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.21 -178.31 6.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.965 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 mtmm -51.37 -42.9 61.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.789 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -86.38 -15.93 38.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.949 0.404 . . . . 0.0 111.018 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.02 29.37 8.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.799 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -94.56 148.25 22.45 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 172.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.546 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 65.9 m95 -115.86 114.37 24.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.958 0.409 . . . . 0.0 110.576 -178.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.513 ' HB3' ' CE1' ' A' ' 55' ' ' TYR . 17.4 mtm -135.86 177.89 7.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.483 ' HG ' ' HA ' ' A' ' 55' ' ' TYR . 6.0 mt -62.34 151.4 36.81 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.642 0.734 . . . . 0.0 110.532 177.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.9 m -78.03 135.09 26.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.47 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.4 8.03 50.54 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.4 -173.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.92 -53.26 49.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.687 0.28 . . . . 0.0 111.255 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.525 HG22 ' CD2' ' A' ' 82' ' ' PHE . 12.9 m -103.63 157.51 33.73 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.489 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 6.4 Cg_endo -48.74 127.04 15.72 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.333 2.689 . . . . 0.0 113.226 -178.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.61 ' O ' HG23 ' A' ' 83' ' ' VAL . 70.6 t-105 -40.85 -46.09 2.65 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 113.848 -1.524 . . . . 0.0 113.811 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.2 -42.95 82.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.713 0.292 . . . . 0.0 111.272 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.2 tmm? -83.88 -27.33 28.72 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.525 ' CD2' HG22 ' A' ' 77' ' ' VAL . 9.2 t80 -60.01 -50.98 71.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.649 -174.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 79' ' ' TRP . 3.8 t -59.75 -36.77 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.129 0.49 . . . . 0.0 111.371 -170.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.2 p -79.1 -11.33 59.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.502 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.6 t -101.5 -19.96 15.3 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.795 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.51 ' SG ' HD13 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -86.1 117.48 24.97 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.302 0.572 . . . . 0.0 110.513 179.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 9.6 ptmm? -118.06 -25.52 6.67 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.572 -174.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -139.78 158.41 44.14 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.63 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 6.6 tp -134.31 131.02 37.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.237 0.541 . . . . 0.0 110.741 -175.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -138.36 123.98 19.69 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.993 0.425 . . . . 0.0 110.654 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.671 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 10.6 mt -114.08 136.61 50.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -158.45 160.79 37.17 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.722 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 52.6 mttt -52.72 149.41 6.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.703 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -61.81 -25.93 66.37 Favored Glycine 0 CA--C 1.504 -0.612 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.731 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.44 HG22 ' HB3' ' A' ' 93' ' ' LYS . 9.9 t -75.16 -13.36 60.45 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.172 0.51 . . . . 0.0 110.715 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -101.52 -46.74 4.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.99 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.73 -23.87 63.47 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -57.15 -38.11 73.04 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.681 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.82 -37.05 93.68 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.229 -0.51 . . . . 0.0 113.458 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.426 ' H ' HD23 ' A' ' 100' ' ' LEU . 1.1 pt? . . . . . 0 C--N 1.327 -0.388 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -175.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.467 HD13 ' HD3' ' A' ' 26' ' ' ARG . 2.0 mp -112.25 104.17 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -92.71 129.08 38.75 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.05 -174.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.594 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -114.33 142.31 27.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.465 -175.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.694 ' HA ' ' HD2' ' A' ' 22' ' ' LYS . 47.6 mtmt -98.22 127.89 44.4 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.736 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -124.54 126.87 72.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.369 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.4 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 20.5 m -112.93 141.48 46.72 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.852 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.46 ' HG3' ' CD2' ' A' ' 19' ' ' TYR . 73.2 mmm -97.75 122.69 41.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.041 0.448 . . . . 0.0 110.807 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.99 130.99 51.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.389 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.32 -33.45 6.52 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.882 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.19 141.31 33.84 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.48 125.11 7.43 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.356 2.037 . . . . 0.0 113.171 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.46 ' CD2' ' HG3' ' A' ' 14' ' ' MET . 97.8 m-85 -152.65 169.48 22.61 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.495 ' C ' ' HD2' ' A' ' 21' ' ' ARG . 56.0 mt -137.75 102.05 4.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.047 0.451 . . . . 0.0 110.195 169.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.495 ' HD2' ' C ' ' A' ' 20' ' ' LEU . 3.6 mpt_? -129.56 138.67 51.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.285 174.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.694 ' HD2' ' HA ' ' A' ' 11' ' ' LYS . 35.3 mmtm -132.46 142.75 49.38 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 169.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 pt -143.33 174.01 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -172.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.444 ' OD1' HG13 ' A' ' 27' ' ' VAL . 3.8 t70 -115.37 143.97 44.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.754 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.455 HD21 ' SG ' ' A' ' 86' ' ' CYS . 40.7 mt -71.62 -44.0 65.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.287 0.565 . . . . 0.0 111.576 -175.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.556 ' HG2' HG11 ' A' ' 83' ' ' VAL . 40.6 mtm180 -80.16 -22.97 41.42 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -165.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.444 HG13 ' OD1' ' A' ' 24' ' ' ASP . 28.1 m -61.11 -12.97 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -92.47 -28.5 16.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.191 0.52 . . . . 0.0 111.079 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.7 14.77 23.63 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.26 -0.882 . . . . 0.0 113.889 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.35 174.35 34.03 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.379 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -69.36 -33.4 73.02 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.9 m -57.96 -53.75 54.7 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.297 -175.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -74.49 -27.17 60.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.286 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.7 tp -60.13 -55.28 35.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.176 0.512 . . . . 0.0 110.483 175.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.509 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 77.5 mt -66.2 -35.13 79.64 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.549 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -68.45 -33.41 74.14 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.464 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.706 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -64.94 -38.5 91.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.152 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.596 HD13 ' HG3' ' A' ' 62' ' ' PRO . 0.5 OUTLIER -61.82 -49.91 74.41 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.043 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.711 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 41.1 mt-10 -53.25 -29.12 31.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.922 173.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.551 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 33.7 m -76.29 -42.62 44.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.475 176.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.706 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 44.2 mmm -55.0 -57.02 13.38 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.141 -169.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.616 ' HZ ' HG21 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -109.7 7.36 24.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.081 179.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 0.0 OUTLIER 61.19 40.84 14.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.963 174.26 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.711 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 2.2 pp -141.34 162.41 35.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.125 176.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.3 m -85.39 103.4 14.26 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -166.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.464 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 12.1 mm -89.22 151.09 3.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 168.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -115.91 -162.03 13.06 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 121.359 -0.448 . . . . 0.0 112.76 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -89.56 171.84 9.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.764 0.792 . . . . 0.0 112.233 -174.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.481 ' CE2' ' HB2' ' A' ' 73' ' ' LEU . 41.4 t80 -72.62 81.3 1.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.292 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 54' ' ' GLY . 14.0 m -57.79 107.82 0.5 Allowed 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.356 175.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -55.74 -26.66 46.63 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -166.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.614 ' HD2' ' N ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -58.2 -49.28 77.62 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -176.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.614 ' N ' ' HD2' ' A' ' 52' ' ' ARG . 48.6 mt-10 -119.51 -26.98 5.64 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.702 0.763 . . . . 0.0 110.252 172.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 50' ' ' SER . . . 54.28 10.04 1.76 Allowed Glycine 0 C--O 1.213 -1.164 0 CA-C-N 113.913 -1.494 . . . . 0.0 115.695 177.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.598 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 19.0 m-85 -127.7 14.96 7.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 119.25 1.525 . . . . 0.0 112.355 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.721 ' HD3' ' N ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -74.66 -45.47 44.37 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.457 171.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.721 ' N ' ' HD3' ' A' ' 56' ' ' LYS . . . 58.38 -27.79 0.02 OUTLIER Glycine 0 CA--C 1.529 0.916 0 CA-C-N 115.246 -0.888 . . . . 0.0 114.485 -172.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.584 ' H ' ' C ' ' A' ' 56' ' ' LYS . 26.8 t 150.09 -138.75 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -175.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.594 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 31.2 tt0 -83.83 -5.48 59.21 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 166.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.445 ' HB2' ' CD1' ' A' ' 46' ' ' ILE . 32.1 m-85 -133.96 130.51 37.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.233 173.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.734 ' HB1' HD21 ' A' ' 73' ' ' LEU . . . -115.51 105.59 51.83 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.28 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.596 ' HG3' HD13 ' A' ' 38' ' ' LEU . 32.7 Cg_endo -69.7 120.39 7.19 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 121.952 1.768 . . . . 0.0 112.08 174.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 72' ' ' MET . 38.3 p -123.73 159.51 29.28 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.436 -176.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 5.0 p90 -135.24 166.25 23.55 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.05 -177.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.55 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 44.1 tt0 -111.58 124.8 53.04 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.565 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.468 ' OD2' ' HG2' ' A' ' 67' ' ' LYS . 23.2 t70 -88.81 -179.81 6.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.968 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.468 ' HG2' ' OD2' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -63.91 -28.58 69.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.508 0.671 . . . . 0.0 110.229 179.26 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -68.11 -18.57 64.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.412 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.57 11.57 71.17 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -95.3 149.56 21.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.149 -0.525 . . . . 0.0 110.111 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.559 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 36.0 m95 -119.82 132.79 55.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.028 -176.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.426 ' HE2' ' CE1' ' A' ' 64' ' ' TYR . 2.0 mpp? -143.11 -179.73 6.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 171.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.734 HD21 ' HB1' ' A' ' 61' ' ' ALA . 4.8 mt -63.06 154.14 31.77 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.893 0.854 . . . . 0.0 110.996 175.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.554 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 57.9 t -78.69 122.2 33.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.866 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.06 -1.18 28.45 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -171.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.34 -46.58 79.88 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.994 0.426 . . . . 0.0 110.313 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.419 HG22 ' CD2' ' A' ' 82' ' ' PHE . 16.0 m -108.62 154.94 41.35 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 173.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 10.9 Cg_endo -54.59 136.57 70.94 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.88 2.387 . . . . 0.0 113.098 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.516 ' O ' HG23 ' A' ' 83' ' ' VAL . 65.1 t-105 -40.64 -48.39 2.91 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 124.096 0.872 . . . . 0.0 112.978 -173.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -53.52 -42.22 67.18 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.782 -177.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 77.2 mtp -82.67 -23.08 34.37 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.262 0.553 . . . . 0.0 110.374 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.554 ' CZ ' ' HA ' ' A' ' 74' ' ' VAL . 7.4 t80 -70.51 -46.49 63.56 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.02 -171.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.556 HG11 ' HG2' ' A' ' 26' ' ' ARG . 3.4 t -61.32 -38.57 80.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.193 0.52 . . . . 0.0 111.478 -171.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.9 p -78.76 -12.52 60.03 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.029 -175.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.2 p -106.52 -31.43 8.52 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 34.0 t -71.92 116.27 12.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.268 0.556 . . . . 0.0 110.978 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -119.38 -19.43 8.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.063 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.55 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 55.9 mtt180 -139.34 156.63 46.89 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 174.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.736 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 5.7 tp -136.12 134.44 38.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.992 0.425 . . . . 0.0 111.247 -173.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 13' ' ' SER . 24.0 ttp180 -140.51 123.58 16.6 Favored 'General case' 0 C--N 1.318 -0.778 0 O-C-N 122.011 -0.431 . . . . 0.0 111.227 168.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.616 HG21 ' HZ ' ' A' ' 42' ' ' PHE . 4.4 mt -106.43 136.03 42.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 168.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -159.0 163.34 36.52 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.15 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 34.0 mtpt -48.55 140.71 7.76 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 124.25 0.969 . . . . 0.0 112.756 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -58.86 -36.33 86.78 Favored Glycine 0 CA--C 1.505 -0.547 0 CA-C-N 113.689 -1.596 . . . . 0.0 113.713 -168.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.44 ' HA ' ' HD3' ' A' ' 98' ' ' LYS . 38.9 p -60.55 -19.86 58.59 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.072 0.463 . . . . 0.0 111.807 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -97.5 -43.56 7.2 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.723 -174.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.59 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -71.16 -29.42 65.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.483 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 95' ' ' THR . 15.1 ptmm? -69.72 -6.86 34.7 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.597 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.96 -7.18 50.9 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.413 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 97' ' ' ALA . 4.0 pp . . . . . 0 CA--C 1.514 -0.415 0 O-C-N 122.496 -0.414 . . . . 0.0 110.929 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.685 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.6 mt -70.12 111.88 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.757 0.313 . . . . 0.0 110.243 175.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -89.59 139.24 30.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.69 -176.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.599 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -118.55 148.31 21.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 176.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.573 ' HA ' ' HD2' ' A' ' 22' ' ' LYS . 56.3 mtmt -107.29 130.25 54.79 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.715 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -126.4 129.41 71.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.971 -176.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.4 m -109.51 146.64 34.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.639 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.555 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 23.1 tpp -97.53 125.2 42.09 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.854 175.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.5 140.65 37.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.913 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.1 -33.66 4.79 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.683 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.555 ' O ' ' HG3' ' A' ' 14' ' ' MET . . . -134.75 140.2 34.61 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 120.661 0.267 . . . . 0.0 110.556 171.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.49 125.08 7.41 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.428 2.085 . . . . 0.0 112.759 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -153.19 168.17 26.85 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 123.048 0.539 . . . . 0.0 109.944 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.42 98.69 4.15 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.67 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 1.6 ptp180 -134.33 123.0 23.45 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.391 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.67 ' HD3' ' O ' ' A' ' 21' ' ' ARG . 60.7 mmtt -120.43 157.19 29.86 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 117.973 0.351 . . . . 0.0 110.602 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -144.99 172.57 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 120.868 0.366 . . . . 0.0 111.849 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.601 ' O ' HG22 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -112.96 130.66 56.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.225 0.536 . . . . 0.0 110.225 -173.029 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.54 HD21 ' HB2' ' A' ' 86' ' ' CYS . 16.5 tp -70.11 -45.5 66.79 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -169.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 26' ' ' ARG . 17.4 mtp180 -79.41 -10.86 59.89 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -173.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.601 HG22 ' O ' ' A' ' 24' ' ' ASP . 20.8 m -84.27 -0.55 5.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.521 -0.471 . . . . 0.0 112.246 -173.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.63 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 23.3 m-85 -84.12 -31.09 25.43 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.583 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 44.75 48.21 9.11 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.745 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.89 172.99 13.81 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.135 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -70.07 -29.85 66.95 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -176.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.5 m -59.36 -53.73 54.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.749 0.309 . . . . 0.0 111.37 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.63 ' HB2' ' O ' ' A' ' 28' ' ' TYR . 49.2 mm-40 -73.67 -29.74 62.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.521 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.4 tp -55.22 -56.64 17.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.103 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.401 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 53.6 mt -68.94 -38.74 79.66 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.592 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -67.8 -33.09 74.14 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.276 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.674 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -61.4 -41.47 97.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.54 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.506 ' H ' ' HG ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -65.58 -46.51 79.15 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.132 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 43.6 mt-10 -51.29 -32.71 25.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.441 174.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.539 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 50.2 m -73.79 -41.83 61.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.154 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.674 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 55.9 mmm -56.71 -56.66 18.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.635 -169.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.644 ' HZ ' HG21 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -103.0 9.12 38.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.083 -176.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.9 mttt 62.04 40.93 11.61 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.618 174.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 3.0 pp -145.01 174.14 11.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.157 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.1 m -102.99 100.78 10.74 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -171.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.495 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 31.5 mm -69.82 139.48 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 168.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.36 -162.3 34.11 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.293 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.58 167.3 12.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.025 0.44 . . . . 0.0 110.839 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.765 ' CE1' HD12 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -63.89 93.03 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.362 172.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.416 ' HB2' ' HA2' ' A' ' 54' ' ' GLY . 1.5 m -61.85 134.06 56.23 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.7 -23.96 60.94 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -168.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.667 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -82.15 -51.5 7.91 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.104 -0.638 . . . . 0.0 112.412 -174.019 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.667 ' N ' ' HD3' ' A' ' 52' ' ' ARG . 60.8 mt-10 -121.3 -31.22 4.13 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 118.956 0.798 . . . . 0.0 110.712 168.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.716 ' O ' HD11 ' A' ' 73' ' ' LEU . . . 38.08 7.78 0.0 OUTLIER Glycine 0 C--O 1.221 -0.701 0 CA-C-N 113.535 -1.666 . . . . 0.0 116.269 -168.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.5 ' CE1' ' HG ' ' A' ' 73' ' ' LEU . 3.8 m-30 -96.24 3.6 52.99 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 118.507 1.154 . . . . 0.0 110.753 -171.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.616 ' C ' ' H ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -69.51 -36.17 76.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.923 168.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.499 ' H ' ' HD3' ' A' ' 56' ' ' LYS . . . 59.52 -24.11 0.03 OUTLIER Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.321 -0.854 . . . . 0.0 114.399 -174.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.616 ' H ' ' C ' ' A' ' 56' ' ' LYS . 44.4 t 146.91 -89.75 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 -176.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -118.44 -3.15 10.96 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 161.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.476 ' O ' ' HA3' ' A' ' 57' ' ' GLY . 46.9 m-85 -137.47 130.05 29.86 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.748 -175.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 55' ' ' TYR . . . -101.67 104.46 34.89 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.129 176.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.566 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 60.3 Cg_endo -73.06 121.5 7.32 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.093 1.862 . . . . 0.0 111.496 172.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.6 p -132.52 164.17 27.21 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.03 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 5.0 p90 -141.61 165.68 26.82 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.532 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 30.7 tt0 -104.98 122.81 46.62 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.734 175.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.08 179.51 7.25 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.378 0.424 . . . . 0.0 110.781 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.0 mtmm -48.61 -46.95 40.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.044 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -86.6 -10.91 52.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.978 0.418 . . . . 0.0 111.382 -174.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.11 29.5 8.45 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.644 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -93.1 148.84 21.67 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 171.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.494 ' CZ2' ' HB2' ' A' ' 65' ' ' GLU . 66.2 m95 -119.16 113.85 21.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.806 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -130.23 -179.65 5.37 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 171.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.765 HD12 ' CE1' ' A' ' 49' ' ' TYR . 76.7 mt -65.62 156.27 33.3 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.344 0.592 . . . . 0.0 111.089 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 62' ' ' PRO . 30.2 m -75.87 128.98 37.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.494 176.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.46 8.21 56.36 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.412 -173.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.67 -61.22 2.57 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.596 0.236 . . . . 0.0 111.454 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.446 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 16.1 m -98.87 161.85 23.53 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.402 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.446 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 85.4 Cg_exo -46.25 131.96 14.94 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.189 2.593 . . . . 0.0 113.217 177.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.582 ' O ' HG23 ' A' ' 83' ' ' VAL . 66.9 t-105 -47.59 -42.19 23.38 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.816 -173.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -59.11 -42.45 90.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.946 0.403 . . . . 0.0 111.335 -176.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 73.7 mtm -82.39 -21.89 35.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.202 0.525 . . . . 0.0 109.982 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.449 ' HZ ' ' HA ' ' A' ' 74' ' ' VAL . 6.7 t80 -65.7 -55.34 17.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.348 -175.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 79' ' ' TRP . 3.0 t -61.1 -38.14 78.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.153 -171.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.7 p -76.21 -10.2 59.22 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.733 -175.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.5 m -102.7 -19.15 14.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.313 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.54 ' HB2' HD21 ' A' ' 25' ' ' LEU . 74.0 m -76.18 112.8 13.02 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.249 0.547 . . . . 0.0 111.823 -175.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -118.08 -26.59 6.34 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.022 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.532 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 71.9 mtt180 -139.73 154.86 47.55 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.715 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 8.5 tp -131.67 138.35 48.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.489 -175.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.462 ' HD3' ' SD ' ' A' ' 92' ' ' MET . 10.8 ttm180 -141.11 121.45 13.97 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.243 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.644 HG21 ' HZ ' ' A' ' 42' ' ' PHE . 4.0 mt -120.2 134.26 64.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 168.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.462 ' SD ' ' HD3' ' A' ' 90' ' ' ARG . 23.5 ptt? -158.96 164.31 35.71 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 123.319 0.387 . . . . 0.0 111.863 -172.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -47.11 129.46 12.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.991 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -65.51 -31.56 80.58 Favored Glycine 0 CA--C 1.506 -0.469 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.795 -172.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.8 p -66.98 -23.27 65.92 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.165 -0.518 . . . . 0.0 111.633 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -100.03 -18.23 17.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.813 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.582 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -71.18 -22.22 62.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.47 0.652 . . . . 0.0 110.303 176.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -57.33 -26.07 60.35 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.504 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.85 -33.76 85.08 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.86 -176.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 97' ' ' ALA . 3.6 pp . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 117.624 0.712 . . . . 0.0 111.868 -175.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.455 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.481 HD13 ' HD2' ' A' ' 26' ' ' ARG . 2.7 mp -82.23 110.05 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.049 0.452 . . . . 0.0 110.151 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -111.14 116.31 30.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.564 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.566 ' CG2' ' HB2' ' A' ' 89' ' ' LEU . 2.9 m -116.37 151.95 18.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 17.0 ptpt -94.86 133.02 39.04 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.131 -176.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.699 ' HB ' ' HB3' ' A' ' 89' ' ' LEU . 1.5 p -148.39 122.45 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 O-C-N 124.037 0.836 . . . . 0.0 110.844 173.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.528 ' HB2' ' N ' ' A' ' 21' ' ' ARG . 7.5 t -160.03 112.41 2.06 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.482 163.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.773 ' HE2' ' O ' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -168.02 141.54 3.3 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 118.282 -1.367 . . . . 0.0 113.888 175.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.431 ' HB2' ' OH ' ' A' ' 60' ' ' TYR . 4.2 p-10 -140.58 76.75 1.57 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.341 0.591 . . . . 0.0 111.619 162.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.522 ' H ' ' CE ' ' A' ' 14' ' ' MET . . . 88.81 -30.71 5.28 Favored Glycine 0 C--O 1.229 -0.174 0 C-N-CA 121.371 -0.442 . . . . 0.0 112.115 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.549 ' O ' ' HG2' ' A' ' 14' ' ' MET . . . -121.21 150.29 53.53 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 177.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.73 129.75 15.99 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.439 2.093 . . . . 0.0 113.736 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' A' ' 13' ' ' SER . 49.5 m-85 -134.67 172.71 12.56 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.9 mt -136.26 104.14 5.54 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.212 0.529 . . . . 0.0 112.425 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.533 ' HE ' ' HA ' ' A' ' 21' ' ' ARG . 0.2 OUTLIER -129.91 173.21 10.9 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 167.319 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 11' ' ' LYS . 0.7 OUTLIER -137.85 148.93 45.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 118.979 0.809 . . . . 0.0 111.418 175.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.498 HD11 ' CD2' ' A' ' 89' ' ' LEU . 8.8 pt -129.41 175.09 11.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.861 170.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.504 ' O ' HG22 ' A' ' 27' ' ' VAL . 0.6 OUTLIER -109.53 124.64 51.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -176.421 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.538 HD23 HG13 ' A' ' 83' ' ' VAL . 3.2 tp -72.18 -44.85 62.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.073 -167.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.49 ' HG2' HG11 ' A' ' 83' ' ' VAL . 47.2 mtp180 -79.4 -22.63 44.05 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -172.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 24' ' ' ASP . 20.7 m -65.49 -11.23 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.834 0.349 . . . . 0.0 111.719 -172.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.402 ' CD2' HD12 ' A' ' 34' ' ' LEU . 23.5 m-85 -84.48 -27.26 27.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.006 0.431 . . . . 0.0 110.564 178.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.26 14.73 20.18 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 114.95 -1.023 . . . . 0.0 113.78 173.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.36 169.82 30.47 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 -176.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -70.49 -32.66 70.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -175.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.0 m -59.27 -53.86 53.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.661 0.267 . . . . 0.0 111.226 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -73.42 -30.1 63.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.726 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.461 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 9.8 tp -59.6 -55.53 33.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.38 177.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.615 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 54.1 mt -66.37 -35.99 81.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.137 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -64.39 -33.8 76.7 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.275 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.588 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -72.43 -32.56 66.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.955 0.407 . . . . 0.0 111.036 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.615 ' CD1' ' HA ' ' A' ' 35' ' ' LEU . 2.2 mt -66.9 -51.65 52.77 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.52 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -52.39 -32.43 38.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.884 173.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.574 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 20.5 m -71.37 -34.22 70.25 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.619 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.588 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 73.2 mmm -64.59 -56.71 12.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.783 0.325 . . . . 0.0 111.852 -170.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.41 12.93 25.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.09 0.472 . . . . 0.0 112.119 -177.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.406 ' HD3' ' O ' ' A' ' 40' ' ' THR . 22.8 mmtm 62.17 53.68 2.85 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.278 170.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 pp -150.28 -172.66 4.23 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.325 -0.235 . . . . 0.0 110.774 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.0 m -100.08 128.04 46.22 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -174.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.584 HG13 ' HB2' ' A' ' 38' ' ' LEU . 41.5 mm -105.16 133.39 49.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.007 174.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.537 ' HA3' ' OG ' ' A' ' 58' ' ' SER . . . -92.09 140.18 15.03 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.228 -0.987 . . . . 0.0 111.235 171.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.17 -179.42 1.95 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.46 0.647 . . . . 0.0 111.896 -173.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -73.56 82.05 1.5 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.661 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 54' ' ' GLY . 3.2 m -64.64 115.8 5.58 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.338 173.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.11 -18.6 37.05 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -169.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.611 ' HD3' ' HG3' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -69.42 -49.27 56.76 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -177.264 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.611 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 44.1 mt-10 -120.11 -27.54 5.29 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.678 0.751 . . . . 0.0 111.238 174.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.476 ' O ' HD22 ' A' ' 73' ' ' LEU . . . 46.29 8.27 0.02 OUTLIER Glycine 0 C--O 1.219 -0.813 0 CA-C-N 113.787 -1.551 . . . . 0.0 116.8 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.493 ' HA ' HD13 ' A' ' 73' ' ' LEU . 12.9 m-85 -127.81 9.24 6.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 119.286 1.543 . . . . 0.0 111.223 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.744 ' HE3' ' N ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -74.42 -24.56 59.11 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.996 -171.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.744 ' N ' ' HE3' ' A' ' 56' ' ' LYS . . . 59.88 -8.07 0.06 OUTLIER Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.283 -0.871 . . . . 0.0 114.551 -175.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.537 ' OG ' ' HA3' ' A' ' 47' ' ' GLY . 16.1 m 69.13 -72.44 0.1 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -171.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 33.2 tt0 -119.9 -27.87 5.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.096 166.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.45 ' HB2' HD13 ' A' ' 46' ' ' ILE . 11.1 m-85 -134.86 124.98 25.89 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 120.906 0.384 . . . . 0.0 111.001 176.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.443 ' HB1' ' CD1' ' A' ' 73' ' ' LEU . . . -102.46 105.93 46.34 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.202 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.554 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 38.1 Cg_endo -69.69 119.69 6.6 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.936 1.757 . . . . 0.0 111.335 174.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 72' ' ' MET . 43.4 p -126.07 162.12 26.05 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.175 0.512 . . . . 0.0 110.767 -176.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.635 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 3.5 p90 -132.84 165.18 25.19 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.307 -177.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.418 ' HB2' ' CZ2' ' A' ' 71' ' ' TRP . 30.9 tt0 -108.42 115.77 30.72 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.46 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.559 ' OD2' ' HG2' ' A' ' 67' ' ' LYS . 17.7 t70 -80.53 -176.8 5.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.819 176.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.559 ' HG2' ' OD2' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -62.83 -39.37 94.12 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -171.33 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.442 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . 20.6 t70 -83.0 -0.98 51.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.18 0.514 . . . . 0.0 110.602 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.41 24.39 28.84 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.177 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.442 ' OD2' ' HB3' ' A' ' 68' ' ' ASP . 20.1 m-20 -81.52 129.0 34.5 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.635 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 71.7 m95 -110.3 113.79 26.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.019 0.438 . . . . 0.0 110.813 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.431 ' O ' ' HA ' ' A' ' 63' ' ' THR . 25.6 mtm -134.81 176.48 8.61 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.554 ' HA ' ' O ' ' A' ' 62' ' ' PRO . 1.2 tp -68.66 154.89 41.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.498 0.665 . . . . 0.0 111.04 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.604 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 3.7 m -77.83 124.38 36.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.136 175.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.94 3.5 28.17 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -172.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.13 -56.65 15.02 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.037 0.446 . . . . 0.0 109.93 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.533 HG22 ' CD2' ' A' ' 82' ' ' PHE . 6.3 m -100.98 154.68 37.0 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 173.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.431 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 11.0 Cg_endo -54.45 136.86 71.15 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.879 2.386 . . . . 0.0 113.075 -176.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.515 ' O ' HG23 ' A' ' 83' ' ' VAL . 69.9 t-105 -40.09 -53.03 2.48 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -174.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -51.58 -43.02 62.31 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.046 0.45 . . . . 0.0 111.674 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 77.7 mtp -83.91 -24.54 30.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.468 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' A' ' 74' ' ' VAL . 13.4 t80 -68.81 -38.21 79.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.676 -173.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.538 HG13 HD23 ' A' ' 25' ' ' LEU . 3.3 t -61.17 -42.86 94.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.897 0.38 . . . . 0.0 111.407 -172.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.5 p -78.52 -13.94 59.59 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.465 0.65 . . . . 0.0 110.588 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.1 t -81.42 -31.41 33.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.651 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.448 ' HA ' ' HD2' ' A' ' 64' ' ' TYR . 43.5 t -86.52 131.67 34.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.736 0.779 . . . . 0.0 112.202 -175.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -119.37 -36.74 3.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.263 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -139.14 153.15 47.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.931 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.699 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 12.4 tp -130.5 127.39 39.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.234 0.54 . . . . 0.0 111.716 -174.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.433 ' HB3' ' CZ3' ' A' ' 71' ' ' TRP . 37.5 ttp180 -140.33 130.0 24.32 Favored 'General case' 0 C--N 1.31 -1.137 0 O-C-N 121.374 -0.829 . . . . 0.0 110.929 171.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.773 ' O ' ' HE2' ' A' ' 14' ' ' MET . 8.8 mt -109.41 132.15 58.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.636 ' HE3' HD21 ' A' ' 100' ' ' LEU . 3.1 ptt? -139.09 141.23 38.16 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -168.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 0.1 OUTLIER -48.38 141.03 7.05 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.229 174.187 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.13 -28.5 49.5 Favored Glycine 0 CA--C 1.508 -0.405 0 CA-C-N 115.398 -0.819 . . . . 0.0 114.146 -169.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.2 t -66.38 -12.79 58.84 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.134 0.493 . . . . 0.0 111.301 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -101.76 -51.53 3.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.614 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.55 -23.81 66.27 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -172.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -57.03 -28.65 62.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.177 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.33 -37.01 22.37 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.638 -176.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.636 HD21 ' HE3' ' A' ' 92' ' ' MET . 2.2 pt? . . . . . 0 C--N 1.324 -0.521 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -173.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 41.0 m80 . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -122.35 77.65 1.43 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.381 0.61 . . . . 0.0 110.268 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.13 -1.58 3.64 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.275 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -126.44 72.3 1.32 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.293 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.439 ' HA ' ' HB3' ' A' ' 26' ' ' ARG . 96.1 t -129.31 114.87 33.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.03 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.595 ' HA2' ' CG ' ' A' ' 24' ' ' ASP . . . 71.75 90.95 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.78 -177.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.84 -48.48 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.539 -1.025 . . . . 0.0 110.539 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.826 HD13 ' CZ ' ' A' ' 26' ' ' ARG . 3.8 mp -94.71 106.23 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-O 121.411 0.625 . . . . 0.0 109.941 173.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -91.55 138.18 31.77 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.473 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.58 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -115.86 140.03 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -174.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.633 ' HA ' ' CD ' ' A' ' 22' ' ' LYS . 8.1 mptt -107.04 128.35 54.29 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.46 -0.791 . . . . 0.0 108.886 -174.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.771 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -124.65 133.3 69.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.474 0.654 . . . . 0.0 112.044 -169.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.5 m -131.9 155.5 47.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.583 -174.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.467 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 31.0 tpp -113.6 148.28 36.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.619 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -116.06 142.26 47.04 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.98 -32.57 3.74 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.467 ' O ' ' HG3' ' A' ' 14' ' ' MET . . . -133.2 142.66 45.22 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 171.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.99 124.76 7.55 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 121.924 1.749 . . . . 0.0 112.685 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.435 ' HB2' ' HB3' ' A' ' 14' ' ' MET . 68.0 m-85 -151.5 142.55 23.12 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.953 174.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.563 ' O ' ' HD2' ' A' ' 21' ' ' ARG . 5.1 mp -130.17 104.67 7.45 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.101 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.563 ' HD2' ' O ' ' A' ' 20' ' ' LEU . 3.2 mpt_? -126.43 164.1 21.86 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.316 176.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.633 ' CD ' ' HA ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -154.95 143.86 20.85 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -153.54 174.01 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 O-C-N 123.34 0.4 . . . . 0.0 111.599 -175.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.595 ' CG ' ' HA2' ' A' ' 6' ' ' GLY . 6.4 t70 -115.17 146.96 40.87 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.184 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.494 ' HG ' ' CG2' ' A' ' 10' ' ' VAL . 70.5 mt -72.13 -40.27 68.22 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -175.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.826 ' CZ ' HD13 ' A' ' 8' ' ' ILE . 9.4 mpt_? -71.08 -30.9 67.14 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -173.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 24' ' ' ASP . 36.0 m -62.78 -2.86 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -170.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -99.21 -27.65 13.7 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.914 0.388 . . . . 0.0 111.731 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.45 12.91 14.57 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.986 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.72 171.03 32.36 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.245 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -70.0 -29.83 67.01 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.8 p -56.71 -53.72 54.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.92 0.391 . . . . 0.0 111.17 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -73.25 -27.09 61.38 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.086 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 20.8 tp -58.26 -54.01 51.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.866 0.365 . . . . 0.0 110.144 175.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 96.0 mt -66.19 -38.52 88.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.841 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.473 ' HD3' ' O ' ' A' ' 36' ' ' LYS . 1.7 tmtp? -66.0 -33.92 76.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.352 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.679 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -63.5 -40.96 98.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.286 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.502 ' H ' ' HG ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -62.56 -49.32 75.74 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.457 ' HG2' ' H ' ' A' ' 46' ' ' ILE . 28.2 mt-10 -52.87 -33.66 50.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.111 175.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.56 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 38.4 m -73.03 -39.63 65.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.245 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.679 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 93.1 mmm -58.2 -55.65 32.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.311 -168.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -104.26 10.38 35.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.013 0.435 . . . . 0.0 111.111 -174.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.58 53.6 4.04 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.649 177.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 pp -154.78 -167.07 2.48 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 61.2 m -117.69 117.04 28.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.959 0.409 . . . . 0.0 111.638 -177.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.457 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 34.8 mm -85.76 135.44 24.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.329 175.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.9 143.56 33.69 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.497 173.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -73.38 172.9 10.38 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.122 0.487 . . . . 0.0 111.46 -174.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.632 ' HD1' HD22 ' A' ' 73' ' ' LEU . 44.5 t80 -76.42 79.14 3.15 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.777 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.5 m -59.29 123.21 15.99 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.05 -11.24 47.06 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -168.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.498 ' HD2' ' HG3' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -78.9 -49.79 12.28 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.025 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.498 ' HG3' ' HD2' ' A' ' 52' ' ' ARG . 90.8 mt-10 -119.32 -29.16 5.23 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.756 -0.59 . . . . 0.0 112.076 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.554 ' O ' HD13 ' A' ' 73' ' ' LEU . . . 41.78 12.1 0.01 OUTLIER Glycine 0 C--O 1.216 -1.022 0 N-CA-C 117.067 1.587 . . . . 0.0 117.067 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.738 ' HA ' HD13 ' A' ' 73' ' ' LEU . 17.5 m-30 -124.26 1.1 8.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 119.493 1.647 . . . . 0.0 110.492 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.422 ' HD3' ' H ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -64.78 -52.94 54.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.787 -175.602 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 60' ' ' TYR . . . 59.1 7.87 5.54 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 116.286 -0.415 . . . . 0.0 113.84 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.5 t 65.9 -82.72 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.199 0.6 . . . . 0.0 110.179 -171.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 40.5 tt0 -117.16 -15.64 10.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.595 0.236 . . . . 0.0 110.821 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.476 ' CZ ' ' HG3' ' A' ' 93' ' ' LYS . 57.7 m-85 -136.63 126.04 25.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.764 0.316 . . . . 0.0 111.432 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.638 ' HB1' HD12 ' A' ' 73' ' ' LEU . . . -103.92 105.79 49.92 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.801 175.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.505 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 28.6 Cg_endo -64.55 120.71 8.07 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.008 1.805 . . . . 0.0 111.243 172.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.619 HG21 HD11 ' A' ' 100' ' ' LEU . 35.9 p -127.22 154.05 45.33 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.214 0.53 . . . . 0.0 110.24 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.598 ' CD2' ' HZ ' ' A' ' 82' ' ' PHE . 44.0 p90 -135.28 167.04 21.75 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.744 -175.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.531 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 33.6 tt0 -108.29 117.35 33.93 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.37 179.38 7.69 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.475 ' HD2' ' N ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -64.18 -25.88 68.27 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.475 ' N ' ' HD2' ' A' ' 67' ' ' LYS . 35.1 t70 -78.15 -18.4 55.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.22 0.533 . . . . 0.0 110.095 177.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.18 15.51 47.73 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.339 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -96.41 142.38 28.59 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.557 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 68.9 m95 -101.13 118.94 37.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.432 0.634 . . . . 0.0 110.828 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.435 ' O ' ' HA ' ' A' ' 63' ' ' THR . 45.1 mtm -125.4 171.75 10.19 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.414 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.738 HD13 ' HA ' ' A' ' 55' ' ' TYR . 7.5 tt -91.63 142.17 27.92 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.481 ' N ' HD23 ' A' ' 73' ' ' LEU . 19.7 m -58.85 143.06 13.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.103 -174.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.37 3.06 25.99 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.881 -173.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -80.23 -59.54 2.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.927 0.394 . . . . 0.0 110.712 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.576 HG12 ' HD2' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -96.55 153.25 38.88 Favored Pre-proline 0 N--CA 1.445 -0.717 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 175.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.576 ' HD2' HG12 ' A' ' 77' ' ' VAL . 7.5 Cg_exo -74.2 155.32 46.92 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.475 2.117 . . . . 0.0 110.791 176.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.722 ' O ' HG23 ' A' ' 83' ' ' VAL . 61.9 t-105 -46.38 -49.64 17.6 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.862 0.726 . . . . 0.0 112.695 -171.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -55.97 -42.18 75.9 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -171.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 78.8 mtp -83.53 -33.74 25.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.239 0.543 . . . . 0.0 110.472 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.598 ' HZ ' ' CD2' ' A' ' 64' ' ' TYR . 7.1 t80 -58.32 -50.93 71.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.95 -175.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 79' ' ' TRP . 2.1 t -60.64 -39.22 80.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.126 0.488 . . . . 0.0 111.307 -171.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.6 p -79.57 -11.7 59.87 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -175.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.5 p -108.8 -28.65 9.08 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -174.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 40.4 t -66.14 136.42 55.91 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.026 0.441 . . . . 0.0 111.051 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -116.86 -40.5 3.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.739 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.531 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 69.9 mtt180 -137.59 161.89 35.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.198 -175.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.771 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 6.5 tp -133.76 122.97 24.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.752 -172.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -139.7 119.67 13.52 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 121.829 -0.545 . . . . 0.0 110.508 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.421 HG23 ' HA ' ' A' ' 62' ' ' PRO . 10.3 mt -116.74 135.14 58.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.429 ' HA ' ' SD ' ' A' ' 14' ' ' MET . 25.5 ptt? -159.25 162.95 36.21 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.336 0.589 . . . . 0.0 112.357 -174.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 36.4 mttt -56.93 146.78 25.61 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.062 -1.426 . . . . 0.0 113.086 -176.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' A' ' 97' ' ' ALA . . . -60.3 -30.09 70.31 Favored Glycine 0 CA--C 1.507 -0.454 0 CA-C-N 114.125 -1.398 . . . . 0.0 113.726 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.498 HG22 ' HB3' ' A' ' 93' ' ' LYS . 1.5 t -56.78 -26.09 56.82 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.161 0.505 . . . . 0.0 111.337 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -102.67 -34.78 8.93 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.167 0.508 . . . . 0.0 110.346 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.407 ' HB3' ' HA2' ' A' ' 94' ' ' GLY . . . -63.08 -23.4 67.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.578 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.457 ' HA ' ' HB3' ' A' ' 106' ' ' SER . 16.0 pttp -62.39 -19.53 63.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.962 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -71.77 -40.61 57.94 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.39 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.619 HD11 HG21 ' A' ' 63' ' ' THR . 0.9 OUTLIER -102.51 11.53 37.76 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 122.599 -0.354 . . . . 0.0 110.87 -178.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.7 71.83 0.68 Allowed Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 173.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 59.1 m -55.21 105.2 0.15 Allowed 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.618 0.767 . . . . 0.0 112.554 -175.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 72.99 65.92 2.16 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 114.439 -1.255 . . . . 0.0 113.054 172.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 42.8 t 59.98 92.19 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.54 0.686 . . . . 0.0 110.324 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -140.86 -50.35 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.455 -0.879 . . . . 0.0 113.089 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.457 ' HB3' ' HA ' ' A' ' 98' ' ' LYS . 8.5 t -132.54 116.98 17.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.858 0.329 . . . . 0.0 111.338 -173.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.177 -0.916 . . . . 0.0 112.17 171.892 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 74.3 t60 . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.698 0.285 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -82.92 74.58 9.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.816 0.341 . . . . 0.0 111.705 -174.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 53.7 61.53 3.05 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.502 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.2 t70 63.28 108.71 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.415 0.686 . . . . 0.0 111.653 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.1 m -84.05 158.16 3.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.373 -176.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 148.97 153.25 5.95 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.117 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.93 -25.94 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.073 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 3.2 mp -114.06 104.5 17.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.184 0.516 . . . . 0.0 109.985 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -115.07 118.56 33.72 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.231 -172.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.597 ' CG2' ' HB2' ' A' ' 89' ' ' LEU . 4.1 m -116.25 162.51 14.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.165 -177.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.555 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 18.8 ptmt -104.07 134.33 47.52 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -126.47 128.08 70.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.607 0.717 . . . . 0.0 111.322 -177.003 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.3 t -122.56 155.2 36.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.763 175.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.739 ' SD ' ' HB ' ' A' ' 91' ' ' ILE . 68.6 mmm -103.18 141.92 35.04 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.847 0.356 . . . . 0.0 111.052 -177.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 92' ' ' MET . 11.0 t70 -110.44 125.02 52.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.024 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.34 -32.75 6.89 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -177.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.05 142.98 42.21 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 172.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.89 122.87 6.5 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 121.554 1.503 . . . . 0.0 112.355 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.482 ' HB2' ' CG ' ' A' ' 14' ' ' MET . 75.4 m-85 -153.43 151.68 30.17 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.044 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -127.81 105.56 8.52 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.008 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.481 ' C ' ' HG2' ' A' ' 22' ' ' LYS . 31.8 mmt180 -127.97 156.1 43.22 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.555 ' HD3' ' HA ' ' A' ' 11' ' ' LYS . 4.9 mmtm -147.81 130.18 15.71 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.415 HD11 ' CD2' ' A' ' 89' ' ' LEU . 4.0 pt -140.95 173.31 9.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.66 0.743 . . . . 0.0 112.168 -174.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.653 ' OD1' ' HG2' ' A' ' 26' ' ' ARG . 7.3 t70 -113.62 126.94 55.83 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.687 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.472 ' HB3' HG13 ' A' ' 83' ' ' VAL . 6.8 mp -70.8 -39.85 72.86 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.697 -174.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.653 ' HG2' ' OD1' ' A' ' 24' ' ' ASP . 8.4 ptm180 -77.66 -23.51 49.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.83 -167.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 24' ' ' ASP . 29.8 m -65.34 -16.12 19.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -176.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -84.74 -27.88 26.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.13 0.49 . . . . 0.0 110.909 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.93 14.3 30.31 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.24 -0.891 . . . . 0.0 113.688 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.07 168.5 32.02 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.412 ' CE1' ' HA2' ' A' ' 75' ' ' GLY . 43.3 m-85 -70.4 -34.24 72.31 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -175.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.1 m -59.05 -51.18 71.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.846 0.355 . . . . 0.0 111.386 -175.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -72.99 -33.71 65.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.797 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.1 tp -55.82 -55.78 28.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.156 0.503 . . . . 0.0 110.796 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.7 mt -66.8 -35.48 80.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.08 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.453 ' HD3' ' C ' ' A' ' 36' ' ' LYS . 13.1 tmtt? -63.27 -43.38 98.09 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.526 -177.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.45 ' O ' ' HB ' ' A' ' 40' ' ' THR . . . -57.71 -42.31 83.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.829 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.444 ' HG ' ' H ' ' A' ' 38' ' ' LEU . 1.3 mt -65.56 -53.3 43.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.841 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.457 ' HG2' ' H ' ' A' ' 46' ' ' ILE . 40.7 mt-10 -52.01 -28.74 18.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.694 175.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 33.6 m -76.48 -45.13 32.4 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.542 175.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.435 ' HG3' ' O ' ' A' ' 37' ' ' ALA . 30.6 mtm -58.91 -55.03 40.45 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -170.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.21 9.15 36.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.249 0.547 . . . . 0.0 111.125 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? 55.24 48.81 18.54 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.792 173.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 pp -141.53 178.86 7.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.7 m -95.73 122.13 38.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.213 0.53 . . . . 0.0 112.237 -173.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.457 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 49.1 mm -102.47 135.05 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.5 174.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.453 ' HA3' ' NZ ' ' A' ' 56' ' ' LYS . . . -89.32 164.96 32.33 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.744 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.4 176.94 8.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.277 0.561 . . . . 0.0 112.009 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -78.18 93.91 4.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.755 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.571 ' N ' ' HA2' ' A' ' 54' ' ' GLY . 2.1 t -49.78 138.98 13.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.05 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -73.87 -13.28 60.89 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.131 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.536 ' HD3' ' HG3' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -104.23 -44.5 4.95 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.064 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.536 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 24.4 mt-10 -118.26 -28.41 5.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.472 0.578 . . . . 0.0 111.555 175.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.571 ' HA2' ' N ' ' A' ' 50' ' ' SER . . . 54.06 11.15 2.1 Favored Glycine 0 C--O 1.219 -0.81 0 CA-C-N 114.699 -1.137 . . . . 0.0 115.216 -178.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.442 ' HB3' HD11 ' A' ' 100' ' ' LEU . 18.5 m-85 -125.54 4.09 7.6 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 118.473 1.136 . . . . 0.0 111.247 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.497 ' HD3' ' H ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -58.74 -37.71 76.8 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -176.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.497 ' H ' ' HD3' ' A' ' 56' ' ' LYS . . . 60.86 -4.94 0.22 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 114.252 0.461 . . . . 0.0 114.252 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.415 ' H ' ' HE2' ' A' ' 56' ' ' LYS . 48.8 m 69.26 -79.33 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.189 0.596 . . . . 0.0 109.892 -172.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 33.2 tt0 -118.57 -19.52 8.73 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.107 172.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -143.43 126.13 16.03 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.066 0.46 . . . . 0.0 110.974 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.434 ' HB1' ' CD1' ' A' ' 73' ' ' LEU . . . -103.01 104.45 40.09 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.06 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.477 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 33.9 Cg_endo -67.99 121.16 8.15 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 121.714 1.609 . . . . 0.0 111.263 172.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.436 HG21 HD22 ' A' ' 100' ' ' LEU . 82.2 p -125.54 160.05 30.52 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.519 -176.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.689 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.7 p90 -121.57 164.1 17.81 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.604 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.492 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 41.3 tt0 -103.42 115.64 30.91 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 14.1 t70 -84.03 -169.25 2.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.007 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.448 ' H ' ' CG ' ' A' ' 66' ' ' ASP . 1.4 mtmp? -66.65 -45.73 78.03 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.647 0.26 . . . . 0.0 111.474 -173.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.53 -3.76 51.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.194 0.521 . . . . 0.0 110.861 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.27 24.27 19.64 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.166 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -76.18 138.81 40.92 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.568 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 90.7 m95 -115.16 113.05 23.44 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 123.405 0.441 . . . . 0.0 109.952 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.433 ' HA ' ' CD1' ' A' ' 100' ' ' LEU . 32.5 mtm -142.36 169.45 17.56 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 176.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 62' ' ' PRO . 2.3 tp -62.88 152.89 35.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.282 0.563 . . . . 0.0 111.204 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.753 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 99.2 t -77.55 127.78 38.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.443 174.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.412 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 111.57 1.68 27.56 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -170.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -63.03 -48.3 79.32 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.571 HG22 ' CD2' ' A' ' 82' ' ' PHE . 3.2 m -113.88 156.8 43.34 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.86 133.11 33.31 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.965 2.443 . . . . 0.0 113.606 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.565 ' O ' HG23 ' A' ' 83' ' ' VAL . 73.2 t-105 -40.03 -53.31 2.4 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.444 1.097 . . . . 0.0 113.552 -173.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -52.51 -42.78 64.61 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -175.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 68.1 mtm -83.75 -27.48 28.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.111 0.482 . . . . 0.0 110.545 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.753 ' CZ ' ' HA ' ' A' ' 74' ' ' VAL . 9.2 t80 -63.16 -45.49 91.59 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.502 -174.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 79' ' ' TRP . 4.7 t -61.14 -42.34 92.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.302 -171.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.7 p -78.58 -19.45 52.74 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.094 0.473 . . . . 0.0 110.985 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.8 t -83.83 -21.73 31.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.302 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.689 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 36.2 t -90.93 133.47 35.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.161 0.505 . . . . 0.0 111.182 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 13.7 pttp -121.91 -29.52 4.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.738 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.492 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 60.2 mtt180 -139.51 167.28 22.46 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 176.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.712 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 10.8 tp -136.86 138.17 40.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.299 0.571 . . . . 0.0 111.527 -173.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -139.22 129.3 25.17 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.832 0.349 . . . . 0.0 110.146 170.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.739 ' HB ' ' SD ' ' A' ' 14' ' ' MET . 13.4 mt -111.65 138.28 40.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 175.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.467 ' HE1' ' HB3' ' A' ' 100' ' ' LEU . 9.1 ptt? -155.9 147.55 22.93 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -170.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 21.0 ttpt -50.83 147.88 4.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 113.591 -1.641 . . . . 0.0 112.828 -175.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.53 -27.98 70.53 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 114.698 -1.137 . . . . 0.0 113.276 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.526 ' O ' ' HE3' ' A' ' 98' ' ' LYS . 44.3 p -68.49 -16.08 63.77 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.91 0.386 . . . . 0.0 111.08 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -101.88 -2.57 29.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.453 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.574 ' HA ' HD23 ' A' ' 100' ' ' LEU . . . -59.61 -29.97 68.36 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -172.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.526 ' HE3' ' O ' ' A' ' 95' ' ' THR . 0.0 OUTLIER -59.6 -23.66 63.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.769 0.318 . . . . 0.0 110.874 178.434 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.52 -22.01 78.93 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 116.101 -0.5 . . . . 0.0 113.195 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.574 HD23 ' HA ' ' A' ' 97' ' ' ALA . 1.0 OUTLIER -103.58 -24.72 13.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.355 0.598 . . . . 0.0 110.756 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.455 ' N ' ' HG ' ' A' ' 100' ' ' LEU . . . -100.91 48.23 1.16 Allowed Glycine 0 CA--C 1.493 -1.299 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.31 -176.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 66.9 m -79.62 4.19 16.75 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.944 -0.628 . . . . 0.0 111.716 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.02 -57.02 1.42 Allowed Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.887 176.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.9 p -85.64 10.79 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 122.083 0.944 . . . . 0.0 110.655 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 56.8 49.55 69.86 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.285 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.2 t -57.35 145.37 32.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.779 0.324 . . . . 0.0 110.25 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.635 -0.698 . . . . 0.0 110.649 -176.021 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.557 0.217 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -105.93 91.52 3.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.525 0.202 . . . . 0.0 110.505 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.78 53.1 7.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.352 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.0 t70 68.27 155.3 0.11 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.335 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.1 t -91.21 75.44 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.586 0.708 . . . . 0.0 109.338 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 137.04 172.56 12.57 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.969 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 154.62 -38.81 0.66 Allowed Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 176.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.495 ' CD1' ' HD2' ' A' ' 26' ' ' ARG . 3.9 mp -92.26 106.3 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-O 121.218 0.532 . . . . 0.0 109.983 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -90.04 134.8 34.03 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.95 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.537 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -116.25 139.74 41.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.443 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -104.55 135.07 46.66 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.706 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -124.39 127.41 73.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.691 0.758 . . . . 0.0 111.472 -172.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.8 p -115.57 155.84 26.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.69 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.456 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 27.4 tpp -110.05 145.08 37.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.624 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -111.89 140.35 46.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.597 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.74 -32.44 4.54 Favored Glycine 0 C--O 1.229 -0.157 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 14' ' ' MET . . . -133.94 143.71 48.58 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 172.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.97 122.21 6.17 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 121.391 1.394 . . . . 0.0 112.262 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -153.29 143.16 22.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.766 174.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.5 mt -127.65 106.95 9.5 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.84 0.353 . . . . 0.0 110.368 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.554 ' O ' HG13 ' A' ' 12' ' ' VAL . 10.3 mmm180 -124.07 155.49 38.25 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.446 ' HD2' ' C ' ' A' ' 21' ' ' ARG . 2.5 mptp? -143.76 144.39 31.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.796 0.332 . . . . 0.0 110.551 175.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -146.87 176.06 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.979 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.485 ' O ' HG22 ' A' ' 27' ' ' VAL . 9.0 t70 -111.32 132.68 54.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.273 0.559 . . . . 0.0 110.275 -175.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.551 HD21 ' HB3' ' A' ' 86' ' ' CYS . 16.6 tp -69.27 -34.31 74.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.733 -172.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.495 ' HD2' ' CD1' ' A' ' 8' ' ' ILE . 65.8 mtp180 -79.47 -32.07 42.53 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -171.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 24' ' ' ASP . 33.6 m -68.81 -0.81 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -169.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.513 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 27.0 m-85 -85.64 -28.7 24.58 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.28 177.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.86 14.86 5.8 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.328 -0.851 . . . . 0.0 114.168 177.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.21 175.94 28.71 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.633 -176.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.4 ' OH ' ' HA ' ' A' ' 78' ' ' PRO . 25.1 m-85 -69.18 -31.63 70.39 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -176.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.9 p -59.69 -56.11 25.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.733 0.301 . . . . 0.0 111.44 -175.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' A' ' 28' ' ' TYR . 47.1 mt-10 -73.98 -25.83 60.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.59 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.64 -56.37 23.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.233 0.54 . . . . 0.0 110.115 174.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.4 mt -69.77 -36.63 75.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.81 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.458 ' HA ' ' HD3' ' A' ' 36' ' ' LYS . 68.0 mmtt -71.62 -31.29 66.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.561 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.684 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -58.59 -42.65 88.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.881 176.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.656 HD13 ' HG3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -58.24 -52.93 63.51 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.598 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 39.0 mt-10 -52.3 -30.22 27.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.896 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.559 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 53.8 m -73.95 -44.89 53.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.135 177.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.684 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 74.5 mmm -57.07 -57.13 13.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.707 -169.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -102.17 8.6 40.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.119 0.485 . . . . 0.0 110.922 -175.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.28 47.72 16.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.633 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 3.0 pp -145.51 -179.31 6.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.705 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 m -111.61 98.21 7.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -171.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.457 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 37.5 mm -65.51 127.66 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.988 172.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.5 149.59 43.82 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.891 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -68.21 162.7 24.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.117 0.484 . . . . 0.0 111.803 -174.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.541 ' CZ ' HD12 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -65.95 89.73 0.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.891 179.007 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.427 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 30.8 t -62.89 146.88 51.85 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.707 0.765 . . . . 0.0 109.849 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -76.37 -16.32 59.75 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.603 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.555 ' HD3' ' HG3' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -82.03 -56.3 4.04 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -172.457 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.555 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 39.5 mt-10 -121.34 -29.64 4.43 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.732 0.777 . . . . 0.0 109.687 165.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.532 ' O ' HD11 ' A' ' 73' ' ' LEU . . . 46.73 8.76 0.03 OUTLIER Glycine 0 C--O 1.214 -1.115 0 CA-C-N 113.317 -1.765 . . . . 0.0 116.216 -177.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.605 ' CD1' ' HA2' ' A' ' 105' ' ' GLY . 11.1 m-85 -114.78 6.49 15.55 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 118.171 0.986 . . . . 0.0 110.992 -176.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.507 ' HG2' ' H ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -63.85 -39.07 93.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.647 177.324 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 60' ' ' TYR . . . 58.31 22.19 49.97 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.78 176.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.507 ' H ' ' HG2' ' A' ' 56' ' ' LYS . 20.4 t 69.27 -86.19 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -165.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -119.75 -16.61 8.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.694 0.283 . . . . 0.0 110.971 169.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.525 ' O ' ' HA3' ' A' ' 57' ' ' GLY . 30.3 m-85 -122.27 125.79 46.78 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -174.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -100.92 105.33 37.68 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.936 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.656 ' HG3' HD13 ' A' ' 38' ' ' LEU . 61.0 Cg_endo -72.8 119.65 6.2 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.986 1.791 . . . . 0.0 111.231 175.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 72' ' ' MET . 71.2 p -128.78 165.49 20.84 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.766 -175.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.549 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 4.3 p90 -137.8 164.74 28.16 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.683 0.278 . . . . 0.0 110.349 -176.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.482 ' OE1' ' HD3' ' A' ' 88' ' ' ARG . 29.5 tt0 -100.24 113.92 26.96 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.89 177.48 8.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.715 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.0 mtmm -48.72 -44.14 37.96 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.117 0.567 . . . . 0.0 111.888 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -81.86 -15.99 52.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.114 0.483 . . . . 0.0 110.74 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.99 23.86 16.56 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.57 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -95.27 143.64 26.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.549 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 67.3 m95 -110.1 114.96 28.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.065 0.46 . . . . 0.0 111.516 -173.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.425 ' O ' ' HA ' ' A' ' 63' ' ' THR . 2.1 mpp? -127.37 179.3 5.54 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 174.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.541 HD12 ' CZ ' ' A' ' 49' ' ' TYR . 10.8 mt -64.0 153.22 37.93 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.54 0.686 . . . . 0.0 111.531 176.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.406 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 22.9 m -77.14 137.83 21.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.855 175.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.73 8.26 80.18 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.624 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.35 -54.03 43.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.664 0.268 . . . . 0.0 111.212 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.542 HG22 ' CD2' ' A' ' 82' ' ' PHE . 12.4 m -98.82 155.52 36.57 Favored Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 4.2 Cg_endo -46.95 132.82 17.8 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.487 2.791 . . . . 0.0 113.326 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.548 ' O ' HG23 ' A' ' 83' ' ' VAL . 70.0 t-105 -43.41 -51.88 6.28 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -171.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -54.63 -42.66 71.48 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.628 0.251 . . . . 0.0 111.637 -174.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 57.2 ttp -84.03 -22.73 31.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.998 0.428 . . . . 0.0 110.547 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.542 ' CD2' HG22 ' A' ' 77' ' ' VAL . 11.4 t80 -66.29 -45.93 78.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.038 -177.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 79' ' ' TRP . 3.5 t -61.37 -37.28 77.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.115 0.483 . . . . 0.0 110.944 -174.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.5 p -79.46 -12.34 59.88 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.334 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.3 m -95.17 -31.32 13.58 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.551 ' HB3' HD21 ' A' ' 25' ' ' LEU . 44.6 t -80.5 130.31 35.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.762 0.791 . . . . 0.0 111.457 -175.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -118.21 -40.66 2.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.674 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.482 ' HD3' ' OE1' ' A' ' 65' ' ' GLU . 51.6 mtp180 -140.14 163.54 32.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.084 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.706 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 5.6 tp -130.02 137.65 50.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.879 0.371 . . . . 0.0 110.826 -171.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.406 ' HD2' ' SD ' ' A' ' 92' ' ' MET . 12.9 ttm180 -139.31 115.03 10.04 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.826 175.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.1 mt -111.25 133.92 55.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 171.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.495 ' C ' ' HD1' ' A' ' 60' ' ' TYR . 21.9 ptt? -159.19 161.46 36.15 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -169.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -56.96 141.22 46.16 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.696 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.69 -22.07 45.38 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.957 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.2 t -63.63 -20.22 65.5 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.002 0.43 . . . . 0.0 111.01 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -101.25 -39.03 7.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.08 0.467 . . . . 0.0 109.887 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.44 -25.76 67.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.004 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.507 ' HA ' ' HB3' ' A' ' 106' ' ' SER . 13.4 ptmm? -65.25 -23.28 67.02 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.37 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.91 -38.1 36.9 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.911 -0.661 . . . . 0.0 113.112 -177.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.472 ' H ' HD23 ' A' ' 100' ' ' LEU . 1.3 pt? -103.59 11.89 35.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.748 0.308 . . . . 0.0 111.65 -174.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.34 81.96 0.37 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.599 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 24.1 p -121.92 128.35 51.45 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.24 0.543 . . . . 0.0 110.55 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.21 68.85 1.17 Allowed Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.478 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.7 t 60.45 57.51 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.988 0.899 . . . . 0.0 108.789 -172.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.605 ' HA2' ' CD1' ' A' ' 55' ' ' TYR . . . -130.74 -168.5 12.25 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.649 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.507 ' HB3' ' HA ' ' A' ' 98' ' ' LYS . 11.5 t -75.36 131.73 40.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.982 0.42 . . . . 0.0 110.254 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.1 m170 . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.648 -0.692 . . . . 0.0 110.579 -175.585 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 39.0 m80 . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 120.462 0.172 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -79.31 59.99 3.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.286 0.565 . . . . 0.0 111.424 -173.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 175.94 -51.51 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.337 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -92.12 26.88 2.34 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.11 -173.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.75 153.04 33.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 176.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.558 ' O ' ' HD3' ' A' ' 26' ' ' ARG . . . 122.71 -177.72 16.47 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.284 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 140.21 -40.93 1.34 Allowed Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -176.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 mp -125.11 107.58 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 114.229 -0.986 . . . . 0.0 109.129 170.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -103.18 141.2 36.28 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.571 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.598 HG21 HD13 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -131.15 152.88 38.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.235 0.54 . . . . 0.0 109.927 -179.029 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -118.72 141.46 48.6 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -125.57 126.88 71.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.61 0.719 . . . . 0.0 111.313 -174.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.6 m -117.41 155.6 29.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.366 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.695 ' SD ' ' HA ' ' A' ' 92' ' ' MET . 25.7 tpp -99.69 151.98 20.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.888 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -119.06 122.46 42.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.079 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.63 -31.94 8.15 Favored Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.43 ' O ' ' HG3' ' A' ' 14' ' ' MET . . . -134.64 149.15 70.04 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 173.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.18 121.75 5.88 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.019 1.146 . . . . 0.0 112.222 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.526 ' HB2' ' CB ' ' A' ' 14' ' ' MET . 56.6 m-85 -153.09 142.89 22.05 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.557 175.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.453 HD22 ' C ' ' A' ' 19' ' ' TYR . 3.1 mm? -129.53 106.71 8.94 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.14 0.495 . . . . 0.0 111.12 -176.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.504 ' C ' ' HD2' ' A' ' 22' ' ' LYS . 37.3 mmt180 -125.52 155.85 39.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.808 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.504 ' HD2' ' C ' ' A' ' 21' ' ' ARG . 2.5 mptp? -146.96 137.2 23.49 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.533 HD11 ' CD2' ' A' ' 89' ' ' LEU . 1.9 pt -140.95 174.11 8.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.576 0.703 . . . . 0.0 111.87 -176.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.536 ' O ' HG22 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -113.16 124.8 53.4 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.036 -0.983 . . . . 0.0 108.956 -177.155 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.598 HD13 HG21 ' A' ' 10' ' ' VAL . 11.8 tp -71.62 -45.58 61.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -165.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.558 ' HD3' ' O ' ' A' ' 6' ' ' GLY . 2.8 ptm180 -79.98 -16.37 55.33 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -171.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 24' ' ' ASP . 19.1 m -75.68 -0.74 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -169.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.461 ' OH ' ' HB ' ' A' ' 23' ' ' ILE . 30.5 m-85 -96.12 -28.93 14.36 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.926 0.394 . . . . 0.0 111.341 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.16 14.21 17.68 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.859 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.31 167.31 33.61 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.876 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -69.23 -34.14 74.38 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 p -57.21 -55.22 37.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.569 0.223 . . . . 0.0 111.159 -176.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -70.3 -29.95 66.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.105 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.5 tp -59.09 -55.6 33.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.187 0.518 . . . . 0.0 109.959 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.54 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 56.4 mt -67.31 -38.13 84.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.259 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 36' ' ' LYS . 62.9 mmtt -69.66 -31.96 70.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.657 -177.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.471 ' O ' ' HB ' ' A' ' 40' ' ' THR . . . -60.54 -41.82 95.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.076 0.465 . . . . 0.0 110.387 176.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.541 ' HB2' HG13 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -63.37 -54.61 34.17 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.54 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 23.6 mt-10 -52.11 -29.8 23.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.938 176.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 24.6 m -71.71 -41.89 68.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.205 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.533 ' HE3' ' CZ ' ' A' ' 42' ' ' PHE . 71.8 mtm -66.51 -55.03 17.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -171.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.533 ' CZ ' ' HE3' ' A' ' 41' ' ' MET . 0.1 OUTLIER -100.46 10.53 41.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.159 0.504 . . . . 0.0 111.929 -173.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp 55.27 47.92 20.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.622 174.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.41 ' CD2' ' HB2' ' A' ' 42' ' ' PHE . 2.8 pp -143.08 -176.37 4.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.007 -177.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 63.4 m -108.18 99.86 9.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.042 0.449 . . . . 0.0 111.713 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.541 HG13 ' HB2' ' A' ' 38' ' ' LEU . 34.2 mm -76.77 123.18 32.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 172.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.02 155.52 53.58 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.013 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -71.01 171.27 11.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.296 0.57 . . . . 0.0 111.249 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.579 ' HD1' HD22 ' A' ' 73' ' ' LEU . 28.2 t80 -79.3 85.66 5.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.542 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.8 m -56.66 135.64 54.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.383 173.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -72.13 -25.73 61.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.282 0.563 . . . . 0.0 110.399 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.588 ' HD2' ' N ' ' A' ' 53' ' ' GLU . 3.4 ppt_? -68.24 -52.98 27.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.367 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.588 ' N ' ' HD2' ' A' ' 52' ' ' ARG . 47.6 mt-10 -122.84 -29.23 4.01 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.634 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.598 ' O ' HD13 ' A' ' 73' ' ' LEU . . . 42.21 10.87 0.01 OUTLIER Glycine 0 C--O 1.218 -0.872 0 N-CA-C 116.303 1.281 . . . . 0.0 116.303 -174.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.455 ' HD1' ' HB3' ' A' ' 73' ' ' LEU . 9.7 m-85 -126.25 6.57 7.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 118.672 1.236 . . . . 0.0 110.269 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.479 ' HG2' ' H ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -67.12 -31.21 71.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.5 -175.29 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 58' ' ' SER . . . 65.56 -12.74 0.31 Allowed Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.527 -0.761 . . . . 0.0 114.727 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.479 ' H ' ' HG2' ' A' ' 56' ' ' LYS . 40.0 m 71.77 -80.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -172.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -118.88 -23.75 6.84 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.656 170.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.424 ' HE1' ' SD ' ' A' ' 14' ' ' MET . 37.4 m-85 -134.79 124.51 25.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.008 0.432 . . . . 0.0 111.205 175.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.431 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . . . -105.46 105.3 51.92 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.681 177.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.516 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 43.8 Cg_endo -68.51 120.17 7.13 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.499 1.466 . . . . 0.0 110.993 174.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.3 p -124.7 168.45 13.16 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.078 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 3.6 p90 -143.77 165.32 28.0 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -176.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.436 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 40.4 tt0 -108.32 121.14 44.29 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.401 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.479 ' O ' ' HE3' ' A' ' 87' ' ' LYS . 14.9 t70 -84.15 -169.34 2.54 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.567 177.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.484 ' NZ ' ' HA ' ' A' ' 85' ' ' SER . 17.4 mmtm -62.36 -49.08 76.99 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.725 0.774 . . . . 0.0 109.82 -172.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -84.39 13.93 4.94 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.714 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.79 19.58 72.84 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.942 175.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -75.61 130.0 38.08 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.526 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 92.8 m95 -106.26 120.72 42.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.167 0.508 . . . . 0.0 110.69 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 46.5 mtm -138.5 170.27 16.32 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.598 HD13 ' O ' ' A' ' 54' ' ' GLY . 10.0 tt -79.08 141.57 37.25 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 16.2 m -66.81 130.11 31.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.649 0.738 . . . . 0.0 112.219 -174.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.87 4.56 26.08 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.807 -175.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.05 -59.43 5.43 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.612 0.244 . . . . 0.0 110.869 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.8 m -98.57 156.06 36.1 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -52.16 137.14 54.67 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.172 2.581 . . . . 0.0 112.975 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.593 ' O ' HG23 ' A' ' 83' ' ' VAL . 71.9 t-105 -43.78 -41.72 5.12 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.347 -174.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -58.74 -42.63 89.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.093 0.473 . . . . 0.0 111.063 -174.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 49.9 ttp -85.11 -27.66 26.11 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.589 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 74' ' ' VAL . 11.8 t80 -63.63 -40.71 97.57 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.162 -172.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 79' ' ' TRP . 2.8 t -60.86 -39.7 82.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.415 0.626 . . . . 0.0 110.942 -173.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.7 p -79.09 -10.85 59.94 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.314 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.484 ' HA ' ' NZ ' ' A' ' 67' ' ' LYS . 68.0 m -89.3 -31.39 17.86 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 30.3 t -90.75 123.91 34.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.176 0.512 . . . . 0.0 112.043 -175.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.479 ' HE3' ' O ' ' A' ' 66' ' ' ASP . 18.8 pttp -118.83 -22.9 7.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.594 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.436 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 84.5 mtt180 -140.23 151.16 44.94 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 174.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.63 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 3.6 tp -125.73 137.72 53.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.018 0.437 . . . . 0.0 111.114 -174.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -139.31 116.08 10.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.154 0.502 . . . . 0.0 110.948 172.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.435 HD12 ' HZ ' ' A' ' 42' ' ' PHE . 22.1 mt -106.8 136.6 41.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 173.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.695 ' HA ' ' SD ' ' A' ' 14' ' ' MET . 19.9 ptt? -157.94 160.05 37.17 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -168.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -56.02 138.66 48.75 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 113.666 -1.606 . . . . 0.0 111.952 -177.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -61.99 -28.72 70.89 Favored Glycine 0 CA--C 1.505 -0.582 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.127 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.3 p -64.17 -20.31 65.91 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.195 -0.502 . . . . 0.0 111.124 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -100.53 -47.53 4.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.39 0.615 . . . . 0.0 110.103 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.96 -21.85 65.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.154 -176.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.652 ' HA ' ' SG ' ' A' ' 102' ' ' CYS . 0.1 OUTLIER -53.6 -29.74 39.09 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -175.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.58 -39.32 93.84 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.786 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.7 pp -103.97 -25.4 13.03 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -174.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -104.42 -48.73 1.1 Allowed Glycine 0 CA--C 1.492 -1.356 0 C-N-CA 120.34 -0.933 . . . . 0.0 112.111 -174.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.652 ' SG ' ' HA ' ' A' ' 98' ' ' LYS . 39.3 m -78.76 5.84 10.34 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.36 0.6 . . . . 0.0 110.821 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.51 33.44 5.49 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 168.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 p 34.73 73.84 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 113.165 -1.518 . . . . 0.0 113.125 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 130.16 73.98 0.13 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.552 174.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 25.4 t -63.91 105.35 0.83 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.77 0.319 . . . . 0.0 110.755 173.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.1 m170 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.369 -0.824 . . . . 0.0 109.767 177.446 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.424 ' H3 ' ' CG ' ' A' ' 4' ' ' ASP . 38.5 m-70 . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.788 0.328 . . . . 0.0 110.409 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -98.76 87.97 3.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.229 0.538 . . . . 0.0 110.68 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 71.95 -8.26 1.15 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.005 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.424 ' CG ' ' H3 ' ' A' ' 1' ' ' HIS . 8.4 p-10 -96.13 34.41 1.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 27' ' ' VAL . 84.3 t 74.63 118.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.255 -175.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 144.17 156.77 6.93 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.15 -21.69 0.29 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.75 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.51 ' CD1' ' HD2' ' A' ' 26' ' ' ARG . 3.3 mp -104.9 105.56 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 121.249 0.547 . . . . 0.0 109.674 177.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -102.9 130.77 50.06 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.439 -172.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.622 HG21 HD13 ' A' ' 25' ' ' LEU . 2.1 t -121.12 150.75 24.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.639 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -105.95 135.13 47.95 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.7 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -124.93 125.94 70.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.449 0.642 . . . . 0.0 110.874 -175.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 p -114.76 148.19 38.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.493 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.512 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 79.0 mmm -104.73 165.84 10.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.791 -177.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -131.75 141.7 49.58 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.99 -33.19 4.32 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.887 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.12 140.09 33.77 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-O 120.805 0.336 . . . . 0.0 110.796 173.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.3 127.77 9.29 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.925 2.416 . . . . 0.0 112.729 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -149.52 172.46 14.95 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.08 103.88 5.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.818 0.818 . . . . 0.0 110.423 170.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.449 ' C ' ' HD2' ' A' ' 22' ' ' LYS . 39.7 mmt180 -127.68 136.63 51.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.1 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.449 ' HD2' ' C ' ' A' ' 21' ' ' ARG . 2.6 mptp? -144.42 141.27 29.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 171.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.537 HD11 ' CD2' ' A' ' 89' ' ' LEU . 3.4 pt -140.86 174.11 8.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.028 0.442 . . . . 0.0 112.142 -175.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -110.45 126.47 54.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.103 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.622 HD13 HG21 ' A' ' 10' ' ' VAL . 10.8 tp -69.84 -43.06 72.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.833 -170.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.51 ' HD2' ' CD1' ' A' ' 8' ' ' ILE . 11.5 ptm180 -80.28 -25.82 39.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.047 0.451 . . . . 0.0 110.719 -171.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.437 ' HA ' HG12 ' A' ' 5' ' ' VAL . 0.5 OUTLIER -49.71 -21.81 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 124.491 1.116 . . . . 0.0 113.767 -179.002 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -86.73 -28.23 23.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.972 0.415 . . . . 0.0 111.805 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.5 13.75 46.14 Favored Glycine 0 CA--C 1.519 0.293 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.414 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 161.4 176.92 34.02 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.171 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.597 ' CE1' ' HA2' ' A' ' 75' ' ' GLY . 38.3 m-85 -69.49 -30.78 68.72 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -177.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.4 m -58.68 -54.76 43.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.671 0.272 . . . . 0.0 111.414 -174.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -73.59 -28.91 62.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.801 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.467 HD21 ' HB ' ' A' ' 74' ' ' VAL . 14.2 tp -58.31 -55.32 36.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.433 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.498 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 79.7 mt -67.12 -36.79 82.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.89 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.514 ' HA ' ' OE1' ' A' ' 39' ' ' GLU . 1.5 tmtp? -64.8 -33.89 77.06 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.499 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.711 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -67.64 -37.5 82.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.298 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.685 HD13 ' HG3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -63.52 -48.84 75.9 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.495 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 51.1 mt-10 -51.34 -33.27 28.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.574 173.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.549 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 21.1 m -74.37 -34.82 63.46 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.424 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.711 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 47.0 mmm -63.39 -57.86 8.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.131 -170.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.567 ' HE1' HD11 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -107.73 11.67 28.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.257 0.551 . . . . 0.0 111.101 -174.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp 61.7 50.53 4.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.72 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.615 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 2.4 pp -152.83 176.1 12.17 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.384 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.9 m -102.46 105.32 15.86 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -174.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.567 HD11 ' HE1' ' A' ' 42' ' ' PHE . 2.3 mt -89.2 120.89 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.601 169.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.46 165.86 54.55 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.558 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -66.02 172.37 3.78 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.725 0.774 . . . . 0.0 112.557 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.407 ' CD1' ' HB3' ' A' ' 73' ' ' LEU . 70.0 t80 -74.72 86.18 2.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.489 177.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 74.5 m -55.56 129.09 37.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.424 173.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.404 ' CD ' ' H ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -64.93 -31.19 72.3 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.042 -171.228 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -50.47 28.43 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -174.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 105' ' ' GLY . 20.1 tt0 -119.68 -28.66 5.22 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.223 0.535 . . . . 0.0 111.068 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.545 ' O ' HD22 ' A' ' 73' ' ' LEU . . . 45.23 12.06 0.03 OUTLIER Glycine 0 C--O 1.218 -0.896 0 N-CA-C 117.102 1.601 . . . . 0.0 117.102 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.434 ' HA ' HD13 ' A' ' 73' ' ' LEU . 17.3 m-30 -124.74 15.04 8.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 119.617 1.709 . . . . 0.0 111.144 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.494 ' HG2' ' H ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -74.44 -38.51 62.99 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.805 -177.042 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.09 7.74 5.36 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 115.797 -0.638 . . . . 0.0 114.436 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.494 ' H ' ' HG2' ' A' ' 56' ' ' LYS . 32.4 m 63.83 -83.87 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 122.733 0.413 . . . . 0.0 110.08 -171.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 39.3 tt0 -118.58 -14.52 9.62 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.681 0.277 . . . . 0.0 110.824 172.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -139.96 125.35 19.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.828 0.347 . . . . 0.0 111.036 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -100.53 103.7 25.69 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.798 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.685 ' HG3' HD13 ' A' ' 38' ' ' LEU . 57.2 Cg_endo -74.18 121.9 7.2 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.92 1.747 . . . . 0.0 111.638 174.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.43 HG21 HD13 ' A' ' 100' ' ' LEU . 63.2 p -124.91 157.27 36.4 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.038 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.689 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 3.4 p90 -129.23 164.5 23.33 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.48 ' CG ' ' HA2' ' A' ' 69' ' ' GLY . 43.9 tt0 -101.14 120.15 39.79 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.81 -168.72 2.31 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.355 0.41 . . . . 0.0 111.022 -176.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.0 mtmm -57.67 -44.09 85.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.458 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -82.86 -14.65 53.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.285 0.564 . . . . 0.0 110.403 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.48 ' HA2' ' CG ' ' A' ' 65' ' ' GLU . . . 96.27 29.3 8.5 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.89 176.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -96.41 160.5 14.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.931 0.365 . . . . 0.0 110.11 172.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.689 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 39.6 m95 -122.46 114.1 20.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.902 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -131.44 174.33 10.18 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 171.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.545 HD22 ' O ' ' A' ' 54' ' ' GLY . 1.0 OUTLIER -62.59 157.33 20.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.75 0.786 . . . . 0.0 111.091 -178.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.467 ' HB ' HD21 ' A' ' 34' ' ' LEU . 31.4 m -76.26 134.54 28.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.101 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.597 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 109.96 0.67 30.22 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -171.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -56.57 -56.1 25.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.415 -0.392 . . . . 0.0 111.158 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 m -112.74 152.32 44.67 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.33 136.83 19.3 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.424 2.749 . . . . 0.0 113.203 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.552 ' O ' HG23 ' A' ' 83' ' ' VAL . 73.2 t-105 -43.21 -48.08 6.48 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 123.954 0.784 . . . . 0.0 113.107 -171.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -53.53 -43.08 68.06 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.2 0.312 . . . . 0.0 111.635 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 58.8 mtm -84.26 -25.33 29.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.963 0.411 . . . . 0.0 110.502 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -64.29 -44.84 90.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.423 -174.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 79' ' ' TRP . 2.5 t -61.68 -41.43 90.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.092 0.472 . . . . 0.0 111.023 -173.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.5 p -79.47 -15.46 57.74 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.569 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 65.8 m -91.19 -31.66 16.09 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.557 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 41.5 t -73.68 135.59 43.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.484 0.659 . . . . 0.0 111.048 -177.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -118.24 -44.17 2.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.324 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -140.15 163.38 32.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.712 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.7 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 2.0 tp -128.14 135.5 49.85 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.921 0.391 . . . . 0.0 110.702 -172.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -139.11 123.04 17.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.801 0.334 . . . . 0.0 110.868 175.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 14' ' ' MET . 6.1 mt -120.41 137.95 52.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 15.3 ptt? -156.65 158.64 37.37 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.213 0.53 . . . . 0.0 112.368 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 7.2 tttp -53.07 149.2 6.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.189 -1.368 . . . . 0.0 112.178 -175.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.67 -28.09 70.94 Favored Glycine 0 CA--C 1.505 -0.576 0 CA-C-N 114.842 -1.072 . . . . 0.0 113.348 -171.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.1 p -68.04 -20.04 64.95 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.963 0.411 . . . . 0.0 111.003 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -97.98 -9.18 26.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.937 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.684 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -60.57 -22.94 64.22 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.904 -176.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.22 -21.86 65.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.934 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.84 -4.43 63.47 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.626 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.684 ' HG ' ' O ' ' A' ' 97' ' ' ALA . 4.5 pp -101.3 -23.12 14.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.386 0.593 . . . . 0.0 110.584 178.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -106.36 -58.44 0.61 Allowed Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 48.5 t 57.78 91.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.763 -0.719 . . . . 0.0 111.831 176.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.55 -66.27 3.45 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.006 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.2 p -70.94 110.4 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-O 121.735 0.779 . . . . 0.0 109.515 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' A' ' 53' ' ' GLU . . . 82.84 -78.8 1.97 Allowed Glycine 0 C--N 1.311 -0.823 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.863 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.6 t -76.5 132.41 39.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.021 0.438 . . . . 0.0 110.403 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.434 ' CD2' ' N ' ' A' ' 107' ' ' HIS . 1.2 p80 . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.486 -0.769 . . . . 0.0 110.108 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 121.037 0.446 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 0.3 OUTLIER -84.21 77.97 9.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.276 0.56 . . . . 0.0 109.499 177.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.49 -174.77 0.17 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.601 -171.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.4 ' H ' ' HA ' ' A' ' 27' ' ' VAL . 38.7 t70 59.69 41.58 18.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 122.287 1.041 . . . . 0.0 109.38 -176.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -90.28 91.22 3.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.929 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 121.42 -167.24 14.25 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.091 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.505 ' HA2' ' NH1' ' A' ' 26' ' ' ARG . . . -141.06 37.21 1.67 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.3 mp -87.54 114.45 26.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.036 0.446 . . . . 0.0 110.44 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -98.72 132.46 44.08 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.098 174.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.617 HG21 HD22 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -118.19 138.76 47.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.496 0.665 . . . . 0.0 110.707 -178.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -104.54 133.94 48.57 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.715 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -125.7 124.85 67.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.746 0.784 . . . . 0.0 111.044 -173.053 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 p -112.13 155.3 24.13 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.119 -174.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.685 ' SD ' ' HA ' ' A' ' 92' ' ' MET . 31.8 tpp -110.78 135.31 51.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.659 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.48 137.98 40.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.435 177.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.75 -33.17 5.15 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.035 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.91 141.63 39.15 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 120.619 0.247 . . . . 0.0 111.085 173.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.92 126.71 8.14 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.707 2.272 . . . . 0.0 112.661 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -151.99 166.68 30.79 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.483 ' C ' ' HD2' ' A' ' 21' ' ' ARG . 78.2 mt -125.14 103.86 8.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.05 0.452 . . . . 0.0 110.255 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.483 ' HD2' ' C ' ' A' ' 20' ' ' LEU . 3.6 mpt_? -127.2 134.15 50.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.735 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.478 ' HD2' ' C ' ' A' ' 21' ' ' ARG . 2.4 mptp? -144.1 141.42 30.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 172.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -144.11 174.48 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.135 0.493 . . . . 0.0 112.044 -175.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.497 ' HB3' ' HE ' ' A' ' 26' ' ' ARG . 1.1 m-20 -109.71 126.76 54.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.65 -175.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.617 HD22 HG21 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -69.4 -36.62 76.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.925 0.869 . . . . 0.0 110.117 -175.196 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.505 ' NH1' ' HA2' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -79.54 -19.22 50.04 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.932 -1.031 . . . . 0.0 113.294 -168.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 24' ' ' ASP . 34.0 m -80.63 -3.96 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -170.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.494 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 25.8 m-85 -85.06 -30.12 24.35 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.22 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.7 14.15 6.93 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.788 -0.642 . . . . 0.0 114.354 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.29 165.78 24.24 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.735 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.572 ' CE1' ' HA2' ' A' ' 75' ' ' GLY . 15.2 m-85 -60.91 -36.12 78.46 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.7 p -62.54 -54.36 40.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.682 0.277 . . . . 0.0 110.961 -175.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -67.67 -27.33 66.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.076 -178.706 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 74' ' ' VAL . 8.6 tp -62.47 -56.75 15.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.285 174.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.453 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 81.5 mt -67.63 -39.87 84.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.63 -176.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -71.2 -32.54 68.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.271 -175.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.708 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -59.9 -39.79 86.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.778 0.323 . . . . 0.0 110.7 177.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.5 HD13 ' HG3' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -68.87 -50.48 49.41 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.307 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 35' ' ' LEU . 35.3 mt-10 -52.27 -28.86 20.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.58 173.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.571 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 17.5 m -74.06 -41.02 62.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.258 175.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.708 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 71.9 mmm -54.85 -55.98 24.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.023 -172.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.519 ' HZ ' HG21 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -102.0 9.69 40.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 -177.173 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.17 44.21 19.37 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.95 174.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 pp -144.51 -171.8 3.67 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 m -113.72 121.14 43.18 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.876 0.369 . . . . 0.0 111.31 -175.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.435 ' CD1' ' HB2' ' A' ' 60' ' ' TYR . 40.8 mm -84.57 -22.77 7.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 122.335 1.064 . . . . 0.0 109.738 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.03 -164.58 31.2 Favored Glycine 0 C--N 1.31 -0.889 0 CA-C-N 114.071 -1.422 . . . . 0.0 112.574 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -92.02 162.4 14.39 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.464 ' CD1' HD22 ' A' ' 73' ' ' LEU . 60.4 t80 -80.43 75.72 7.27 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 171.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 m -49.05 128.97 17.14 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.804 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -68.06 -17.82 64.5 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.049 -173.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.519 ' HD2' ' N ' ' A' ' 53' ' ' GLU . 3.0 ppt_? -74.58 -51.95 13.14 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.519 ' N ' ' HD2' ' A' ' 52' ' ' ARG . 50.9 mt-10 -122.57 -29.95 3.98 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 119.934 -0.707 . . . . 0.0 112.728 176.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.693 ' O ' HD13 ' A' ' 73' ' ' LEU . . . 48.97 12.9 0.26 Allowed Glycine 0 C--O 1.218 -0.855 0 N-CA-C 115.288 0.875 . . . . 0.0 115.288 -175.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.572 ' CE2' ' HB3' ' A' ' 106' ' ' SER . 11.6 m-85 -124.8 10.04 8.29 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.535 1.167 . . . . 0.0 110.608 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.475 ' HB2' ' NZ ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -61.38 -51.37 69.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.428 -179.024 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.16 3.04 4.53 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 115.079 0.792 . . . . 0.0 115.079 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.2 t 67.86 -86.99 0.03 OUTLIER 'General case' 0 C--O 1.234 0.238 0 CA-C-N 117.357 0.579 . . . . 0.0 110.037 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -117.65 -6.84 11.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.741 0.305 . . . . 0.0 110.501 175.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.435 ' HB2' ' CD1' ' A' ' 46' ' ' ILE . 70.3 m-85 -143.17 124.49 14.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.611 0.243 . . . . 0.0 111.354 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.411 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . . . -104.2 105.06 47.46 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.653 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 42.8 Cg_endo -68.98 120.93 7.78 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.992 1.795 . . . . 0.0 111.009 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 72' ' ' MET . 77.0 p -129.92 165.67 21.61 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.478 -175.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.759 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.4 p90 -136.51 164.66 27.66 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -178.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.479 ' CG ' ' HA2' ' A' ' 69' ' ' GLY . 33.3 tt0 -104.53 121.63 43.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.711 0.291 . . . . 0.0 110.361 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 25.5 t70 -84.51 -170.87 3.32 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.519 175.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.463 ' H ' ' CG ' ' A' ' 66' ' ' ASP . 13.3 mmtm -65.46 -34.41 78.22 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.643 0.735 . . . . 0.0 109.349 -175.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -72.26 -18.52 61.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.083 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.479 ' HA2' ' CG ' ' A' ' 65' ' ' GLU . . . 92.58 11.98 58.75 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.639 -175.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -86.95 144.11 27.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.646 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 64.0 m95 -112.11 115.67 29.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.048 0.451 . . . . 0.0 110.983 -176.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.416 ' O ' ' HA ' ' A' ' 63' ' ' THR . 49.8 mtm -121.54 161.09 22.96 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.693 HD13 ' O ' ' A' ' 54' ' ' GLY . 9.5 tt -71.05 141.42 50.89 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 17.2 m -66.87 129.57 31.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.655 0.741 . . . . 0.0 112.166 -174.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.572 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 111.3 6.93 25.21 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.513 -174.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -71.57 -56.91 4.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.513 0.197 . . . . 0.0 111.302 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.583 HG22 ' CD2' ' A' ' 82' ' ' PHE . 12.6 m -98.34 155.11 37.25 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.484 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 5.1 Cg_endo -46.94 131.89 17.14 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.668 2.912 . . . . 0.0 113.667 -176.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.491 ' O ' HG23 ' A' ' 83' ' ' VAL . 72.9 t-105 -43.16 -54.28 4.55 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.68 -172.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -51.41 -42.04 61.17 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.587 0.554 . . . . 0.0 111.542 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 57.4 ttp -83.37 -31.86 26.51 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.807 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.583 ' CD2' HG22 ' A' ' 77' ' ' VAL . 6.3 t80 -58.23 -46.66 85.5 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.68 -174.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 79' ' ' TRP . 2.8 t -60.54 -48.18 89.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.342 -170.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.8 p -78.87 -14.37 59.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.55 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.6 t -85.97 -25.18 26.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.12 -175.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.759 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 40.4 t -79.22 131.15 36.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.751 0.31 . . . . 0.0 110.922 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 13.5 ptmm? -116.03 -23.94 8.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.694 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.426 ' HD3' ' OE1' ' A' ' 65' ' ' GLU . 62.1 mtp180 -140.81 154.67 46.33 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 176.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.715 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 9.6 tp -127.51 133.37 49.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.114 -176.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.451 ' HD2' ' SD ' ' A' ' 92' ' ' MET . 2.6 ttm180 -139.47 117.78 12.01 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.289 -0.565 . . . . 0.0 111.096 174.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.519 HG21 ' HZ ' ' A' ' 42' ' ' PHE . 4.1 mt -116.1 133.55 62.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 170.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.685 ' HA ' ' SD ' ' A' ' 14' ' ' MET . 14.6 ptt? -158.13 161.13 37.9 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.212 0.53 . . . . 0.0 112.122 -170.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -53.94 141.81 26.58 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.727 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.4 -27.29 57.96 Favored Glycine 0 CA--C 1.505 -0.582 0 CA-C-N 114.437 -1.256 . . . . 0.0 113.092 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 59.1 p -60.21 -25.96 66.01 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.469 0.652 . . . . 0.0 110.779 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -101.11 -49.41 4.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.8 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.437 ' HA ' ' HE3' ' A' ' 92' ' ' MET . . . -63.87 -21.15 66.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.635 -175.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.489 ' HA ' ' HB3' ' A' ' 102' ' ' CYS . 14.7 ptmm? -53.63 -32.41 51.25 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.55 -38.43 90.49 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.727 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.82 5.53 28.61 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -175.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.35 -77.25 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 119.572 -1.299 . . . . 0.0 114.135 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.489 ' HB3' ' HA ' ' A' ' 98' ' ' LYS . 44.3 t -57.71 97.46 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.798 0.808 . . . . 0.0 111.669 -172.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 106.17 60.57 0.61 Allowed Glycine 0 N--CA 1.435 -1.409 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.492 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.9 m 32.7 61.27 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.186 0.995 . . . . 0.0 112.528 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -111.21 -6.23 25.98 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.205 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.572 ' HB3' ' CE2' ' A' ' 55' ' ' TYR . 16.7 t -94.76 -168.42 1.82 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 . . . . . 0 C--O 1.246 0.89 0 CA-C-O 118.419 -0.8 . . . . 0.0 110.235 -177.771 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.988 0.423 . . . . 0.0 110.65 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -98.52 97.89 9.14 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.644 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 61.61 77.62 0.32 Allowed 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.889 0.743 . . . . 0.0 110.217 -175.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.56 121.66 11.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.774 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 p -76.87 105.37 5.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.941 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.427 ' HA2' ' CG ' ' A' ' 24' ' ' ASP . . . 91.48 155.39 31.68 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.367 -174.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 169.25 -27.8 0.13 Allowed Glycine 0 N--CA 1.442 -0.923 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.424 HG22 HD12 ' A' ' 25' ' ' LEU . 4.1 mp -117.37 105.51 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 174.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -97.76 142.51 29.44 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.068 -170.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.59 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -118.49 145.21 24.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.085 179.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.529 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 48.9 mttm -102.07 128.35 48.56 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -125.2 126.5 70.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.874 0.845 . . . . 0.0 111.377 -176.486 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.6 m -117.28 151.05 37.76 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.81 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.568 ' SD ' ' HB ' ' A' ' 91' ' ' ILE . 69.2 mmm -101.31 160.48 14.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.757 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -134.41 146.5 49.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.352 -0.386 . . . . 0.0 109.988 175.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.78 -34.62 3.84 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -174.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.62 138.38 28.19 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 169.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -76.72 125.5 8.22 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.419 2.079 . . . . 0.0 112.735 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.474 ' HB2' ' CG ' ' A' ' 14' ' ' MET . 93.2 m-85 -152.17 165.5 34.61 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.709 174.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.34 105.88 5.57 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 177.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.54 ' HB2' HG22 ' A' ' 12' ' ' VAL . 10.8 mmm180 -125.86 155.51 41.06 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.691 -176.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.529 ' HD3' ' HA ' ' A' ' 11' ' ' LYS . 5.5 mmtm -148.08 140.55 24.43 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 174.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 pt -145.66 173.49 3.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.09 0.471 . . . . 0.0 111.397 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.49 ' O ' HG22 ' A' ' 27' ' ' VAL . 9.9 t70 -115.83 140.85 48.82 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.399 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.51 HD13 ' SG ' ' A' ' 86' ' ' CYS . 15.6 mt -73.61 -47.71 38.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.166 -173.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.409 ' HE ' ' C ' ' A' ' 6' ' ' GLY . 31.1 ptt180 -82.33 -11.56 58.52 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -169.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 24' ' ' ASP . 35.8 m -63.94 -17.87 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 120.867 0.365 . . . . 0.0 111.283 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -84.02 -28.1 27.9 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.085 0.469 . . . . 0.0 110.893 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.77 15.92 36.28 Favored Glycine 0 CA--C 1.519 0.302 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.384 175.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.05 175.68 31.29 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.777 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -69.5 -30.56 68.46 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -176.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.8 p -60.08 -54.93 40.17 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.553 -174.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -71.5 -28.43 63.9 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.508 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.416 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 20.8 tp -58.13 -55.66 32.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.185 0.516 . . . . 0.0 109.844 174.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.478 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 63.0 mt -67.58 -37.05 82.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.333 -177.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -70.72 -32.19 69.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.241 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.709 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -62.24 -42.46 99.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.761 176.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.495 HD13 ' HG3' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -61.89 -50.37 72.48 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.752 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 45.5 mt-10 -51.76 -30.66 23.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.828 173.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.555 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 26.5 m -76.2 -43.03 44.24 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.65 178.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.709 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 63.9 mmm -54.79 -57.87 9.83 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -168.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.671 ' CZ ' HG21 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -107.14 10.31 30.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.223 -177.168 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.8 mptt 62.51 42.55 8.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.101 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.752 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 1.2 pp -149.45 168.82 22.39 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 175.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.0 m -93.81 104.18 16.27 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -165.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.434 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 3.9 mm -97.64 148.97 5.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 170.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.52 -168.88 38.35 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.302 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 45.37 83.02 0.03 OUTLIER 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.1 0.96 . . . . 0.0 113.526 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.441 ' CE2' ' HB2' ' A' ' 73' ' ' LEU . 30.2 t80 -66.4 86.4 0.11 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 167.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 t -65.61 151.18 47.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.388 0.613 . . . . 0.0 110.837 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -73.3 -16.13 61.38 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.021 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.592 ' HD3' ' HG3' ' A' ' 53' ' ' GLU . 1.2 tmt_? -80.42 -54.73 5.43 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.592 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 33.1 mt-10 -121.53 -29.11 4.47 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.338 171.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 43.01 10.99 0.01 OUTLIER Glycine 0 C--O 1.218 -0.9 0 CA-C-N 114.213 -1.358 . . . . 0.0 116.325 -175.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.513 ' CE1' ' HB3' ' A' ' 72' ' ' MET . 19.4 m-85 -128.64 16.69 6.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 119.222 1.511 . . . . 0.0 111.529 178.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.447 ' HE3' ' N ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -70.57 -37.14 73.95 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.979 -172.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.447 ' N ' ' HE3' ' A' ' 56' ' ' LYS . . . 58.35 19.32 39.69 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.806 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.3 t 63.77 -82.9 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -169.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.605 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 40.0 tt0 -119.28 -20.16 8.03 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.611 173.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.447 ' CE1' ' HG3' ' A' ' 93' ' ' LYS . 37.3 m-85 -131.89 125.98 33.05 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.993 0.425 . . . . 0.0 111.395 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -105.85 105.28 52.67 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.129 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.495 ' HG3' HD13 ' A' ' 38' ' ' LEU . 28.4 Cg_endo -72.24 120.33 6.71 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 121.443 1.428 . . . . 0.0 111.166 173.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 72' ' ' MET . 61.0 p -124.64 150.85 45.6 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.228 -176.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 5.2 p90 -117.74 161.85 19.03 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.503 ' HB2' ' CZ2' ' A' ' 71' ' ' TRP . 42.0 tt0 -100.37 118.82 37.4 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 173.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.21 -178.31 6.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.965 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 mtmm -51.37 -42.9 61.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.789 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -86.38 -15.93 38.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.949 0.404 . . . . 0.0 111.018 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.02 29.37 8.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.799 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -94.56 148.25 22.45 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 172.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.546 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 65.9 m95 -115.86 114.37 24.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.958 0.409 . . . . 0.0 110.576 -178.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.513 ' HB3' ' CE1' ' A' ' 55' ' ' TYR . 17.4 mtm -135.86 177.89 7.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.483 ' HG ' ' HA ' ' A' ' 55' ' ' TYR . 6.0 mt -62.34 151.4 36.81 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.642 0.734 . . . . 0.0 110.532 177.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.9 m -78.03 135.09 26.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.47 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.4 8.03 50.54 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.4 -173.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.92 -53.26 49.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.687 0.28 . . . . 0.0 111.255 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.525 HG22 ' CD2' ' A' ' 82' ' ' PHE . 12.9 m -103.63 157.51 33.73 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.489 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 6.4 Cg_endo -48.74 127.04 15.72 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.333 2.689 . . . . 0.0 113.226 -178.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.61 ' O ' HG23 ' A' ' 83' ' ' VAL . 70.6 t-105 -40.85 -46.09 2.65 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 113.848 -1.524 . . . . 0.0 113.811 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.2 -42.95 82.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.713 0.292 . . . . 0.0 111.272 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.2 tmm? -83.88 -27.33 28.72 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.525 ' CD2' HG22 ' A' ' 77' ' ' VAL . 9.2 t80 -60.01 -50.98 71.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.649 -174.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 79' ' ' TRP . 3.8 t -59.75 -36.77 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.129 0.49 . . . . 0.0 111.371 -170.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.2 p -79.1 -11.33 59.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.502 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.6 t -101.5 -19.96 15.3 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.795 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.51 ' SG ' HD13 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -86.1 117.48 24.97 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.302 0.572 . . . . 0.0 110.513 179.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 9.6 ptmm? -118.06 -25.52 6.67 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.572 -174.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -139.78 158.41 44.14 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.63 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 6.6 tp -134.31 131.02 37.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.237 0.541 . . . . 0.0 110.741 -175.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -138.36 123.98 19.69 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.993 0.425 . . . . 0.0 110.654 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.671 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 10.6 mt -114.08 136.61 50.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -158.45 160.79 37.17 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.722 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 52.6 mttt -52.72 149.41 6.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.703 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -61.81 -25.93 66.37 Favored Glycine 0 CA--C 1.504 -0.612 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.731 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.44 HG22 ' HB3' ' A' ' 93' ' ' LYS . 9.9 t -75.16 -13.36 60.45 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.172 0.51 . . . . 0.0 110.715 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -101.52 -46.74 4.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.99 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.73 -23.87 63.47 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -57.15 -38.11 73.04 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.681 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.82 -37.05 93.68 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.229 -0.51 . . . . 0.0 113.458 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.426 ' H ' HD23 ' A' ' 100' ' ' LEU . 1.1 pt? -104.55 11.94 33.72 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -175.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -71.83 65.79 1.14 Allowed Glycine 0 CA--C 1.509 -0.332 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.122 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 61.5 m -90.91 25.96 2.25 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.037 0.446 . . . . 0.0 111.563 -176.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.499 ' HA3' ' OH ' ' A' ' 55' ' ' TYR . . . -95.39 -73.81 1.2 Allowed Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.054 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.5 m -101.24 19.14 3.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.254 0.549 . . . . 0.0 111.12 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.96 80.33 0.48 Allowed Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.125 -0.943 . . . . 0.0 114.154 174.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.1 t -89.95 104.42 16.99 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.439 -0.447 . . . . 0.0 109.9 173.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 . . . . . 0 C--O 1.245 0.858 0 CA-C-O 118.569 -0.729 . . . . 0.0 110.264 179.604 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 . . . . . 0 N--CA 1.484 1.237 0 CA-C-O 120.882 0.372 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -103.26 99.87 9.74 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.057 0.456 . . . . 0.0 110.523 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -113.43 -2.5 13.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.199 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -93.91 141.95 27.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.904 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.9 t 61.79 86.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 121.501 0.667 . . . . 0.0 109.316 -172.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.405 ' HA2' ' OD1' ' A' ' 24' ' ' ASP . . . 104.96 143.69 12.24 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -172.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.436 ' H ' ' H ' ' A' ' 8' ' ' ILE . . . 178.17 -11.51 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.467 HD13 ' HD3' ' A' ' 26' ' ' ARG . 2.0 mp -112.25 104.17 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -92.71 129.08 38.75 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.05 -174.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.594 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -114.33 142.31 27.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.465 -175.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.694 ' HA ' ' HD2' ' A' ' 22' ' ' LYS . 47.6 mtmt -98.22 127.89 44.4 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.736 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -124.54 126.87 72.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.369 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.4 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 20.5 m -112.93 141.48 46.72 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.852 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.46 ' HG3' ' CD2' ' A' ' 19' ' ' TYR . 73.2 mmm -97.75 122.69 41.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.041 0.448 . . . . 0.0 110.807 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.99 130.99 51.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.389 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.32 -33.45 6.52 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.882 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.19 141.31 33.84 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.48 125.11 7.43 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.356 2.037 . . . . 0.0 113.171 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.46 ' CD2' ' HG3' ' A' ' 14' ' ' MET . 97.8 m-85 -152.65 169.48 22.61 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.495 ' C ' ' HD2' ' A' ' 21' ' ' ARG . 56.0 mt -137.75 102.05 4.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.047 0.451 . . . . 0.0 110.195 169.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.495 ' HD2' ' C ' ' A' ' 20' ' ' LEU . 3.6 mpt_? -129.56 138.67 51.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.285 174.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.694 ' HD2' ' HA ' ' A' ' 11' ' ' LYS . 35.3 mmtm -132.46 142.75 49.38 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 169.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 pt -143.33 174.01 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -172.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.444 ' OD1' HG13 ' A' ' 27' ' ' VAL . 3.8 t70 -115.37 143.97 44.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.754 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.455 HD21 ' SG ' ' A' ' 86' ' ' CYS . 40.7 mt -71.62 -44.0 65.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.287 0.565 . . . . 0.0 111.576 -175.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.556 ' HG2' HG11 ' A' ' 83' ' ' VAL . 40.6 mtm180 -80.16 -22.97 41.42 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -165.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.444 HG13 ' OD1' ' A' ' 24' ' ' ASP . 28.1 m -61.11 -12.97 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -92.47 -28.5 16.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.191 0.52 . . . . 0.0 111.079 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.7 14.77 23.63 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.26 -0.882 . . . . 0.0 113.889 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.35 174.35 34.03 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.379 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -69.36 -33.4 73.02 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.9 m -57.96 -53.75 54.7 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.297 -175.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -74.49 -27.17 60.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.286 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.7 tp -60.13 -55.28 35.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.176 0.512 . . . . 0.0 110.483 175.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.509 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 77.5 mt -66.2 -35.13 79.64 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.549 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -68.45 -33.41 74.14 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.464 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.706 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -64.94 -38.5 91.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.152 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.596 HD13 ' HG3' ' A' ' 62' ' ' PRO . 0.5 OUTLIER -61.82 -49.91 74.41 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.043 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.711 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 41.1 mt-10 -53.25 -29.12 31.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.922 173.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.551 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 33.7 m -76.29 -42.62 44.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.475 176.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.706 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 44.2 mmm -55.0 -57.02 13.38 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.141 -169.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.616 ' HZ ' HG21 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -109.7 7.36 24.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.081 179.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 0.0 OUTLIER 61.19 40.84 14.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.963 174.26 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.711 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 2.2 pp -141.34 162.41 35.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.125 176.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.3 m -85.39 103.4 14.26 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -166.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.464 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 12.1 mm -89.22 151.09 3.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 168.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -115.91 -162.03 13.06 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 121.359 -0.448 . . . . 0.0 112.76 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -89.56 171.84 9.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.764 0.792 . . . . 0.0 112.233 -174.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.481 ' CE2' ' HB2' ' A' ' 73' ' ' LEU . 41.4 t80 -72.62 81.3 1.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.292 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 54' ' ' GLY . 14.0 m -57.79 107.82 0.5 Allowed 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.356 175.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -55.74 -26.66 46.63 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -166.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.614 ' HD2' ' N ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -58.2 -49.28 77.62 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -176.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.614 ' N ' ' HD2' ' A' ' 52' ' ' ARG . 48.6 mt-10 -119.51 -26.98 5.64 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.702 0.763 . . . . 0.0 110.252 172.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 50' ' ' SER . . . 54.28 10.04 1.76 Allowed Glycine 0 C--O 1.213 -1.164 0 CA-C-N 113.913 -1.494 . . . . 0.0 115.695 177.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.598 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 19.0 m-85 -127.7 14.96 7.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 119.25 1.525 . . . . 0.0 112.355 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.721 ' HD3' ' N ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -74.66 -45.47 44.37 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.457 171.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.721 ' N ' ' HD3' ' A' ' 56' ' ' LYS . . . 58.38 -27.79 0.02 OUTLIER Glycine 0 CA--C 1.529 0.916 0 CA-C-N 115.246 -0.888 . . . . 0.0 114.485 -172.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.584 ' H ' ' C ' ' A' ' 56' ' ' LYS . 26.8 t 150.09 -138.75 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -175.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.594 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 31.2 tt0 -83.83 -5.48 59.21 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 166.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.445 ' HB2' ' CD1' ' A' ' 46' ' ' ILE . 32.1 m-85 -133.96 130.51 37.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.233 173.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.734 ' HB1' HD21 ' A' ' 73' ' ' LEU . . . -115.51 105.59 51.83 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.28 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.596 ' HG3' HD13 ' A' ' 38' ' ' LEU . 32.7 Cg_endo -69.7 120.39 7.19 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 121.952 1.768 . . . . 0.0 112.08 174.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 72' ' ' MET . 38.3 p -123.73 159.51 29.28 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.436 -176.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 5.0 p90 -135.24 166.25 23.55 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.05 -177.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.55 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 44.1 tt0 -111.58 124.8 53.04 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.565 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.468 ' OD2' ' HG2' ' A' ' 67' ' ' LYS . 23.2 t70 -88.81 -179.81 6.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.968 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.468 ' HG2' ' OD2' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -63.91 -28.58 69.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.508 0.671 . . . . 0.0 110.229 179.26 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -68.11 -18.57 64.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.412 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.57 11.57 71.17 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -95.3 149.56 21.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.149 -0.525 . . . . 0.0 110.111 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.559 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 36.0 m95 -119.82 132.79 55.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.028 -176.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.426 ' HE2' ' CE1' ' A' ' 64' ' ' TYR . 2.0 mpp? -143.11 -179.73 6.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 171.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.734 HD21 ' HB1' ' A' ' 61' ' ' ALA . 4.8 mt -63.06 154.14 31.77 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.893 0.854 . . . . 0.0 110.996 175.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.554 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 57.9 t -78.69 122.2 33.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.866 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.06 -1.18 28.45 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -171.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.34 -46.58 79.88 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.994 0.426 . . . . 0.0 110.313 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.419 HG22 ' CD2' ' A' ' 82' ' ' PHE . 16.0 m -108.62 154.94 41.35 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 173.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 10.9 Cg_endo -54.59 136.57 70.94 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.88 2.387 . . . . 0.0 113.098 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.516 ' O ' HG23 ' A' ' 83' ' ' VAL . 65.1 t-105 -40.64 -48.39 2.91 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 124.096 0.872 . . . . 0.0 112.978 -173.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -53.52 -42.22 67.18 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.782 -177.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 77.2 mtp -82.67 -23.08 34.37 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.262 0.553 . . . . 0.0 110.374 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.554 ' CZ ' ' HA ' ' A' ' 74' ' ' VAL . 7.4 t80 -70.51 -46.49 63.56 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.02 -171.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.556 HG11 ' HG2' ' A' ' 26' ' ' ARG . 3.4 t -61.32 -38.57 80.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.193 0.52 . . . . 0.0 111.478 -171.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.9 p -78.76 -12.52 60.03 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.029 -175.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.2 p -106.52 -31.43 8.52 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 34.0 t -71.92 116.27 12.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.268 0.556 . . . . 0.0 110.978 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -119.38 -19.43 8.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.063 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.55 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 55.9 mtt180 -139.34 156.63 46.89 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 174.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.736 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 5.7 tp -136.12 134.44 38.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.992 0.425 . . . . 0.0 111.247 -173.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 13' ' ' SER . 24.0 ttp180 -140.51 123.58 16.6 Favored 'General case' 0 C--N 1.318 -0.778 0 O-C-N 122.011 -0.431 . . . . 0.0 111.227 168.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.616 HG21 ' HZ ' ' A' ' 42' ' ' PHE . 4.4 mt -106.43 136.03 42.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 168.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -159.0 163.34 36.52 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.15 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 34.0 mtpt -48.55 140.71 7.76 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 124.25 0.969 . . . . 0.0 112.756 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -58.86 -36.33 86.78 Favored Glycine 0 CA--C 1.505 -0.547 0 CA-C-N 113.689 -1.596 . . . . 0.0 113.713 -168.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.44 ' HA ' ' HD3' ' A' ' 98' ' ' LYS . 38.9 p -60.55 -19.86 58.59 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.072 0.463 . . . . 0.0 111.807 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -97.5 -43.56 7.2 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.723 -174.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.59 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -71.16 -29.42 65.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.483 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 95' ' ' THR . 15.1 ptmm? -69.72 -6.86 34.7 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.597 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.96 -7.18 50.9 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.413 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 97' ' ' ALA . 4.0 pp -103.4 -8.23 20.37 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 122.496 -0.414 . . . . 0.0 110.929 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -28.21 95.24 0.01 OUTLIER Glycine 0 C--N 1.336 0.554 0 O-C-N 124.826 1.329 . . . . 0.0 115.25 -171.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 5.4 p 42.02 55.05 3.93 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.7 0.8 . . . . 0.0 112.344 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.62 49.37 2.17 Favored Glycine 0 N--CA 1.436 -1.31 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.079 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.7 t 51.89 55.53 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.671 -0.764 . . . . 0.0 111.272 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -162.71 68.87 0.22 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.482 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.2 t -83.43 58.63 4.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.994 0.426 . . . . 0.0 110.586 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 . . . . . 0 C--O 1.245 0.863 0 CA-C-O 118.463 -0.779 . . . . 0.0 110.293 179.007 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 36.5 tt0 -97.23 69.43 2.29 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 2' ' ' GLU . . . 77.92 142.99 0.08 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.034 -165.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -68.53 130.39 42.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -172.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 6' ' ' GLY . 21.9 t 67.61 167.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.695 177.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.531 ' HA3' ' HE ' ' A' ' 26' ' ' ARG . . . -170.92 175.76 44.53 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.406 177.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -139.24 26.9 2.67 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.453 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.6 mt -70.12 111.88 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.757 0.313 . . . . 0.0 110.243 175.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -89.59 139.24 30.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.69 -176.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.599 ' CG1' ' HB2' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -118.55 148.31 21.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 176.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.573 ' HA ' ' HD2' ' A' ' 22' ' ' LYS . 56.3 mtmt -107.29 130.25 54.79 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.715 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -126.4 129.41 71.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.971 -176.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.4 m -109.51 146.64 34.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.639 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.555 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 23.1 tpp -97.53 125.2 42.09 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.854 175.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.5 140.65 37.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.913 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.1 -33.66 4.79 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.683 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.555 ' O ' ' HG3' ' A' ' 14' ' ' MET . . . -134.75 140.2 34.61 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 120.661 0.267 . . . . 0.0 110.556 171.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.49 125.08 7.41 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.428 2.085 . . . . 0.0 112.759 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -153.19 168.17 26.85 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 123.048 0.539 . . . . 0.0 109.944 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.42 98.69 4.15 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.67 ' O ' ' HD3' ' A' ' 22' ' ' LYS . 1.6 ptp180 -134.33 123.0 23.45 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.391 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.67 ' HD3' ' O ' ' A' ' 21' ' ' ARG . 60.7 mmtt -120.43 157.19 29.86 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 117.973 0.351 . . . . 0.0 110.602 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -144.99 172.57 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 120.868 0.366 . . . . 0.0 111.849 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.601 ' O ' HG22 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -112.96 130.66 56.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.225 0.536 . . . . 0.0 110.225 -173.029 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.54 HD21 ' HB2' ' A' ' 86' ' ' CYS . 16.5 tp -70.11 -45.5 66.79 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -169.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.531 ' HE ' ' HA3' ' A' ' 6' ' ' GLY . 17.4 mtp180 -79.41 -10.86 59.89 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -173.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.601 HG22 ' O ' ' A' ' 24' ' ' ASP . 20.8 m -84.27 -0.55 5.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.521 -0.471 . . . . 0.0 112.246 -173.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.63 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 23.3 m-85 -84.12 -31.09 25.43 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.583 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 44.75 48.21 9.11 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.745 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.89 172.99 13.81 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.135 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -70.07 -29.85 66.95 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -176.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.5 m -59.36 -53.73 54.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.749 0.309 . . . . 0.0 111.37 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.63 ' HB2' ' O ' ' A' ' 28' ' ' TYR . 49.2 mm-40 -73.67 -29.74 62.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.521 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.4 tp -55.22 -56.64 17.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.103 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.401 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 53.6 mt -68.94 -38.74 79.66 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.592 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -67.8 -33.09 74.14 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.276 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.674 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -61.4 -41.47 97.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.54 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.506 ' H ' ' HG ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -65.58 -46.51 79.15 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.132 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 43.6 mt-10 -51.29 -32.71 25.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.441 174.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.539 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 50.2 m -73.79 -41.83 61.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.154 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.674 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 55.9 mmm -56.71 -56.66 18.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.635 -169.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.644 ' HZ ' HG21 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -103.0 9.12 38.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.083 -176.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.9 mttt 62.04 40.93 11.61 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.618 174.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 3.0 pp -145.01 174.14 11.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.157 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.1 m -102.99 100.78 10.74 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -171.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.495 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 31.5 mm -69.82 139.48 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 168.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.36 -162.3 34.11 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.293 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.58 167.3 12.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.025 0.44 . . . . 0.0 110.839 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.765 ' CE1' HD12 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -63.89 93.03 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.362 172.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.416 ' HB2' ' HA2' ' A' ' 54' ' ' GLY . 1.5 m -61.85 134.06 56.23 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.7 -23.96 60.94 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -168.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.667 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -82.15 -51.5 7.91 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.104 -0.638 . . . . 0.0 112.412 -174.019 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.667 ' N ' ' HD3' ' A' ' 52' ' ' ARG . 60.8 mt-10 -121.3 -31.22 4.13 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 118.956 0.798 . . . . 0.0 110.712 168.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.716 ' O ' HD11 ' A' ' 73' ' ' LEU . . . 38.08 7.78 0.0 OUTLIER Glycine 0 C--O 1.221 -0.701 0 CA-C-N 113.535 -1.666 . . . . 0.0 116.269 -168.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.5 ' CE1' ' HG ' ' A' ' 73' ' ' LEU . 3.8 m-30 -96.24 3.6 52.99 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 118.507 1.154 . . . . 0.0 110.753 -171.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.616 ' C ' ' H ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -69.51 -36.17 76.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.923 168.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.499 ' H ' ' HD3' ' A' ' 56' ' ' LYS . . . 59.52 -24.11 0.03 OUTLIER Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.321 -0.854 . . . . 0.0 114.399 -174.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.616 ' H ' ' C ' ' A' ' 56' ' ' LYS . 44.4 t 146.91 -89.75 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 -176.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -118.44 -3.15 10.96 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 161.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.476 ' O ' ' HA3' ' A' ' 57' ' ' GLY . 46.9 m-85 -137.47 130.05 29.86 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.748 -175.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 55' ' ' TYR . . . -101.67 104.46 34.89 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.129 176.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.566 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 60.3 Cg_endo -73.06 121.5 7.32 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.093 1.862 . . . . 0.0 111.496 172.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.6 p -132.52 164.17 27.21 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.03 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 5.0 p90 -141.61 165.68 26.82 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.532 ' OE1' ' HD2' ' A' ' 88' ' ' ARG . 30.7 tt0 -104.98 122.81 46.62 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.734 175.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.08 179.51 7.25 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.378 0.424 . . . . 0.0 110.781 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.0 mtmm -48.61 -46.95 40.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.044 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -86.6 -10.91 52.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.978 0.418 . . . . 0.0 111.382 -174.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.11 29.5 8.45 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.644 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -93.1 148.84 21.67 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 171.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.494 ' CZ2' ' HB2' ' A' ' 65' ' ' GLU . 66.2 m95 -119.16 113.85 21.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.806 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -130.23 -179.65 5.37 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 171.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.765 HD12 ' CE1' ' A' ' 49' ' ' TYR . 76.7 mt -65.62 156.27 33.3 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.344 0.592 . . . . 0.0 111.089 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 62' ' ' PRO . 30.2 m -75.87 128.98 37.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.494 176.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.46 8.21 56.36 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.412 -173.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.67 -61.22 2.57 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.596 0.236 . . . . 0.0 111.454 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.446 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 16.1 m -98.87 161.85 23.53 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.402 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.446 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 85.4 Cg_exo -46.25 131.96 14.94 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.189 2.593 . . . . 0.0 113.217 177.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.582 ' O ' HG23 ' A' ' 83' ' ' VAL . 66.9 t-105 -47.59 -42.19 23.38 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.816 -173.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -59.11 -42.45 90.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.946 0.403 . . . . 0.0 111.335 -176.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 73.7 mtm -82.39 -21.89 35.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.202 0.525 . . . . 0.0 109.982 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.449 ' HZ ' ' HA ' ' A' ' 74' ' ' VAL . 6.7 t80 -65.7 -55.34 17.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.348 -175.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 79' ' ' TRP . 3.0 t -61.1 -38.14 78.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.153 -171.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.7 p -76.21 -10.2 59.22 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.733 -175.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.5 m -102.7 -19.15 14.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.313 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.54 ' HB2' HD21 ' A' ' 25' ' ' LEU . 74.0 m -76.18 112.8 13.02 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.249 0.547 . . . . 0.0 111.823 -175.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -118.08 -26.59 6.34 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.022 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.532 ' HD2' ' OE1' ' A' ' 65' ' ' GLU . 71.9 mtt180 -139.73 154.86 47.55 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.715 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 8.5 tp -131.67 138.35 48.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.489 -175.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.462 ' HD3' ' SD ' ' A' ' 92' ' ' MET . 10.8 ttm180 -141.11 121.45 13.97 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.243 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.644 HG21 ' HZ ' ' A' ' 42' ' ' PHE . 4.0 mt -120.2 134.26 64.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 168.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.462 ' SD ' ' HD3' ' A' ' 90' ' ' ARG . 23.5 ptt? -158.96 164.31 35.71 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 123.319 0.387 . . . . 0.0 111.863 -172.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -47.11 129.46 12.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.991 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -65.51 -31.56 80.58 Favored Glycine 0 CA--C 1.506 -0.469 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.795 -172.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.8 p -66.98 -23.27 65.92 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.165 -0.518 . . . . 0.0 111.633 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -100.03 -18.23 17.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.813 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.582 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -71.18 -22.22 62.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.47 0.652 . . . . 0.0 110.303 176.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -57.33 -26.07 60.35 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.504 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -66.85 -33.76 85.08 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.86 -176.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 97' ' ' ALA . 3.6 pp -78.92 -21.94 46.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.624 0.712 . . . . 0.0 111.868 -175.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.447 ' N ' HD12 ' A' ' 100' ' ' LEU . . . 29.72 64.69 0.14 Allowed Glycine 0 N--CA 1.468 0.796 0 O-C-N 124.363 1.04 . . . . 0.0 114.372 177.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.469 ' SG ' HD13 ' A' ' 100' ' ' LEU . 70.9 m -95.07 101.56 13.32 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.319 0.581 . . . . 0.0 111.598 -175.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.74 -117.2 10.41 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.672 175.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.0 t -82.07 74.53 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.424 0.63 . . . . 0.0 109.537 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 53' ' ' GLU . . . -137.15 -142.9 4.48 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 177.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 t -75.02 110.26 9.17 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 24.0 m170 . . . . . 0 C--O 1.249 1.073 0 O-C-N 123.899 0.749 . . . . 0.0 110.618 -174.923 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.821 0.343 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -94.97 69.43 3.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.731 0.777 . . . . 0.0 110.045 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -153.39 111.16 3.56 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.936 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -85.65 148.71 25.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.414 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.5 m -104.0 39.68 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.776 -175.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.41 102.18 1.07 Allowed Glycine 0 CA--C 1.504 -0.637 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.112 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.29 -7.83 63.37 Favored Glycine 0 C--N 1.308 -0.991 0 CA-C-N 114.658 -0.771 . . . . 0.0 111.804 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.481 HD13 ' HD2' ' A' ' 26' ' ' ARG . 2.7 mp -82.23 110.05 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.049 0.452 . . . . 0.0 110.151 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -111.14 116.31 30.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.564 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.566 ' CG2' ' HB2' ' A' ' 89' ' ' LEU . 2.9 m -116.37 151.95 18.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 17.0 ptpt -94.86 133.02 39.04 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.131 -176.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.699 ' HB ' ' HB3' ' A' ' 89' ' ' LEU . 1.5 p -148.39 122.45 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 O-C-N 124.037 0.836 . . . . 0.0 110.844 173.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.528 ' HB2' ' N ' ' A' ' 21' ' ' ARG . 7.5 t -160.03 112.41 2.06 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.482 163.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.773 ' HE2' ' O ' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -168.02 141.54 3.3 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 118.282 -1.367 . . . . 0.0 113.888 175.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.431 ' HB2' ' OH ' ' A' ' 60' ' ' TYR . 4.2 p-10 -140.58 76.75 1.57 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.341 0.591 . . . . 0.0 111.619 162.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.522 ' H ' ' CE ' ' A' ' 14' ' ' MET . . . 88.81 -30.71 5.28 Favored Glycine 0 C--O 1.229 -0.174 0 C-N-CA 121.371 -0.442 . . . . 0.0 112.115 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.549 ' O ' ' HG2' ' A' ' 14' ' ' MET . . . -121.21 150.29 53.53 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 177.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.73 129.75 15.99 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.439 2.093 . . . . 0.0 113.736 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' A' ' 13' ' ' SER . 49.5 m-85 -134.67 172.71 12.56 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.9 mt -136.26 104.14 5.54 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.212 0.529 . . . . 0.0 112.425 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.533 ' HE ' ' HA ' ' A' ' 21' ' ' ARG . 0.2 OUTLIER -129.91 173.21 10.9 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 167.319 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 11' ' ' LYS . 0.7 OUTLIER -137.85 148.93 45.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 118.979 0.809 . . . . 0.0 111.418 175.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.498 HD11 ' CD2' ' A' ' 89' ' ' LEU . 8.8 pt -129.41 175.09 11.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.861 170.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.504 ' O ' HG22 ' A' ' 27' ' ' VAL . 0.6 OUTLIER -109.53 124.64 51.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -176.421 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.538 HD23 HG13 ' A' ' 83' ' ' VAL . 3.2 tp -72.18 -44.85 62.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.073 -167.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.49 ' HG2' HG11 ' A' ' 83' ' ' VAL . 47.2 mtp180 -79.4 -22.63 44.05 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -172.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 24' ' ' ASP . 20.7 m -65.49 -11.23 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.834 0.349 . . . . 0.0 111.719 -172.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.402 ' CD2' HD12 ' A' ' 34' ' ' LEU . 23.5 m-85 -84.48 -27.26 27.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.006 0.431 . . . . 0.0 110.564 178.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.26 14.73 20.18 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 114.95 -1.023 . . . . 0.0 113.78 173.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.36 169.82 30.47 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 -176.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -70.49 -32.66 70.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -175.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.0 m -59.27 -53.86 53.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.661 0.267 . . . . 0.0 111.226 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -73.42 -30.1 63.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.726 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.461 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 9.8 tp -59.6 -55.53 33.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.38 177.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.615 ' HA ' ' CD1' ' A' ' 38' ' ' LEU . 54.1 mt -66.37 -35.99 81.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.137 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -64.39 -33.8 76.7 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.275 -177.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.588 ' O ' ' HG2' ' A' ' 41' ' ' MET . . . -72.43 -32.56 66.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.955 0.407 . . . . 0.0 111.036 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.615 ' CD1' ' HA ' ' A' ' 35' ' ' LEU . 2.2 mt -66.9 -51.65 52.77 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.52 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -52.39 -32.43 38.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.884 173.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.574 ' HB ' ' O ' ' A' ' 37' ' ' ALA . 20.5 m -71.37 -34.22 70.25 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.619 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.588 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 73.2 mmm -64.59 -56.71 12.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.783 0.325 . . . . 0.0 111.852 -170.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.41 12.93 25.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.09 0.472 . . . . 0.0 112.119 -177.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.406 ' HD3' ' O ' ' A' ' 40' ' ' THR . 22.8 mmtm 62.17 53.68 2.85 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.278 170.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 pp -150.28 -172.66 4.23 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.325 -0.235 . . . . 0.0 110.774 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.0 m -100.08 128.04 46.22 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -174.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.584 HG13 ' HB2' ' A' ' 38' ' ' LEU . 41.5 mm -105.16 133.39 49.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.007 174.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.537 ' HA3' ' OG ' ' A' ' 58' ' ' SER . . . -92.09 140.18 15.03 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.228 -0.987 . . . . 0.0 111.235 171.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.17 -179.42 1.95 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.46 0.647 . . . . 0.0 111.896 -173.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -73.56 82.05 1.5 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.661 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 54' ' ' GLY . 3.2 m -64.64 115.8 5.58 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.338 173.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.11 -18.6 37.05 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -169.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.611 ' HD3' ' HG3' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -69.42 -49.27 56.76 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -177.264 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.611 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 44.1 mt-10 -120.11 -27.54 5.29 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.678 0.751 . . . . 0.0 111.238 174.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.476 ' O ' HD22 ' A' ' 73' ' ' LEU . . . 46.29 8.27 0.02 OUTLIER Glycine 0 C--O 1.219 -0.813 0 CA-C-N 113.787 -1.551 . . . . 0.0 116.8 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.493 ' HA ' HD13 ' A' ' 73' ' ' LEU . 12.9 m-85 -127.81 9.24 6.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 119.286 1.543 . . . . 0.0 111.223 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.744 ' HE3' ' N ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -74.42 -24.56 59.11 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.996 -171.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.744 ' N ' ' HE3' ' A' ' 56' ' ' LYS . . . 59.88 -8.07 0.06 OUTLIER Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.283 -0.871 . . . . 0.0 114.551 -175.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.537 ' OG ' ' HA3' ' A' ' 47' ' ' GLY . 16.1 m 69.13 -72.44 0.1 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -171.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 93' ' ' LYS . 33.2 tt0 -119.9 -27.87 5.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.096 166.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.45 ' HB2' HD13 ' A' ' 46' ' ' ILE . 11.1 m-85 -134.86 124.98 25.89 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 120.906 0.384 . . . . 0.0 111.001 176.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.443 ' HB1' ' CD1' ' A' ' 73' ' ' LEU . . . -102.46 105.93 46.34 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.202 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.554 ' O ' ' HA ' ' A' ' 73' ' ' LEU . 38.1 Cg_endo -69.69 119.69 6.6 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.936 1.757 . . . . 0.0 111.335 174.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 72' ' ' MET . 43.4 p -126.07 162.12 26.05 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.175 0.512 . . . . 0.0 110.767 -176.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.635 ' O ' ' HA ' ' A' ' 71' ' ' TRP . 3.5 p90 -132.84 165.18 25.19 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.307 -177.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.418 ' HB2' ' CZ2' ' A' ' 71' ' ' TRP . 30.9 tt0 -108.42 115.77 30.72 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.46 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.559 ' OD2' ' HG2' ' A' ' 67' ' ' LYS . 17.7 t70 -80.53 -176.8 5.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.819 176.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.559 ' HG2' ' OD2' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -62.83 -39.37 94.12 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -171.33 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.442 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . 20.6 t70 -83.0 -0.98 51.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.18 0.514 . . . . 0.0 110.602 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.41 24.39 28.84 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.177 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.442 ' OD2' ' HB3' ' A' ' 68' ' ' ASP . 20.1 m-20 -81.52 129.0 34.5 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.635 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 71.7 m95 -110.3 113.79 26.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.019 0.438 . . . . 0.0 110.813 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.431 ' O ' ' HA ' ' A' ' 63' ' ' THR . 25.6 mtm -134.81 176.48 8.61 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.554 ' HA ' ' O ' ' A' ' 62' ' ' PRO . 1.2 tp -68.66 154.89 41.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.498 0.665 . . . . 0.0 111.04 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.604 ' HA ' ' CZ ' ' A' ' 82' ' ' PHE . 3.7 m -77.83 124.38 36.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.136 175.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.94 3.5 28.17 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -172.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.13 -56.65 15.02 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.037 0.446 . . . . 0.0 109.93 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.533 HG22 ' CD2' ' A' ' 82' ' ' PHE . 6.3 m -100.98 154.68 37.0 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 173.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.431 ' HD2' ' HB ' ' A' ' 77' ' ' VAL . 11.0 Cg_endo -54.45 136.86 71.15 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.879 2.386 . . . . 0.0 113.075 -176.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.515 ' O ' HG23 ' A' ' 83' ' ' VAL . 69.9 t-105 -40.09 -53.03 2.48 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -174.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -51.58 -43.02 62.31 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.046 0.45 . . . . 0.0 111.674 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 77.7 mtp -83.91 -24.54 30.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.468 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' A' ' 74' ' ' VAL . 13.4 t80 -68.81 -38.21 79.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.676 -173.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.538 HG13 HD23 ' A' ' 25' ' ' LEU . 3.3 t -61.17 -42.86 94.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.897 0.38 . . . . 0.0 111.407 -172.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.5 p -78.52 -13.94 59.59 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.465 0.65 . . . . 0.0 110.588 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.1 t -81.42 -31.41 33.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.651 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.448 ' HA ' ' HD2' ' A' ' 64' ' ' TYR . 43.5 t -86.52 131.67 34.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.736 0.779 . . . . 0.0 112.202 -175.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -119.37 -36.74 3.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.263 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -139.14 153.15 47.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.931 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.699 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 12.4 tp -130.5 127.39 39.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.234 0.54 . . . . 0.0 111.716 -174.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.433 ' HB3' ' CZ3' ' A' ' 71' ' ' TRP . 37.5 ttp180 -140.33 130.0 24.32 Favored 'General case' 0 C--N 1.31 -1.137 0 O-C-N 121.374 -0.829 . . . . 0.0 110.929 171.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.773 ' O ' ' HE2' ' A' ' 14' ' ' MET . 8.8 mt -109.41 132.15 58.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.636 ' HE3' HD21 ' A' ' 100' ' ' LEU . 3.1 ptt? -139.09 141.23 38.16 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -168.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 0.1 OUTLIER -48.38 141.03 7.05 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.229 174.187 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.13 -28.5 49.5 Favored Glycine 0 CA--C 1.508 -0.405 0 CA-C-N 115.398 -0.819 . . . . 0.0 114.146 -169.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.2 t -66.38 -12.79 58.84 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.134 0.493 . . . . 0.0 111.301 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -101.76 -51.53 3.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.614 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.55 -23.81 66.27 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -172.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -57.03 -28.65 62.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.177 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.33 -37.01 22.37 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.638 -176.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.636 HD21 ' HE3' ' A' ' 92' ' ' MET . 2.2 pt? -105.2 14.44 29.06 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -173.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.78 68.15 0.3 Allowed Glycine 0 CA--C 1.521 0.415 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.597 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 6.9 p -83.51 93.16 7.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.703 0.763 . . . . 0.0 111.091 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -179.52 -66.29 0.07 OUTLIER Glycine 0 N--CA 1.428 -1.854 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.785 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.2 t -113.62 11.33 8.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.63 0.728 . . . . 0.0 110.487 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 58.76 65.39 3.52 Favored Glycine 0 N--CA 1.453 -0.171 0 CA-C-N 114.821 -1.081 . . . . 0.0 112.823 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.457 ' CB ' ' HB2' ' A' ' 55' ' ' TYR . 8.5 t -73.81 127.96 34.24 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -177.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.9 m170 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.55 -0.738 . . . . 0.0 110.237 -178.345 . . . . . . . . 0 0 . 1 stop_ save_